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ABSTRACT 
 
Our developments toward the total synthesis of the original and revised structures 
of palau’amine are presented in this study.  This includes the construction of the fully 
functionalized cyclopentane cores of both the original and revised structures via the 
application of a Diels-Alder/[3,3]-sigmatropic rearrangement of tricyclodecadienes.  A 
cyclization strategy for the formation of the strained trans-fused azabicyclo[3.3.0]octane 
bicyclic system of the core of the revised structure of palau’amine was also developed 
within the context the natural product analogs dimethylcyclopentaphakellin and 10,6-
epidimethylcyclopentaphakellin utilizing an intramolecular azide [3+2]-dipolar 
cylcoaddition.  Also of note is the development of new methods for the preparation of the 
polycyclic pyrazinones.  Application of this cyclization strategy has allowed for synthesis 
of the advanced intermediates possessing the fully functionalized skeleton of the revised 
structure of palau’amine encompassing the A, E, and D rings. 
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CHAPTER 1. INTRODUCTION 
 
1.1 Pyrrole-Imidazole Alkaloids 
Marine sponges have been and continue to be a rich source of structurally diverse 
natural products.  Over the past thirty-five years, isolation of pyrrole-imidazole alkaloids 
has led to the discovery of a class of compounds with an unprecedented skeletal diversity 
(Figure 1.1) and a broad range of biological activities.1  This family of alkaloids ranges 
from the structurally complex (e.g., hexacyclic palau’amine (1b)), to the relatively simple 
(i.e., oroidin (2)).  The entire family of more than 100 natural products is thought to be 
derived from this rather inconspicuous parent molecule, 2, one of the first members 
isolated in 1971.2  The more elaborate members of this family of natural products arise 
from various modes of functionalization, cyclization, and dimerization of 2.  Monomeric  
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Figure 1.1. Structures of various pyrrole-imidazole alkaloids. 
 2 
cyclized derivatives of 2 include agelastatin A (3) and dibromophakellin (4).  
Alternatively, dimerization can, in the simpler cases, lead to formation of one new bond  
(e. g., leading to nagelamide A (5)),3 or two new bonds (e.g., sceptrin (6) and ageliferin 
(7)).  However, the dimeric structures of palau’amine (1b), axinellamine A (8), and 
massadine chloride4 (9) result from the formation of multiple new bonds of these 
polycyclic structures with an impressive array of functionality.  Overall, six modes of 
monomeric cyclization (cyclooroidin, hymenialdisine, phakellin, isophakellin, 
agelaspongin, and agelastatin) and seven modes of dimerization (mauritiamine, 
nagelamide, sceptrin, ageliferin, axinellamine, massadine, and konbu’acidin) of the 
oroidin motif have been observed in natural products.5  Of the pyrrole-imidazole 
alkaloids, palau’amine has received the most attention and is the focus of the work 
reported in this dissertation. 
 
1.2 Isolation and Structural Revision of Palau’amine and Other Congeners 
(-)-Palau’amine was first isolated from the sponge Stylotella aurantium by Scheuer 
and coworkers in the Western Caroline Islands in 1993.6  At the time, the unique 
hexacyclic structure was unequal in complexity to any other pyrrole-imidazole alkaloid 
isolated and was originally proposed as structure 1a (Figure 1.2) based on extensive 
spectroscopic investigations and the similarity to known dibromophakellin7 (4), which 
contains four rings common to 1a.  Palau’amine possesses an intricate molecular 
architecture on a nitrogen-rich hexacyclic skeleton including two guanidine rings and 
eight contiguous stereogenic centers.  Further complexity results from the chlorine 
containing central cyclopentane (Ring E), which on structure 1a, possesses an all-cis 
substitution pattern, leading to a cis-fused [3.3.0]-azabicyclic ring system.  The absolute 
stereochemistry is not known, but can possibly be inferred from circular dichroism 
studies of partial structures.8   
Other congeners were soon discovered: including brominated derivatives 10 and 
11;9 structurally isomeric styloguanidines 12, 13, and 14;10 as well as the N19 acylated 
analog konbu’acidin A (15, Figure 1.2).11  All of these structures were originally assigned 
to possess the same cyclopentane core, based on comparisons to palau’amine (1a).  In 
1998, the axinellamines (8, 16, 17, and 18) were first isolated.12  These molecules 
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possessed a similar carbon skeleton to that of palau’amine, but incorporated a distinct 
cyclization pattern.  More importantly, the central cyclopentane ring (Ring E) was 
diastereomeric at the C12-ring fusion and C17-chloro stereogenic centers relative to 1a.  
This raised questions about how a divergent biosynthetic pathway would lead to these 
two similar, but stereochemically different, classes of molecules.  Regardless, the 
structure of 1a was universally accepted for well over a decade, and was only called into 
question after three separate reports in 2007 on two new palau’amine congeners: 
tetrabromostyloguanidine (19)13,14 and konbu’acidin B (20).15  In these studies, the 
structures were verified by modern NMR techniques, in which all three reports inverted 
the relative stereochemistry of the C17-chloro and C12-ring fusion stereogenic centers of 
the cyclopentane core, which leads to a rare trans-fused [3.3.0]-azabicyclic ring system.  
The structural identities of these two new compounds, in conjunction with extensive 
calculations and even biosynthetic considerations, has led a revision for all of the 
palau’amine congeners (1b, 10-15);16 however, this revision is yet to be conclusively 
confirmed by crystallographic analysis or independent synthesis. 
 
N
NN
NH
Cl
H
HHN N
NH2
HO
O
HN
NH2 R
1
Br
O
H
NBr
Br
konbu'acidin A (15) (R1 = H)
konbu'acidin B (20) (R1 = Br)
12
17
N
NN
NH
Cl
H
HHN N
NH2
HO
O
H2N
NH2
Cl H
N
N NH
H
N NH
OH
H
H
HN
HN
R4O HN
Br
Br
OHN
O
H
NBr
Br
H
N
NN
NH
Cl
H
HHN N
NH2
HO
O
H2N
NH2
N
NH
N
NH
Cl
H
HHN N
NH2
HO
O
R3HN
NH2
palau'amine (1b) (R1 = R2 = H)
bromopalau'amine (10) (R1 = H, R2 = Br)
dibromopalau'amine (11) (R1 = R2 = Br)
R1
R2
R2
R1
styloguanidine (12) (R1 = R2 = R3 = H)
bromostyloguanidine (13) (R1 =R3 = H, R2 = Br)
dibromostyloguanidine (14) (R1 = R2 = Br, R3 = H)
tetrabromostyloguanidine (19) (R1 = R2 = Br,
R3 = 4,5-dibromopyrrolo-2-carboxamide)
palau'amine (1a)
12
17
12
17
axinellamine A (8) ( -H6, -OH10, R4 = H)
axinellamine B (16) ( -H6, -OH10, R4 = H)
axinellamine C (17) ( -H6, -OH10, R4 = Me)
axinellamine D (18) ( -H6, -OH10, R4 = Me)
12
17
12
17
10
6
revised proposed structureoriginally proposed structure
N
NN
NH
O
NH2
dibromophakellin (4)
Br
Br
A
B
C
D
F
E
A
B
C
D
DE
E
19
6
10
E
E
A A
 
Figure 1.2.  Structures of palau’amine and related congeners. 
 
 4 
The differences between the original (1a) and revised (1b) proposed structures of 
palau’amine are best observed in their 3-dimensional representations (Figure 1.3), in 
which the cis and trans-fusion for the [3.3.0]-azabicyclic ring systems can clearly be 
seen.  Perhaps one reason why the original assignment persisted so long is the intuitive 
image of a cis-fused 5,5-bicycle as being thermodynamically more stable.  Indeed, 
calculations have shown that the cis-fused system of 1a is energetically favored by 
approximately 6.5 kcal/mol over the trans-fused system of 1b.  At the time of the 
isolation of palau’amine, no other dimeric pyrrole-imidazole alkaloids were known, and 
it seems likely that the assignment of the ring fusion of 1a was made based on these 
thermodynamic considerations.  However, this assignment was made with the knowledge 
of some discrepancies in the NMR data.  First, no NOE interaction was observed for H11 
and H12, where one would predict 1a to possess a significant correlation; however, no  
 
 
Figure 1.3.  Comparison of the original and revised structures of palau’amine. 
 
definitive conclusions can be drawn from the absence of an NOE.  Second, the coupling 
constant between H11 and H12 for palau’amine is 14.1 Hz, which is an exceptionally 
large value for a vicinal coupling constant.  In fact, the Karplus equation17 predicts a 
maximum coupling constant value of 13.1 Hz between two vicinal protons with a 
dihedral angle of 180° and only 11.7 Hz for a dihedral angle of 0°.  While the 
experimentally observed value is higher than both of these values, it would seem to be 
more in line with a dihedral angle of 180°, which is present only in the revised structure 
1b.  Following the controversy concerning the structural revision of palau’amine based 
on the spectroscopic evidence of only congeners of palau’amine, Quinn and coworkers18 
isolated a fresh sample of palau’amine and came to the conclusion that the revised 
structure was indeed the correct one based on the NOE correlations indicated 
 5 
(Figure 1.3).  The authors note in reference to the original isolation and structural 
elucidation paper6 that, “Taking a look at the ROESY spectrum for palau’amine, included 
in the Supplementary data, suggested it may have been hard to interpret with some 
difficulty in distinguishing between noise and real correlations.”  The story that has 
evolved concerning the structure of palau’amine highlights the adventure of natural 
product isolation and the role that modern analytical techniques can play.  The advent of 
powerful computational techniques in recent years complements NMR spectroscopy in 
the ability to unambiguously assign structures of compounds that otherwise fail to be 
elucidated by crystallographic analysis. 
 
 
Figure 1.4.  Structures of selected monomeric tetracyclic pyrrole-imidazole alkaloids. 
 
Embedded within the dimeric pyrrole-imidazole structure of palau’amine (1b) 
(Figure 1.4) exists the monomeric pyrrole-imidazole phakellin subunit comprising the A, 
B, C, and D rings.   The monomeric pyrrole–imidazole members (-)-dibromophakellin (4) 
and (-)-monobromophakellin (21) were isolated in 1969 from the marine sponge 
Phakellia flabellata.7,19  Subsequently, enantiomeric (+)-dibromophakellin (ent-4) was 
isolated from Pseudoaxinyssa cantharella in 1985.20  Neither (-)- nor (+)-phakellin (22) 
has been isolated from natural sources, but can be obtained by hydrogenolysis of 
dibromophakellin (4).19b  Other related monomeric alkaloids21 have been isolated 
including the isophakellins22 (23 and 24), which differ in the connectivity of the pyrrole, 
and phakellstatins23 (25 and 26), which differ by bearing a cyclic urea rather than a cyclic 
guanidine group.  
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1.3 Biological Activity of Palau’amine and its Congeners 
Palau’amine (1) displays a broad range of biological activities.6,9 In addition to 
moderate antibiotic and antifungal activity, it has potent antitumor and 
immunosuppressive activities.  Specifically, 1 is active against P-388 leukemia and A- 49 
lung adenocarcinoma cell lines, with respective IC50 values of 0.1 and 0.2 µg/mL. 
Additionally, the IC50 value of 1 against the mixed lymphocyte reaction is 18 ng/mL, 
comparable to the immunosuppressant activity of both cyclosporine A and FK-506.  This 
activity translates into the ability to block stimulated T-cell proliferation in vitro, and yet 
remain relatively innocuous toward resting lymphocytes. 
The related congeners of palau’amine possess varied biological activities.  Non-
brominated styloguanidine (12) has been shown to be a powerful chitinase inhibitor, 
whereas, in stark contrast, brominated palau’amine analogs 10 and 11 as well as 
brominated styloguanidines 13, 14, and 19 show no comparable activity.  Konbu’acidin 
A (15) exhibits nonspecific bioactivity against P2X7, a ligand-gated cation-channel 
receptor implicated in the treatment of the inflammatory diseases,15a while konbu’acidin 
B (20) inhibits the chemotaxis of neutrophils with an IC50 value of 5 µM.  Axinellamines 
A (8) has been shown to possess bactericidal activity against Helicobacter pylori, a 
bacterium implicated in pepticular and gastric cancer.12a  Finally, oroidin (2), which is the 
dominant pyrrole-imidazole constituent of the sponge sources, has been shown be a 
feeding deterrent against coral reef fish.24 
Dibromophakellin (4) exhibits moderate cell growth inhibitory activity against a 
variety of human cancer cell lines, but is dwarfed in comparison to its urea derivative, 
dibromophakellstatin (26), which is 100 fold more potent (ED50 0.28-3.9 µM).23a  In 
2006, Harran investigated the biological activity of non-brominated phakellin (22), on the 
premise that non-brominated palau’amine was far more biologically active than its 
brominated analogs; however it was found to be devoid of activity against a panel of 
gram negative and gram positive bacteria.25 
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1.4 Biosynthetic Origins of Pyrrole-Imidazole Alkaloids 
The similarities of the pyrrole-imidazole alkaloids and their often simultaneous 
occurrence from natural resources is indicative of a common biosynthetic pathway.  Now 
that palau’amine (1b) is recognized to possess a cyclopentane core with the same 
stereochemical configuration as the other congeners, a universal biosynthetic pathway 
towards the dimeric alkaloids has been adopted.16,26  The first half of the proposal 
contends that the hypothesized intermediate 30 (Scheme 1.1), dubbed “pre-axinellamine”, 
is assembled from the dimerization and functionalization of two oroidin (2) molecules.  
There are three proposed biosynthetic pathways for the construction of 30, the two of 
which that have been realized experimentally are depicted in Schemes 1.1 and 1.2.  In the 
first proposal (linear), two oroidin-like molecules (2) (Scheme 1.1) undergo head-to-head 
dimerization to generate the C18,C12 C-C bond within intermediate 27.  Hydration of the 
imine at C20 within 27 leads to hemi-aminal 28.  Electrophilic chlorination at C17 then 
leads to cyclopentane construction by generation of the C16,C11 C-C bond within 29, 
followed by C6 oxidation to afford “pre-axinellamine” (30). 
 
Scheme 1.1 
 
 
The second proposal (ring contraction) to access “pre-axinellamine” (30) bears its 
conceptual roots in the earlier hypothesis9 for the formation of the original structure of 
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palau’amine (Scheme 1.2).  Although structure 31 was not used as a precursor by Scheuer 
and co-workers (presumably because of the C11,C12 cis-relationship of the originally 
proposed structure of palau’amine (1a)), the essence of the hypothesis remains valid.  
Thus, dimerization of two oroidin molecules in a formal [4+2] fashion provides 
ageliferin-like tautomer 31.  “Pre-axinellamine” (30) is then generated by reaction with 
an electrophilic chlorine source at C17, ring contraction via C11 bond migration from 
C20 to C16, and hydration of the C20 position in addition to oxidation at aminoimidazole 
ring. 
 
Scheme 1.2 
 
 
“Pre-axinellamine” is hypothesized to exist in a non-hydrated 30 and C10-hydrated 
32 form (Scheme 1.3), from which, one of four biosynthetic pathways may occur.  
Pathways A and B leading from non-hydrated form 30 describe closures of the N14 atom 
onto the electrophilic aminoimidazole ring at C10, followed by attack of the pyrrole at C6 
to generate a total of two new bonds.  Path A, involving attack of the pyrrole N1, would 
furnish the phakellin framework to directly access the konbu’acidins (15 and 20) in 
addition to the palau’amines (1b, 10, and 11) after C19 amide hydrolysis.  Alternatively, 
path B, involving attack of the pyrrole C3, would assemble the isophakellin framework 
found in the styloguanidines (12-14, and 19).  Cyclizations occurring from hydrated from 
32 involve the addition of a nucleophilic functionality from the F ring onto C6 for the 
formation of only one new bond.  In path C, closure of the C16-spiro N-functionality onto 
C6 leads to axinellamines (8, 16-18).  Alternatively, path D involves closure of the  
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C20-O-functionality onto C6 to generate massadine chloride (9). 
 
Scheme 1.3 
 
 
Although the validity of these biosynthetic postulates might be suspect without 
biochemical evidence, such suppositions often lead to innovative synthetic approaches.  
Indeed, several portions of this universal biosynthetic hypothesis have been observed 
experimentally on synthetic intermediates, vide infra. 
 
1.5 Synthetic Efforts Toward the Pyrrole-Imidazole Alkaloids 
Polyhetereocyclic nitrogen-rich alkaloids probably rank among the most 
challenging synthetic targets in organic synthesis.  In this regard the pyrrole-imidazole 
alkaloids do not disappoint.  Due to their interesting biological activities, scarce natural 
sources, and complex molecular architectures, the pyrrole-imidazole alkaloids have 
received much synthetic attention.1,5,16,27  While the synthesis of the simpler members of 
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this family was first accomplished in 1982,28 the total synthesis of the first complex 
dimeric structures has only recently been realized. 
 
1.5.1 Selected Approaches Toward the Original Structure of Palau’amine 
Due to its unique cis-fused hexacyclic bisguanidine structure, the original structure 
of palau’amine (1a) had received considerable synthetic attention, prior to its structural 
revision.  Despite several synthetic efforts, no complete total synthesis of 1a has been 
reported to date.29,30,31,32,33,34,35,36  Herein, selected efforts are depicted that accessed 
significant portions of structure 1a. 
 
1.5.1.1 Gleason Strategy 
In 2008, Gleason and co-workers29a reported the synthesis of 39 (Scheme 1.4), the 
fully functionalized cyclopentane core of the original structure of palau’amine (1a).  The 
key step involved the [4+2] cycloaddition of β-chloromethyleneoxazolone 33 with 
substituted cyclopentadiene 34 to generate a 1:1 mixture of cycloadducts 35 and 36.  
Subjection of the cycloadducts to enol ether oxidation followed by methanolysis of the  
 
Scheme 1.4 
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oxazolone afforded separable hydroxyl ketones 37 and 38 in a combined 52% yield over 
three steps.  Subsequent oxidative cleavage with lead tetraacetate afforded cyclopentane 
39 in 51% yield, which maps directly onto the cyclopentane core of 1a.  Significant 
optimization29b of coupling partners was conducted in order to achieve a high yielding 
exo-selective cycloaddition applicable to a synthesis of 1a.  Another innovation was the 
use 5-substituted siloxymethylene cyclopentadienes as the diene component of the 
cycloaddition, which exhibited stability to [1,5]-sigmatropic shifts at room temperature. 
 
1.5.1.2 Overman Strategy 
In 2008, Overman and co-workers30a accessed 46 (Scheme 1.5), the most advanced 
synthetic intermediate en route to the originally proposed structure of palau’amine (1a).  
Key to the synthesis of cis-fused palau’amine scaffold 46 was a distinctive bicyclization 
to afford tetracycle 43 in 70% yield from dihydropyrrole 41.  The elegant transformation 
begins with condensation of α-ketoester 41 with thiosemicarbazide to generate 
azomethine imine 42.  After [3+2] cycloaddition, the thiourea moiety condenses with the 
methyl ester to form tetracyclic thiohydantoin, in which three contiguous stereocenters on 
the cis-fused azabicyclo[3.3.0]octane are generated with the formation of three new 
bonds.   Thiohydantoin 43 was advanced to 2-(trimethylsilyl)ethoxycarbonyl-(Teoc)-
protected isothiourea 44 by cleavage of the N-N bond tether and selective manipulation of 
the heterocycles.  Formation of the dihydropyrazinone (B ring) of 45 was then initiated 
by Teoc deprotection of 44 with tetrabutylammonium fluoride (TBAF), which resulted in 
concomitant loss of acetate to generate the putative C6 imine.  Cyclization from the 
pendant pyrrole nitrogen then generated hexacyclic isothiourea 45 in 95% yield.  
Functional group interconversions allowed for isolation of 46 in six steps as a mixture of 
C20-hemiaminal stereoisomers.  All that are lacking from structure 46 when compared to 
1a are the C17-chloro and the C18-aminomethylene substituents.  Nonetheless, The 
NMR spectroscopic data for 46 and its synthetic intermediates were found to differ 
significantly from the reported data for palau’amine.  The authors note that the data 
provides additional strong evidence in favor of the proposed structural revision which 
possesses the trans-stereochemical configuration of the central azabicyclo[3.3.0]octane 
ring system.  Nevertheless, the synthesis is characterized by an elegant steady buildup of 
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the complex functionality, and should be instructional for the future total synthesis efforts 
toward targets 1a or 1b.  
 
Scheme 1.5 
 
 
1.5.2 Selected Approaches Toward the Cyclopentane Core Common to the Revised 
Structure of Palau’amine 
Since the structural revision of palau’amine a frenzy of activity has occurred in 
attempts to access portions of this new target,33,37,38,39,40 but no total synthesis has been 
published to date.  However, other related natural products equal in complexity that share 
the substitution pattern of the cyclopentane ring have been accessed and are also 
discussed in this section.   
 
1.5.2.1 Carreira Strategy 
In 2000, Carreira and co-workers37 reported the synthesis of the 55 (Scheme 1.6), 
the first reported synthesis of the cyclopentane core common to the revised structure of 
palau’amine (1b) and the axinellamines (8, 16-18).  The enantioselective synthesis began 
with the [4+2] cycloaddition of spiro 5-cyclopropylcyclopentadiene 47 and  
N- henylmaleimide (48) to afford cycloadduct imide 49 in 74% yield after recycling of 
material, which was converted to cyclic anhydride 50 in six steps.  Desymmetrization of 
meso-50 was achieved with quinine by using the method of Bolm et al.,41 followed by 
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epimerization of the more acidic ester α-CH group allowed access to enantioenriched 
carboxylic acid 51 in 74% yield over two steps.  The three N-moieties of 52 were then 
installed over nine steps, at which point oxidative cleavage by ozonolysis followed by 
reductive workup (triphenylphosphine) afforded thermodynamically favored C11,C17 
trans-dialdehyde 53 in 86% yield.  Selective manipulation of the aldehydes yielded 
carboxylic acid 54 in two steps, which was converted to chloride 55 in 76% yield after 
oxidative radical decarboxylation.  Chloride 55 was accessed via this stereoselective 
route in at total of 23 linear steps.  In addition Carreira and co-workers have recently 
published a synthetic route to the cyclopentane core of massadine in 24 linear steps,42 
which bears significant resemblance to this earlier work. 
 
Scheme 1.6 
 
 
1.5.2.2 Harran Strategy 
In 2009, Harran and co-workers33 accessed 61 (Scheme 1.7), via a biomimetically 
derived strategy similar to the linear biosynthetic hypothesis invoked in Scheme 1.1.  
Accordingly, dimerization of the potassium enolate of enamide 57 afforded γ,γ-dimer  
C2-symmetric product 58 in a 3:1 ratio with the corresponding meso isomer in a 
combined 62% yield.  Both isomers contain the entire carbon and heterocyclic framework 
corresponding to konbu’acidin, axinellamine and massadine classes of dimeric pyrrole-
imidazole alkaloids.  Elaboration of 58 to bisalkylidene 59 in two steps allowed for 
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application of the key the oxidative cyclization.  Subjection of 59 to t-butyl hypochlorite 
effected formation of the C17-chloro bond and C11,C16 C-C bond of intermediate 60, 
which after an elimination generated cyclopentane 61 in 20-32% yield.  Unfortunately, 
assignment of the alkylidene geometry and the relative configuration of C16-stereogenic 
center has not yet been accomplished, making assignment of product 61 as a 
functionalized cyclopentane core of the revised structure of palau’amine or a synthetic 
intermediate related to “pre-axinellamine” 61 tenuous.  In addition, the unusual  
1,3-benzodiazepine guanidine protecting group introduced to facilitate the oxidative 
cyclization is not amenable to removal.  Regardless, the synthetic route generates an 
impressive amount of molecular complexity in short order by exploring a nature-derived 
symmetry-based synthetic strategy.  
 
Scheme 1.7 
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1.5.2.3 Romo Strategy 
In 2008, Romo and co-workers38a,b accessed 69 (Scheme 1.8), the only synthetic structure 
published to date that possesses the sought-after trans-fused [3.3.0]-azabicyclic ring 
system of the revised structure of palau’amine 1b.  The approach was designed after the 
ring-contraction proposed biosynthetic pathway (Scheme 1.2).  The first key step 
involves the Diels-Alder [4+2] cycloaddition between enantiopure lactam 63, derived 
from pyroglutamic acid, and vinyl imidazolone 62 to generate tricyclic cycloadduct 64 in 
48% yield as part of a 1:1 mixture of constitutional isomers.  Conversion into vinyl 
hemiaminal over three steps allowed for application of the key oxidative ring contraction.  
Exposure of 65 to chloramine-T constructed 66, the C12 epimer of the cyclopentane core 
of the revised structure of palau’amine (1b), in a stereoselective manner.  This step not 
only generated the desired five-membered ring, but also set the stereochemical 
configuration of the C17- and C16- stereogenic centers.  A multistep sequence then lead  
to the conversion of the C11,C12 cis-fused [3.3.0]-azabicyclic ring system into the  
 
Scheme 1.8 
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desired trans-fused system 69.  This process began with selective silyl deprotection of 66 
 followed by simultaneous ring cleavage/C12-epimerization under conditions of 
methanolysis to afford ester 67 in 60% yield over two steps.  Three step conversion of 
ester 67 into primary alcohol 68 allowed for application of an intramolecular Mitsunobu 
reaction to generate 69, the trans-fused [3.3.0]-bicyclic core of 1b, in 74% yield. Alcohol 
68 could also be used to access the tricyclic core of the axinellamines in 36% yield over 
three steps.  This enantioselective synthesis demonstrated for the first time the feasibility 
of fashioning the trans-fused [3.3.0]-bicyclic ring system under surprisingly mild 
conditions.  Future efforts will involve access to the phakellin subunit of palau’amine via 
an oxidative cyclization previously developed within the context of (+)-
monobromophakellin (21).43 
 
1.5.2.4 Baran Strategy 
In 2008, Baran and co-workers39a,b reported the first example of a total synthesis of 
a complex dimeric pyrrole-imidazole alkaloids, with the syntheses of axinellamines A (8) 
and B (16) (Scheme 1.9).  The synthesis commenced with a [4+2] cycloaddition of 
dimethyl fumarate (72) and dienyl silyl ether 71 to afford cycloadduct 73 in 95% yield.  
Straightforward manipulation of diester 73 into cyclopentane 74 in ten steps was 
accomplished in part by oxidative cleavage of the C16,C10 alkene followed by an 
intramolecular aldol addition to generate the C11,C16 C-C bond.  Conversion of diol 74 
into allylic chloride 75 in 38-43% yield was accomplished with sulfuryl chloride, which 
effected elimination of the C16-tertiary alcohol as well as invertive displacement of the 
C17 alcohol in a single operation.  Six steps were expended to introduce both guanidine 
rings of cyclopentane 76, which represents the fully functionalized cyclopentane core of 
the palau’amine, styloguanidine, axinellamine, and massadine family of natural products 
as well as a near synthetic equivalent of the hypothesized “pre-axinellamine” (30).  A 
series of awe-inspiring chemoselective transformations allowed conversion of 
bisguanidine 76 into the two diastereomers of tetracycle 77 in 40% yield by first 
oxidation of the C6,C10-imidazole double bond, followed by cyclization of the  
C16-N-functionality onto C6, and finally oxidation of the C20-methylene group to the 
hemiaminal.  Only two steps remained to convert diastereomers 77 into the 
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diastereomeric natural products axinellamine A (8) and axinellamine B (16) in a total of 
24 steps.  The efficiency of these total syntheses is derived from an impeccable choice of 
chemoselective conditions as well as use of no less than nine reactions in which one 
reagent completes more than one independent synthetic transformation.  In addition to the 
total synthesis of these two natural products, Baran and co-workers have also 
successfully synthesized massadine chloride (9) and massadine44 using intermediates 
from this route. 
 
Scheme 1.9 
 
 
1.5.3 Selected Total Syntheses of Monomeric Pyrrole-Imidazole Alkaloids 
The monomeric pyrrole-imidazole alkaloids have also received significant attention 
from the synthetic community due to their interesting biological activity and compact 
structures.28,43,45,46,47,48,49,50 The syntheses of these tetracyclic alkaloids have in some 
cases also provided a training ground for construction of the phakellin subunit within the 
palau’amine congeners. 
 
1.5.3.1 Austin Strategy 
In 2004, Austin and co-workers45a completed a concise total synthesis of 
dibromophakellstatin (26, Scheme 1.10).  The synthesis commenced with transformation 
of D-prolinol (78) into achiral tricyclic pyrazinone 79 over three steps.  The key  
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N-functionalization step involved a hypervalent iodine-mediated diazidation of the 
C10,C6 pyrazinone alkene to generate predominately the desired cis-diazide 81 in 41% 
yield in addition to trans-diazide 80 in 7% yield.  The identity of the hypervalent iodine 
reagent had a strong influence on the product outcome.  Reduction of cis-diazide 81 lead 
to the cis-diamine 82, which after condensation with thiocarbonyldiimidazole generated 
tetracycle 83 in 52% over two steps.  Finally, oxidation to the urea and pyrrole 
bromination afforded dibromophakellstatin (26) in 27% yield over two steps.  The 
synthesis developed an interesting method to introduce the N-functionality at C10 and 
C6, but fell short of the ultimate goal, dibromophakellin (4).  All attempts to convert 
diamine 82, thiourea 83 or urea 26 into the guanidine containing natural product met with 
failure.45b 
 
Scheme 1.10 
 
 
1.5.3.2 Lindel Strategy 
In 2006, Lindel and co-workers46a developed a complimentary method to access 
dibromophakellstatin (26) that also used tricyclic pyrazinone 79 (Scheme 1.11).  This 
strategy used an in situ generation of an electrophilic N-acyl nitrene derived from ethyl-
N-tosyloxycarbamate (84) to generate N-acyl iminium 85.  Intermolecular trapping with 
another equivalent of 84 then afford tetracyclic 86 in 60% yield after intramolecular 
condensation.  Bromination and deprotection allowed for isolation of 
dibromophakellstatin (26) in 78% yield over two steps.  One interesting facet of the  
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N-functionalization step was that the analogous reaction using the C4,C5-dibromo 
derivative of pyrazinone 79 lead to only a 25% yield of the corresponding C4,C5-
dibromo derivative of tetracycle 86. 
 
Scheme 1.11 
 
 
1.5.3.3 Feldman Strategy 
In 2005, Feldman and co-workers47a developed a biomimetically derived oxidative 
cyclization, similar to the hypothesis invoked in Scheme 1.3 (path A) to access 
dibromophakellstatin (26) and dibromophakellin (4) (Scheme 1.12).  The approach took 
advantage of oroidin surrogate 87, possessing a thioimidazole moiety.  Exposure of 87 to  
 
Scheme 1.12 
 
Stang’s reagent (iodobenzene cyanotrifluoromethanesulfonate)51 yielded tetracyclic 
isothiourea 88 in 60-73% yield.  Oxidative hydrolysis allowed access to 
dibromophakellstatin (26) in 80-93% yield.  In a subsequent publication Feldman and  
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co-workers47b were able to convert 26 into dibromophakellin (4) in a two-step sequence 
in 27% yield involving formation of ethyl isourea 89 followed by dissolution in neat 
ammonium propionate at 135 °C.  These combined methodologies verified that oroidin-
like molecules (i.e., 87) can undergo oxidative cyclization to afford polycyclic guanidine 
containing products. 
 
Scheme 1.13 
 
 
The mechanism for the key oxidative cyclization developed by Feldman is 
postulated in Scheme 1.13 featuring a vinylogous Pummerer reaction.  Upon exposure of 
thioimidazole 87 to Stang’s reagent oxidation occurs chemoselectively at the  
C8-S-functionality to generate activated sulfonium 90.  Ring closure by the N14 at the 
electrophilic C10 position generates sulfonium imine 91, which can undergo a second 
cyclization of the pyrrole N1 onto the C6 to generate tetracycle 88.  One interesting facet 
of the oxidative cyclization was that neither desbromo- nor monobromo analogs of 
thioimidazole 87 provided characterizable compounds upon exposure to similar 
conditions.  Mechanistically similar oxidative cyclization approaches of aminoimidazole 
anologs of 87 have been used to directly access guanidine containing 
dibromophakellin;28,48,50 however, the conditions are quite harsh (i.e., bromine in acetic 
acid) and not broadly applicable.  In contrast, this work succeeded in the development of 
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a strategy to effect the oxidative cyclization of the phakellin-like ring structure under 
mild conditions. 
 
1.6 Analysis of Previous Synthetic Efforts 
The primary challenges in the synthesis of the palau’amine congeners of the 
dimeric pyrrole-imidazole alkaloids is construction of the densely substituted fully 
functionalized cyclopentane core (Ring E) and assembly of the phakellin subunit (Rings 
A, B, C, D).  The conjunction of the these two subunits is further complicated in the 
revised structure of palau’amine (1b), in which the E,D-ring fusion for the [3.3.0]-
azabicyclic ring system possesses the thermodynamically disfavored trans-
stereochemical configuration. 
 
 
Figure 1.5.  Analysis of the original and revised structures of palau’amine. 
 
The principal focus of five of the six synthetic efforts discussed toward palau’amine 
(Gleason, Carreira, Baran, Romo, Harran) has been establishing strategies for 
construction of the E ring.  Four of these efforts used Diels-Alder [4+2] cycloadditions to 
assemble, in part, the relative configuration of the five stereogenic centers resident on the 
E ring.  The fifth approach (Harran) used a diastereoselective biomimetically derived 
oxidative cyclization to establish the E ring.  This focus on early construction of the E 
ring is suggestive of the prediction that late installation of the E-ring substituents would 
be difficult.  In fact, the only synthesis in which the fully substituted E ring was not the 
initial priority (Overman) was progressed to an advanced stage just short of the final 
target 1a.  However, it is likely that although significant effort was expended to complete 
the synthesis of the targeted structure, elaboration to the fully substituted E ring on such 
an advanced intermediate was not possible.   
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Biomimetically derived strategies towards the dimeric as well as monomeric 
pyrrole-imidazole alkaloids have also proven extremely expeditious in accessing both the 
cyclopentane core and phakellin ring system.  Five of the total nine synthetic efforts 
discussed (Overman, Romo, Baran, Haran, Feldman) have incorporated different 
biomimetic modes of reactivity, providing indication that although abiotic routes can be 
effective, the most direct pathway to this class of natural products will likely mimic 
aspects of their proposed biogenesis. 
 
1.7 Retrosynthetic Analysis of Palau’amine 
Our initial approach to the original (1a) and revised (1b) structures of palau’amine 
(Scheme 1.14) involved parallel syntheses of these diastereomeric targets from the same 
starting material.  It was envisioned that 1a or 1b could be accessed from pentacyclic 
isothioureas 93a/b via late-stage introduction of the two guanidine rings.  Further 
retrosynthetic analysis suggested that the B-ring dihydropyrazinone could be introduced 
via the biomimetically derived oxidative cyclization of thioimidazoles 94a/b, developed 
by Feldman and co-workers in the context of dibromophakellstatin (26), vide supra.  
Furthermore, the thioimidazole and pyrrole amide functionalities of 94a/b could be  
 
Scheme 1.14 
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derived from cis-fused bicyclo[3.3.0]octanes 95a/b, wherein, after opening of the 
cyclopentene, selective retention or epimerization of the C12-stereogenic center would 
allow  access to the fully functionalized cyclopentane cores of 1a or 1b.  Furthermore, 
95a/b could be accessed via ring opening of bridged tricyclo[5.2.1.0]decadienes 96a/b, 
which are epimeric at C17 and represent the chlorocyclopentane cores of 1a and 1b.  
Finally, it was envisioned that the stereochemical configuration of 96a/b could be 
accessed via the [3,3]-sigmatropic rearrangement52 of the allylic chlorides 97a/b that 
would be derived from a common starting material. 
 
Scheme 1.15 
 
 
In addition, a novel alternative synthetic approach was designed to secure the 
strained trans-fused [3.3.0]-azabicyclic ring system of the revised structure of 
palau’amine (1b) (Scheme 1.15).  It was envisioned that 1b could be accessed from 
tetracyclic pyrazinone 98 via late stage incorporation of the guanidine rings.  Specifically, 
the C ring guanidine could be appended at C10 and C6 via one of the methods developed 
toward the phakellin class of compounds, vide supra.  Retrosynthetic analysis of 98 
revealed trans-fused tricyclic triazoline 99, the immediate product of an intramolecular 
[3+2]-1,3-dipolar cycloaddition between azide 100 and the tethered electron-deficient 
alkene.  Finally, 100 could be accessed via cyclopentene manipulation of cis-fused 
bicyclo[3.3.0]octane 95b, discussed previously in Scheme 1.14.  
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CHAPTER 2.  DEVELOPMENT OF [3,3]-SIGMATROPIC REARRANGEMENTS 
OF CHLOROTRICYCLODECADIENES 
 
2.1 Synthetic Strategy Toward the E Ring of Palau’amine 
Embedded within the structure of palau’amine (1) is a stereochemically complex 
and densely functionalized cyclopentane core (Ring E) that presents a daunting synthetic 
challenge for stereocontrolled synthesis.  At the inception of this project, multiple groups 
had published synthetic efforts1 towards the original structure of palau’amine (1a); 
however, the fully functionalized cyclopentane core had not been accessed, and strategies 
involving late stage installation of the cyclopentane substituents appeared difficult, due to 
its all-cis stereochemical substitution pattern.  Therefore, a strategy was desired which 
would generate this densely substituted cyclopentane ring early on in the synthesis and, 
followed by elaboration, the rest of the heterocyclic structure.  As delineated in the 
retrosynthesis (Scheme 1.14) it was envisioned that the chlorocyclopentane core of both 
the original (1a) and revised (1b) structures of palau’amine (Scheme 2.1) could be 
accessed from the corresponding C17-chloro epimers, 96a/b, possessing the 
tricyclodecadiene skeleton, via the diastereomeric chlorides 102a/b.   
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A traditional disconnection for the bicyclo[2.2.1]heptene structure within 96 would 
involve a Diels-Alder transform2 leading to cyclopentadiene (103) (Scheme 2.2A) and the 
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highly functionalized cyclopentadiene 104.  Such a transformation would require the use 
of 5-chloro,protio-substituted cyclopentadienes that are prone to [1,5]-sigmatropic shifts, 
which in turn would lead to a mixture of cycloadducts during the Diels-Alder reaction.3  
Instead, an indirect approach was devised to access tricyclodecadiene 96 via a Diels-
Alder/[3,3]-sigmatropic-rearrangement approach (Scheme 2.2B).  With this 
disconnection, the roles of the diene and dienophile would formally be reversed through 
the use of a synthetic equivalent of the highly functionalized cyclopentadiene 104.  After 
the cycloaddition, 97a/b would, after manipulation, participate in a [3,3]-sigmatropic 
rearrangement to directly access either C17-chloro diastereomer of 96.  The advantage of 
this strategy over the direct Diels-Alder approach includes both the flexibility to access 
either C17-chloro epimer via selective manipulation prior to rearrangement and the 
ability to construct the carbocyclic skeleton with the desired stereochemical configuration 
via a facile Diels-Alder cycloaddition. 
 
Scheme 2.2 
 
 
The proposed Diels-Alder/[3,3]-sigmatropic-rearrangement was envisioned to serve 
as a versatile method to access the highly substituted cyclopentane core (Ring E) of the 
original (1a) and revised (1b) structures of palau’amine, including either configuration at 
the C17-chloro stereogenic center.  In addition, epimeric chlorocyclopentanes 96a/b 
would possess all the diverse latent functionalities required for the completion of the 
syntheses. Accordingly, this approach would provide an opportunity to develop a flexible 
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strategy to generate densely substituted chlorocyclopentanes via the [3,3]-sigmatropic 
rearrangement of chlorotricyclodecadienes. 
 
2.2 Development of [3,3]-Sigmatropic Rearrangements of Chlorotricyclodecadienes 
2.2.1 Background 
[3,3]-Sigmatropic rearrangements have become ubiquitous in organic synthesis 
because of their extremely broad substrate scope and their ability to predictably transfer 
stereochemical information.  The Cope rearrangement, the [3,3]-sigmatropic 
rearrangement of 1,5-hexadienes (Scheme 2.3), has been widely used in the synthesis of 
the carbocyclic framework for targeted orientated syntheses.4   The rearrangement is  
 
Scheme 2.3 
 
 
reversible and the position of the equilibrium is determined by the relative stabilities of 
the starting material and product. The reaction is stereospecific and typically 
stereoselective as a consequence of well-defined cyclic transition states (e.g., boat or 
chair).  Typically very high temperatures (e.g., 200 °C) are required to overcome the 
energy barrier in unactivated acyclic substrates.  However, if the conformation of the 
1,5-diene system can be restricted to enforce close proximity of the two pi-systems, then 
the kinetic barrier for equilibration can be significantly reduced.  This phenomena has 
been observed in the highly rigid tricyclo[5.2.1.0]decadiene ring system, which 
constrains the 1,5-diene system in a boat conformation.5  In the seminal work by 
Woodward and Katz,5a endo-allylic alcohol 105 (Scheme 2.4), stable to rearrangement at 
room temperature, was found to rearrange upon heating to 140 °C to afford homo-allylic 
alcohol 106 in near quantitative yield.  The formation of alcohol 106 is consistent with a 
process under thermodynamic control in which relief of steric strain, derived from 
placement of the hydroxyl within the concave face of the carbocyclic skeleton of 105, is 
responsible for biasing the equilibrium. 
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Scheme 2.4 
 
 
 In a related system, bridged ketone 107 (Scheme 2.5) underwent slow 
rearrangement at 20 °C to afford α,β-unsaturated ketone 108 with quantitative 
conversion.5c  This equilibrium position is consistent with relief of angle strain within the 
bridging sp2 carbonyl carbon of 107 in addition to enhancement of conjugative 
stabilization within product 108.  The significantly enhanced rate for the isomerization as 
compared to Scheme 2.4 suggests that conjugative stabilization, in addition to biasing the 
equilibrium position, can also alter the rate of the rearrangement by reducing the barrier 
of activation for isomerization. 
 
Scheme 2.5 
 
 
 Zwanenburg and coworkers found that 2-carbethoxy-tricyclodecadienes substituted 
at the C6-angular position rapidly underwent facile rearrangement (Table 2.1).5d   
α-Alkylation of ketone 109 with methyl iodide smoothly afforded 110 as a crystalline 
solid.  However, upon standing at room temperature for several days, the crystals slowly 
liquefied and converted to a mixture of 110 and 111.  In this study, other similarly 
alkylated products were prepared and a correlation was found between the steric demand 
of the C6 substituent and the thermodynamic ratio preference for the isomerized product 
111.  By contrast, ketone 109 exhibited no evidence of rearrangement even at elevated 
temperatures.  The authors note that the conjugative stabilization of enone 110 is largely 
compensated by the similar conjugative stabilization within enoate isomer 111, and that 
the thermodynamic ratio observed is likely a result of the competing destabilizing steric 
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demand of the C6 substituent in 110 and the destabilizing angle strain of the bridged 
carbonyl in 111. 
 
Table 2.1.  Equilibrium position for the rearrangement of 
tricyclodecadienes alkylated at C6-angular position 
 
 
Based on the examples in Scheme 2.4, 2.5, and 2.6 it was recognized that the 
[3,3]-sigmatropic rearrangement of  tricyclo[5.2.1.0]decadienes could possibly be used 
for the construction of the cyclopentane core (Ring E) of both the original (1a) and 
revised (1b) structures of palau’amine, if the desired C17-chloro functionality could be 
appended prior to rearrangement.  However, due to the subtle substituent effects observed 
in the previous examples that effect both the rate of equilibration and the equilibrium 
position of the [3,3]-sigmatropic rearrangement, it was unclear how to specifically begin 
the target-orientated synthesis of 1a or 1b.  The [3,3]-sigmatropic rearrangement of the 
tricyclodecadiene skeleton was therefore explored, initially within the context of 
synthesizing the chlorocyclopentane core of 1a, in order to better understand the 
substituent effects that affected the outcome and generate a flexible and controlled 
method for the construction of chlorocyclopentanes applicable to both 1a and 1b.  
 
2.2.2  Proof of Principle - Rearrangement of a Simple Chlorotricyclodecadiene 
 In order to establish proof of principle for the proposed Diels-Alder/ 
[3,3]-sigmatropic rearrangement strategy possessing the crucial C17-chloro substituent, a 
simple model system was designed that lacked the C16-alkyl group (palau’amine 
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numbering) for ease of synthesis (Scheme 2.6).  It was envisioned that 
chlorocyclopentane 115 could be accessed from known dicyclopentadiendione (112) via 
manipulation into allylic chloride 113, possessing both the C17-chloro substituent as well 
as the functionality with which to trigger the rearrangement.  Deprotection of the ketal 
would trigger the rearrangement by formation of highly strained bridging ketone 114.  
After equilibration via the [3,3]-sigmatropic rearrangement, enone 115 would 
predominate due to relief of angle strain within ketone 114 as well as enhancement of 
conjugative stabilization in the product 115.  
 
Scheme 2.6 
 
 
 The tricyclodecadiene skeleton necessary for the planned route can conveniently be 
accessed via the Diels-Alder cycloaddition of simple commercially available starting 
materials.  Dicyclopentadienone (112) was synthesized by a known route6 starting with 
readily available cyclopentadiene (Scheme 2.7).  Exposure of freshly distilled 
cyclopentadiene (103) to sodium metal and tert-butyl nitrite yielded dioximes 117 in 74% 
via the Diels-Alder dimerization of putative cyclopentadienoxime (116).  Acidic 
hydrolysis of both oxime functionalities afforded dicyclopentadienone (112) in 88% yield 
on multi-gram scale. 
The convex/concave topology of the tricyclodecadiene skeleton then conveniently 
provided the means to introduce exo-C17-allylic chloride within 113 (Scheme 2.8) with 
high diastereoselectivity.  In order to manipulate the C17 enone, protection of the more 
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Scheme 2.7 
 
 
reactive bridging ketone was first required.  This was accomplished by ketalization of 
112 with ethylene glycol to afford ketal 118 in 99% yield.  The α,β-unsaturated ketone 
within 118 was then stereoselectively reduced to alcohol 119 with DiBAL-H7 and 
subjected to invertive chlorination to afford a mixture of chloride 113 and alcohol 120.*  
Isolation of alcohol 120, the epimer of starting material 119, was the result of hydrolysis 
of allylic chloride 113 during silica gel chromatography, highlighting the acidic lability 
of these allylic chlorides 
 
Scheme 2.8 
 
 
Allylic chloride 113 was then poised to undergo the planned [3,3]-sigmatropic 
rearrangement upon unmasking of the bridged ketal.  However, removal the ketal 
required forcing conditions (i.e., 100 °C in 1:1 AcOH: H2O) and resulted in the isolation 
of alcohol 1226b (Scheme 2.9).  The unexpected formation of alcohol 122 is likely the 
result of: (1) acidic hydrolysis of the allylic chloride; (2) ketal deprotection; and (3) 
                                                 
*
 The relative configurations of both 113 and 120 were verified by NOE correlations between the endo- 
H17-allylic proton and proximal H12-vinyl proton. 
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[3,3]-sigmatropic rearrangement of putative ketone 121.  Evidence for this rationale is 
supported by the control experiment in which product 122 was independently isolated 
after subjection of alcohol 120 to the same reaction conditions. 
 
Scheme 2.9 
 
 
 In order to avoid hydrolysis of the sensitive C17-allylic chloride moiety in 113 
(Scheme 2.9) anhydrous conditions for ketal deprotection were required.  Ultimately, the 
reagent combination of boron trifluoride diethyl etherate (BF3·OEt2) and anhydrous 
sodium chloride8 were found to effect removal of the ketal (Scheme 2.10), resulting in the 
isolation chlorocyclopentane 115 as a single diastereomer.  This transformation is 
proposed to proceed via a [3,3]-sigmatropic rearrangement of transient ketone 114, which  
 
Scheme 2.10 
 
 
was not detected during the reaction, and driven by relief of angle strain within ketone 
114 as well as enhancement of conjugative stabilization within enone isomer 115.  The 
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stereochemical integrity of the C17-chloro substituent had been maintained as verified by 
NOE correlations between H17 and the angular H12 of the cyclopentenone ring, 
establishing that the C17 chloride was proximal to the norbornene alkene, which 
corresponds to the stereochemical configuration of the chlorocyclopentane core of the 
original structure of palau’amine (1a).   
 Formation of 115, albeit in a low yield (28%), demonstrated in this simple system 
that a [3,3]-sigmatropic rearrangement of a tricyclodecadiene possessing an  
exo-C17- allylic-chloro substituent was a viable method to form the chlorocyclopentane 
core (Ring E) of the original structure of palau’amine (1a) in a stereoselective fashion.  
The establishment of an exo-allylic chloride (i.e., 114) as a viable intermediate for the 
planned rearrangement strategy suggested that higher efficiencies could be achieved for 
the rearrangement step if only milder conditions could be used to generate chloride 114.  
Accordingly, alternative strategies were developed on more functionalized systems in 
which the rearrangement of an allylic chloride such as 114 would be effected in a milder 
fashion.   
 
2.2.3  Unsuccessful Efforts to Alkylate Dicyclopentadiendione Derivatives 
 After demonstrating the feasibility of applying the [3,3]-sigmatropic rearrangement  
 
Scheme 2.11 
 
on a simple chlorotricyclodecadiene, the next task was to develop a synthesis and  
rearrangement protocol to access the fully substituted chlorocyclopentane (e.g., 125, 
Scheme 2.11), containing the C16-alkyl substituent (palau’amine numbering).  It was  
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envisioned that access to a chlorocyclopentane 125 could be accomplished by first 
alkylation of a dicyclopentadiendione (112) at the C16 position, to afford 123.  
Subsequent introduction of the C17-allylic chloride substituent of 124 followed by 
[3,3]-sigmatropic rearrangement would provide chlorocyclopentane 125. 
Before the alkylation dicyclopentadienone (112, Scheme 2.12) was attempted, a 
deuterium incorporation study was undertaken to determine the site of enolization (e.g., 
α' or γ).  Unfortunately, deuterium exchange did not occur as expected.  Under the  
majority of conditions screened 112 was entirely consumed and the only isolable product, 
tentatively assigned as 128, was dimeric in nature.  Conditions screened included: bases 
(lithium diisopropylamide (LDA), lithium hexamethyldisilizane (LHMDS), potassium 
hexamethyldisilizane (KHMDS), potassium hydride, and sodium hydride); temperatures 
and addition methods (-78 °C, -45 °C, immediate quench, inverse addition, and syringe 
pump addition), and deuterium sources (methanol-d4 (MeOD) or acetic acid-d4 (AcOD)). 
  
Scheme 2.12 
 
 
In one instance the starting material was recovered in 12% yield with 30% desired 
deuterium incorporation as determined by 1H NMR integrations.  In all the other 
experiments, starting material was completely consumed and low mass recoveries were 
experienced.  The major and only identified product, 128 (Scheme 2.12), resulted from 
the aldol condensation of the enolate into another molecule followed by dehydration.  
These results suggest that enolate 127 is formed, but due to its highly strained nature 
readily undergoes self-condensation.  Attempted trapping of the enolate with methyl 
iodide or benzyl chloromethyl ether (BOMCl) resulted in the same distribution of 
products.  To alleviate the problem of self-condensation, slow addition of ketone 112 to 
the base was attempted; however, this resulted in no change in outcome.  In efforts to 
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alter the steric environment of the enolate, structural permutations of substrate 112 were 
explored; however, exclusively dimeric products were continued to be observed. 
Ultimately, alkylation of dicyclopentadienone derivatives was not successful.  
Although evidence suggests that enolization occurred at the desired α’ location, the 
highly strained nature of the enolate made it difficult to be efficiently trapped with other 
electrophiles.   
 
2.2.4  Successful Synthesis of an Alkylated Tricyclodecadiene and Rearrangement 
 With no success in the alkylation of dicyclopentadiendione derivatives, efforts were 
then focused on a known tricyclodecadiene that had been shown to competently undergo 
alkylation, 2-carboethoxy-tricyclo[5.2.1.0]decadienone (109) (Scheme 2.13), likely due 
to steric shielding of the corresponding enolate by the additional C23 ester.5d  Inclusion 
of the ester carbon into the substrate to facilitate the alkylation, however, would require 
its excision at a later stage.   
 It was envisioned that access to a fully substituted chlorocyclopentane 131a 
(Scheme 2.13) could be accomplished from ketone 109 by alkylation at the C16-angular  
position (palau’amine numbering) to afford 129.  Installation of the C17-allylic chloride 
moiety within 130a followed by the planned [3,3]-sigmatropic rearrangement strategy 
verified in the model system, would allow access to 131a. It had previously been shown  
by Zwanenburg, however, that ketones substituted at the C16-angular position, like 129, 
undergo facile [3,3]-sigmatropic rearrangements at room temperature.5d  This would 
 
Scheme 2.13 
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complicate the installation of the chloride functionality due to uncontrollable and 
undesirable premature rearrangements.  Therefore, in order to overcome the propensity of 
C23-ester substituted tricyclodecadienes to isomerizes as well as develop an approach 
amenable to an efficient synthesis of palau’amine, a novel strategy would be required to 
allow for installation of the desired functionality prior to rearrangement.  
 2-Carboethoxy-tricyclo[5.2.1.0]decadienone (109, Scheme 2.14) was synthesized 
according to the procedure of Ogawasara and co-workers, beginning with the simple 
Diels-Alder cycloaddition between cyclopentadiene (103) and benzoquinone (132) to 
afford dihydroquinone 133 in 80% yield.9  The electron-deficient alkene of 133 was then 
epoxidized under basic conditions to generate endo-epoxide 134 in 95% yield.10  An 
ethoxide-mediated Favorskii-like rearrangement then furnished ring contracted 
cyclopentenone 109 in 60% yield.11  This three step sequence was very robust, allowing 
for the access to hundreds of grams of 109 without need for purification at any step.  
 
Scheme 2.14 
 
 
 Alkylation of 109 (Scheme 2.15) with BOMCl at -78 °C was achieved according to 
the procedure by Zwanenburg and co-workers providing enone 129 in 53% yield.5d  The 
mass balance of the reaction was once again products of self-condensation of the enolate; 
however, rather than the consequence of an aldol condensation as seen on a previous 
substrate (cf. Scheme 2.12), acylation of the enolate with the C23-ester of another 
molecule had occurred to form products consistent with β-diketone 135.  After screening 
different temperatures for enolate formation and the subsequent quench, it was found that 
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deprotonation did not occur at -78 °C and was not appreciable until -30 °C.  Accordingly, 
the procedure was altered to involve the slow addition of a solution of ketone 109 and the 
electrophile to a -20 °C solution of the base in tetrahydrofuran, resulting in a simpler and 
more reliable method to generate 129 in comparable yield.  
 
Scheme 2.15 
 
 
 Analogous to the study conducted by Zwanenburg and co-workers on 
tricyclodecadienones, substituted at the angular position (Table 2.1), enone 129 (Scheme 
2.16) equilibrated via a spontaneous [3,3]-sigmatropic rearrangement at room 
temperature to afford a mixture with enoate isomer 136 in a 72:28 thermodynamic ratio 
(129:136).  The thermodynamic ratio is likely the net result of the competing eclipsing 
strain between the adjacent quaternary centers within 129 and the angle strain of bridged 
ketone within 136.  The same ratio of products was observed after standing at room 
temperature for 14 days or heating in solution at 75 °C for 15 minutes.*  Nevertheless, 
with access to the alkylated substrate 129, efforts were focused on methods for 
installation of the allylic chloride functionality prior to rearrangement. 
 
Scheme 2.16 
 
 
 
                                                 
*
 Despite rearrangement in solution at room temperature, enone 129 could be isolated pure after 
chromatography on silica gel and the integrity of the sample could be maintained by storage as a crystalline 
solid at -20 °C. 
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2.2.5  Tandem Reduction/Chlorination/Rearrangement 
 While the isomerization of enone 129 into enoate 136 (Scheme 2.16) showed 
promise for the application of the desired sigmatropic rearrangement strategy, this 
premature rearrangement at room temperature presented a challenge as far as how to 
introduce the allylic chloride moiety prior to rearrangement.  In addition, it was known 
that reduction of the enone moiety to the alcohol (i.e., 129 converted to 137, Scheme 
2.17) would significantly increase the rate of equilibration for the sigmatropic 
rearrangement relative to enone 129;5c making derivatization of alcohol 137 difficult at 
room temperature.   Consequently, any direct attempts to derivative enone 129 into allylic 
chloride 130a would likely result in premature rearrangement prior to the desired 
functionalization.  This problem therefore required the accomplishment of three synthetic 
tasks in order to successfully access chlorocyclopentane 131a (Scheme 2.17): (1) 
prevention of the premature rearrangement; (2) installation of the allylic chloride 
functionality in a stereoselective fashion; and lastly (3) triggering the rearrangement in 
which the equilibrium position is biased entirely toward the desired product.   
 
Scheme 2.17 
 
 
 The most direct method to access chlorocyclopentane 131a (Scheme 2.18) from 
enone 129 would be to attempt to control the rate of the sigmatropic rearrangement by 
regulation of the reaction temperature.  Although the rearrangement of reduced alcohol 
137 would proceed quickly at room temperature, handling the material at low 
temperatures might reduce the rate of the rearrangement to the point that it could be 
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further manipulated into allylic chloride 130a.  This strategy would require compatible 
and chemoselective conditions for the sequential ketone reduction and subsequent 
chlorination in the same reaction flask at low temperatures.  Upon warming the reaction 
to room temperature the rearrangement would then ensue to afford desired 
chlorocyclopentane 131a.  
 
Scheme 2.18 
 
 
 The application of this thermal strategy began with simply the reduction of enone 
129 (Scheme 2.19) with a hydride source in order to ascertain the chemoselectively of the 
reduction.  Exposure of ketone 129 at -78 °C to diisobutylaluminum hydride (DiBAL-H) 
in tetrahydrofuran cleanly afforded rearranged alcohol 139 with greater than 20:1 
diastereoselectivity at the C17 stereocenter.  The stereochemistry of product 139 suggests 
that the ketone reduction proceeds as expected, exclusively via exo-delivery of hydride to  
afford endo-aluminate 138.  The lack of observation of aluminate 138 or the 
corresponding alcohol 137 during the progress of this reaction suggests that its 
rearrangement is extremely facile, consistent with the hypothesis that C16-alkylated  
2-carboethoxy-tricyclodecadienones lacking the C17-ketone functionality undergo facile 
 
Scheme 2.19 
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rearrangements that exclusively favor the formation of the isomerized product.  
 With evidence suggesting that the DiBAL-H reduction of 129 proceeded with high 
facial selectivity, the sequential reduction/chlorination of enone 129 (Scheme 2.20) was 
conducted.  Sequential addition of DiBAL-H followed by thionyl chloride and pyridine to 
enone 129 at -78 °C afforded a 2.5:1 mixture of allylic chloride 140 and 
chlorocyclopentane 131a upon warming to room temperature.  endo-C19-Allylic chloride 
140 was found to be unstable and unisolable.  Subsequently, after silica gel purification 
of the mixture of 140 and 131a, a 2.5:1 mixture of epimeric chlorides 131b and 131a was 
obtained in 30% and 18% yield respectively, during which chlorocyclopentane 131a 
remained unchanged. The same isomerization products were also observed upon standing 
at room temperature for 24 hours and heating at 60 °C for 15 minutes.  Epimers 131a and 
131b represent the desired chlorocyclopentane cores of the original (1a) and revised (1b) 
structures of palau’amine, which differ in the stereochemical configuration of the  
C17-chloro substituent.*  The similar ratio of 140:131a to 131b:131a before and after 
heating suggests that allylic chloride 140 transforms stereoselectively into chloride 131b.  
 
Scheme 2.20 
 
 
 A possible mechanistic explanation for these transformations was formulated after 
structural elucidation of all the products was obtained (Scheme 2.21). Upon addition of 
                                                 
*
 The connectivity and relative stereochemistry of allylic chloride 140 and chlorocyclopentanes 131a and 
131b were unambiguously verified by COSY and NOE NMR experiments as indicated.   
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thionyl chloride to endo-aluminate 138 at -78 °C, chlorination likely occurs via two 
separate mechanisms.  Following path A, activation of the alcohol as alkyl chlorosulfite 
141 results in an SN2 mechanism wherein pyridinium chloride acts as an external 
nucleophile to yield transient exo-C17-allylic chloride 130a.  Upon warming the 
[3,3]-sigmatropic rearrangement ensues, forming  chlorocyclopentane 131a 
corresponding to the core of the original structure of palau’amine.  Alternatively, on path 
B, the same alkyl chlorosulfite 141 undergoes an intramolecular delivery of chloride on 
the endo-face of the allylic system, either via a well-defined 6-membered transition state 
in a SN2’ fashion or via a closed-ion pair after loss of sulfur dioxide.  The net result is the 
formation of the allylicly transposed endo-C19-chloride 140.  This intermediate does not 
undergo a [3,3]-sigmatropic rearrangement upon warming to room temperature because 
the ester substituent is not located at C3 position within the 1,5-diene system and 
therefore does not lower the kinetic barrier to rearrangement as seen in compounds 130a 
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and 137.  Instead, chloride 140 transforms slowly into endo-C17-allylic chloride isomer 
130b, likely via a closed-ion-pair formal [1,3]-rearrangement, which can then undergo a 
facile [3,3]-sigmatropic rearrangement to afford chlorocyclopentane 131b due to the 
repositioning of the C23-ester substituent at C3 relative to the 1,5-diene system.  This 
sequence of events rationalizes that the formation of multiple chloride products is a result 
of a non-selective chlorination following a diastereoselective reduction rather than the 
reverse, a diastereoselective chlorination following a non-stereoselective reduction.   
 In attempts to improve the yield of either C17-chloro epimer, a survey of different 
conditions were tried including solvents (methylene chloride, tetrahydrofuran, toluene), 
temperatures for the reduction and chlorination steps (-78 °C, -60 °C, -45 °C), reducing 
agents (DiBAL-H, sodium bis(2-methoxyethoxy)aluminumhydride (Red-Al)), and 
chlorinating agents (thionyl chloride, methanesulfonyl chloride/triethylamine, 
tributylphosphine/carbontetrachloride).  Unfortunately, none of these modifications 
resulted in improvement of the isolated yield of the two products and the narrow window 
for chemoselectivity and functional group compatibility for the two-step sequence limited 
the choice of reagents.  In addition, upon increasing the scale of this two-step sequence 
above 5 milligrams, the reduction step was plagued by irreproducible results.*  While this 
reaction sequence allowed initial access to the chlorocyclopentane cores of both the 
original and revised structures of palau’amine, alternative routes were sought in order to 
obtain more efficient, selective, and reliable routes to both epimers. 
 
2.2.6  Rearrangement Trigger: Regeneration of the C23 Carbonyl 
 While the previous strategy demonstrated that the individual functionalization steps 
can proceed as desired, it ultimately failed due to an inability to install the allylic chloride 
in a stereo- and regioselective fashion within the limited reaction scope of a one-pot, low 
temperature reaction.  In order to address the failings of the previous strategy a different 
method was sought that would first prevent the premature [3,3]-sigmatropic 
rearrangement and then install the allylic chloride functionality selectively. 
                                                 
*
 Reduction products observed include 1,4-reduction of the enone and reduction of the C23 ester to the 
aldehyde or primary alcohol. 
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 Consistent with the difference in rates between the rearrangements of allylic 
chlorides 131a and 140 (Scheme 2.21), it was discovered that the presence of the C23 
carbonyl at the C3 position within the 1,5-diene system was a requirement for facile 
rearrangements at room temperature and, conversely, the absence of the C23 carbonyl 
allowed for the isolation of products that were stable to rearrangement at room 
temperature.  Accordingly, a strategy was devised (Scheme 2.22) that involved: (1) 
prevention of the rearrangement by modulation of the C23-carbonyl oxidation state 
within 142 to access 143; (2) introduction of the chloride moiety within 144; and (3) 
triggering the rearrangement through oxidation to regenerate the C23-carbonyl oxidation 
state within 145.  This oxidation is theorized to act as a trigger for [3,3]-sigmatropic 
rearrangement to afford 146, for as the new pi-bond is formed during the rearrangement, 
the conjugative stabilization that lowers the ground state of the product can manifests 
itself in the transition state, lowering the kinetic barrier for the rearrangement. 
 
Scheme 2.22 
 
 
 In practice, the first task, prevention of the rearrangement, was accomplished by 
double reduction of the ester and ketone moieties within 129 (Scheme 2.23) with excess  
DiBAL-H to afford thermally stable diol 148 in 70% yield.  Selective O-silylation of the 
 
Scheme 2.23 
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more accessible primary alcohol generated silyl ether 149 in 69% yield. 
 Chlorination of allylic alcohol 149 (Table 2.2) was found to be problematic due to 
the formation of isomeric mixtures and the hydrolytic instability of the corresponding 
allylic chloride products.  Due to instability on silica gel the chloride isomers where not 
separable and the ratio of products was determined by 1H NMR.  Use of thionyl chloride 
resulted in a 1:3 ratio of products 150 and 151, favoring formation of undesired 
constitutional isomer 151 (Table 2.3, Entry 1), similar to the results obtained from 
aluminate 138 (Scheme 2.21).  The reagent combinations of cyanuric 
chloride/dimethylformamide,12 methanesulfonyl chloride/triethylamine,  
N-chlorosuccinimide/triphenylphosphine13 did not improve the yield of the desired 
isomer or resulted in the formation of all 4 stereo- and constitutional isomers.  The most 
efficient formation of 150 was observed upon chlorination under Appel conditions14 with 
tributylphosphine at -10 °C, resulting in isolation of exo-allylic chlorides 150 and 152 
(3:1 ratio) in 85% yield (Entry 2).  
 
Table 2.2.  Chlorination of allylic alcohol 149. 
 
 
 Interestingly, attempts at chlorination of 149 under Appel conditions with less 
reactive triphenylphosphine at an elevated temperature of 80 °C resulted in the isolation 
of isomerized alcohol 153 in 90% yield (Scheme 2.24) rather than chlorination.  This 
result illustrates that although fully substituted substrates (i.e., 149) that lack the C23 
carbonyl do not rearrange at room temperature, the rearrangement pathway is still 
accessible at elevated temperatures and the equilibrium position favors the isomerized 
product without the requirement for conjugative stabilization in the product. 
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Scheme 2.24 
 
 
 With access to the desired exo-chloride 150, the oxidative strategy to trigger the 
rearrangement was attempted (Scheme 2.25).*  First, silyl ether deprotection of 150 with 
TBAF yielded highly unstable alcohol 144 (85%).†  Oxidation with pyridinium 
dichromate then afforded transient aldehyde 155, which underwent rapid  
[3,3]- sigmatropic rearrangement, driven by relief of eclipsing strain in 155 in addition to 
enhancement of conjugative stabilization in 156.  Ultimately, the reaction afforded 
chlorocyclopentane 156 in 15% yield as well as 9% yield of the C17 epimer.  Efforts to 
improve the sequence with the use of other oxidants resulted in no improvement in yield.   
Although this route provided an alternative rearrangement trigger method and 
demonstrated another example that the stereochemical information of an exo-allylic 
 
Scheme 2.25 
 
                                                 
*
 Although only one chloride isomer is depicted, the material actually consisted of a 3:1 ratio of inseparable 
isomers 150 and 152. 
†
 Alcohol 144 could be purified through a short plug of silica gel, but was prone to undefined 
decomposition upon storage as a neat oil. 
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chloride could be successfully transferred during the course of the sigmatropic 
rearrangement, it also highlighted two problems:  (1) chloride introduction to the allylic 
system is neither highly stereoselective nor regioselective; and (2) the resulting allylic 
chlorides are highly unstable to purification and storage.  
 
2.2.7  Rearrangement Trigger: Opening of Constraining Lactone Ring 
 In order to address the failings of the previous strategy a different approach was 
sought that would allow for easy manipulation and selective introduction of the allylic 
chloride functionality with an alternative rearrangement trigger.  It was considered that 
the issue of allylic chloride stability could be addressed by sterically shielding this 
sensitive moiety in a propellane-like structure 159 (Scheme 2.26).  In this strategy the 
rearrangement would be prevented by formation of a constraining lactone ring 158, 
followed by formation of allylic chloride 159 that would hopefully be less prone to 
hydrolysis.  Finally, the rearrangement would be triggered by reduction of the lactone, 
which after opening to aldehyde 160 would undergo facile rearrangement to 
chlorocyclopentane 161, consistent with the trends observed in Schemes 2.21 and 2.25. 
 
Scheme 2.26 
 
 
 In order to access known lactone 158,15 a new method was developed involving 
the alkylation of ketone 109 with 2-(trimethylsilyl)-ethoxymethyl chloride (SEMCl) to 
afford ketone 162 in 40% yield (Scheme 2.27).*  Transformation of 162 to lactone 158 
was accomplished in 99% yield in one pot by sequential exposure to BF3·OEt2 to affect 
                                                 
*
 Following the published method using formaldehyde as the electrophile did not result in the formation of 
any desired product. 
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silyl deprotection, followed by p-toluenesulfonic acid (p-TsOH) to effect lactonization.  
Subjection of α,β-unsaturated ketone 158 to a Luche reduction resulted in a non-
stereoselective formation of alcohols 163 and 164 in 35% yield for each diastereomer.  
The two isomers were subjected to different chlorination conditions optimized for the 
formation of the same desired stereo- and constitutional isomer 159 for the preparation of 
the original structure of palau’amine.  For alcohol 163, the optimal conditions for a 
stereoretentive chlorination were found to be thionyl chloride in THF without the addition 
of pyridine, resulting in a 40% isolated yield of chloride 159.  For alcohol 164, the 
optimal conditions for an invertive chlorination were Appel conditions with 
tributylphosphine, resulting in a 71% yield of chloride 159.  In both cases, the other three 
stereo- and constitutional chloride isomers were observed; however, contrary to previous 
substrates, these products were stable to purification and could be obtained pure after 
silica chromatography.   
 
 Scheme 2.27 
 
 
 The lactone ring imparted two primary benefits for this route:  (1) the allylic 
chlorides were now hydrolytically stable due to the hindered propellane-like structure; 
and (2) no rearrangement of any intermediates was observed due to the constraining 
lactone ring.  In addition, reduction of the lactone could also efficiently serve as a trigger 
for the [3,3]-sigmatropic rearrangement.  Exposure of lactone 159 to DiBAL-H at -60 °C 
resulted in observable lactol 165 (Scheme 2.28), which upon warming isomerized to open 
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form γ-hydroxyaldehyde 160. Aldehyde 160 lacks the same conformational restrictions 
as lactol 165 and correspondingly underwent rapid [3,3]-sigmatropic rearrangement to 
afford chlorocyclopentane 161 in 65% over two steps.  This route demonstrated that an 
allylic chloride can undergo successful rearrangement in good yield under neutral 
conditions; however, because of the low yields in the production of the allylic chloride, a 
more efficient formation for chloride installation was sought. 
 
Scheme 2.28 
 
 
2.2.8  Rearrangement Trigger: Regeneration of C18,19 Alkene 
 Although multiple avenues had been explored in order to access the 
chlorocyclopentane core of 1a, none had been able to install the chloride substituent in a 
selective manner on the allylic system necessary for the rearrangement.  It was therefore 
decided to attempt to install the chloride on a non-allylic system, (i.e., 166 Scheme 2.29),  
 
Scheme 2.29 
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which would avoid the complications arising the formation of multiple isomers.  The 
synthetic plan would rely on: (1) prevention of the [3,3]-sigmatropic rearrangement by 
temporarily masking the C18,19 alkene within 129; (2) introduction of the chloride 
within 167 on a non-allylic system in a stereoselective fashion; and lastly (3) triggering 
the [3,3]-sigmatropic rearrangement by reformation of the C18,19 alkene to generate 
130a, which would then rearrange to afford 131a. 
  Accordingly, the C18,19 alkene of 129 (Scheme 2.30) was temporarily masked by 
conjugate addition of phenyl selenol16 followed by the addition of sodium borohydride to 
generate β-hydroxyselenide 168 in 70% yield as a single stereo- and constitutional 
isomer.  Chlorination of 168 under Appel conditions provided exo-C17-chloride 169 in 
73% yield.  Multiple NOE correlations verified that the chloride had been introduced 
onto the exo-face as desired and that the selenide attack had unexpectedly occurred from 
the endo-face.  As the hydride had been delivered from the exo-face, introduction of the 
selenide from the endo-face would seem to be contra-steric.  However, the pi∗-orbital at 
the β-position of the alkene (Figure 2.1), which is projecting away from the cyclic system  
 
 
Figure 2.1.  Possible trajectories for reaction with α,β-unsaturated ketone 129. 
 
in 129, has a different steric environment than pi*-orbital of the carbonyl.  The product 
observed would suggest that the constrained norbornene alkene provides less steric 
encumbrance than the C23-ester substituent.  In contrast, during the hydride delivery, 
which follows the Burgi-Dunitz trajectory for reduction of the carbonyl, the endo-face is 
blocked by both the norbornene alkene and β-phenylselenide substituent resulting in exo-
delivery. 
 The rearrangement of 169 was finally triggered by regeneration of the C18,19 
alkene by selenide oxidation with meta-chloroperoxybenzoic acid to afford selenoxide 
170 (Scheme 2.30).  Addition of triethylamine and heating the solution to 90 °C resulted 
in α-elimination to afford putative allylic chloride 130a, which underwent rapid 
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Scheme 2.30 
 
 
[3,3]-sigmatropic rearrangement to generate chlorocyclopentane 131a in 95% yield from 
selenide 169.  This rearrangement was triggered by regeneration of the C18,19 olefin and 
energetically driven by relief of eclipsing strain in 130a and enhancement of conjugative 
stabilization in 131a, consistent with the trend observed  in Scheme 2.21, 2.25, and 2.28.  
Incorporating a temporary protection of the C18-19 alkene provided a reliable and 
scalable route to the chlorocyclopentane core of the original structure of palau’amine 
(1a).  
 
2.2.9  Synthesis of the Chlorocyclopentane of the Revised Structure of Palau’amine 
 With an efficient access to the chlorocyclopentane core of the originally proposed 
structure of palau’amine (1a), a method to access the chlorocyclopentane core of revised 
structure (1b) was desired, which is epimeric at the C17 and C12 positions.  It was 
envisioned that if the C17 epimer of chlorocyclopentane 131a, (131b, Scheme 2.31) 
could be accessed, the C12 position could be epimerized at a later point in the synthesis, 
likely after manipulation of the cyclopentene alkene.  As C17-epimer 131b had already 
been accessed earlier via the [3,3]-sigmatropic strategy (Scheme 2.20), albeit in low 
yields, it was envisioned that a modified strategy could be used to generate an efficient 
route to this compound.  Scheme 2.21 demonstrated that if endo-allylic chloride 130b 
(Scheme 2.31, top pathway) could be accessed, an efficient a sigmatropic rearrangement 
would ensue to deliver chlorocyclopentane 131b.  However, no previous attempt to form 
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a single stereo- and constitutional chloride isomer on an allylic system had been selective 
or efficient.  In order to avoid this formation of isomers we elected to pursue an 
alternative route that did not involve accessing allylic chloride 131b directly.  Instead, it 
was considered if chlorocyclopentane 131b could be accessed from rearranged alcohol 
139 (Scheme 2.31, bottom pathway) via a net-stereoretentive chlorination.  
 
Scheme 2.31 
 
 
 Alcohol 139 had previously been prepared on small scale (2 mg) upon 
diastereoselective 1,2-reduction of enone 129 with DiBAL-H at -78 °C (Scheme 2.19); 
however, upon increasing the scale of the reaction significant amounts of 1,4-reduced 
product 171 were observed (Scheme 2.32).  On gram scale the reaction was sluggish  
at -78 °C and possessed very poor chemoselectivity at -45 °C.  In attempts to avoid the 
formation of an exotherm during addition, the procedure was altered to involve the 
transfer of a -78 °C solution of DiBAL-H to a -78 °C solution of ketone 129, followed by 
stirring at -60 °C for six days.  This change allowed for the isolation of alcohol 139 in an 
improved but disappointing 47% yield.  A survey of other reducing agents at low 
temperatures was conducted, in order to effect the chemoselective 1,2-reduction of the 
enone rather than the competing 1,4-reduction or ester reduction, with no improvement in 
yield.  The extreme steric encumbrance for the 1,2-reduction of the ketone via the Burgi-
Dunitz trajectory (Figure 2.1) possibly leads to the preference in the formation of the  
1,4-reduction product 171. 
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Scheme 2.32 
 
 
 Reliable access to alcohol 139 could not be achieved by 1,2-reduction of enone 129 
followed by the ensuing rearrangement due to the chemoselectivity issues plaguing the 
DiBAL-H reduction, necessitating an alternative strategy.  Subsequently, reversing the 
order of these two steps was considered.  Isomerization of enone 129 via the 
[3,3]-sigmatropic rearrangement had been observed earlier (Scheme 2.16) at elevated 
temperatures to generate a thermodynamic 78:22 ratio of enone 129 and isomeric ketone 
136 (Scheme 2.33).  In contrast to the difficulty in the reduction of enone 129, the 
reduction of bridging ketone 136 should be more favorable due to its increased steric 
accessibility and more reactive nature due to the angle strain associated with the bridging 
sp2 center.  It was therefore considered if it would be possible to take advantage of a 
Curtin-Hammett energy profile, wherein the less abundant but more reactive component 
(i.e., 136) of a dynamic equilibrium would undergo a chemoselective transformation.  It 
would be necessary to conduct the reduction at elevated temperatures (e.g., 80 °C) for at 
these temperatures a rapid equilibration is achieved between enone 129 and ketone 136.   
Indeed, application of the Meerwein-Verley-Ponndorf reducing conditions17 using 
aluminum isopropoxide in isopropyl alcohol at 80 °C resulted in the chemoselective and 
stereoselective formation of alcohol 139 in 99% yield.* 
 
Scheme 2.33 
 
                                                 
*
 The same result was observed if the starting material was pure enone 129 or a pre-equilibrated mixture of 
enone 129 and ketone 136. 
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With efficient access to homo-allylic alcohol 139, all that remained to access the 
C17-chloro epimer 131b (Table 2.3) was a net-stereoretentive chlorination.  Activation 
and displacement of a bridging alcohol on a norbornene skeleton with retention of 
stereochemistry is precedented when the alcohol is orientated opposite of a pi-system, 
such as 139.18  Consistent with these expectations, chloride 131b was isolated in 70% 
yield when alcohol 139 was subjected to thionyl chloride with triethylamine in 
tetrahydrofuran (Table 2.3, Entry 1).  A minor byproduct of the reaction was the 
formation of chlorobutylether 172, resulting from incorporation of one equivalent of the 
solvent.  Accordingly, the yield was improved upon switching to the non-nucleophile 
solvent dichloromethane (Entry 2), and further improved to 97% upon removing 
triethylamine base (Entry 3).   
 
Table 2.3.  Chlorination of alcohol 139. 
 
 
The stereoretentive displacement of anti-norbornene alcohol 139 is presumably the 
result of pi-bond anchimeric assistance, to generate non-classical carbocation 173 after  
 
Scheme 2.34 
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activation with thionyl chloride (Scheme 2.34).  Any nucleophile is then introduced anti 
to the pi-system in order to return the electron density back to the alkene within 174.*,†   
 
2.3 Discussion of Effects that Affect the Thermodynamic Ratio 
 Over the course of the studies toward accessing the chlorocyclopentane core of the 
original (1a) and revised (1b) structures of palau’amine, via the [3,3]-sigmatropic 
rearrangement of tricyclodecadienes, many different rearrangement substrates were 
prepared and the corresponding rearrangements observed.  As a result of these studies, 
four categories of substituent effects that affect the equilibrium position have been 
identified: eclipsing strain, angle strain, ring strain, and resonance conjugation.  
Frequently, multiple effects affect the thermodynamic ratio for a specific example, 
making it difficult to distinguish separate issues.  Table 2.4 contains several examples of  
these substituent effects, where structures A represent the initial unrearranged structure in 
each example and structures B represent the corresponding rearrangement isomer.  The 
boxed compounds represent those that are observed after the thermodynamic ratio is 
achieved.   
 In Entry 1, both isomers A and B possess conjugative resonance stabilization 
resulting in a net approximate cancelation.  However, the angle strain within bridging 
ketone B, due to bond angle compression imposed by the bicyclic ring system, disfavors 
isomer B energetically resulting in an equilibrium position favoring A.  Entry 2 
represents the reduction of the ketone within Entry 1.  In this case, isomer A lacks any 
resonance stabilization and the previous destabilizing angle strain of isomer B that had 
been a dominating effect in Entry 1 has been removed; the result is that isomer B is now 
highly favored thermodynamically.  In Entry 3, isomers A and B possess an additional 
C16 substituent as compared to Entry 2, however, no carbonyls are present in either 
isomer resulting in no conjugative stabilization.  As a result, the dominant effect that 
influences the equilibrium position is the eclipsing strain disfavoring A, due to steric 
encumbrance surrounding the C16- and C24-alkyl substituents.  In Entry 4, isomers A  
                                                 
*
 No products of cationic rearrangements were observed. 
†
 Loss of the C17 chloride of 131b via pi-bond anchimeric assistance was observed at elevated temperatures 
with nucleophilic solvents.  The presence of the electron-withdrawing C23 ester attenuated this undesired 
reactivity as compared to unsubstituted alkene derivatives. 
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Table 2.4.  Discussion of thermodynamic parameters of  
the [3,3]-sigmatropic rearrangement of tricyclodecadienes. 
 
 
and B possess an additional C16 alkyl substituent as compared to Entry 1.  All of the 
same factors that influence Entry 1 apply equally, but now isomer A is destabilized due to 
the eclipsing strain between the two α-substituted quaternary stereocenters resulting in a 
shift in the equilibrium position toward isomer B; however, the influence of the eclipsing 
strain is relatively minor as isomer A is still the predominant species at equilibrium.  In 
Entry 5, isomer A and B possess a similar arrangement of substituents compared to Entry 
2, including the C23 carbonyl; however, isomer A is constrained within a rigid lactone.  
Although isomer B does possess resonance conjugation, which is the major contributing 
factor in Entry 2, it would appear that the ring strain overpowers this effect as isomer A is 
favored by the equilibrium position.  Entry 6 as compared to Entry 5 removes the element 
of ring strain, which allows resonance conjugation to dominate the energy influences 
such that B the only observed isomer after equilibration.  A working knowledge and 
understanding of these substituent effects led to the efficient application of the 
[3,3]-sigmatropic rearrangement of tricyclodecadienes to access both the original and 
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revised chlorocyclopentane cores of palau’amine wherein the desired rearranged products 
were favored exclusively by the equilibrium position.   
 
2.4 Discussion of Effects that Affect the Kinetic Rate 
 An important feature for implementing a successful [3,3]-sigmatropic 
rearrangement strategy towards to the chlorocyclopentane cores of the original (1a) and 
revised (1b) structures of palau’amine was the ability to successfully manipulate 
intermediates when the rearrangement was not desired and, conversely, allow for a facile 
rearrangement under mild conditions when the rearrangement was desired.  The rate of 
isomerization for the [3,3]-sigmatropic rearrangements varied greatly for the substrates 
studied and representative examples are illustrated in Table 2.5.  The presence of the C23 
carbonyl that could participate in resonance conjugation was the most dominant 
substituent effect observed with respect to increasing the rate of equilibration.  Entry 1 
represents an example that is primed to undergo a quick equilibration.  Intermediates like  
 
Table 2.5.  Discussion of kinetic parameters of  
the [3,3]-sigmatropic rearrangement of tricyclodecadienes. 
 
 
137 have never been observed experimentally during the course of these studies.  
Importantly, isomer A (137) possesses a C23 carbonyl that participates in resonance 
conjugation not only in isomer B, but also influences the rate; for as the new pi-bond is 
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formed during the rearrangement, the conjugative stabilization that lowers the ground 
state of isomer B manifests itself in the transition state, therefore lowering the kinetic 
barrier for the rearrangement.  The additional C16-alkyl substituent also likely increases 
the rate of equilibration, as illustrated more clearly with Entry 4.  In Entry 2, isomers A 
and B differ from 137 and 139 of Entry 1 only by the absence of the C16-alkyl 
substituent.5c  This change results in a moderate rate of equilibration at room temperature 
that is detectable over the course of a couple of hours.  In Entry 3, isomers A and B differ 
from Entry 1 by replacement of the alcohol with a ketone.  Although this increases the 
resonance conjugation for isomer A, it appears to retard the rate of isomerization such 
that the rearrangement is slow at room temperature requiring two weeks to achieve the 
thermodynamic ratio, which is significantly slower than the rate observed for the related 
ketones 107 and 108 (Scheme 2.5).  In Entry 4, isomers A and B lack any conjugation 
and differ from 137 and 139 of Entry 1 only by replacement of the C23-ester for a 
C23-alkoxy substituent.  This lack of conjugation resulted in no evidence of equilibration 
at room temperature and required 6 hours at 80 °C to reach equilibrium.  Although slower 
than the previous three examples, the rate of Entry 4 is faster than that observed by 
Woodward for a similar endo-alcohol 105 (Scheme 2.4) lacking the C16- and C23-alkyl 
substituents.  This alkyl substituent effect is likely the leading factor for the observed rate 
differences between Entry 4 and alcohols 105/106 (Scheme 2.4) as well as between 
Entries 1 and 2.  The alkyl substituent effect possibly results from minor bond angle 
distortions of the tricyclodecadiene skeleton, due to steric repulsion of the additional 
alkyl substituents, that constrains the conformation of the 1,5-diene system closer to the 
transition state necessary for the rearrangement. 
 
2.5 Summary 
The [3,3]-sigmatropic rearrangement of tricyclodecadienes has been explored and 
evaluated for the formation of the chlorocyclopentane core of the original (1a) and 
revised (1b) structures of palau’amine.  The studies have resulted in a better 
understanding of the substituent effects that affect both the thermodynamic and kinetic 
parameters.  Multiple methods were developed to allow for manipulation of the 
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tricyclodecadiene skeleton followed by triggering the rearrangement in a controlled 
manner when desired.  
A divergent synthetic route has been developed that allows access to the 
chlorocyclopentane core (Ring E) of the original (1a) and revised (1b) structures of 
palau’amine in only three and two steps, respectively, from common ketone 109, which 
in turn is available in four steps from commercially available benzoquinone (132) 
(Scheme 2.35).  The key steps involve a simple Diels-Alder cycloaddition to quickly 
establish the four stereogenic centers of 109 and a [3,3]-sigmatropic rearrangement to 
generate the chlorocyclopentanes 131a and 131b in selective manners.  Attempts to 
alkylate dicyclopentadiendione derivatives was not successful, but 2-carboethoxy-
tricyclo[5.2.1.0]decadienone (109) allowed access to fully substituted ketone 129. 
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Multiple avenues toward the chlorocyclopentane core of 1a (i.e., 131a) were 
explored using different methods to trigger the sigmatropic rearrangement and selectively 
introduce the C17-chloro substituent.  Ultimately, the most successful route involved 
temporarily masking the C18-19 alkene of 129 in order to prevent the rearrangement and 
allow for introduction of the chloride substituent in a stereo- and regioselective manner, 
followed by triggering the rearrangement by regeneration of the alkene.  The 
chlorocyclopentane core of 1b (i.e., 131b) was accessed via capitalization of Curtin-
Hammett energy profile to chemoselectively generate alcohol 139.  Chlorocyclopentane 
131b was then synthesized via a net-stereoretentive chlorination.  Successful access to 
the cyclopentane cores of both the original and revised structures of palau’amine provides 
the opportunity to further pursue the daunting synthetic challenge that is palau’amine. 
 
2.6 Experimental 
General Procedures.  All reactions were performed in flame-dried round bottom 
or modified Schlenk (Kjeldahl shape) flasks fitted with rubber septa or glass stoppers 
under a positive pressure of argon, unless otherwise noted.  Air- and moisture-sensitive 
liquids and solutions were transferred via syringe or stainless steel cannula.  Organic 
solutions were concentrated by rotary evaporation below 30 °C at ca. 25 Torr.  Flash 
column chromatography was performed employing 230-400 mesh silica gel.  Thin-layer 
chromatography (analytical and preparative) was performed using glass plates precoated 
to a depth of 0.25 mm with 230-400 mesh silica gel impregnated with a fluorescent 
indicator (254 nm).  Reaction temperatures were maintained through the use of the 
following baths unless stated otherwise:  above ambient temperature (oil bath), 0 °C 
(ice/water), -78 °C (dry ice/acetone). 
Materials.  Commercial reagents and solvents were used as received with the 
following exceptions:  tetrahydrofuran, benzene, acetonitrile, dimethoxyethane, diethyl 
ether, toluene, and dichloromethane were dried by passage through activated alumina 
columns under a positive pressure of argon.  Ethanol, 1,2-dichloroethane, dimethyl 
formamide, and dimethylsulfoxide was dried over activated 4 Å molecular sieves.  
Triethylamine, pyridine, and methanol were distilled from calcium hydride at 760 Torr.   
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Instrumentation.  Infrared (FTIR) spectra were obtained using a Perkin-Elmer 
Spectrum BX or a Bruker Tensor 27 spectrophotometer and referenced to a polystyrene 
standard.  Data are presented as the frequency of absorption (cm-1), and intensity of 
absorption (s = strong, m = medium, w = weak, br = broad).  Proton and carbon-13 
nuclear magnetic resonance (1H NMR and 13C NMR) spectra were recorded on a Varian 
Unity 400, Varian Unity 500, Varian Unity Inova 500NB NMR or Bruker Avance III 500 
spectrometer.  Chemical shifts are expressed in parts per million (δ scale) downfield from 
tetramethylsilane and are referenced to residual protium in the NMR solvent (CHCl3: δ 
7.26 for 1H, δ 77.16 for 13C; C6HD5: δ 7.16 for 1H, δ 128.06 for 13C; CHD2OD: δ 3.31 for 
1H, δ 49.00 for 13C).  Data are presented as follows:  chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quadruplet, ABq = non-first order quadruplet, p = 
pentet, br = broadened signal, m = multiplet and/or multiple resonances), integration, and 
coupling constants in Hertz (Hz).  1H NMR assignments were generally supported by 
COSY experiments. 
The following compounds were prepared according to literature methods 
referenced within the text: dioxime 117, dicyclopentadienedione (112), ketal 118, ketal 
alcohol 119, hydroquinone 133, epoxide 134, cyclopentenone 109. 
 
 
 
1-Chloro-8,8-dioxalane-3a,4,7,7a-tetrahydro-1H-4,7-methano-indene (113) and 
1’-hydroxy-8,8-dioxalane-3a,4,7,7a-tetrahydro-1H-4,7-methano-indene (120), 
(MSB-II-099).  To a solution of alcohol 119 (0.125 g, 0.607 mmol, 1 equiv) in a mixture 
of diethyl ether: tetrahydrofuran (4: 1.5 mL) at 23 °C was added pyridine (137 µL, 
1.70 mmol, 2.8 equiv) and thionyl chloride (48.6 µL, 0.667 mmol, 1.1 equiv).  A 
precipitate was immediately formed.  After 15 min the reaction was filtered through a 
plug of celite and the solvent was removed in vacuo to afford only chloride 113.  The 
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residue was purified by silica gel flash chromatography (33% hexane in ethyl acetate) to 
afford chloride 113 (0.100 g, 75%) and alcohol 120 (23 mg, 11%) as white solids.   
Chloride (113).  Rf  0.73 (20% hexane in ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 
6.07 (dd, 1H, J = 3.0, 6.5 Hz, CHCH=CHCH), 6.00 (dd, 1H, J = 3.0, 6.0 Hz, 
CHCH=CHCH), 5.74 (d, 1H, J = 5.0 Hz, CHCH=CHCHClCH), 5.70 (d, 1H, J = 5.5 Hz, 
CHCH=CHCHClCH), 4.38 (s, 1H, CHCH=CHCHClCH), 3.91 (m, 2H, OCH2CH2O), 
3.84 (m, 2H, OCH2CH2O), 3.69 (br s, 1H, CHCH=CHCHClCH), 3.18 (m, 1H, 
CHCH=CHCHClCH), 2.94 (s, 1H, CHCH=CHCH), 2.69 (br s, 1H, CHCH=CHCH);  13C 
NMR (125 MHz, C6D6) δ 135.8, 135.2, 134.2, 130.1, 127.5, 65.6, 65.1, 64.6, 52.6, 51.1, 
49.7, 49.2;  IR (neat film) 2975 (m), 2884 (m), 1299 (s), 1284 (s), 1097 (s), 1079 (s);  
LRMS (EI) 224. 
Alcohol (120).  Rf  0.23 (20% hexane in ethyl acetate); 1H NMR (500 MHz, CDCl3) δ 
6.06 (dq, 1H, J = 1.5, 3.5 Hz, CH=CHCHCHCHOH), 5.97 (dq, 1H, J = 1.0, 3.5 Hz, 
CH=CHCHCHCHOH), 5.73 (m, 2H, HOCHCH=CHCHCH), 4.16 (d, 1H, J = 5.5 Hz, 
HOCHCH=CHCHCH), 3.95 (m, 2H, OCH2CH2O), 3.84 (m, 2H, OCH2CH2O), 3.60 (m, 
1H, HOCHCH=CHCHCH), 2.91 (t, 1H, J = 3.5 Hz, CH=CHCHCHCHOH), 2.71 (m, 1H, 
CH=CHCHCHCHOH), 2.65 (m, 1H, HOCHCH=CHCHCH), 1.39 (d, 1H, J = 8.0 Hz, 
HOCHCH=CHCHCH);  IR (neat film) 3394 (s), 3056 (w), 2971 (m), 2884 (m), 1299 (s), 
1284 (s), 1105 (s), 1079 (s), 1017 (s);  LRMS (EI) 207. 
 
 
 
8-Hydroxy-3a,4,7,7a-tetrahydro-4,7-methano-inden-1-one (122), (MSB-II-036).  A 
solution of chloride 113 (1.2 mg, 0.0053 mmol) in a mixture of glacial acetic acid: water 
(0.2:0.2 mL) was heated up to 100 °C.  After 45 min the reaction was cooled to room 
temperature and quenched with saturated sodium bicarbonate solution (10 mL) and 
extracted with dichloromethane (3 x 10 mL).  The combined organic layers were then 
dried (sodium sulfate), filtered, and concentrated in vacuo to afford alcohol 122 (0.8 mg, 
83%) as a clear oil.  Spectral data match previously reported values.6b 
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8-Hydroxy-3a,4,7,7a-tetrahydro-4,7-methano-inden-1-one (122), (MSB-II-035).  A 
solution of alcohol 120 (23 mg, 0.112 mmol) in a mixture of glacial acetic acid: water 
(1:1 mL) was heated up to 100 °C.  After 3 hr the reaction was cooled to room 
temperature and quenched with saturated sodium bicarbonate solution (10 mL) and 
extracted with dichloromethane (3 x 10 mL).  The combined organic layers were then 
dried (sodium sulfate), filtered, and concentrated in vacuo to afford alcohol 122 (6.5 mg, 
36%) as a clear oil.  Spectral data match previously reported values.6b 
 
 
 
8-Chloro-3a,4,7,7a-tetrahydro-4,7-methano-inden-1-one (115), (MSB-II-150).  To a 
solution of chloride 113 (20 mg, 0.089 mmol, 1 equiv) in acetonitrile (1 mL) was added 
sodium chloride (0.01 mg, 0.178 mmol, 2 equiv) and boron trifluoride diethyl etherate 
(22 µL, 0.178 mmol, 2 equiv).  The solution turned yellow and was heated to 90° C when 
it changed to blue and then black.  After 5.5 hr the reaction was diluted with dilute 
sodium bicarbonate solution (30 mL) and extracted with dichloromethane (3 x 30 mL).  
The combined organic layers were then dried (sodium sulfate), filtered, and concentrated 
in vacuo. The residue was purified by silica gel flash chromatography (33% hexane in 
ethyl acetate) to afford chloride 115 (4.5 mg, 28%) as a clear oil.  
Rf  0.54 (50% hexane in ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.38 (dd, 1H, J = 
2.5, 5.5 Hz, O=CCH=CH), 6.10 (dd, 1H, J = 1.5, 5.5 Hz, O=CCH=CH), 5.93 (dd, 1H, J = 
2.5, 5.0 Hz, O=CCHCHCH=CHCHCH), 5.78 (d, 1H, J = 3.0, 5.5 Hz, 
O=CCHCHCH=CHCHCH), 4.07 (br s, 1H, ClCH), 3.41 (m, 2H, 
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O=CCHCHCH=CHCHCH), 3.22 (m, 1H, O=CCHCHCH=CHCHCH), 2.82 (t, 1H, J = 
5.0 Hz, O=CCHCHCH=CHCHCH);  IR (neat film) 2975 (w), 1695 (s), 1580 (w), 1339 
(m), 754 (s);  HRMS (EI) m/z calcd for C10H9OCl (M)+ 180.0342, observed 180.0345. 
 
 
 
4,7,7',7'a-Tetrahydro-3aH,4'H-[1,3'a]bi[4,7-methano-indenyl]-8,3',8'-trione (128), 
(MSB-II-010).  A solution of lithium hexamethyldisilizane (0.063 g, 0.376 mmol, 
1.2 equiv) in tetrahydrofuran (2.1 mL) was prepared at –78 °C.  To this was added via 
cannula a solution of ketone 112 (0.05 g, 0.313 mmol, 1 equiv) in tetrahydrofuran 
(2.1 mL) at -78 °C in portions.  After stirring for 1 hr a solution of acetic acid-d (90 µL, 
1.565 mmol, 5 equiv) in tetrahydrofuran (0.35 mL) was added and allowed to warm to 
room temperature.  The reaction mixture was diluted with water (50 mL) and extracted 
with diethyl ether (3 x 50 ml).  The combined organic layers were then dried (magnesium 
sulfate), filtered, and concentrated in vacuo.  The residue was then dissolved in boiling 
ethyl acetate and cooled to -30 °C.  The resulting crystals were collected to afford 
triketone 128 (9.0 mg, 20 %) as white crystals.   
Rf  0.46 (20% hexane in ethyl acetate); 1H NMR (500 MHz, CDCl3) δ 7.44 (q, 1H, J = 
3.0 Hz, CHCH=CHCHCHCH=CHCO), 6.53 (q, 1H, J = 3.0 Hz, 
C=CCHCH=CHCHCHCH=CH), 6.41 (ddd, 1H, J = 1.0, 4.0, 6.5 Hz 
CHCH=CHCHCHCH=CHCO) 6.37 (d, 1H, J = 4.5 Hz, CHCH=CHCHCHCH=CHCO), 
6.17 (ddd, 1H, J = 1.0, 3.5, 6.5 Hz, CHCH=CHCHCHCH=CHCO), 6.06 (q, 1H, J = 3.5 
Hz, C=CCHCH=CHCHCHCH=CH), 5.75 (d, 1H, J = 4.5 Hz, 
C=CCHCH=CHCHCHCH=CH), 5.53 (dd, 1H, J = 2.0, 5.5 Hz, 
C=CCHCH=CHCHCHCH=CH), 3.58 (br s, 1H, CHCH=CHCHCHCH=CHCO), 3.41 
(m, 1H, C=CCHCH=CHCHCHCH=CH), 3.38 (br s, 1H, CHCH=CHCHCHCH=CHCO), 
3.22 (m, 1H, CHCH=CHCHCHCH=CHCO), 3.11 (m, 1H, 
C=CCHCH=CHCHCHCH=CH), 2.94 (br s, 1H, C=CCHCH=CHCHCHCH=CH);  IR 
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(neat film) 3071 (w), 2956 (m), 1777 (s), 1694 (s), 1106 (m);  HRMS (ESI) m/z calcd for 
C20H15O3 (M+H)+ 303.1021, observed 303.1031. 
 
 
 
6,7-Epoxy-1,4,4a,6,7,8a-hexahydro-1,4-methano-naphthalene-5,8-dione (134), 
(MSB-II-191).  To a solution of dienone 133 (1.88 g, 0.0108 mol, 1 equiv) in ethanol 
(6 mL, 190 proof) and acetone (2.5 mL) at 0 °C was added a solution of hydrogen 
peroxide (30% in water, 4.0 mL, 0.039 mol, 3.5 equiv) and a solution of sodium 
carbonate (1.0 g, 0.0094 mol, 0.9 equiv) in water (4.0 mL) simultaneously.  The reaction 
effervesced and formed an off-white precipitate over the course of 30 min, at which time 
no starting material was observed by TLC analysis.  The solution was diluted with water 
(200 mL) and extracted with diethyl ether (3 x 100 ml).  The combined organic layers 
were then dried (magnesium sulfate), filtered, and concentrated in vacuo to afford 
epoxide 134 (1.95 g, 95%) as a white highly crystalline solid, which was of high purity 
(>95%) and could be used directly in the following step.  
Rf  0.70 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 6.06 (br s, 2H, 
CHCH=CHCH), 3.52 (s, 2H, CHOCH), 3.44 (s, 2H, CHCHCHCH), 3.33 (br s, 2H, 
CHCH=CHCH), 1.49 (dt, 1H, J = 1.7, 8.7 Hz, CH2), 1.29 (br d, 1H, J = 8.7 Hz, CH2);  
13C NMR (125 MHz, CDCl3) δ 204.3, 136.8, 58.0, 49.6, 46.5, 43.4;  IR (neat film) 2983 
(w), 2939 (w), 1709 (s), 1340 (w), 1287 (w), 1224 (s), 1042 (w), 800 (m), 737 (m) cm-1;  
LRMS (ESI) m/z for C11H9O3, (M-H)- 188.92.  All spectra data matched that as 
previously reported.10 
 
 
 
 
 68 
 
 
Ethyl 5-oxo-tricyclo[5.2.1.0]deca-3,8-diene-2-carboxylate (109), (MSB-II-261).  To a 
solution of epoxide 134 (15.4 g, 0.081 mol, 1 equiv) in ethanol (200 proof, 390 mL) at 
23 °C was added a solution of sodium hydroxide (1.62 g, 0.04 mol, 0.5 equiv) in ethanol 
(200 proof, 10 mL).  The solution instantly turned deep purple and then dark brown.  
After stirring for 3 hr, 2/3’s of the volume of ethanol was removed in vacuo; the resulting 
solution was diluted with water (1 L) and extracted with diethyl ether (5 x 400 ml).  The 
combined organic layers were then dried (magnesium sulfate), filtered, and concentrated 
in vacuo to afford enone 109 (10.39 g, 60%) as a brown oil, which was of high purity 
(>95%) and could be used directly in the following step.   
Rf  0.52 (1:1 benzene: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.39 (d, 1H, J = 5.7, 
O=CH=CH), 6.02 (dd, 1H, J = 2.8, 5.6 Hz, CHCH=CHCH), 5.95-5.93 (m, 2H, 
O=CH=CH, CHCH=CHCH), 4.22 (q, 2H, J = 7.2 Hz, OCH2CH3), 3.32 (s, 1H, 
CHCHCH=CHCH), 3.30 (br s, 1H, CHCHCH=CHCH), 3.22 (br s, 1H, 
CHCHCH=CHCH), 1.94 (br d, 1H, J = 8.8 Hz, CH2), 1.74 (dt, 1H, J = 1.6, 8.8 Hz, CH2), 
1.30 (t, 3H, J = 7.2 Hz, OCH2CH3);  13C NMR (125 MHz, CDCl3) δ 208.7, 173.0, 161.8, 
136.3, 134.9, 133.7, 64.6, 61.8, 54.3, 51.3, 49.8, 45.8, 14.3;  IR (neat film) 2996 (w), 
2966 (m), 2933 (w), 1714 (s), 1340 (w), 1190 (w), 847 (m), 736 (m) cm-1;  LRMS (ESI) 
m/z for C13H15O3, (M+H)+ 219.07.  All spectra data matched that as previously 
reported.5d,11 
 
 
 
7a-Benzyloxymethyl-1-oxo-1,4,7,7a-tetrahydro-4,7-methano-indene-3a-carboxylic 
acid ethyl ester (129), (MSB-III-269).  A solution of lithium hexamethyldisilizane 
(2.5 g, 0.015 mol, 1.5 equiv) in tetrahydrofuran (35 mL) was prepared at -78 °C.  To this 
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was added via cannula a solution of ketone 109 (2.19 g, 0.1 mmol, 1 equiv) in 
tetrahydrofuran (36 mL) at -78 °C in portions.  After stirring for 45 min a solution of 
benzyloxymethyl chloride (2.6 mL, 0.017 mol, 1.7 equiv) in tetrahydrofuran (10 mL) at 
-78 °C was added via cannula.  After 30 min the solution was allowed to warm to -20 °C, 
then quenched after 30 min with saturated ammonium chloride (500 mL) and extracted 
with diethyl ether (3 x 250 ml).  The combined organic layers were then dried 
(magnesium sulfate), filtered, and concentrated in vacuo.  The residue was purified by 
silica gel flash chromatography (gradient 8:1 to 6:1 benzene: ethyl acetate) to afford 
enone 129 (1.84 g, 53%) as yellow crystals.  
Rf  0.55 (5:1 benzene: ethyl acetate);  1H NMR (400 MHz, CDCl3) δ 7.50 (d, 1H, J = 6.0 
Hz, O=CCH=CH), 7.23 (m, 5H, C6H5CH2OCH2), 6.04 (dd, 1H, J = 3.1, 5.5 Hz, 
CHCH=CHCH), 6.01 (d, 1H, J = 6.0 Hz, O=CCH=CH), 5.92 (dd, 1H, J = 3.0, 5.5 Hz, 
CHCH=CHCH), 4.37 (ABq, 2H, J = 12.1, 18.0 Hz, C6H5CH2OCH2), 4.11 (dq, 1H, J = 
7.2, 10.8 Hz, OCH2CH3), 4.03 (d, 1H, J = 8.6 Hz, C6H5CH2OCH2), 3.91 (dq, 1H, J = 7.2, 
10.8 Hz, OCH2CH3), 3.75 (d, 1H, J = 8.6 Hz, C6H5CH2OCH2), 3.06 (br s, 1H, 
CHCH=CHCH), 2.80 (d, 1H, J = 9.0 Hz, CH2), 2.76 (br s, 1H, CHCH=CHCH),  1.71 (dt, 
1H, J = 1.5, 9.0 Hz, CH2), 1.13 (t, 3H, J = 7.2 Hz, OCH2CH3);  13C NMR (125 MHz, 
CDCl3) δ 209.5, 172.8, 163.0, 138.2, 135.8, 134.4, 128.2, 127.3, 127.1, 73.2, 72.7, 65.3, 
63.1, 61.4, 51.0, 50.6, 48.6, 14.0;  IR (neat film) 2977 (w), 2863 (w), 1712 (s), 1453 (m), 
1235 (s), 1092 (m) cm-1;  HRMS (ESI) m/z calcd for C21H23O4 (M+H)+ 339.1596, 
observed 339.1600. 
 
 
 
4-Benzyloxymethyl-8-oxo-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-carboxylic 
acid ethyl ester (136), (MSB-II-194).  Crystalline enone 129 was stable to 
rearrangement at room temperature for several months, however, in solution 129 was 
found to exist in a dynamic equilibrium with 1,5 diene isomer 136 under a variety of 
conditions.  It took 2 weeks for pure sample of 129 in d-benzene at 23 °C to achieve a 
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stable ratio of 72:28 of 129:136 respectively.  The same ratio was observed upon heating 
a pure sample of 129 in dichloromethane to 90 °C in a sealed tube for 15 min.  The most 
enriched sample of 136 was obtained via column chromatography (8:1 gradient to 6:1 
and then 2:1 benzene: ethyl acetate) as a 4:1 mixture of 136:129, respectively.   
Rf  0.72 (5:1 toluene: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.28 (m, 5H, 
C6H5CH2OCH2), 7.01 (d, 1H, J = 4.0 Hz, C=CHCHCHCH), 5.69 (dq, 1H, J = 2.5, 6.0 
Hz, CH2CH=CH), 5.33 (dq, 1H, J = 2.5, 6.0 Hz, CH2CH=CH), 4.65 (ABq, 2H, J = 12.0 
Hz, C6H5CH2OCH2), 4.15 (dd, 1H, J = 7.4, 10.5 Hz, OCH2CH3), 4.08 (dd, 1H, J = 7.4, 
10.5 Hz, OCH2CH3), 4.03 (d, 1H, J = 9.5 Hz, C6H5CH2OCH2), 3.93 (d, 1H, J = 10.0 Hz, 
C6H5CH2OCH2), 3.52-3.48 (m, 1H, C=CHCHCHCH), 3.20 (t, 1H, J = 4.3 Hz, 
C=CHCHCHCH), 2.65 (ddd, 1H, J = 3.8, 9.0, 9.9 Hz, C=CHCHCHCH), 2.29 (ddq, 1H, J 
= 2.1, 9.8, 17.6 Hz, CH2CH=CH), 2.12-2.06 (m, 1H, CH2CH=CH), 1.19 (t, 3H, J = 7.3 
Hz, OCH2CH3);  HRMS (ESI) m/z calcd for C21H23O4 (M+H)+ 339.1596, observed 
339.1602. 
 
 
 
4-Benzyloxymethyl-8-hydroxy-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic acid ethyl ester (139), (MSB-II-214).  To a solution of ketone 129 (2.0 mg, 
0.006 mmol, 1.0 equiv) in tetrahydrofuran (0.2 mL) at -45 °C was added a solution of 
diisobutyl aluminumhydride (1.0 M in hexanes, 65 µL, 0.065 mmol, 10 equiv).  After 
stirring for 40 min the reaction was quenched with saturated ammonium chloride solution 
(10 mL) and allowed to warm to room temperature.  The solution was extracted with 
dichloromethane (3 x 10) and the combined organic layers were then dried (sodium 
sulfate), filtered, and concentrated in vacuo to afford alcohol 139 (1.5 mg, 95% pure 
based on 1H NMR).  The material was used without purification.   
Rf  0.49 (20% ethyl acetate in benzene);  1H NMR (500 MHz, CDCl3) δ 7.34 (m, 5H, 
C6H6CH2O), 6.80 (d, 1H, J = 4.0 Hz, C=CHCHCH), 5.50 (m, 1H, CH=CHCH2CH), 4.48 
(q, 2H, J = 12.0 Hz, PhCH2O), 4.20 (d, 1H, J = 9.5 Hz, CCH2O), 4.15 (d, 1H, J = 10.0 
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Hz, CCH2O), 4.13 (m, 2H, CH3CH2O), 3.85 (br s, 1H, CHOH), 3.74 (m, 1H, 
C=CHCHCH), 3.25 (d, 1H, J = 1.5 Hz, CHOH), 3.16 (m, 1H, CH=CHCH2CH), 2.90 (m, 
1H, C=CHCHCH), 2.25 (m, 1H, CH=CHCH2CH), 1.90 (m, 1H, CH=CHCH2CH), 1.25 
(t, 3H, J = 7.0 Hz, CH3CH2O);  13C NMR (125 MHz, CDCl3) δ 164.8, 146.5, 138.2, 
135.7, 132.9, 130.2, 128.6, 127.8, 127.7, 87.6, 73.8, 60.2, 59.6, 54.0, 50.0, 39.1, 32.6, 
14.3;  IR (neat film) 3323 (w), 2930 (w), 1709 (s), 1235 (m), 1099 (s), 737 (m) cm-1.  
HRMS (ESI) m/z calcd for C21H25O4 (M+H)+ 341.1753, observed 341.1763. 
 
 
 
4-Benzyloxymethyl-8-chloro-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic acid ethyl ester (131a) and 4-benzyloxymethyl-8'-chloro-3a,4,7,7a-
tetrahydro-3H-4,7-methano-indene-5-carboxylic acid ethyl ester (131b) and chloride 
140, (MSB-III-077).  To a solution of ketone 129 (0.10 g, 0.296 mmol, 1 equiv) in 
tetrahydrofuran (15 mL) was added diisobutylaluminum hydride (0.59 mL,  0.355 mmol, 
1.2 equiv, 0.6 M solution in hexanes) at -60 °C and warmed to -45 °C.  Three portions of 
diisobutylaluminum hydride (200 µL) were added every 45 min with the same 
temperature cycles until starting material was consumed.  The solution was then cooled to 
-78 °C and pyridine (72 µL, 0.888 mmol, 3.0 equiv) and thionyl chloride (170 µL, 
1.48 mmol, 5.0 equiv) were added, upon which the reaction turned yellow and 
effervesced.   The reaction was then warmed to room temperature and diluted with 
saturated sodium potassium tartrate solution (100 mL) and extracted with 
dichloromethane (3 x 100 mL). The combined organic layers were then dried (sodium 
sulfate), filtered, and concentrated in vacuo.  1H NMR analysis of the crude residue 
showed a 0.71:1.0:0.30:0.24 ratio of products (129:140:131a:139).  The residue was 
purified by silica gel flash chromatography (dichloromethane) to afford chloride 131a 
(0.014 g, 13%) and 131b (0.030 g, 28%) as a clear oils.   
Chloride 131a.  Rf  0.56 (dichloromethane);  1H NMR (400 MHz, CDCl3) δ 7.36 (m, 5H, 
C6H5CH2OCH2), 6.86 (dd, 1H, J = 1.5, 3.5 Hz, C=CHCHCHCH), 5.57 (dq, 1H, J = 2.0, 
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5.5 Hz, CH2CH=CH), 5.43 (dq, 1H, J = 2.0, 5.5 Hz, CH2CH=CH), 4.61 (ABq, 2H, 
C6H5CH2OCH2), 4.32 (d, 1H, J = 10.0 Hz, C6H5CH2OCH2), 4.15 (m, 3H, CHCl, 
OCH2CH3), 3.90 (d, 1H, J = 10.0 Hz, C6H5CH2OCH2), 3.39 (m, 1H, C=CHCHCHCH), 
3.21 (t, 1H, J = 3.5 Hz, C=CHCHCHCH), 3.09 (m, 1H, C=CHCHCHCH), 2.26 (ddq, 1H, 
J = 2.0, 8.5, 18.0 Hz, CH2CH=CH), 1.87 (m, 1H, CH2CH=CH), 1.26 (t, 3H, J = 7.0 Hz, 
OCH2CH3);  13C NMR (100 MHz, CDCl3) δ 164.8, 146.6, 138.7, 134.4, 134.0, 130.1, 
129.2, 128.2, 127.5, 75.5, 73.4, 66.1, 63.2, 60.2, 52.5, 51.2, 38.2, 34.0, 14.1;  IR (neat 
film) 2917 (w), 2852 (w), 1709 (s), 1454 (m), 1276 (s), 1090 (s) cm-1;  HRMS (ESI) m/z 
calcd for C21H24O3Cl (M+H)+ 359.1424, observed 359.1414. 
Allylic chloride 140.  Rf  0.53 (chloroform);  1H NMR (400 MHz, CDCl3) δ Key signals 
6.39 (dd, 1H, J = 3.0, 5.5 Hz, CHCH=CHCH), 5.96 (dd, 1H, J = 3.0, 5.5 Hz, 
CHCH=CHCH), 5.62 (s, 2H, CH=CHCHCl), 5.17 (s, 1H, CH=CHCHCl). 
Chloride 131b.  Rf  0.47 (dichloromethane);  1H NMR (400 MHz, CDCl3) δ 7.31 (m, 5H, 
C6H5CH2OCH2), 6.81 (d, 1H, J = 3.5 Hz, C=CHCHCHCH), 5.51 (dq, 1H, J = 2.0, 
6.0 Hz, CH2CH=CH), 5.47 (dq, 1H, J = 2.0, 5.5 Hz, CH2CH=CH), 4.59 (d, 1H, J = 12.5 
Hz, C6H5CH2OCH2), 4.51 (d, 1H, J = 12.0 Hz, C6H5CH2OCH2), 4.17 (m, 4H, 
C6H5CH2OCH2, OCH2CH3, CHCl), 3.79 (m, 1H, C=CHCHCHCH), 3.66 (dd, 1H, J = 1.0, 
9.5 Hz, C6H5CH2OCH2), 3.05 (m, 1H, C=CHCHCHCH), 2.78 (m, 1H, C=CHCHCHCH), 
2.20 (ddq, 1H, J = 2.0, 10.0, 17.5 Hz, CH2CH=CH), 2.23 (m, 1H, CH2CH=CH), 1.26 (t, 
3H, J = 7.0 Hz, OCH2CH3);  13C NMR (100 MHz, C6D6) δ 164.4, 144.7, 139.1, 137.6, 
128.2, 73.4, 71.6, 66.6, 62.9, 60.0, 53.7, 50.3, 39.9, 32.4, 14.0;  IR (neat film) 2917 (w), 
2852 (w), 1713 (s), 1454 (w), 1272 (s), 1111 (s) cm-1;  HRMS (ESI) m/z calcd for 
C21H24O3Cl (M+H)+ 359.1424, observed 359.1414. 
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7a-Benzyloxymethyl-3a-hydroxymethyl-3a,4,7,7a-tetrahydro-1H-4,7-methano-
inden-1-ol (148), (MSB-II-213).  To a solution of ketone 129 (0.161 g, 0.476 mmol, 
1 equiv) in dichloromethane (4.76 mL) at -78 °C was added diisobutylaluminum hydride 
solution (1.0 M in hexanes, 2.86 mL, 2.86 mmol, 6.0 equiv).  After 35 min, an additional 
portion of diisobutylaluminum hydride solution (1 mL) was added.  After 1 hr the 
reaction was diluted with saturated ammonium chloride (50 mL) and allowed to warm up 
to room temperature.  The aqueous layer was extracted with dichloromethane (3 x 
50 mL) and the combined organic layers were dried (sodium sulfate), filtered, and 
concentrated in vacuo. The residue was purified by silica gel flash chromatography (2:1 
ethyl acetate: hexanes) to afford diol 148 (0.99 g, 70%) as a clear oil.   
Rf  0.47 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.32 (m, 5H, 
C6H6CH2OCH2), 6.23 (dd, 1H, J = 3.0, 5.5 Hz, CHCH=CHCH), 5.93 (dd, 1H, J = 3.0,6.0 
Hz, CHCH=CHCH), 5.62 (dd, 1H, J = 2.0, 6.0 Hz, HOCHCH=CH), 5.46 (dd, 1H, J = 
1.5, 5.5 Hz, HOCHCH=CH), 4.81 (d, 1H, J = 6.5 Hz, HOCHCH=CH), 4.56 (s, 2H, 
C6H6CH2OCH2), 3.78 (m, 4H, C6H6CH2OCH2, CCH2OH), 3.40 (dd, 1H, J = 4.0, 9.0 Hz, 
CCH2OH), 2.69 (br s, 1H, CHCH=CHCH), 2.54 (br s, 1H, CHCH=CHCH), 1.85 (d, 1H, 
J = 7.0 Hz, HOCHCH=CH), 1.72 (d, 1H, J = 9.0 Hz, CH2), 1.45 (d, 1H, J = 8.5 Hz, 
CH2);  13C NMR (100 MHz, CDCl3) δ 137.4, 137.3, 135.5, 133.9, 128.8, 126.3, 126.2, 
80.3, 76.3, 74.2, 68.2, 66.4, 58.2, 51.4, 49.5, 48.8;  IR (neat film) 3391 (s), 3060 (w), 
2961 (m), 2881 (m), 1454 (w), 1250 (m), 1067 (s), 747 (s) cm-1;  HRMS (ESI) m/z calcd 
for C19H21O2 (M+H)+ 281.1542, observed 281.1527. 
 
 
 
7a-Benzyloxymethyl-3a-(tert-butyl-dimethyl-silanyloxymethyl)-3a,4,7,7a-tetrahydro-
1H-4,7-methano-inden-1-ol (149), (MSB-II-256).  To a solution of diol 148 (0.170 g, 
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0.57 mmol, 1 equiv) in dimethylformamide (1.5mL) was added tert-butyldimethylsilyl 
chloride (103 mg, 0.68 mmol, 1.2 equiv) and imidazole (194 mg, 2.85 mmol, 5 equiv).  
After 50 min the reaction was diluted with saturated ammonium chloride (100 mL) and 
extracted with diethyl ether (3 x 75 mL).  The combined organic layers were dried 
(sodium sulfate), filtered, and concentrated in vacuo. The residue was purified by silica 
gel flash chromatography (gradient 5:1 to 2:1 to 1:1 hexanes: ethyl acetate) to afford silyl 
ether 149 (162 mg, 69%) as a clear oil.   
Rf  0.47 (2:1 hexanes: ethyl acetate);  1H NMR (400 MHz, CDCl3) δ 7.33 (m, 5H, 
C6H5CH2OCH2), 6.40 (dd, 1H, J = 4.0, 7.0 Hz, CHCH=CHCH), 5.89 (dd, 1H, J = 4.0, 
6.5 Hz, CHCH=CHCH), 5.56 (dd, 1H, J = 2.5, 7.0 Hz, HOCHCH=CH), 5.41 (dd, 1H, J = 
2.5, 7.0 Hz, HOCHCH=CH), 4.68 (m, 1H, HOCHCH=CH), 4.55 (q, 2H, J = 15.0, 
C6H5CH2OCH2), 3.68 (m, 4H, C6H5CH2OCH2, CH2OSi), 3.00 (br s, CHCH=CHCH), 
2.71 (br s, CHCH=CHCH), 1.85 (d, 1H, J = 11.0 Hz, CHCH2CH), 1.70 (d, 1H, J = 7.0 
Hz, HOCHCH=CH), 1.45 (d, 1H, J = 11.0 Hz, CHCH2CH), 0.85 (s, 9H, SiC(CH3)3), 0.00 
(s, 6H, Si(CH3)2);  13C NMR (100 MHz, CDCl3) δ 138.8, 137.1, 136.7, 135.8, 132.9, 
128.6, 127.8, 127.7, 127.7, 82.9, 76.4, 73.8, 67.6, 66.2, 58.2, 49.9, 48.1, 47.9, 26.0, 18.4, 
-5.3;  IR (neat film) 3443 (w), 2955 (s), 2856 (s), 1471 (m), 1077 (s), 838 (s) cm-1;  
HRMS (ESI) m/z calcd for C25H37O3Si (M+H)+ 413.2512, observed 413.2523. 
 
 
 
(7a-Benzyloxymethyl-3-chloro-3,4,7,7a-tetrahydro-4,7-methano-inden-3a-
ylmethoxy)-tert-butyl-dimethyl-silane (151) and (7a-Benzyloxymethyl-1-chloro-
1,4,7,7a-tetrahydro-4,7-methano-inden-3a-ylmethoxy)-tert-butyl-dimethyl-silane 
(150), (MSB-II-216).  To a solution of alcohol 149 (2 mg, 0.0048 mmol, 1.0 equiv) in 
tetrahydrofuran (0.1 mL) was added pyridine (1.1 µL, 0.0134 mmol, 2.8 equiv) and 
thionyl chloride (0.5 µL, 0.0053 mmol, 1.1 equiv) at 0 °C.  After 15 min the solvent was 
removed in vacuo to yield a 1:3 mixture of 150 and 151 (2 mg, 99%) as a clear oil.   
 75 
Chloride 151.  Rf  0.73 (2:1 hexanes: ethyl acetate);  1H NMR (400 MHz, CDCl3) δ 7.34 
(m, 5H, C6H5CH2OCH2), 6.35 (dd, 1H, J = 3.0, 5.5 Hz, CHCH=CHCH), 5.97 (dd, 1H, J 
= 3.5, 5.5 Hz, CHCH=CHCH), 5.55 (dd, 1H, J = 1.5, 5.5 Hz, ClCHCH=CH), 5.51 (dd, 
1H, J = 1.5, 5.5 Hz, ClCHCH=CH), 5.05 (t, 1H, ClCHCH=CH), 4.56 (ABq, 2H, J = 12.5, 
30.0, C6H5CH2OCH2), 3.83 (d, 1H, CH2OSi), 3.69 (m, 3H, CH2OSi, C6H5CH2OCH2), 
2.94 (br s, CHCH=CHCH), 2.79 (br s, CHCH=CHCH), 1.85 (d, 1H, J = 9.0 Hz, 
CHCH2CH), 1.44 (dt, 1H, J = 1.5, 8.5 Hz, CHCH2CH), 0.87 (s, 9H, SiC(CH3)3), 0.01 (s, 
6H, Si(CH3)2);  IR (neat film) 2955 (s), 2856 (s), 1486 (w), 1252 (m), 1078 (s), 838 (s), 
775 (s) cm-1;  HRMS (ESI) m/z calcd for C25H35O2Si (M-Cl)+ 395.2401, observed 
395.2406. 
Chloride 150.  Rf  0.73 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.18 
(m, 5H, C6H5CH2OCH2), 5.81 (dd, 1H, J = 3.5, 9.0 Hz, CHCH=CHCH), 5.74 (dd, 1H, J 
= 3.0, 9.5 Hz, CHCH=CHCH), 5.49 (dd, 1H, J = 2.5, 6.0 Hz, ClCHCH=CH), 5.39 (dd, 
1H, J = 0.5, 6.0 Hz, ClCHCH=CH), 4.58 (d, 1H, J = 11.5 Hz, C6H5CH2OCH2), 4.43 (t, 
1H, J = 2.0 Hz, ClCHCH=CH), 4.34 (d, 1H, J = 11.5 Hz, C6H5CH2OCH2), 4.19 (d, 1H, J 
= 9.0 Hz, CH2OSi), 3.72 (d, 1H, J = 9.5 Hz, CH2OSi), 3.64 (d, 1H, J = 10.0 Hz, 
C6H5CH2OCH2), 3.58 (d, 1H, J = 10.0 Hz, C6H5CH2OCH2), 3.36 (br s, CHCH=CHCH), 
2.45 (br s, CHCH=CHCH), 1.94 (d, 1H, J = 9.0 Hz, CHCH2CH), 1.43 (dt, 1H, J = 1.5, 
9.0 Hz, CHCH2CH), 0.94 (s, 9H, SiC(CH3)3), -0.04 (s, 6H, Si(CH3)2);  13C NMR (125 
MHz, C6D6) δ 139.6, 138.6, 133.1, 132.7, 132.9, 128.6, 127.9, 127.6, 73.1, 72.0, 69.0, 
65.7, 49.0, 48.1, 47.6, 26.1, -5.4;  IR (neat film) 2955 (s), 2856 (s), 1486 (w), 1252 (m), 
1078 (s), 838 (s), 775 (s) cm-1;  HRMS (ESI) m/z calcd for C25H35O2Si (M-Cl)+ 
395.2401, observed 395.2406. 
 
 
 
 
(7a-Benzyloxymethyl-1-chloro-1,4,7,7a-tetrahydro-4,7-methano-inden-3a-
ylmethoxy)-tert-butyl-dimethyl-silane (150), (MSB-II-279).  To a solution of alcohol 
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149 (42 mg, 0.097mmol, 1 equiv) in carbontetrachloride (1.0 mL) at -15 °C was added 
tributylphosphine (31 µL, 0.015 mmol, 1.2 equiv).  After 2 hr, additional 
tributylphosphine (5.0 µL, 0.0005 mmol, 0.05 equiv) was added and then solvent was 
removed in vacuo.  The residue was purified by silica gel flash chromatography (gradient 
1:2 hexanes: ethyl acetate) to afford a 4:1 mixture of 150 and 152 (37.5 mg, 85%) as a 
clear oil.  All spectra matched that previously reported. 
 
 
 
Alcohol 153, (MSB-II-239).  To a solution of alcohol 149 (1 mg, 0.0024mol, 1 equiv) in 
carbontetrachloride (0.4 mL) was added triphenylphosphine (0.8 mg, 0.032 mmol, 
1.3 equiv) and heated to 50 °C.  After 1 hr temperature was increased to 80 °C. After 6 hr 
the solvent was removed in vacuo.  The residue was purified by silica gel flash 
chromatography (4:1 hexanes: ethyl acetate) to afford alcohol 153 (0.9 mg, 90%) as a 
clear oil.   
Rf  0.51 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.38 – 7.27 (m, 5H, 
C6H5CH2OCH2), 5.65 (dt, J = 3.4, 1.6 Hz, 1H, C=CHCHCHCH), 5.54 – 5.43 (m, 2H, 
CH2CH=CH), 4.56 (q, J = 12.1 Hz, 2H, C6H5CH2OCH2), 4.17 (dd, 1H, J = 14.1, 1.6 Hz, 
TBSOCH2), 4.11 (dd, 1H, J = 14.1, 1.7 Hz, TBSOCH2), 3.92 (d, J = 9.5 Hz, 1H, 
C6H5CH2OCH2), 3.83 – 3.76 (m, 2H, C6H5CH2OCH2, CHOH), 3.59 (ddd, J = 8.3, 4.1, 2.1 
Hz, 1H, C=CHCHCHCH), 2.99 (ddd, J = 10.2, 8.7, 3.9 Hz, 1H, C=CHCHCHCH), 2.72 – 
2.63 (m, 2H, C=CHCHCHCH, CHOH), 2.27 – 2.16 (m, 1H, CH2CH=CH), 1.98 – 1.87 
(m, 1H, CH2CH=CH), 0.87 (s, 9H, (CH3)3CSi), 0.02 (s, 3H, (CH3)2Si), 0.01 (s, 3H, 
(CH3)2Si);  IR (neat film) 3424 (w), 3044 (s), 2928 (s), 2855 (w), 1462 (w), 1254 (s), 
1092 (s), 836 (s) cm-1;  HRMS (ESI) m/z calcd for C25H37O3Si (M+H)+ 413.2512, 
observed 413.2519. 
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(7a-Benzyloxymethyl-1-chloro-1,4,7,7a-tetrahydro-4,7-methano-inden-3a-yl)-
methanol (144), (MSB-II-281).  To a solution of a 4:1 mixture of chlorides 150 and 152 
(0.0375 g, 0.087 mmol, 1.0 equiv) in tetrahydrofuran (1.16 mL) was added 
tetrabutylammonium fluoride solution (13 µL, 0.131 mmol, 1.5 equiv, 1.0 M sol in THF) 
and 4Å molecular sieves (0.087 g, 1 g/mmol).  After 15 min the solvent removed in 
vacuo.  The unstable chlorides were passed through a short plug of silica gel (25% 
hexanes in ethyl acetate) to afford unstable chloride 144 (31 mg, 85%) as 80% of a 
mixture with two additional undefined isomers.   
Chloride 144.  Rf  0.81 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.41 
– 7.27 (m, 5H, C6H5CH2OCH2), 6.09 (s, 2H, CHCH=CHCH), 5.69 (d, J = 5.9 Hz, 1H, 
ClCHCH=CH), 5.65 (dd, J = 5.8, 2.1 Hz, 1H, ClCHCH=CH), 4.57 - 4.52 (m, 2H, 
C6H5CH2OCH2), 4.48 (t, J = 1.5 Hz, 1H, ClCHCH=CH), 3.97 (d, J = 10.0 Hz, 1H, 
C6H5CH2OCH2), 3.86 - 3.79 (m, 2H, C6H5CH2OCH2, CH2OH), 3.72 (d, J = 12.0 Hz, 1H, 
CH2OH), 3.02 (br s, 1H, CHCH=CHCH), 2.53 (dd, J = 8.3, 6.6 Hz, 1H, CHCH=CHCH), 
1.86 (d, J = 9.0 Hz, 1H, CHCH2CH), 1.53 (d, J = 9.1 Hz, 1H, CHCH2CH);  IR (neat film) 
3443 (m), 2960 (m), 1069 (s), 760 (s) cm-1;  HRMS (ESI) m/z calcd for C21H21O2 (M-
Cl)+ 281.1542, observed 281.1536. 
 
 
 
7a-Benzyloxymethyl-1-chloro-1,4,7,7a-tetrahydro-4,7-methano-indene-3a-
carbaldehyde (156), (MSB-II-282).  To a solution of chloride 144 (14 mg, 0.044 mmol, 
1.0 equiv) in dichloromethane (0.44 mL) was added pyridinium dichromate (0.033 g, 
0.088 mmol, 2.0 equiv), celite (0.044 g, 1 g/mmol) and 4Å molecular sieves (0.044 g, 
1 g/mmol).  After 100 min the solution was diluted with diethyl ether (20 mL) and 
filtered through a pad of celite and the solvent was removed in vacuo.  The residue was 
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purified by silica gel flash chromatography (50% chloroform in dichloromethane) to 
afford aldehyde 156 (2.2 mg, 16%).   
Rf  0.58 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 9.68 (s, 1H, HC=O), 
7.35 (m, 5H, C6H5CH2OCH2), 6.91 (dd, 1H, J = 1.5, 3.0 Hz, C=CHCHCHCH), 5.56 (dq, 
1H, J = 2.5, 4.0 Hz, CH2CH=CH), 5.42 (dq, 1H, J = 2.5, 4.0 Hz, CH2CH=CH), 4.61 (s, 
2H, C6H5CH2OCH2), 4.40 (d, 1H, J = 10.5 Hz, C6H5CH2OCH2), 4.19 (s, 1H, CHCl), 3.92 
(d, 1H, J = 10.5 Hz, C6H5CH2OCH2), 3.45 (m, 1H, C=CHCHCHCH), 3.35 (m, 1H, 
C=CHCHCHCH), 3.21 (m, 1H, C=CHCHCHCH), 2.26 (dq, 1H, J = 2.0, 10.5 Hz, 
CH2CH=CH), 1.73 (m, 1H, CH2CH=CH);  IR (neat film) 2921 (s), 2856 (m), 1684 (s), 
1099 (m), 743 (m) cm-1;  HRMS (ESI) m/z calcd for C19H20O2Cl (M+H)+ 315.1152, 
observed 315.1148. 
 
 
 
1-Oxo-7a-(2-trimethylsilanyl-ethoxymethyl)-1,4,7,7a-tetrahydro-4,7-methano-
indene-3a-carboxylic acid ethyl ester (162), (MSB-III-069).  A solution of lithium 
hexamethyldisilizane (454 mg, 2.72 mol, 1.6 equiv) in tetrahydrofuran (10 mL) was 
prepared at –78 °C.  To this was added via cannula a solution of ketone 109 (371 mg, 
1.70 mmol, 1 equiv) in tetrahydrofuran (5 mL) at -78 °C in portions.  After stirring for 
1 hr 2-(trimethylsilyl)ethoxymethyl chloride (449 µL, 2.55 mol, 1.5 equiv) was added.  
After 20 min the solution was allowed to warm to -20 °C and then quenched after 2 hr 
with water (100 mL) and extracted with diethyl ether (3 x 70 ml).  The combined organic 
layers were then dried (magnesium sulfate), filtered, and concentrated in vacuo.  The 
residue was purified by silica gel flash chromatography (gradient 4:1 to 2:1 hexane: ethyl 
acetate) to afford enone 162 (234 mg, 40%) as a yellow oil.  
Rf  0.77 (1:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.47 (d, 1H, J = 6.0 
Hz, O=CCH=CH), 6.05 (dd, 1H, J = 3.5, 5.5 Hz, CHCH=CHCH), 5.97 (dd, 1H, J = 1.0, 
6.0 Hz, O=CCH=CH), 5.91 (dd, 1H, J = 3.0, 5.5 Hz, CHCH=CHCH), 4.24 (m, 1H, 
OCH2CH3), 4.11 (m, 1H, OCH2CH3), 3.93 (d, 1H, J = 8.5 Hz, CCH2O), 3.64 (d, 1H, J = 
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8.5 Hz, CCH2O), 3.34 (m, 1H, OCH2CH2Si), 3.05 (br s, 1H, CHCH=CHCH), 2.79 (dd, 
1H, J = 0.5, 9.0 Hz, CH2), 2.75 (br s, 1H, CHCH=CHCH), 1.70 (dd, 1H, J = 1.0, 9.0 Hz, 
CH2), 1.31 (dt, 3H, J = 1.0, 7.0 Hz, OCH2CH3), 0.80 (m, 1H, OCH2CH2Si), 0.72 (m, 1H, 
OCH2CH2Si), -0.06 (s, 9H, Si(CH3)3);  IR (neat film) 2953 (w), 2860 (w), 1715 (s), 1463 
(m), 1234 (s), 1096 (m) cm-1;  HRMS (ESI) m/z calcd for C19H29O4Si (M+H)+ 349.1835, 
observed 349.1825. 
 
 
 
Lactone 158, (MSB-III-092).  To a solution of silane 162 (164 mg, 0.47 mmol, 
1.0 equiv) in dichloromethane (1.0 mL) was added boron trifluoride diethyl etherate 
complex (0.179 µL, 1.41 mmol, 3.0 equiv) at 23 °C and the solution turned light brown.  
After consumption of starting material (1 hr) toluene sulfonic acid monohydrate (0.089 g, 
0.47 mmol, 1.0 equiv) was added and the reaction turned red.  After 3 hr the solution was 
diluted with brine (100 mL) and extracted with dichloromethane (3 x 50 mL).  The 
combined organic layers were dried (sodium sulfate), filtered, and concentrated in vacuo 
to afford lactone 158 (94 mg, 99%) as a white solid.   
Rf  0.52 (1:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.45 (d, 1H, J = 5.5 
Hz, O=CCH=CH), 6.12 (dd, 1H, J = 3.0, 5.5 Hz, CHCH=CHCH), 6.07 (dd, 1H, J = 5.5 
Hz, O=CCH=CH), 6.02 (dd, 1H, J = 3.0, 5.5 Hz, CHCH=CHCH), 4.47 (d, 1H, J = 10.0 
Hz, CCH2O), 4.27 (d, 1H, J = 10.5 Hz, CCH2O), 3.39 (br s, 1H,  CHCH=CHCH), 3.24 
(br s, 1H,  CHCH=CHCH), 1.97 (ABq, 2H, J = 10.0 Hz, CH2);  IR (neat film) 2982 (w), 
2887 (w), 1765 (s), 1712 (s), 1189 (m), 1023 (m) cm-1;  LRMS (EI) m/z for C12H13O3 
(M)+ 202.0. 
 
 
 
 80 
 
 
 Allylic alcohol 163 and allylic alcohol 164, (MSB-III-091).  To a solution of ketone 
158 (5.0 mg, 0.025 mmol, 1.0 equiv) in methanol (0.625 mL) was added cerium 
trichloride (11.0 mg, 0.029 mmol, 1.2 equiv) and cooled to 0 °C.  Then sodium 
borohydride (2.8 mg, 0.074 mmol, 3.0 equiv) was added and the reaction effervesced.  
After 10 min the solution was quenched with 10 drops of acetone, diluted with water 
(10 mL), and extracted with diethyl ether (3 x 10 mL).  The combined organic layers 
were dried (magnesium sulfate), filtered, and concentrated in vacuo.  The residue was 
purified by silica gel flash chromatography (1.5:1 ethyl acetate: hexane) to afford alcohol 
163 (1.8 mg, 35%) and alcohol 164 (1.8 mg, 35%) as colorless crystals.  
Allylic alcohol 163.  Rf  0.28 (1:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 
6.15 (br s, 2H, HOCCH=CH), 5.89 (dd, 1H, J = 1.0, 5.0 Hz, CHCH=CHCH), 5.66 (dd, 
1H, J = 2.0, 6.0 Hz, CHCH=CHCH), 5.10 (d, 1H, J = 10.5 Hz, CCH2O), 4.17 (dd, 1H, J 
= 1.5, 5.5 Hz, HOCHCH=CH), 4.01 (d, 1H, J = 10.5 Hz, CCH2O), 3.20 (br s, 1H,  
CHCH=CHCH), 3.05 (br s, 1H, CHCH=CHCH), 1.81 (ABq, 2H, J = 10.0 Hz, CH2), 1.64 
(d, 1H, J = 7.5 Hz, HOCHCH=CH);  13C NMR (100 MHz, CDCl3) δ 174.2, 137.7, 137.4, 
134.7, 133.6, 79.7, 76.1, 71.3, 61.8, 51.3, 48.4, 47.9;  IR (neat film) 3478 (s), 2977 (w), 
2919 (w), 1737 (s), 1126 (m), 1028 (m), 989 (m) cm-1;  HRMS (ESI) m/z calcd for 
C12H12O3 (M+Na)+ 227.0684, observed 227.0676. 
Allylic alcohol 164.  Rf  0.24 (1:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ  
6.34 (dd, 1H, J = 2.5, 6.0 Hz, CHCH=CHCH), 6.01 (dd, 1H, J = 3.5, 6.0 Hz, 
CHCH=CHCH), 5.81 (d, 1H, J = 5.5 Hz, HOCCH=CH), 5.77 (dd, 1H, J = 2.0, 5.5 Hz, 
HOCCH=CH), 4.71 (d, 1H, J = 9.5 Hz, HOCHCH=CH), 4.39 (d, 1H, J = 10.0 Hz, 
CCH2O), 4.34 (d, 1H, J = 10.0 Hz, CCH2O), 3.27 (br s, 1H,  CHCH=CHCH), 3.02 (br s, 
1H, CHCH=CHCH), 1.79 (m, 2H, CH2), 1.47 (d, 1H, J = 9.5 Hz, HOCHCH=CH);  
13C NMR (100 MHz, CDCl3) δ 177.4, 138.3, 136.2, 135.2, 132.1, 85.1, 80.1, 75.3, 63.6, 
50.7, 50.4, 49.1;  IR (neat film) 3445 (s), 2975 (w), 2911 (w), 1744 (s), 1106 (m), 1028 
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(m), 734 (m) cm-1;  HRMS (ESI) m/z calcd for C12H12O3 (M+Na)+ 227.0684, observed 
227.0676. 
 
 
 
Allylic chloride 159, (MSB-II-115).  To a solution of alcohol 164 (9.0 mg, 0.044 mmol, 
1.0 equiv) in carbontetrachloride (0.440 mL) was added tributylphosphine (10 µL, 
0.048 mmol, 1.1 equiv).  After 30 min, more tributylphosphine (9 µL, 0.043 mmol, 
1 equiv) was added.  After 5 hr the reaction was warmed to 60 °C and stirred for 17 hr.  
The reaction was then diluted with brine (10 mL), and extracted with dichloromethane 
(3 x 10 mL).  The combined organic layers were dried (sodium sulfate), filtered, and 
concentrated in vacuo.  The residue was purified by silica gel flash chromatography (4:1 
to 2:1 hexane: ethyl acetate) to afford chloride 159 (7.0 mg, 71%) as a white solid.   
Rf  0.68 (1:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ  6.23 (dd, 1H, J = 3.5, 
6.0 Hz, CHCH=CHCH), 6.18 (dd, 1H, J = 3.5, 6.0 Hz, CHCH=CHCH), 5.90 (dd, 1H, J = 
2.0, 5.5 Hz, ClCCH=CH), 5.65 (dd, 1H, J = 2.0, 5.5 Hz, ClCCH=CH), 4.39 (d, 1H, J = 
11.0 Hz, CCH2O), 4.40 (t, 1H, J = 2.0 Hz, ClCHCH=CH), 4.14 (d, 1H, J = 11.0 Hz, 
CCH2O), 3.24 (br s, 1H,  CHCH=CHCH), 3.11 (br s, 1H, CHCH=CHCH), 1.87 (dd, 1H, 
J = 2.0, 10.0 Hz, CH2), 1.81 (dd, 1H, J = 2.0, 10.0 Hz, CH2);  IR (neat film) 2995 (w), 
2978 (w), 1748 (s), 1223 (m), 1029 (m), 783 (m) cm-1;  HRMS (ESI) m/z calcd for 
C12H11O3Cl (M+H)+ 223.0526, observed 223.0524. 
 
 
 
Allylic chloride 159, (MSB-II-117).  To a solution of alcohol 163 (8.0 mg, 0.039 mmol, 
1.0 equiv) in tetrahydrofuran (0.390 mL) was added thionyl chloride (5.5 µL, 
0.047 mmol, 1.2 equiv) at 0 °C.  After 2 hr thionyl chloride (5.5 µL, 0.047 mmol, 
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1.2 equiv) was added.  After 90 minute thionyl chloride (5.5 µL, 0.047 mmol, 1.2 equiv) 
was added and heated to 45 °C and stirred for 17 hr.  The reaction was then diluted with 
brine (10 mL), and extracted with dichloromethane (3 x 10 mL).  The combined organic 
layers were dried (sodium sulfate), filtered, and concentrated in vacuo.  The residue was 
purified by silica gel flash chromatography (4:1 hexane: ethyl acetate) to afford chloride 
159 (4.6 mg, 40%) as a white solid.  Spectra data matched previously reported values. 
 
 
 
8-Chloro-4-hydroxymethyl-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carbaldehyde (161), (MSB-III-128).  To a solution of lactone 159 (5.5 mg, 0.025 mmol, 
1.0 equiv) in dichloromethane (0.25 mL) was added diisobutylaluminum hydride solution 
(1.0 M in hexanes, 100 µL, 0.05 mmol, 2 equiv) at -78 °C.  After 1 hr, more 
diisobutylaluminum hydride solution (1.0 M in hexanes, 60 µL, 0.13 mmol, 2 equiv) was 
added and after 2 hr the solution was warmed to -45 °C.  The reaction was then quenched 
with ten drops acetone and the reaction was diluted with hydrochloric acid solution 
(0.1 N, 10 mL), and extracted with dichloromethane (3 x 10 mL).  The combined organic 
layers were dried (sodium sulfate), filtered, and concentrated in vacuo.  The residue was 
diluted with dichloromethane (1 mL) and heated to 90 °C for 20 min.  The residue was 
reduced in vacuo and purified by silica gel flash chromatography (1:1 hexane: ethyl 
acetate) to afford aldehyde 161 (3.3 mg, 60%) as a clear oil.   
Rf  0.48 (1:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 9.69 (d, 1H, HCO), 
7.08 (d, 1H, J = 3.0 Hz, C=CHCHCHCH), 5.59 (dq, 1H, J = 2.0, 6.0 Hz, CH2CH=CH), 
5.44 (dq, 1H, J = 2.0, 6.0 Hz, CH2CH=CH), 4.33 (dd, 1H, J = 3.0, 12.0 Hz, HOCH2), 
3.91 (d, 1H, J = 0.5 Hz, CHCl), 3.80 (dd, 1H, J = 10.5, 11.5 Hz, HOCH2), 3.59 (dd, 1H, J 
= 3.3, 10.5 Hz, HOCH2), 3.53-3.50 (m, 1H, C=CHCHCHCH), 3.36 (ddd, 1H, J = 1.3, 
3.0, 4.5 Hz, C=CHCHCHCH), 2.87 (ddd, 1H, J = 4.0, 8.5, 10.0 Hz, C=CHCHCHCH), 
2.48 (dq, 1H, J = 2.0, 10.0 Hz, CH2CH=CH), 1.81 (m, 1H, CH2CH=CH);  IR (neat film) 
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3426 (w), 2923 (w), 2853 (w), 1673 (s), 1447 (w), 1264 (s), 1049 (s) cm-1;  HRMS (ESI) 
m/z calcd for C12H13O3ClNa (M+Na)+ 263.0451, observed 263.0428. 
 
 
 
7a-Benzyloxymethyl-1-hydroxy-3-phenylselanyl-1,2,3,4,7,7a-hexahydro-4,7-
methano-indene-3a-carboxylic acid ethyl ester (168), (MSB-III-273).   To a solution 
of diphenyldiselenide (4.4 g, 0.014 mol, 3.0 equiv) in ethanol (31 mL) was added sodium 
borohydride (2.4 g, 0.063 mol, 13 equiv) at 0 °C and the solution effervesced and turned 
tan.  After 1 hr acetic acid (2.7 mL, 0.047 mol, 10 equiv) was added.  The resulting 
solution was stirred for 30 min, at which point enone 129 (1.633 g, 4.8 mmol, 1 equiv) in 
ethanol (15 mL) was added via cannula and the solution was allowed to warm to 23 °C.  
After 52 hr sodium borohydride (1.8 g, 0.048 mol, 10 equiv) was added at 0 °C with 
much effervescence.  After one hr the solution was diluted with water (500 mL), and 
extracted with diethyl ether (3 x 300 mL).  The combined organic layers were dried 
(magnesium sulfate), filtered, and concentrated in vacuo.  The residue was purified by 
silica gel flash chromatography (4:1 hexane: ethyl acetate) to afford alcohol 168 (1.67 g, 
70%) as a clear oil.   
Rf  0.15 (4:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.54 (m, 2H, 
C6H5Se), 7.30 (m, 8H, C6H5Se, C6H5CH2OCH2), 6.46 (dd, 1H, J = 3.0, 5.5 Hz, 
CHCH=CHCH), 6.37 (dd, 1H, J = 3.0, 5.5 Hz, CHCH=CHCH), 4.49 (q, 2H, J = 11.5 Hz, 
C6H5CH2OCH2), 4.16 (m, 2H, HOCHCH2CHSe), 3.84 (q, 2H, J = 7.0 Hz, OCH2CH3), 
3.63 (d, 1H, J = 8.5 Hz, C6H5CH2OCH2), 3.37 (br s, 1H, CHCH=CHCH), 3.35 (d, 1H, J 
= 8.5 Hz, C6H5CH2OCH2), 3.07 (br s, 1H, CHCH=CHCH), 2.38 (d, 1H, J = 2.5 Hz, 
HOCH), 2.28 (dt, 1H, J = 8.0, 12.5 Hz, HOCHCH2CHSe), 2.07 (dt, 1H, J = 11.0, 13.0 
Hz, HOCHCH2CHSe), 1.85 (d, 1H, J = 9.0 Hz, CH2), 1.55 (d, 1H, J = 9.0 Hz, CH2), 1.04 
(t, 3H, J = 7.0 Hz, OCH2CH3);  13C NMR (100 MHz, CDCl3) δ 173.9, 139.8, 136.9, 
133.8, 127.9, 127.6, 127.0, 126.7, 126.6, 78.2, 77.1, 72.9, 66.5, 64.7, 60.1, 50.4, 49.1, 
46.8, 45.4, 41.5, 13.0;  IR (neat film) 3564 (w), 2979 (w), 2870 (w), 1713 (s), 1476 (m), 
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1231 (s), 1074 (m) cm-1;  HRMS (ESI) m/z calcd for C27H31O4Se (M+H)+ 499.1388, 
observed 499.1388. 
 
 
 
7a-Benzyloxymethyl-1-chloro-3-phenylselanyl-1,2,3,4,7,7a-hexahydro-4,7-methano-
indene-3a-carboxylic acid ethyl ester (169), (MSB-III-247).  To a solution of alcohol 
168 (85 mg, 0.171 mmol, 1.0 equiv) in carbontetrachloride (1.4 mL) was added 
tributylphosphine (126 µL, 0.513 mol, 3 equiv) and the solution was heated to 90 °C.  
After 15 hr the reaction was diluted with dichloromethane (0.2 mL) and purified directly 
by silica gel flash chromatography (4:1 hexane: ethyl acetate) to afford chloride 169 
(72 mg, 82%) as a clear oil.   
Rf  0.42 (4:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.59-7.56 (m, 2H, 
C6H5Se), 7.43-7.30 (m, 8H, C6H5Se, C6H5CH2OCH2), 6.50 (dd, 1H, J = 3.0, 5.3 Hz, 
CHCH=CHCH), 6.28 (dd, 1H, J = 3.2, 5.4 Hz, CHCH=CHCH), 4.62 (dd, 1H, J = 8.2, 
13.2, ClCHCH2CHSe), 4.56 (d, 1H, J = 11.6 Hz, C6H5CH2OCH2), 4.40 (d, 1H, J = 11.5 
Hz, C6H5CH2OCH2), 4.29 (d, 1H, J = 6.4 Hz, ClCHCH2CHSe), 4.07 (d, 1H, J = 9.1 Hz, 
C6H5CH2OCH2), 3.94-3.82 (m, 2H, J = 7.0 Hz, OCH2CH3), 3.45 (br s, 1H, 
CHCH=CHCH), 3.35-3.33 (m, 2H, C6H5CH2OCH2, CHCH=CHCH), 2.61 (dt, 1H, J = 
6.5, 14.6 Hz, ClCHCH2CHSe), 2.39 (dt, 1H, J = 8.2, 14.7 Hz, ClCHCH2CHSe), 1.98 (d, 
1H, J = 9.3 Hz, CH2), 1.54 (d, 1H, J = 9.4 Hz, CH2), 1.08 (t, 3H, J = 7.0 Hz, OCH2CH3);  
13C NMR (125 MHz, CDCl3) δ 174.2, 138.9, 138.5, 138.4, 134.6, 129.2, 128.9, 128.5, 
127.7, 127.6, 127.5, 73.8, 73.1, 68.6, 67.8, 66.6, 61.1, 51.8, 51.3, 50.4, 48.7, 48.6, 13.9;  
IR (neat film) 2924 (s), 2853 (s), 1724 (s), 1455 (w), 1231 (s), 1093 (m) cm-1;  HRMS 
(ESI) m/z calcd for C27H30ClO3Se (M+H)+ 517.1049, observed 517.1027. 
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4-Benzyloxymethyl-8-chloro-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic acid ethyl ester (131a), (MSB-IV-080).  To a solution of chloride 169 (5.0 g, 
9.7 mmol, 1.0 equiv) in dichloromethane (51 mL) at -20 °C was added meta-
chloroperoxybenzoic acid (2.14 g, 9.6 mol, 0.99 equiv).  After 20 min triethylamine 
(2.7 mL, 19.0 mmol, 2 equiv) was added and the solution was heated to 80 °C in a sealed 
tube.  After 17 hr the solution was cooled, the solvent was concentrated in vacuo, and the 
residue was purified directly by silica gel flash chromatography (dichloromethane) to 
afford chloride 131a (3.2 g, 92%) as a yellow oil.  
Rf  0.56 (dichloromethane);  1H NMR (400 MHz, CDCl3) δ 7.36 (m, 5H, 
C6H5CH2OCH2), 6.86 (dd, 1H, J = 1.5, 3.5 Hz, C=CHCHCHCH), 5.57 (dq, 1H, J = 2.0, 
5.5 Hz, CH2CH=CH), 5.43 (dq, 1H, J = 2.0, 5.5 Hz, CH2CH=CH), 4.61 (ABq, 2H, J = 
12.0 Hz, C6H5CH2OCH2), 4.32 (d, 1H, J = 10.0 Hz, C6H5CH2OCH2), 4.15 (m, 3H, CHCl, 
OCH2CH3), 3.90 (d, 1H, J = 10.0 Hz, C6H5CH2OCH2), 3.39 (m, 1H, C=CHCHCHCH), 
3.21 (t, 1H, J = 3.5 Hz, C=CHCHCHCH), 3.09 (m, 1H, C=CHCHCHCH), 2.26 (ddq, 1H, 
J = 2.0, 8.5, 18.0 Hz, CH2CH=CH), 1.87 (m, 1H, CH2CH=CH), 1.26 (t, 3H, J = 7.0 Hz, 
OCH2CH3);  13C NMR (100 MHz, CDCl3) δ 164.8, 146.6, 138.7, 134.4, 134.0, 130.1, 
129.2, 128.2, 127.5, 75.5, 73.4, 66.1, 63.2, 60.2, 52.5, 51.2, 38.2, 34.0, 14.1;  IR (neat 
film) 2917 (w), 2852 (w), 1709 (s), 1454 (m), 1276 (s), 1090 (s) cm-1;  HRMS (ESI) m/z 
calcd for C21H24O3Cl (M+H)+ 359.1424, observed 359.1414. 
 
 
 
Ketone 171, (MSB-IV-157).  To a solution of ketone 129 (212 mg, 0.627 mmol, 
1.0 equiv) in tetrahydrofuran (0.2 mL) at -45 °C was added a solution of diisobutyl 
aluminumhydride (1.0 M in hexanes) (0.94 mL, 0.94 mmol, 1.5 equiv).  After stirring for 
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2 hr the reaction was quenched with saturated Rochelle’s salt (50 mL) and allowed to 
warm to room temperature.  The solution was diluted with brine (20 mL) and then 
extracted with diethyl ether (3 x 30 mL) and the combined organic layers were then dried 
(magnesium sulfate), filtered, and concentrated in vacuo.  The residue was purified by 
silica gel flash chromatography (6:1 gradient to 4:1 hexanes: ethyl acetate) to afford 
ketone 171 (140 mg, 66%) and alcohol 139 (39 mg, 18%) as clear oils.   
Alcohol 139.  All spectra data matched that previously reported.   
Ketone 171.  Rf  0.51 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.26 
(m, 5H, C6H5CH2OCH2), 6.29 (dd, J = 5.5, 3.1 Hz, 1H, CHCH=CHCH), 6.23 (dd, J = 
5.5, 3.0 Hz, 1H, CHCH=CHCH), 4.38 (m, 2H, C6H5CH2OCH2), 4.06 (dddd, J = 22.7, 
10.8, 7.1, 3.7 Hz, 2H, OCH2CH3), 3.91 (d, J = 8.6 Hz, 1H, C6H5CH2OCH2), 3.77 (d, J = 
8.6 Hz, 1H, C6H5CH2OCH2), 3.16 (s, 1H, CHCH=CHCH), 2.79 (s, 1H, CHCH=CHCH), 
2.64 (ddd, J = 14.1, 11.7, 6.5 Hz, 1H, O=CCH2CH2), 2.55 (d, J = 8.9 Hz, 1H, CH2), 2.40 
(m, 1H, O=CCH2CH2), 2.11 (ddd, J = 19.1, 10.4, 6.5 Hz, 1H, O=CCH2CH2), 1.64 (ddd, J 
= 14.1, 10.3, 6.4 Hz, 1H, O=CCH2CH2), 1.56 (d, J = 8.9 Hz, 1H, CH2), 1.17 (t, J = 7.1 
Hz, 3H, OCH2CH3);  IR (neat film) 3063 (w), 2977 (s), 2888 (w), 2866 (w), 1733 (s), 
1717 (s), 1456 (m), 1286 (s), 1101 (m), 739 (s) cm-1;  LRMS (ESI) for C21H24O4 
(M+Na)+ 363.30. 
 
 
 
4-Benzyloxymethyl-8-hydroxy-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic acid ethyl ester (139), (MSB-IV-253).  To a solution of ketone 129 (7.7 g, 
22.8 mmol, 1.0 equiv) in isopropyl alcohol (45 mL) was added aluminum isopropoxide 
(3.5 g, 17.0 mmol, 0.75 equiv) and heated up to 90 °C.  After stirring for 100 min the 
reaction was cooled and quenched with hydrochloric acid (300 mL, 1N).   
The solution was extracted with dichloromethane (3 x 300 mL) and the combined organic 
layers were then dried (sodium sulfate), filtered, and concentrated in vacuo to afford 
alcohol 139 (7.60 g, 98%).  All spectra data matched that previously reported.   
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Ether 172, (MSB-IV-175).  To a solution of alcohol 139 (0.321 g, 0.944 mmol, 
1.0 equiv) in tetrahydrofuran (9.5 mL) at was added pyridine (153 µL, 1.88 mmol, 2 
equiv) and then thionyl chloride (217 µL, 1.88 mmol, 2 equiv) to form a white 
precipitate.  The solution was then heated up to 40 °C.  After stirring for 15 hr the 
solution was diluted with hydrochloric acid (100 mL, 1N) and extracted with 
dichloromethane (3 x 50 mL).  The combined organic layers were then dried (sodium 
sulfate), filtered, and concentrated in vacuo.  The residue was purified by silica gel flash 
chromatography (dichloromethane) to afford chloride 131b (235 mg, 70%) and ether 172 
(23 mg, 5%) as clear oils.   
Chloride 131b.  All spectra data matched that previously reported.   
Ether 172.  Rf  0.52 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.37 – 
7.26 (m, 5H, C6H5CH2OCH2), 6.71 (d, J = 3.8 Hz, 1H, C=CHCHCHCH), 5.50 – 5.46 (m, 
1H, CH2CH=CH), 5.46 – 5.42 (m, 1H, CH2CH=CH), 4.61 (d, J = 12.2 Hz, 1H, 
C6H5CH2OCH2), 4.46 (d, J = 12.2 Hz, 1H, C6H5CH2OCH2), 4.25 – 4.08 (m, 3H, 
OCH2CH3, C6H5CH2OCH2), 3.60 (d, J = 9.0 Hz, 1H, C6H5CH2OCH2), 3.51 (m, 3H, 
C=CHCHCHCH, OCH2(CH2)2CH2Cl), 3.48 – 3.42 (m, 1H, OCH2(CH2)2CH2Cl), 3.37 
(dt, J = 9.5, 6.1 Hz, 1H, OCH2(CH2)2CH2Cl), 2.96 (td, J = 4.2, 1.7 Hz, 1H, 
C=CHCHCHCH), 2.66 (ddd, J = 10.2, 8.5, 3.8 Hz, 1H, C=CHCHCHCH), 2.17 (ddd, J = 
17.8, 10.3, 2.0 Hz, 1H, CH2CH=CH), 2.05 – 1.96 (m, 1H, CH2CH=CH), 1.80 (dq, J = 
8.5, 6.3 Hz, 2H, OCH2CH2CH2CH2Cl), 1.63 (dq, J = 9.8, 6.4 Hz, 2H, 
OCH2CH2CH2CH2Cl), 1.25 (t, J = 7.1 Hz, 3H, OCH2CH3);  DEPT135 NMR (125 MHz, 
CDCl3) δ 144.1(+), 133.2(+), 129.66(+), 128.2(+), 127.5(+), 127.3(+), 91.6(+), 73.2(-), 
68.5(-), 66.7(-), 60.0(-), 53.7(+), 47.4(+), 45.0(-), 40.7(+), 32.6(-), 29.6(-), 27.3(-), 
14.2(+);  IR (neat film) 3044 (w), 2937 (s), 2858 (s), 1712 (s), 1592 (w), 1472 (m), 1391 
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(m), 1310 (s), 1112 (s), 1028 (m), 698 (m) cm-1;  LRMS (ESI) m/z C24H31O4Cl, (M+H)+ 
430.99, (M+Na)+ 452.88. 
 
 
 
4-Benzyloxymethyl-8'-chloro-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic acid ethyl ester (131b), (MSB-IV-187).  To a solution of alcohol 139 
(0.860 g, 2.53 mmol, 1.0 equiv) in dichloromethane (20.0 mL) at was added thionyl 
chloride (436 µL, 3.8 mmol, 1.5 equiv) and the solution was heated up to 55 °C.  After 
stirring for 15 hr the solvent was removed in vacuo to afford chloride 131b as a brown oil 
(0.905 g, 95% pure based on NMR).  The material was used without purification.  All 
spectra data matched that previously reported.   
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CHAPTER 3.  FLEXIBLE ACCESS TO THE FULLY FUNCTIONALIZED 
CORES OF BOTH THE ORIGINAL  
AND REVISED STRUCTURES OF PALAU’AMINE 
 
3.1 Divergent Synthetic Strategy for the Two Proposed Structures of Palau’amine 
 Both the original (1a) and revised (1b) structures of palau’amine possess a highly 
substituted cyclopentane core, with stereochemical configurations that only differ at the 
C17 and C12 stereogenic centers.  Due to the difficulty in accessing the challenging 
arrangement of functionality on the densely substituted rings of these diastereomeric 
structures, the fully functionalized cyclopentane cores were targeted as initial synthetic 
goals.  According to our retrosynthetic analysis (Scheme 1.14), both the original and 
revised structures of palau’amine could be derived from the simple tricyclodecadienone 
129 (Scheme 3.1).  The elaboration of enone 129 in a divergent fashion to C17-chloro  
epimers 131a/b was achieved by individually tailored [3,3]-sigmatropic rearrangements 
of chlorotricyclodecadienes 97a/b in a highly efficient manner, as described in Chapter 2.  
However, epimers 131a/b possess only a portion of the functionality of the cyclopentane 
cores of 1a and 1b and a synthetic strategy was required to elaborate the latent 
functionality of the tricyclodecadiene skeleton to secure the fully functionalized 
 
Scheme 3.1 
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diastereomeric cyclopentane cores 102a/b.  These synthetic strategies would further 
diverge by retention of the C11,C12 cis-configuration within 102a en route to 1a and by 
epimerization to the  thermodynamically favored C11,C12 trans-configuration within 
102b en route to 1b.   
 
3.2 Synthesis of the Fully Functionalized Core of the Original Structure of 
Palau’amine 
3.2.1 Synthesis of the Ring E Chlorocyclopentane 
 Chlorocyclopentane 131a was synthesized efficiently in three steps from enone 129 
(Scheme 3.2), as described in Chapter 2, by the employment of a [3,3]-sigmatropic 
rearrangement of chlorotricyclodecadiene 130a.  This process began with conjugate 
addition of benzeneselenol in an endo-selective addition to the cyclopentenone group in 
129. This operation served to avoid premature sigmatropic rearrangement through 
disruption of the 1,5-diene system in 129 via “protection” of the alkene moiety. This 
allowed for introduction of the C17-chloro substituent through an exo-selective hydride 
addition to the C17 ketone, followed by chloride invertive displacement of the activated 
alcohol to afford the exo-C17-chloride 169 in 51% over two steps. Selenide oxidation and 
elimination regenerated the 1,5-diene system of 130a, which spontaneously underwent 
sigmatropic rearrangement to form chlorocyclopentane 131a in 95% yield.  This short 
sequence generated the stereochemical configuration of the chlorocyclopentane within 
the original structure of palau’amine (1a) and incorporated the appropriate latent 
peripheral functionality with proper stereochemistry for further advancement.  
 
Scheme 3.2 
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3.2.2 Unsuccessful Access to the Fully Functionalized Cyclopentane Core:  
Double Oxidative Cleavage Strategy 
Having secured the chlorocyclopentane core of the original structure of palau’amine 
(1a), the tricyclodecadiene skeleton that had served quite well as a platform for the [3,3]-
sigmatropic rearrangement was ready for further elaboration.  Concomitant ring opening 
of both cyclopentenes within 131a (Scheme 3.3) would unveil the diverse functionality 
required for eventual advancement to the oxidative cyclization precursor 175.  The 
synthesis of 175 would require cleavage of the C23-C24 bond and insertion of a nitrogen 
atom into the C16-C24 bond of 174, as well as selective manipulation of the aldehyde 
moieties at C6 and C13 into the imidazole and pyrrole amide motifs required for the 
oxidative cyclization strategy.  
 
Scheme 3.3 
 
 
It was envisioned that oxidative cleavage of both the olefins of tricycle 131a (Scheme 
3.4), either in a sequential or tandem process, would allow access to a monocyclic 
cyclopentane intermediate (i.e., 174), bearing the desired stereochemistry of the E Ring 
of palau’amine (1a).  Manipulation and isolation of 174, containing multiple sensitive 
aldehyde moieties, would likely be difficult; however, it was predicted that one  
 
Scheme 3.4 
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equivalent of water would be absorbed in order to form stable cyclic polyacetals 176, as 
precedented by certain natural product structures (vide infra).  With a polycyclic platform 
such as 176, systematic differentiation of the acetal centers into the individual functional 
groups with 175 would allow for application of the key oxidative cyclization strategy. 
  The formation of cyclic polyacetals on a 1,2,3-cis-substituted cyclopentane such as 
that proposed in 176 (Scheme 3.4) is well precedented, as exemplified by udoteatrial 
hydrate (178) (Scheme 3.5).1,2  The molecule possesses three aldehyde units on an all cis-
substituted cyclopentane.  The parent trialdehyde 177 has never been isolated; instead, it 
exists in its hydrated form 178 as a mixture of two stereoisomers.  The similarity in 
substitution pattern of the udoteatrial cyclopentane to our proposed substrate 174 
suggests the likelihood of similar structures arising via the planned double oxidative 
cleavage strategy. 
 
Scheme 3.5 
 
 
 As a means to accessing the hydrated trialdehyde 176 (Scheme 3.4), an ambitious 
plan was developed that would oxidatively cleave both olefins of the tricyclodecadiene 
skeleton of 131a in a single operation.  This process began with double dihydroxylation  
 
Table 3.1.  Dihydroxylation of diene 131a. 
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of diene 131a with osmium tetroxide to afford tetraol 179 (Table 3.1).  Under the 
standard conditions3 for dihydroxylation in aqueous acetone with N-methylmorpholine N-
oxide (NMO) as the stoichiometric oxidant (Entry 1), the desired tetraol 179 was 
obtained in capricious yields (0-56%).  Upon switching the co-solvent from acetone to 
tert-butanol (Entry 2), tetraol 179 could be accessed in a more consistent 25-59% yield; 
however, analysis of the mass balance suggested the formation of a stable adduct with 
NMO.  Alternatively, the use of potassium ferricyanide as the co-oxidant with potassium 
carbonate (Entry 3) resulted in the formation of the desired tetraol 179 in a reliable 71% 
yield.   
 Implementation of the double oxidative cleavage strategy was accomplished by 
subjection of 179 (Scheme 3.6) to excess sodium periodate, which resulted in the clean 
formation of two inseparable structurally isomeric polycyclic acetals in 180 and 181 in a 
2:1 ratio.  The two compounds were separated and structurally characterized after 
silylation of the hydroxyls to afford protected polycyclic acetals 182 and 183 in 26% and 
20% yield, respectively, over two steps.  NMR analysis (1H, 13C, DEPT135, COSY, 
HSQC, HMBC, and NOESY) excluded the possibility of the anticipated udoteatrial 
hydrate ring system (i.e., 176).  Instead, ketal formation involving participation of the 
C24 ketone was observed, resulting in the formation of polycyclic ketals 180 and 181.  
There are 12 distinct possible constitutionally isomeric structures resulting from  
 
Scheme 3.6 
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alternative connectivities of the four carbonyl centers (C6, C13, C19, C24), in addition to 
the  multiple stereoisomeric forms of each constitutional isomer.  Despite the large 
number of possible isomers, assignment of structures 182 and 183 was accomplished 
primarily through coupling constant analysis, HMBC couplings through the acetal/ketal 
linkages, and further derivatization (vide infra).  
 Having established the structures of polycyclic hydrate acetals 180 and 181, it 
was envisioned that both isomers could be use towards a synthesis of the original 
structure of palau’amine (1a).  Despite the isomeric nature of these two structures, 
advancement of the synthesis could be accomplished on this inseparable mixture of 
constitutional isomers by effecting chemoselective transformations on the same 
functionalities present within both isomers (Scheme 3.7).  One feature common to both 
180 and 181 is the presence of the C6 hemiacetal at the terminus of the polyacetal 
structure.  Selective manipulation of the C6-O-hemiacetals might allow for installation of 
the thioimidazole moiety within 184 and 185, and at the same time simplify the resulting 
polycyclic structure by removal of one acetal carbon.  The route could then converge 
toward tetraol 186 by reduction of the remaining carbonyl centers.  Selective 
manipulation of the alcohol moieties would then allow for formation of the oxidative 
cyclization precursor 187.  With this synthetic plan in mind, subjection of a 1.4:1 mixture  
 
Scheme 3.7 
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of 180 and 181 (Scheme 3.8) to methanesulfonyl chloride and triethylamine resulted in 
selective activation of the C6-O-hemiacetals and elimination to afford enol ethers 188 
and 189 in a combined 98% yield in a 1.9:1 ratio, along with a third minor undefined 
isomeric enol ether.  The mixture of enol ethers 188 and 189 could be separated by silica 
gel chromatography and the relative constitutional structures verified after oxidation to 
yield lactones 190 and 191 in 30% and 50% yield, respectively.  While assignment of 180 
and 181 by COSY analysis had been tenuous, COSY assignments of 190 and 191 could 
be made with certainty due to the simpler arrangement of protons and the fewer number 
of sp3 stereocenters.  From this assignment, the relative stereochemical arrangement of 
the synthetic precursors could also be inferred with confidence and were found to be 
consistent with the originally proposed structures.  
 
Scheme 3.8 
 
 
 Although progress had been made toward selectively derivatizating the complex 
framework of polyacetal structures 180 and 181, the low yields and formation of an 
increasing numbers of isomers* rendered the double oxidative cleavage route unwieldy.  
In addition, concurrent with this route, a more promising avenue toward the fully 
functionalized core of the original structure of palau’amine (1a) was discovered and is 
discussed below. 
                                                 
*
 The TIPS silyl ether protection of the crude mixture of enol ethers including 188 and 189 yielded five 
isomeric structures. 
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3.2.3 Successful Introduction of the C-16 Nitrogen via Curtius and Beckmann 
Rearrangement Strategies 
 Alternative strategy was developed to access the fully functionalized cyclopentane 
core of the original structure of palau’amine (1a) that relied on the use of two internal 
[1,2]-rearrangements (Scheme 3.9).*  It was envisioned that cleavage of the C23-C24 
bond could be accomplished by conversion of α,β-unsaturated ester 131a into ketone 
193a by hydrolysis of the corresponding N-acyl imine obtained from a Curtius 
rearrangement. Ketone 193a would then serve as an ideal substrate for a Beckmann 
rearrangement in which to insert a nitrogen atom into the C16-C24 bond resulting in ring-
expanded lactam 194a.  Contrary to the double oxidative cleavage strategy, this route 
would tackle the manipulation of the C24 carbon center early, and lead into an alternative 
strategy with which to effect the ring opening of the bridged bicyclic system.   
 
Scheme 3.9 
 
 
 Application of the Curtius strategy began with hydrolysis of the ester 131a to the 
corresponding carboxylic acid 195a under alkaline conditions in 97% yield (Scheme 
3.10).  The Curtius rearrangement was then effected in a one-pot process by first 
exposure of acid 195 to diphenylphosphoryl azide (DPPA) and triethylamine to generate 
acyl azide 196a.  Addition of four equivalents of methanol followed by heating at 80 °C 
then resulted in the formation of putative isocyanate 197a, which was trapped by 
methanol to produce N-acyl imine 198a after tautomerization of the enamine alkene.  
Strongly acidic hydrolysis conditions then afforded ketone 193a in 90% yield over two 
steps. 
 
 
 
                                                 
*
 Work described in sections 3.2.4 was spearheaded by Dr. Jun Ma. 
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Scheme 3.10 
 
 
With access to tricyclic ketone 193a via the Curtius rearrangement, examination of 
the Beckmann ring expansion strategy was possible.  Transformation of ketone 193a 
(Scheme 3.11) into the corresponding oxime 199a was accomplished via condensation 
with hydroxylamine.  This condensation required long reactions times due to the steric 
crowding of the ketone by the C17-chloro substituent on one face and the cyclopentene 
framework on the opposing face.  However, after heating for 5 ½ days with portionwise 
addition of hydroxylamine over time, oxime 199a could be isolated as a single 
stereoisomer in 91% yield.*  The Beckmann rearrangement was effected by thionyl 
chloride,4 which produced lactam 194a in a completely regioselective process, thereby 
effecting the net insertion of nitrogen into the C16-C24 bond.† 
 
Scheme 3.11 
 
 
The remaining synthetic tasks required to access the fully functionalized 
cyclopentane core of the original structure of palau’amine (1a) included ring opening of 
                                                 
*
 Although only one stereoisomer of oxime 199a was isolated, the stereochemistry could not be verified.  
However, formation of lactam 194a suggests the formation of the indicated stereoisomer. 
†
 Constitutional isomer verified by a significant NOE signal between the lactam NH and the C20-methylene 
protons in 194a. 
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the bridged bicyclic system and the cyclopentene ring in order to elaborate the remaining 
substituents for the cyclopentane core.  This process began with oxidative cleavage of the 
cyclopentene substructure within 194a (Scheme 3.12) by alkene ozonolysis followed by 
reductive work-up (sodium borohydride) and selective protection of the C6,  
C13-hydroxyl groups as acetate esters to afford diacetate 200 in 77% yield over two 
steps.  Acylation of lactam 200 with di-tert-butyl dicarbonate (Boc2O) then furnished the 
bicyclic imide 201 in 99% yield.  Access to the advanced cyclopentane intermediate with 
differentiation of C13 and C6-O-functionalities was then accomplished by selective 
saponification of the acetate esters and ring opening of the bridged bicyclic system via 
intramolecular alcoholysis of the imide to generate carboxylic acid 202.*  Mild acid 
treatment then effected an intramolecular cyclization to afford lactone 203 in 96% over 
two steps.†  This furnished the bridged (i.e., 201) and non-bridged (i.e., 203) 
cyclopentane cores, which map directly onto the originally proposed structure of 
palau’amine 1a.  Indeed, both structures have the potential to serve as useful advanced 
precursors for future elaboration of the nitrogen-rich periphery of 1a. 
 
Scheme 3.12 
 
 
                                                 
*
 Imide 201 was very resistant to hydrolysis, and the saponification reaction is thought to occur via 
intramolecular C13 alcoholysis to generate lactone 203 directly, followed by further hydrolysis under the 
reactions conditions to yield hydroxy acid 202. 
†
 The structure of 203 was verified by extensive NOE analysis, from which the relative stereochemical 
arrangement of its synthetic precursors can also be inferred with confidence. 
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 Synthetic access to cyclopentane 203 (Scheme 3.12), represents the first published 
synthesis5 of the fully functionalized cyclopentane core of the originally proposed 
structure of palau’amine (1a), possessing all of the appropriate substituents and 
stereochemistry of the cyclopentane core, as well as functionality with which to continue 
pursuit of the synthetic target.  While this synthesis is significant, there was increasing 
evidence implicating the revised structure of palau’amine (1b) as the correct structure.6  
As a result, it was decided to pursue this alternative target.  However the strategy that was 
developed to access the fully functionalized cyclopentane core of 1a was anticipated to 
be instrumental in developing an efficient method to generate the diastereomeric fully 
functionalized cyclopentane core of 1b. 
 
3.3 Synthesis of the Fully Functionalized Core of the Revised Structure of 
Palau’amine 
 Increasing evidence supporting the revised structural assignment of palau’amine 
(1b) challenged the utility of the route developed towards the original structure (1a) in its 
ability to access the redefined target structure 1b.  Nevertheless, it was found that the 
previously described Diels-Alder/[3,3]-rearrangement strategy could be conveniently 
modified to accommodate the stereochemical inversions required at C12 and C17. 
Compared with the previous route (Section 3.2), two necessary changes would be needed 
to access the redefined fully functionalized cyclopentane core of 1b (102b, Scheme 3.13).   
These modifications would include an alternative route to access the new C17-chloro 
 
Scheme 3.13  
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epimer 131b via the [3,3]-sigmatropic rearrangement of a tricyclodecadiene, and 
epimerization of the C12-stereogenic center at a later stage. Thus, the synthetic plan 
would access an epimeric series of compounds 131b, 193b, and 194b, relative to the 
previous route, using the same key steps of a [3,3]-sigmatropic rearrangement, Curtius 
rearrangement, and Beckmann rearrangement.  The fully functionalized cyclopentane 
102b would then be accessed by ring opening of both the bridged bicyclic system and 
cyclopentene followed by epimerization of the C12 stereocenter to generate the presumed 
thermodynamically favored trans-C11,C12 configuration.     
 
3.3.1 Synthesis of the Ring E Chlorocyclopentane  
As shown in Chapter 2, efforts to access the chlorocyclopentane core 131b of the 
revised structure of palau’amine (1b) capitalized on the common early stage enone 
intermediate 129 (Scheme 3.14), which was found to exist as a 72:28 isomeric 
thermodynamic ratio with its enoate counterpart 136. Whereas the initial synthetic route 
focused on avoiding sigmatropic rearrangement of 129 to 136 through irreversible 
derivatization of 129 (cf. Scheme 3.2), access to the revised cyclopentane core structure 
relied on perturbing the electrocyclic equilibration of 129/136 in the opposite direction. 
Thus, the dynamic 129/136 mixture was subjected to a selective Meerwein-Verley-
Pondorf reduction of the bridging ketone group in 136, thereby accumulating the desired  
secondary alcohol 139 in 99% yield.  This process capitalizes on a Curtin-Hammett 
energy profile, wherein the less abundant but more reactive component of a dynamic 
 
Scheme 3.14 
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equilibrium, bridging ketone 136, underwent chemoselective reduction.  Nucleophilic 
substitution of the resulting bridgehead hydroxyl group in 139 with chloride occurred 
with net stereochemical retention at C17, presumably the result of pi-bond anchimeric 
assistance.  The substitution reaction afforded chlorocyclopentane 131b in 98% yield 
over two steps, constituting the C17-epimer of 131a (cf. Scheme 3.2). 
 
3.3.2 Successful Introduction of the C-16 Nitrogen via Curtius and Beckmann 
Rearrangements 
 With access to C17-chloro epimer 131b, the Curtius strategy, analogous to the 
previous synthetic route (Scheme 3.10), was evaluated.  Hydrolysis of enoate 131b 
(Scheme 3.15) under alkaline conditions generated carboxylic acid 195b in 98% yield.  
The outcome of this hydrolysis was highly dependent on the temperature of the reaction.  
Contrary to enoate 131a (cf. scheme 3.10), reaction at temperatures above 23 °C resulted 
in exchange of the C17-chloro substituent for a C17-hydroxyl group with net 
stereochemical retention at C17, likely the result of neighboring group assistance from 
the norbornene alkene followed by trapping with water.  The Curtius rearrangement of 
acid 195a was then effected in a three-step sequence by first exposure of acid 195a to 
oxalyl chloride and catalytic dimethylformamide to generate the corresponding acyl 
chloride, which after subjection to sodium azide afforded acyl azide 196b in 95% yield.   
Heating of 196b at 80 °C in the presence of eight equivalents of ethanol resulted in the 
 
 Scheme 3.15 
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formation of putative isocyanate 197b, which was trapped by ethanol to give a 4:1 
mixture of N-acyl enamine 204 and N-acyl imine 205, after partial tautomerization of the 
enamine alkene.  Strongly acidic hydrolysis of both isomers then equally afforded ketone 
193b in 94% yield over two steps. 
 The procedure for the Curtius rearrangement of 196b, as compared to C17-epimer 
196a (cf. scheme 3.10), was altered to include the use of ethanol rather than methanol as 
both the nucleophile for trapping the isocyanate and the solvent for the acidic hydrolysis 
to generate ketone 193b.  The use of the more bulky alcohol was required for the 
abatement of undesired byproducts; if the same reaction sequence was performed with 
methanol present, then methyl ether 207 (Scheme 3.16) was observed as a significant 
byproduct (20%).  The formation of methyl ether 207 is presumed to occur via pi-bond 
anchimeric assistance of enamine 206 or the enol tautomer of ketone 193b followed by 
trapping with methanol.   
 
Scheme 3.16 
 
 
With efficient access to tricyclic ketone 193b via the Curtius rearrangement 
strategy, examination of the Beckmann rearrangement was conducted.  Transformation of 
ketone 193b into the corresponding oxime 199b was accomplished via condensation with 
hydroxylamine in 96% yield (Scheme 3.17).*  The Beckmann rearrangement was then 
                                                 
*
 Formation of oxime 199b from the ketone precursor was significantly more facile than with epimer 199a 
(Scheme 3.11), likely due to the less sterically-demanding environment of the ketone. 
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successfully mediated by thionyl chloride4 to produce lactam 194b in 59% yield.*  The 
process was regioselective as constitutional isomer 208 was isolated in only 2% yield.  
The majority of the remaining mass balance was nitrile 209†, the result of a Beckmann 
fragmentation.7  Beckmann fragmentation products were exclusively observed when the 
transformation was attempted at elevated temperatures with methanesulfonyl chloride,  
p-toluenesulfonyl chloride, or cyanuric chloride. 
 
Scheme 3.17 
 
  
 A possible mechanism for the formation of the products observed during the 
Beckmann rearrangement is presented in Scheme 3.18.  Activation of oxime 199b with 
thionyl chloride afforded activated oxime 210.  Following path A, bond migration of the 
C16,C24 C-C bond resulted in loss of sulfur dioxide and trapping with chloride ion to 
generate chloroimidate 211;‡ lactam 194b was then isolated after aqueous workup.  
Bicyclic nitrile 209 may be formed via path B, where the antiperiplanar arrangement of 
the C17-chloro bond with the migrating C16,C24 bond facilitates fragmentation of the 
bridged bicyclic system generating the C16,C17 alkene and nitrile moiety within 
bicyclo[3.3.0]octadiene 209.   
 
 
                                                 
*
  The lactam connectivity was verified by a NOE signal between the lactam NH and C20-methylene 
protons.   
†
 Due to volatility the exact yield of nitrile 209 was difficult to quantify. 
‡
 An anhydrous NMR aliquot at the end of the reaction before workup indicated that lactam 194b was not 
present, suggesting the intermediacy of chloroimidate 211. 
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Scheme 3.18 
 
 
3.3.3 Completion of the Synthesis of the Fully Functionalized Cyclopentane Core of 
the Revised Structure of Palau’amine 
 The Curtius and Beckmann rearrangements allowed efficient access to lactam 
194b, which closely approximates the cyclopentane core of the revised structure of 
palau’amine (1b). Three distinct challenges need to be addressed in order to access the 
fully functionalized cyclopentane core 214 (Scheme 3.19): (1) oxidative cleavage of the 
cyclopentene within 194b with epimerization of the C12 stereocenter; (2) C10 oxidation; 
 
 Scheme 3.19 
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and (3) ring opening of the imide.*  Access to general structure 214 was successfully 
accomplished through two independent routes that differed in the order with which the 
second and third tasks were accomplished (i.e., 212 to 102b to 214, vs. 212 to 213 to 
214).   
 
Scheme 3.20 
 
 
 Before undertaking the oxidative cleavage of cyclopentene 194b, protection of the 
amide nitrogen was required to avoid undesirable nitrogen interactions in later sequences.  
Accordingly, Boc protection of amide 194b (Scheme 3.20) afforded imide 216 in 94% 
yield.†  The oxidative cleavage of the cyclopentene 216 was then accomplished by 
application of modified Lemieux-Johnson conditions,8 yielding a complex mixture of 
cyclic hemiacetals after incorporation of one equivalent of water.  When this mixture of 
products was exposed to silica gel and triethylamine, dehydration and desired  
C12-epimerization provided dialdehyde 212 in 88% yield as the thermodynamically 
favored C12-diastereomer.‡,§  Preparation of 212 constitutes the first successful route to a 
cyclopentane intermediate corresponding to the elaborate cyclopentane core of the  
revised structure of palau’amine (1b); however, C10 oxidation and ring opening of the 
imide were still required to transform this intermediate into the fully functionalized 
cyclopentane core.  
 With successful access to dialdehyde 212 via the oxidative cleavage of the 
cyclopentene and epimerization of the C12 stereocenter, attention was focused on 
                                                 
*
 Although it may be possible to perform these three tasks in any order, success was only observed upon 
tackling the oxidative cleavage step first.  Each individual task could be initially accomplished from lactam 
194b; however, no route successfully incorporating all three tasks was discovered which began with C10 
oxidation or lactam ring opening. 
†
 The Boc protection proceeds through first formation of the O-imidate species followed by thermal 
rearrangement to the N-imide product. 
‡
 The silica gel is thought to play a dual role, both as a desiccant as well as a Lewis acid.   
§
 On gram scale it was more reliable to conduct the oxidative cleavage via two distinct steps, by first 
dihydroxylation with OsO4/NMO and then oxidative cleavage with NaIO4 (see experimental section). 
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opening of the imide moiety.  The synthetic sequence began with protection of 
dialdehyde 212 as the bisdimethyl acetal 217 in 99% yield (Scheme 3.21).  Imide 
hydrolysis then furnished aziridine 219 as the only observable product, rather than the 
expected monocyclic cyclopentane 218.  The structure of 219 was verified after 
esterification with trimethylsilyl diazomethane to afford methyl ester 220 in 90% yield 
over the two steps.*  The undesired aziridine formation results from displacement of the 
C17-chloro substituent by backside attack from the C16-N-functionalitity under the imide 
hydrolysis conditions.  Subsequently, intermediates bearing the C16,C17  
trans-stereochemical configuration of the revised structure of palau’amine were found to 
be prone to aziridine formation under thermal or basic reaction conditions.†9 In particular, 
monocyclic substrates (e.g., carboxylic acid 218, Scheme 3.21) possessing only the 
cyclopentane ring were quite susceptible to aziridine formation due to the high degree of 
conformational flexibility that permits the orbital overlap necessary for backside 
displacement.   
 
Scheme 3.21 
 
 
 The need to effect the ring opening of the imide without concomitant aziridine 
formation was a significant synthetic problem.  A number of efforts to effect opening of 
                                                 
*
 The C17-aziridynl proton of 220 was significantly shielded (3.32 ppm) relative to similar C17-chloro 
substrates (e.g., 5.1-5.0 ppm). 
†
 Displacement of the C17 chloride via aziridine formation is implicated in the formation of certain  
non-chlorine-containing members of pyrrole-imidazole alkaloids possessing the same cyclopentane core.9 
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the imide ring on a variety of substrates of general structure 221 (Table 3.2, Entry 1), 
which contains the [3.2.1]-azabicyclic structure and C11,C12 trans-stereochemical 
configuration, also led to concomitant aziridine formation.  Alternatively, simply Boc 
deprotection of 221 was observed under the acidic conditions of Entry 2, and no reaction 
was observed under the conditions of Entry 3.  The solution to this synthetic problem 
would require that during the ring-opening event there was either the presence of an 
additional ring, which could bias the conformation away from aziridine formation, or the 
use of more chemoselective conditions than those used in Table 3.2. 
 
Table 3.2.  Attempted conditions for opening 
the imide ring without aziridine formation. 
 
 
 Success was finally achieved in opening the imide ring without concomitant 
aziridine formation through the use of an internal nucleophile, leading to formation of a 
polycyclic intermediate.*  As opposed to previous efforts in which the C12 stereogenic 
center was epimerized prior to ring opening, this strategy maintained the C11,C12  
cis-stereochemical configuration of 216 (Scheme 3.22).  This process began with 
oxidative cleavage of the cyclopentene substructure within 216 by alkene ozonolysis 
followed by reductive work-up (sodium borohydride) to yield C11,C12-cis-configured 
diol 224.  Exposure of diol 224 to mild acidic conditions led to differentiation of the  
                                                 
*
 The work in Schemes 3.22, 3.23, and 3.24 was performed by Dr. Jun Ma. 
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C6- and C13-O-functionalities by spontaneous intramolecular opening of the imide 
functionality with the C13-hydroxyl group to form the C13-C24 lactone.  In the same 
flask, silyl protection of the remaining C6 hydroxyl by sequential addition of 
triisopropylsilylchloride and imidazole afforded bicyclic lactone 225 in 91% yield over 
two steps.  Formation of lactone 225 represented a significant synthetic milestone, as it 
established a method to open the imide ring without concomitant aziridine formation. 
However, this method required maintaining the C12 stereocenter in the original C11,C12-
cis-configuration, an artifact of the sequence that would need to be rectified at a later 
time.     
 
Scheme 3.22 
 
 
 With a solution to the problematic aziridine formation, efforts were focused on 
epimerization of the C12 stereocenter of 225 (Scheme 3.22).  This task would require an 
effective strategy to unveil the C13 hydroxyl without concomitant aziridine formation 
upon opening of the C13-C24 lactone ring.  Accordingly, the elected strategy to avoid 
future aziridine formation involved incorporation of the C16-N-functionality into a cyclic 
hemiaminal ether (227, Scheme 3.23) so as to preclude aziridine formation by occupying 
the three valencies of the C16-nitrogen atom.  Formation of the hemiaminal ether was 
accomplished by removal of the C20-benzyl ether in 90% yield, followed by exposure of 
α-hydroxycarbamate 226 to benzaldehyde dimethyl acetal and catalytic acid to afford 
cyclic hemiaminal ether 227 in 59% yield as a single diastereomer.  Tethering of the C16-
N-functionality allowed for facile lactone hydrolysis to generate acid 228 followed by 
esterification to afford 229 in 99% yield over two steps.  C13 oxidation and C12 
epimerization were then effected by Dess-Martin periodane and triethylamine, 
respectively.  This sequence afforded aldehyde 230, which bears the stereochemical 
configuration of the core of the revised structure of palau’amine (1b), in 89% yield over 
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two steps.  Substrate 230 is a near-functional-equivalent of the C12, C17-diastereomeric 
counterpart 203 bearing the core of the original structure of palau’amine (1a) (cf. Scheme 
3.12).  
 
Scheme 3.23 
 
 
 While the synthesis of aldehyde 230 had accomplished two of the afore mentioned 
synthetic challenges, the use of the benzylidene hemiaminal tether as a strategy to avoid 
aziridine formation was undesirable.  The formation of spirocycle 227 was somewhat 
inconsistent as well as cumbersome in that it would require an additional deprotection 
step.  Consequently, an alternative route was developed that would use a more-readily 
accessible tricyclic structure to avoid unproductive aziridine formation and 
simultaneously accomplish the last challenge of C10 oxidation.  The revised route took 
advantage of the previously prepared diol 224 (Scheme 3.24), which under acidic 
conditions underwent intramolecular opening of the imide ring to generate lactone 203b.  
The C6 hydroxyl was then formally eliminated according to the Grieco protocol,10  which 
involved Mitsunobu inversion with o-nitrophenylseleno cyanate (232) followed by a 
hydrogen peroxide mediated oxidation and α-elimination generated monosubstituted 
alkene 233 in 72% yield over three steps starting from alkene 216 (Scheme 3.22).  
Oxidation of alkene 233 with N-bromosuccimide (NBS) resulted in intramolecular 
cyclization of the Boc carbonyl O-functionality and loss of butene to afford tricyclic 
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carbamate 234 in 78% yield.  Formation of the carbamate ring accomplished the desired 
C10 oxidation as well as the generated a tricyclic intermediate in which opening of the 
lactone ring could be realized without concomitant aziridine formation.  Derivatization of 
lactone 234 followed a strategy similar that described in Scheme 3.23, beginning with 
lactone hydrolysis and ester formation to expose primary alcohol 235.  Subsequent C13 
oxidation and C12 epimerization generated in 62% yield over four steps aldehyde 236, a 
fully functionalized cyclopentane core for the revised structure of palau’amine (1b).  
Importantly, 236 possesses all of the peripheral functionality with proper stereochemistry 
for further advancement to the natural product. 
 
Scheme 3.24 
 
 
 Concurrent with the route developed in Scheme 3.24, an alternative strategy was 
discovered that used the judicious choice of reagents and conditions to access a fully 
functionalized cyclopentane core without the necessity of polycyclic structures to 
preclude aziridine formation.  This endeavor began with dialdehyde 212 (Scheme 3.25) 
and relied on selective differentiation of the C6- and C13-O-functionalities.  Attempts to 
achieve selective differentiation of dialdehyde 212 via reduction, enol ether formation, 
and acetal formation all yielded constitutional mixtures of products.   However, 
successful differentiation could be accomplished via the derived diol 237, which was 
generated by reduction with sodium borohydride in 84% yield.  Differentiation of the C6 
 112 
and C13 hydroxyls was achieved by application of the Grieco protocol to access 
monosubstituted alkene 238.  Use of the more sterically demanding tributylphosphine (cf. 
Scheme 3.24 with trimethylphosphine) was required in order to selectively react with the 
less sterically encumbered C6 hydroxyl.  After one recycling of starting material, a 
combined 69% yield of alkene 238 was realized.  Mitsunobu inversion of the remaining 
C13 hydroxyl with hydrazoic acid generated alkyl azide 239 in 85% yield.  Opening of 
the imide ring was accomplished without undesired concomitant aziridine formation 
through the use of the highly nucleophilic but only moderately basic reagent, hydrazine. 
Upon exposure of imide 239 to hydrazine in methanol at 50 °C, monocyclic acyl 
hydrazide 240 was isolated in 88% yield with retention of the C17-chloro functionality.  
Acyl hydrazide 240 could then be conveniently transformed into the synthetically more 
useful acyl azide 241 in 95% yield with tert-butyl nitrite.  Moreover, analogous to 
carbamate 236 (Scheme 3.24), 241 possesses all of the peripheral functionality with 
proper stereochemistry for further advancement to target 1b, the revised structure of 
palau’amine. 
 
Scheme 3.25 
 
 
3.4 Summary 
A divergent synthetic route starting from enone 129 (Scheme 3.26) has been 
developed that allows access to the fully functionalized cyclopentane cores (Ring E) of 
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the original (1a) and revised (1b) structures of palau’amine in thirteen and sixteen steps, 
respectively. Both syntheses generated the cyclopentane framework through the strategic 
use of a [3,3]-sigmatropic rearrangement of tricyclo[5.2.1.0]decadienes to access 
epimeric chlorocyclopentanes 131a (Scheme 3.26) and 131b (Scheme 3.27).  Each of 
these intermediates was independently advanced along similar routes to epimeric 
tricyclo[5.3.1.0]azaundecenes 194a (Scheme 3.26) and 194b (Scheme 3.27) using Curtius 
and Beckmann rearrangements as key steps. 
The routes then diverged using different strategies to oxidatively cleave the 
cyclopentene and effect the imide ring opening in a mutually compatible fashion with the 
rest of the functional groups present.  The route towards the cyclopentane core of the 
original structure of palau’amine (1a) (Scheme 3.26) relied on hydrolysis of the sterically 
encumbered imide 201 via intramolecular alcoholysis under basic conditions.  Following  
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treatment with acid, bicyclic lactone 203a was secured, which possesses all of the 
peripheral functionality with proper stereochemistry for further advancement to target 1a 
Two routes were successfully developed toward the fully functionalized 
cyclopentane core of the revised structure of palau’amine (1b) (Scheme 3.27).  The key 
additional challenges to accessing the cyclopentane core of 1b involved orchestrating the 
epimerization of the C12 stereogenic center and opening of the imide ring without 
concomitant aziridine formation.  The first route, developed by Dr. Jun Ma, used the 
conformational constraints of polycyclic intermediates to avoid the unproductive and 
deleterious formation of aziridine byproducts.  Ring opening of the imide was 
accomplished via intramolecular alcoholysis under acidic conditions to generate bicyclic 
lactone 233.  An intramolecular tether strategy was then used to restrain the  
C16-N-functionality from aziridine formation.  Eventually the C12 position was 
epimerized to generate bicyclic carbamate 236 representing a potentially viable 
intermediate en route to 1b.  Alternatively, the second route developed toward a fully 
functionalized cyclopentane core of 1b accomplished early epimerization of the C12 
stereocenter immediately following the oxidative cleavage of cyclopentene 216.  Other 
key steps involved differentiation of diol 237 via the Grieco protocol with a sterically 
demanding phosphine and opening of imide 239 under mild conditions with hydrazine.   
Both routes towards the revised structure of palau’amine (1b) (Scheme 3.27) used 
different strategies to successfully accomplish the latter three synthetic challenges: 
oxidative cleavage of the cyclopentene with epimerization of the C12 stereocenter, C10 
oxidation, and opening of the imide ring.  In the first route, delaying the epimerization of 
the C12 stereocenter allowed for facile opening of the imide ring as well as 
differentiation of the C6- and C13-O-functionalities.  However, the need to form 
polycyclic structures and effect late epimerization of the C12 stereocenter lead to a 
circuitous route that required deprotection/protection and reduction/oxidation sequences 
of the same functionalities.  The second route accomplished early epimerization of the 
C12 stereocenter, which lead to the synthetic problems of differentiation of the C6- and 
C13-O-functionalities and opening of the imide ring without concomitant aziridine 
formation.  Ultimately both of the issues were accomplished by the judicious choice of 
reagents which allowed for the desired transformation to occur while avoiding undesired  
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pathways.  The lack of deprotection/reprotection sequences and direct solutions to the 
synthetic problems resulted in a concise synthesis of acyl azide 241, which already 
possesses the C13-N-functionality in addition to a synthetic handle to install the  
C19-N-functionality.  However, without the presence of a polycyclic structure or an 
alternative protection group strategy for the C16-N-functionality, aziridine formation will 
potentially be a problem upon further advancement of intermediate 241. 
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H
NH
Cl
O
O
H
BnO
Boc
1. NaOH, MeOH
2. TMSCHN2
C6H6/MeOH
3. DMP, CH2Cl2
4. Et3N, CH2Cl2
233 72%
over three steps
CO2Et
H
H
O
OBn
17
H
H
H
Cl
EtO2C
OBn
H
H
H
H
H
OBn
ClH
O
193b 91%
over two steps
131b 98%
over two steps
N
H
H
H
ClH
O
OBnBoc
1. OsO4, NMO
acetone/H2O
2. NaIO4, THF/H2O
3. SiO2, Et3N, EtOAc
N
H
H
ClH
O
OBnBoc
OH
OH
H
N
H
H
ClH
O
OBnBoc
N3
H
NO2
SeCN
CH2Cl2, 50 °C
1. NaOH, EtOH
2. DPPA, Et3N;
EtOH, PhCH3, 80 °C
3. HCl, EtOH
1. NH2OH•HCl, py
EtOH, 95 °C
2. SOCl2, Et2O
3. Boc2O, THF, 85 °C
216 53%
over three steps
237 92%
over four steps
1. 232, PBu3; H2O2
THF
2. HN3, PPh3,
DIAD, THF
239 59%
over two steps
1. H2NNH2
MeOH, 50 °C
2. t-BuNitrite, HCl
DMF, -20 °C
241 84%
over two steps
4. NaBH4, MeOH
H
Cl
BocNH
O
H
OBn
N3
N3
1. O3, -78 °C; NaBH4
MeOH/CH2Cl2
2. p-TsOH, CH2Cl2
3. 232, PMe3; H2O2
THF, 0 °C
Cl
HN O
O
BrBnO
O
O
H
H
234 78%
Cl
HN O
O
BrBnO
H
12
H
O
MeO
236 62%
over four steps
O
NBS
CH3CN, 23
oC
12
1212
10
16
1016
20
232
H
H
H
OH
EtO2C
OBn
H
H
H
H
H
EtO2C
OBn
H
O
17
Al(Oi-Pr)3
i-PrOH
80 °C
SOCl2
1217 N
NN
NH
Cl
H
HHN N
NH2
HO
O
H2N
NH2
1b
13
19
13
19
129 136 139
 
 
 116 
The routes illustrated demonstrate novel strategies to access the densely substituted 
cyclopentane cores of both the original (1a) and revised (1b) structures of palau’amine. 
The successful synthesis of 203a, 236, and 241 allows for opportunity to pursue the 
remaining daunting heterocyclic structure within the challenging synthetic target 1a and 
1b. 
 
3.5 Experimental 
General Procedures.  All reactions were performed in flame-dried round bottom 
or modified Schlenk (Kjeldahl shape) flasks fitted with rubber septa or glass stoppers 
under a positive pressure of argon, unless otherwise noted.  Air- and moisture-sensitive 
liquids and solutions were transferred via syringe or stainless steel cannula.  Organic 
solutions were concentrated by rotary evaporation below 30 °C at ca. 25 Torr.  Flash 
column chromatography was performed employing 230-400 mesh silica gel.  Thin-layer 
chromatography (analytical and preparative) was performed using glass plates precoated 
to a depth of 0.25 mm with 230-400 mesh silica gel impregnated with a fluorescent 
indicator (254 nm).  Reaction temperatures were maintained through the use of the 
following baths unless stated otherwise:  above ambient temperature (oil bath), 0 °C 
(ice/water), -78 °C (dry ice/acetone). 
Materials.  Commercial reagents and solvents were used as received with the 
following exceptions:  tetrahydrofuran, benzene, acetonitrile, dimethoxyethane, diethyl 
ether, toluene, and dichloromethane were dried by passage through activated alumina 
columns under a positive pressure of argon.  Ethanol, 1,2-dichloroethane, dimethyl 
formamide, and dimethylsulfoxide was dried over activated 4 Å molecular sieves.  
Triethylamine, pyridine, and methanol were distilled from calcium hydride at 760 Torr.   
Instrumentation.  Infrared (FTIR) spectra were obtained using a Perkin-Elmer 
Spectrum BX or a Bruker Tensor 27 spectrophotometer and referenced to a polystyrene 
standard.  Data are presented as the frequency of absorption (cm-1), and intensity of 
absorption (s = strong, m = medium, w = weak, br = broad).  Proton and carbon-13 
nuclear magnetic resonance (1H NMR and 13C NMR) spectra were recorded on a Varian 
Unity 400, Varian Unity 500, Varian Unity Inova 500NB NMR or Bruker Avance III 500 
spectrometer.  Chemical shifts are expressed in parts per million (δ scale) downfield from 
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tetramethylsilane and are referenced to residual protium in the NMR solvent (CHCl3: δ 
7.26 for 1H, δ 77.16 for 13C; C6HD5: δ 7.16 for 1H, δ 128.06 for 13C; CHD2OD: δ 3.31 for 
1H, δ 49.00 for 13C).  Data are presented as follows:  chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quadruplet, ABq = non-first order quadruplet, p = 
pentet, br = broadened signal, m = multiplet and/or multiple resonances), integration, and 
coupling constants in Hertz (Hz).  1H NMR assignments were generally supported by 
COSY experiments. 
 
 
 
Tetraol 179, (MSB-IV-048).  To a solution of chloride 131a (93 mg, 0.26 mmol, 
1.0 equiv) in tetrahydrofuran (2.25 mL) and water (0.75 mL) was added potassium 
carbonate (208 mg, 1.5 mmol, 6.0 equiv), potassium ferricyanide (493 mg, 1.5 mmol, 
6.0 equiv), and osmium tetroxide (2 mg, 0.008 mmol, 0.03 equiv).  After 2 days the 
solution was diluted with tert-butanol (3 mL) and osmium tetroxide (38 mg, 0.15 mmol, 
0.6 equiv) was added.  After 23 hr the reaction was diluted with saturated sodium 
chloride (50 mL) and extracted with dichloromethane (3 x 50 mL), dried with sodium 
sulfate, and reduced in vacuo to yield tetraol 179 (93 mg, 84 %) as a green solid.   
Rf  0.18 (6:1 ethyl acetate: hexane);  1H NMR (500 MHz, CDCl3) δ 7.36-7.30 (m, 5H, 
C6H5CH2OCH2), 4.84 (dd, 1H, J = 2.0, 8.0 Hz, HOC), 4.76 (s, 1H, CHCl), 4.65 (d, 1H, J 
= 11.6 Hz, C6H5CH2OCH2), 4.56 (d, 1H, J = 11.5 Hz, C6H5CH2OCH2), 4.22-4.11 (m, 5H, 
CCH2O, CHOHCHOH, CH3CH2O), 3.94 (d, 1H, J = 10.0 Hz, CCH2O), 3.14 (d, 1H, J = 
8.0 Hz, COHCHOHCH), 2.89-2.86 (m, 1H, CH2CHCH), 2.68 (d, 1H, J = 10.5 Hz, 
COHCHOHCH), 2.49-2.44 (m, 1H, CH2CHCH), 2.25-2.23 (m, 1H, HOC), 1.66-1.60 (m, 
1H, CH2CHCH), 1.28-1.23 (m, 4H, CH2CHCH, OCH2CH3);  IR (neat film) 3384 (s), 
2926 (m), 1728 (s), 1454 (w), 1252 (s), 1093 (s), 1028 (s) cm-1;  HRMS (ESI) m/z calcd 
for C21H27ClO7Na (M+Na)+ 449.1343, observed 449.1340. 
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Polyacetal 180 and Polyacetal 181, (MSB-IV-037).  To a solution of tetraol 179 
(30 mg, 0.0704 mmol, 1.0 equiv) in tetrahydrofuran (1.1 mL) and water (1.1 mL) was 
added sodium periodate (75 mg, 0.352 mmol, 5 equiv).  After 5 days the solution was 
diluted with a saturated sodium chloride solution (10 mL) and extracted with 
dichloromethane (3 x 10 mL), dried with sodium sulfate, and reduced in vacuo to yield a 
mixture of polyacetals 180 and 181 in a 2:1 ratio (27 mg, 87%), respectively.  The 
mixture was used without purification.   
Rf  0.51 and 0.40 (4:1 ethyl acetate: hexane);  1H NMR (500 MHz, CDCl3) Key NMR 
signals δ [5.94, 5.92 (s, CH(OC)2)], [(5.75, d, J = 4.0 Hz), 5.73, d, J = 2.5 Hz), 
CH(OC)2)], [5.34-5.30, 5.25-5.23,  (m, CH2HC(OC)2)];  HRMS (ESI) m/z calcd for 
C21H25ClO8Na (M+Na)+ 463.1136, observed 463.1138. 
 
 
                                     
TIPS polyacetal 182 and TIPS polyacetal 183, (MSB-IV-043).  To a solution of 
polyacetals 180 and 181 (27 mg, 0.061 mmol, 1.0 equiv) in dichloromethane (1.0 mL) 
were added 2,6-lutidine (50 µL, 0.427 mmol, 7.0 equiv) and triisopropylsilyl chloride 
(56 µL, 0.207 mmol, 3.5 equiv).  After 2 and ½ hr the solution was diluted with brine 
(10 mL), then hydrochloric acid (10 mL, 0.01N), and extracted with dichloromethane 
(3 x 10 mL).  The combined organic layers were dried (sodium sulfate), filtered, and 
concentrated in vacuo.  The residue was purified by silica gel flash chromatography 
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(1:1 gradient to 3:1 dichloromethane: hexane) to afford acetal 183 (10.5 mg, 20%) and 
acetal 182 (13.9 mg, 26%) as clear oils.   
Acetal 183.  Rf  0.56 (2:1 dichloromethane: hexane);  1H NMR (500 MHz, CDCl3) δ 
7.34-7.27 (m, 5H, C6H5CH2OCH2), 5.90 (s, 1H, ClHCCHCHO2), 5.70 (d, 1H, J = 4.1 Hz, 
O2CHCHCHCH2CHO2), 5.22 (dd, 1H, J = 3.6, 9.9 Hz, CH2CHO2), 4.60-4.55 (m, 3H, 
C6H5CH2OCH2, ClHCCHCHO2), 4.22-4.14 (m, 2H, CH3CH2O), 4.12 (d, 1H, J = 
10.4 Hz, CCH2O), 4.07 (d, 1H, J = 10.4 Hz, CCH2O), 2.93-2.90 (m, 1H, 
CHCHCH2CHO2), 2.72-2.68 (m, 2H, CHCHCHCH2CHO2), 1.99 (ddd, 1H, J = 2.4, 3.4, 
14.4 Hz, CH2CHO2), 1.85 (ddd, 1H, J = 5.6, 9.9, 14.4 Hz, CH2CHO2), 1.25 (t, 1H, J = 
7.1 Hz, OCH2CH3), 1.16-0.98 (m, 42H, Si(CH(CH3)2)3);  13C NMR (125 MHz, CDCl3) δ 
165.9, 138.2, 128.4, 127.7, 127.6, 101.9, 101.4, 100.2, 91.7, 73.3, 66.3, 61.6, 59.4, 51.8, 
50.7, 48.4, 33.7, 31.2, 17.9, 17.8, 17.8, 13.8, 12.1, 12;  LRMS (ESI) m/z for C39H66ClO8, 
(M+Na)+  775.5. 
Acetal 182. Rf  0.46 (2:1 dichloromethane: hexane);  1H NMR (500 MHz, CDCl3) δ 7.36-
7.28 (m, 5H, C6H5CH2OCH2), 5.88 (d, 1H, J = 5.6 Hz, ClHCCHCHO2), 5.68 (s, 1H, 
O2CHCHCHCH2CHO2), 5.33 (dd, 1H, J = 2.5, 9.9 Hz, CH2CHO2), 4.58 (s, 2H, 
C6H5CH2OCH2), 4.38 (d, 1H, J = 4.3 Hz, ClHCCHCHO2), 4.23-4.13 (m, 2H, CH3CH2O), 
4.00 (ABq, 2H, J = 10.3, 15.1 Hz, CCH2O), 3.20-3.14 (m, 2H, CHCHCHCH2CHO2), 
2.52 (dd, 1H, J = 6.1, 12.0 Hz, CHCHCH2CHO2), 1.87 (d, 1H, J = 14.5 Hz, CH2CHO2), 
1.81-1.77 (m, 1H, CH2CHO2), 1.24 (t, 1H, J = 7.1 Hz, OCH2CH3), 1.12-1.02 (m, 42H, 
Si(CH(CH3)2)3);  13C NMR (125 MHz, CDCl3) δ 166.7, 138.2, 128.4, 127.7, 127.6, 
102.4, 101.6, 100.4, 89.7, 73.4, 65.5, 61.6, 56.0, 48.7, 48.6, 47.3, 33.1, 29.2, 17.8, 17.7, 
17.7, 13.9, 12.1, 11.9;  LRMS (ESI) m/z for C39H65ClO8, (M+Cl)-  787.8. 
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Enol ether 188 and enol ether 189, (MSB-IV-050).  To a solution of polyacetals 180 
and 181 (5.5 mg, 0.013 mmol, 1.0 equiv) in tetrahydrofuran (0.41 mL) was added 
triethylamine (9.0 µL, 0.013 mmol, 10 equiv) and methanesulfonyl chloride (4.9 µL, 
0.063 mmol, 5 equiv) at 0 °C.  After 2 and ½ hr the solution was heated to 35 °C.  After 
90 min the solution was diluted with brine (10 mL) and extracted with dichloromethane 
(3 x 10 mL).  The combined organic layers were dried (sodium sulfate), filtered, and 
concentrated in vacuo to afford a mixture of enol ethers 188 and 189 as well as an 
unidentified isomer in a 0.9:1.5:0.4 ratio, respectively (5.2 mg, 98%) as a clear oil.   
Rf  0.60 (4:1 ethyl acetate: hexane);  1H NMR (500 MHz, CDCl3) Key NMR signals δ 
6.45-6.42 (m, CH=CHO), [(5.95, d, J = 4.7 Hz), (5.84, d, J = 4.6 Hz), (5.77-5.76, m), 
(5.65, d, J = 4.41 Hz) CHO2], [(5.09, t, J = 6.1 Hz), (4.91-4.88, m), CH=CHO];  LRMS 
(ESI) m/z C21H23ClO7, (M+Na)+ 445.1. 
 
 
        
Lactone 190 and lactone 191, (MSB-IV-053).  To a solution of a 0.9:1.5 mixture of enol 
ethers 188 and 189 (1.0 mg, 0.0024 mmol, 1.0 equiv) in dichloromethane (0.15 mL) was 
added tetrapropyl ammonium perruthenate (0.1 mg, 0.00012 mmol, 0.05 equiv) and  
N- methyl morpholine N-oxide (0.5 mg, 0.0036 mol, 1.5 equiv) and 4 Å molecular sieves 
(5.0 mg, 500 mg/mmol).  After 2 additional hr, N-methyl morpholine N-oxide (0.5 mg, 
0.0036 mol, 1.5 equiv) was added.  After 2 hr the solution was filtered through a plug of 
celite and concentrated in vacuo to afford a crude mixture of lactones 190 and 191 as well 
as the third unidentified starting material in a 1.0:1.8: 0.4 as determined by 1H NMR 
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analysis.  The residue was purified by silica gel flash chromatography (1:1 hexanes: ethyl 
acetate) to afford lactone 190 (0.3 mg, 30%) and lactone 191 (0.5 mg, 50%) as clear 
films.   
Lactone 191. Rf  0.55 (1:1 ethyl acetate: hexane);  1H NMR (500 MHz, CDCl3) δ 7.34 -
7.27 (m, 5H, C6H5CH2OCH2), 6.37 (d, 1H, J = 5.6 Hz, CHCHCH=CHO), 6.08 (d, 1H, J 
= 5.4 Hz, ClHCCHCHO2), 5.10 (t, 1H, J = 6.0 Hz, CHCHCH=CHO), 4.64 (d, 1H, J = 
3.8 Hz, ClHCCHCHO2), 4.57 (s, 2H, C6H5CH2OCH2), 4.28-4.21 (m, 2H, CH3CH2O), 
4.07 (d, 1H, J = 10.4 Hz, CCH2O), 3.70 (d, 1H, J = 10.4 Hz, CCH2O), 3.45 (dd, 1H, J = 
4.9, 10.8 Hz, CHCHCH=CHO), 3.27-3.25 (m, 1H, ClHCCHCHO2), 2.98 (dd, 1H, J = 
6.6, 11.5 Hz, CHCHCH=CHO), 1.25 (t, 1H, J = 7.1 Hz, OCH2CH3);  LRMS (ESI) m/z 
C21H21ClO7, (M+Na)+ 443.2. 
Lactone 190. Rf  0.39 (1:1 ethyl acetate: hexane);  1H NMR (500 MHz, CDCl3) δ 7.34 -
7.27 (m, 5H, C6H5CH2OCH2), 6.49 (d, 1H, J = 5.9 Hz, CHCH=CHO), 5.90 (d, 1H, J = 
5.2 Hz, CHCHO2), 5.11 (t, 1H, J = 6.0 Hz, CHCH=CHO), 4.95 (d, 1H, J = 11.4 Hz, 
ClHCCH), 4.54 (q, 2H, C6H5CH2OCH2), 4.30-4.20 (m, 2H, CH3CH2O), 4.19-4.11 (d, 1H, 
CCH2O), 3.60 (d, 1H, J = 10.4 Hz, CCH2O), 3.24 (dd, 1H, J = 6.5, 11.1 Hz, ClHCCH), 
3.18-3.15 (m, 1H, CHCO2), 2.95 (t, 1H, J = 5.4 Hz, CHCH=CHO), 1.25 (t, 1H, J = 
7.1 Hz, OCH2CH3);  LRMS (ESI) m/z C21H21ClO7, (M+Cl)+ 455.4. 
 
 
 
4-Benzyloxymethyl-8-chloro-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic acid (195a), (MSB-IV-059).  To a solution of chloride 131a (125 mg, 
0.349 mmol, 1.0 equiv) in ethanol (3 mL) at 23 °C was added a sodium hydroxide 
solution (3 mL, 5.0 M).  After 90 min the reaction was warmed to 30 °C.  After 5 hr the 
reaction was diluted with hydrochloric acid (10 mL, 1 M) and extracted with ethyl acetate 
(3 x 10 mL), dried with sodium sulfate, and reduced in vacuo to afford acid 195a 
(111.5 mg, 97%) as a clear oil.  Rf  0.58 (2:1 ethyl acetate: hexane);  1H NMR (500 MHz, 
CDCl3) δ 7.38-7.28 (m, 5H, C6H5CH2OCH2), 7.06-7.05 (m, 1H, C=CHCHCHCH), 5.59 
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(dq, 1H, J = 2.0, 5.7 Hz, CH2CH=CH), 5.43 (dq, 1H, J = 2.2, 5.7 Hz, CH2CH=CH), 4.62 
(s, 2H, C6H5CH2OCH2), 4.28 (d, 1H, J = 10.2 Hz, C6H5CH2OCH2), 4.13 (s, 1H, CHCl), 
3.91 (d, 1H, J = 10.2 Hz, C6H5CH2OCH2), 3.43-3.40 (m, 1H, C=CHCHCHCH), 3.25 (t, 
1H, J = 3.2 Hz, C=CHCHCHCH), 3.08 (m, 1H, C=CHCHCHCH), 2.31 (ddd, 1H, J = 
1.5, 10.2, 18.1 Hz, CH2CH=CH), 1.90 (dt, 1H, J = 2.2, 18.02 Hz, CH2CH=CH);  IR (neat 
film)  3049 (w), 2904 (w), 2676 (w), 1680 (s), 1454 (m), 1146 (s) cm-1;  13C NMR (125 
MHz, CDCl3) δ 169.0, 149.6, 137.5, 133.3, 132.8, 128.2, 127.5, 126.7, 126.6, 73.6, 72.6, 
65.5, 62.1, 51.9, 50.5, 37.7, 33.4;  HRMS (ESI) m/z calcd for C19H20O3Cl (M+H)+ 
331.1101, observed 331.1093. 
 
 
 
Imine 198a, (MSB-IV-135).  To a solution of acid 195a (139 mg, 0.421 mmol, 
1.0 equiv) in toluene (8 mL) at 23 °C was added diphenylphosphorylazide (100 µL, 
0.463 mmol, 1.1 equiv) and triethylamine (65 µL, 0.463 mmol, 1.1 equiv).  After 15 min 
additional diphenyl phosphorylazide (15 µL, 0.070 mmol, 0.16 equiv) was added.  After 
5 hr TLC analysis showed complete conversion to the corresponding acyl azide, at which 
point methanol (70 µL, 1.68 mmol, 4.0 equiv) was added and the solution was heated to 
80 °C.  After 1 hr the solvent was reduced in vacuo to afford imine 198a which was used 
without purification.   
Rf  0.42 (4:1 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.37-7.31 (m, 5H, 
C6H5CH2OCH2), 5.76 (dd, 1H, J = 2.1, 5.7 Hz, CH2CH=CH), 5.45 (dd, 1H, J = 2.3, 
5.7 Hz, CH2CH=CH), 4.59 (d, 1H, J = 12.1 Hz, C6H5CH2OCH2), 4.54 (d, 1H, J = 
12.1 Hz, C6H5CH2OCH2), 4.40 (t, 1H, J = 2.1 Hz, CHCl), 3.77 (s, 3H, OCH3), 3.69-3.64 
(m, 2H, C6H5CH2OCH2), 3.34-3.30 (m, 1H, CCH2CHCHCH), 3.19 (dt, 1H, J = 4.0, 
9.7 Hz, CCH2CHCHCH), 2.74 (t, 1H, J = 2.8 Hz, CCH2CHCHCH), 2.62 (dd, 1H, J = 
4.6, 18.0 Hz, CCH2CHCHCH), 2.38 (dd, 1H, J = 2.4, 17.9 Hz, CCH2CHCHCH), 2.28-
2.24 (m, 2H, CH2CH=CH);  IR (neat film)  3043 (w), 2904 (w), 1733 (s), 1690 (s), 1253 
(s) cm-1;  LRMS (ESI) m/z for C20H23O3ClN (M+H)+ 360.06. 
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Ketone 193a, (MSB-IV-136).  To a solution of imine 198a (151 mg, 0.421 mmol, 
1.0 equiv) in methanol (2 mL) at 23 °C was added concentrated hydrochloric acid (0.6 
mL).  After 12 hr the solution was diluted with saturated sodium chloride solution (50 
mL) and extracted with dichloromethane (3 x 50 mL).  The organic layer was dried with 
sodium sulfate, and reduced in vacuo.  The residue was purified via silica gel 
chromatography (4:1 gradient to 1:1 hexane: ethyl acetate) to yield ketone 193a (114 mg, 
90% over two steps) as a clear oil.   
Rf  0.56 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.36-7.27 (m, 5H, 
C6H5CH2OCH2), 5.73-5.71 (m, 1H, CH2CH=CH), 5.52-5.50 (m, 1H, CH2CH=CH), 4.59 
(d, 1H, J = 12.1 Hz, C6H5CH2OCH2), 4.53 (d, 1H, J = 12.1 Hz, C6H5CH2OCH2), 4.43 (t, 
1H, J = 2.4 Hz, CHCl), 3.67 (d, 1H, J = 10.6 Hz, C6H5CH2OCH2), 3.63 (d, 1H, J = 
10.6 Hz, C6H5CH2OCH2), 3.41-3.38 (m, 1H, CCH2CHCHCH), 3.13 (dt, 1H, J = 3.8, 10.3 
Hz, CCH2CHCHCH), 2.87-2.85 (m, 1H, CCH2CHCHCH), 2.49 (dd, 1H, J = 4.7, 18.2 
Hz, CCH2CHCHCH), 2.32 (ddd, 1H, J = 1.7, 10.4, 18.0 Hz, CH2CH=CH), 2.13 (dd, 1H, 
J = 2.6, 18.2 Hz, CCH2CHCHCH), 1.99-1.94 (m, 1H, CH2CH=CH);  13C NMR (125 
MHz, CDCl3) δ 213.2, 138.5, 133.6, 130.3, 128.6, 127.8, 126.4, 73.8, 67.1, 66.5, 64.5, 
52.8, 48.7, 43.1, 38.6, 38.4, 33.3;  IR (neat film) 2929 (w), 2856 (w), 1745 (s), 1101 (m), 
1070 (m) cm-1;  LRMS (ESI) m/z C18H19O2Cl, (M+Na)+ 324.87. 
 
 
 
Oxime 199a, (JM-I-275).  To a solution of ketone 193a (35.1 mg, 0.116 mmol, 
1.0 equiv) in ethanol (2 mL) and water (1 mL) was added hydroxylamine hydrochloric 
salt (80.6 mg, 1.162 mmol, 10 equiv) and pyridine (94 µL, 1.162 mmol, 10 equiv).  The 
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resulting mixture was then heated up to reflux for 68 hrs at which point ketone 193a 
could still be detected by TLC analysis.  Another portion of hydroxylamine hydrochloric 
salt (80.6 mg, 1.162 mmol, 10 equiv) and pyridine (94 µL, 1.162 mmol, 10 equiv) was 
added and the reaction was refluxed for another 68 hrs until the complete consumption of 
the starting material (by TLC analysis).  The solution was diluted with ethyl acetate 
(30 mL), and washed with water (3 x 10 mL), brine (10 mL), dried (sodium sulfate), 
filtered, and concentrated in vacuo to afford oxime 199a (33.6 mg, 91%) as highly 
crystalline white solid.   
Rf  0.44 (30% ethyl acetate in hexane);  1H NMR (500 MHz, CDCl3) δ 7.37-7.34  (m, 4H, 
C6H6CH2O), 7.33-7.26 (m, 1H, C6H6CH2O), 5.73 (m, 1H, CH2CH=CH), 5.45 (m, 1H, 
CH2CH=CH), 4.60 (d, 1H, J = 12.1 Hz, PhCH2O), 4.54 (d, 1H, J = 12.1 Hz, PhCH2O), 
4.32 (t, 1H, J = 1.9 Hz, CHCl), 3.66 (d, 1H, J = 10.2 Hz, C6H5CH2OCH2), 3.61 (d, 1H, J 
= 10.3 Hz, C6H5CH2OCH2), 3.31-3.24 (m, 1H, CCH2CHCHCH), 3.08 (dt, 1H, J = 3.6, 
10.0 Hz, CCH2CHCHCH), 2.67 (dt, 1H, J = 1.7, 4.6 Hz, CCH2CHCHCH), 2.59 (dd, 1H, 
J = 4.4, 17.7 Hz, CCH2CHCHCH), 2.37 (dd, 1H, J = 2.2, 17.6 Hz, CH2CH=CH), 2.33-
2.23 (m, 1H, CCH2CHCHCH), 2.22-2.13 (m, 1H, CH2CH=CH);  13C NMR (125 MHz, 
CDCl3) δ 162.6, 138.8, 133.5, 130.4, 128.7, 127.92, 127.89, 73.8, 67.6, 65.6, 61.3, 48.9, 
43.7, 39.3, 33.4, 28.2;  IR (neat film) 3333 (w), 2921 (m), 2856 (m), 1735 (m), 1684 (m);  
LRMS (ESI) m/z C18H20ClNO2, (M+Na)+ 340.2. 
 
 
 
Lactam 194a, (JM-I-276).  To a solution of the oxime 199a (12.6 mg, 0.0397 mmol, 
1.0 equiv) in diethyl ether (1.2 mL) was added thionyl chloride (11.6 uL, 0.159 mmol, 
4.0 equiv) and the resulting mixture was stirred at 23 °C for 20 hr.  The solution was then 
diluted with ethyl acetate (20 mL), washed with water (3 x 10 mL), brine (10 mL), dried 
(sodium sulfate), filtered, and concentrated in vacuo. The residue was purified via silica 
gel chromatography (90: 10 gradient to 60:40 hexane: ethyl acetate) to yield the lactam 
194a (6.8 mg, 54%) as a yellow solid.  
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Rf  0.14 (70:30 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.38-7.29 (m, 5H, 
C6H6CH2O), 5.98 (s, 1H, NH), 5.80 (m, 1H, CH=CHCH2CH), 5.58 (m, 1H, 
CH=CHCH2CH), 4.54 (ABq, 2H, J = 12.0 Hz, PhCH2O), 4.13 (d, 1H, J = 5.0 Hz, CHCl), 
3.58 (d, 1H, J = 9.0 Hz, CCH2O), 3.50 (d, 1H, J = 8.9 Hz, CCH2O), 3.41 (t, 1H, J = 
1.0 Hz, NHCOCH2CHCH), 2.83 (dt, 1H, J = 3.2, 9.8 Hz, CH=CHCH2CH), 2.75-2.65 (m, 
2H, NHCOCH2CH, NHCOCH2), 2.57-2.45 (m, 2H, CH=CHCH2), 2.29 (d, 1H, J = 
17.9 Hz, NHCOCH2);  13C NMR (125 MHz, CDCl3) δ 170.7, 137.8, 134.2, 129.9, 128.9, 
128.3, 127.8, 74.0, 72.3, 65.0, 60.5, 50.5, 47.2, 40.4, 33.7, 31.7;  IR (neat film) 3200 (br), 
3062 (w), 2946 (w), 2860 (w), 1670 (s);  LRMS (ESI) m/z C18H21ClNO2, (M+H)+ 318.0.  
 
 
 
Diacetate 200, (JM-III-026).  To a solution of the alkene 194a (18.1 mg, 0.0571 mmol, 
1.0 equiv) in methanol (1.5 mL) and dichloromethane (1.5 mL) at -78 ºC was bubbled 
ozone for 10 min, then argon was bubbled through for 3 min. After the cooling bath was 
removed sodium borohydride (10.8 mg, 5 equiv) was added. The solution warmed to 
23 °C and stirred for 1 hr when the solution was quenched with a saturated Rochelle’s 
salt solution (2 mL), and stirred for 25 min. The mixture was then extracted with ethyl 
acetate (3 x 2 mL), and dichloromethane (3 x 2 mL). The organic layers were combined, 
dried (sodium sulfate), and concentrated in vacuo.  The residue was then diluted with 
pyridine (2 mL) followed by addition of acetic anhydride (54 uL, 10 equiv) and stirred at 
23 °C for 12 h. The solvent was then concentrated in vacuo, and the residue was purified 
via silica gel chromatography (80: 20 gradient to 30:70 hexane: ethyl acetate) to yield the 
diacetate 200 (19.1 mg, 77%) as a white solid.  
Rf  0.29 (50:50 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.40-7.28 (m, 5H, 
C6H6CH2O), 6.42 (s, 1H, NH), 4.54 (ABq, 2H, J = 11.8, PhCH2O), 4.40 (dd, 1H, J = 5.7, 
11.4 Hz, CHCH2OAc), 4.24 (d, 1H, J = 4.0 Hz, CHCl), 4.12-3.96 (m, 2H, CH2CH2OAc), 
4.00 (dd, 1H, J = 9.2, 11.3 Hz, CHCH2OAc), 3.53 (d, 1H, J = 9.4 Hz, C6H5CH2OCH2), 
3.45 (d, 1H, J = 9.4 Hz, C6H5CH2OCH2), 2.83 (dd, 1H, J = 4.5, 17.6 Hz, CH2CONH, 
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2.70-2.61 (m, 2H, CHCH2OAc, CHClCH), 2.48-2.41 (m, 1H, CHCH2CH2OAc), 2.36 (d, 
1H, J = 18.8, CH2CONH), 2.05 (s, 3H, O2CCH3), 2.01 (s, 3H, O2CCH3), 1.89-1.81 (m, 
1H, CH2CH2OAc), 1.74-1.67 (m, 1H, CH2CH2OAc);  13C NMR (125 MHz, CDCl3) δ 
170.4, 170.0, 169.9, 136.7, 128.1, 127.6, 127.2, 73.3, 67.9, 65.4, 62.9, 61.8, 59.0, 40.6, 
39.4, 37.0, 30.0, 24.1, 20.41, 20.38;  IR (neat film) 3199 (w), 3089 (w),  3070 (w), 2955 
(w), 1741 (s), 1674 (s), 1237 (s); LRMS (ESI) m/z C22H28ClNO6, (M+Na)+ 460.04. 
 
 
 
Imide 201, (JM-III-027).  To a solution of lactam 200 (19.1 mg, 0.0437 mmol, 
1.0 equiv) in tetrahydrofuran (1.5 mL) was added di-tert-butyl carbonate (28.3 mg, 
0.131 mmol, 3 equiv) and 4-dimethylamino pyridine (1 mg, 0.00874 mmol, 0.2 equiv). 
The resulting mixture was stirred at 23 °C for 1 hr and then heated up to reflux for 30 
min, at which point another portion of 4-dimethylamino pyridine (1 mg, 0.00874 mmol, 
0.2 equiv) was added and heating was continued at reflux for 16 hr. The solvent was then 
removed in vacuo, and the residue was purified via silica gel chromatography (95:5 
gradient to 70:30 hexane: ethyl acetate) to yield the imide 201 (24.0 mg, 99%) as yellow 
oil.   
Rf  0.13 (70:30 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.39-7.33 (m, 2H, 
C6H6CH2O), 7.32-7.28 (m, 3H, C6H6CH2O), 4.56 (ABq, 2H, J= 11.8, PhCH2O), 4.47 (d, 
1H, J = 4.3 Hz, CHCl), 4.40 (dd, 1H, J = 4.1, 11.0 Hz, CHCH2OAc), 4.15-4.05 (m, 2H, 
CH2CH2OAc), 4.04-3.98 (m, 1H, CHCH2OAc), 3.64 (d, 1H, J = 9.3 Hz, C6H5CH2OCH2), 
3.57 (d, 1H, J = 9.3 Hz, C6H5CH2OCH2), 2.94 (dd, 1H, J = 4.7, 18.6 Hz, CH2CONBoc), 
2.63 (m, 3H, CHCH2OAc, CHClCH, CHCH2CH2OAc), 2,43 (d, 1H, J = 18.7 Hz, 
CH2CONBoc), 2.19-2.10 (m, 1H, CH2CH2OAc), 2.04 (s, 3H, O2CCH3), 2.01 (s, 3H, 
O2CCH3), 1.79-1.71 (m, 1H, CH2CH2OAc), 1.44 (s, 9H, C(CH3)3);  13C NMR (125 MHz, 
CDCl3) δ 171.3, 170.9, 169.0, 152.5, 137.6, 128.8, 128.4, 128.0, 84.8, 74.0, 71.8, 66.1, 
63.8, 62.5, 59.6, 40.0, 39.9, 37.9, 31.5, 27.7, 25.3, 21.22, 21.18;  IR (neat film) 2980 (w), 
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2935 (w), 2874 (w), 1741 (s), 1680 (m), 1243 (s);  LRMS (ESI) m/z for C27H36ClNO8, 
(M+Na)+ 560.10. 
 
 
 
Lactone 203, (JM-III-031).  To a solution of diacetate 201 (12.3 mg, 0.0229 mmol, 
1.0 equiv) in methanol (1.3 mL) and water (0.6 mL) was added potassium carbonate 
(79.0 mg, 0.573 mmol, 25 equiv). The resulting mixture was stirred at 23 °C for 14 h, at 
which point the diacetate was completely consumed (by TLC analysis). The solution was 
then diluted with ethyl acetate (30 mL), water (5 mL) and hydrochloric acid (4.4 mL, 2 
N).  After partitioning, the organic layer was washed with water (10 mL), brine (10 mL), 
dried (sodium sulfate), filtered, and concentrated in vacuo to yield the carboxylic acid 
202 (11.4 mg). Crude 202 was dissolved in dichloromethane (2 mL) and  
p-toluenesulfonic acid monohydrate (1.0 mg, 0.00458 mmol, 0.2 equiv) was added.  The 
resulting mixture was stirred at 23 °C for 3 hr until the starting material was consumed 
(by TLC analysis). Potassium carbonate (6.3 mg, 0.0458 mmol, 2 equiv) was then added, 
and the reaction was stirred for 40 min, at which point it was diluted with ethyl acetate 
(25 mL) and water (25 mL). After partitioning, the organic layer was washed with water 
(10 mL), brine (10 mL), dried (sodium sulfate), filtered, and concentrated in vacuo. The 
residue was purified via silica gel chromatography (95:5 gradient to 30:70 hexane: ethyl 
acetate) to yield the lactone 203 (10.0 mg, 96%) as a clear oil.  
Rf  0.45 (ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.37-7.34 (m, 2H, C6H6CH2O), 
7.33-7.26 (m, 3H, C6H6CH2O), 4.96 (s, 1H, NHBoc), 4.75 (d, 1H, J = 8.4 Hz, CHCl), 
4.54 (s, 2H, PhCH2O), 4.42-4.33 (m, 2H, CH2O2C), 4.01 (d, 1H, J = 7.1 Hz, 
C6H5CH2OCH2), 3.79-3.73 (m, 1H, CH2OH), 3.67-3.61 (m, 2H, C6H5CH2OCH2, 
CH2OH), 2.85-2.77 (m, 1H, CHClCH), 2.77-2.67 (m, 1H, CHClCHCH), 2.67-2.58 (m, 
3H, CHClCH(CH2)CHCH), 2.08-2.01 (m, 1H, CH2CH2OH), 1.79 (dd, 1H, J = 4.8, 
5.8 Hz, CH2OH), 1.72-1.64 (m, 1H, CH2CH2OH), 1.42 (s, 9H, C(CH3)3);  13C NMR (125 
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Hz, CDCl3) δ 173.0, 155.3, 137.9, 128.9, 128.4, 128.1, 80.8, 73.8, 68.0, 67.6, 67.4, 65.2, 
62.1, 40.1, 38.8, 36.3, 31.8, 29.6, 28.6;  IR (neat film) 3404 (br), 3209 (w), 2975 (w), 
2871 (w), 1733 (s), 1495 (s);  LRMS (ESI) m/z for C23H32ClNO6, (M+Na)+ 476.1. 
 
 
 
4-Benzyloxymethyl-8'-chloro-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic acid (195b), (MSB-IV-191).  To a solution of chloride 131b (905 mg, 
2.53 mmol, 1.0 equiv) in ethanol (12 mL, 190 proof) at 23 °C was added sodium 
hydroxide (12 mL, 30 wt % in water, 1:1 volume ratio).  The brown solution formed a 
white precipitate that slowly dissolved over time.  After 43 hr the reaction was diluted 
with ethyl acetate (80 mL), then hydrochloric acid (100 mL, 1.0 N), and the layers were 
separated.  The aqueous layer was extracted with ethyl acetate (2 x 80 mL), and then the 
organic layers were combined, dried with sodium sulfate, and reduced in vacuo to afford 
pure carboxylic acid 195b (820 mg, 98%) as orange crystals.   
Rf  0.49 (1:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.34-7.30 (m, 5H, 
C6H6CH2O), 7.04 (d, 1H, J = 3.7 Hz, C=CHCHCH), 5.52 (m, 1H, CH=CHCH2CH), 5.49 
(m, 1H, CH=CHCH2CH), 4.61 (d, 1H, J = 12.0 Hz, PhCH2O), 4.54 (d, 1H, J = 12.0 Hz, 
PhCH2O), 4.18 (d, 1H, J = 9.5 Hz, CCH2O), 4.10 (d, 1H, J = 1.0 Hz, CHCl), 3.82-3.80 
(m, 1H, C=CHCHCH), 3.68 (d, 1H, J = 9.5 Hz, CCH2O), 3.09 (dt, 1H, J = 1.7, 4.1 Hz, 
C=CHCHCH), 2.83-2.79 (m, 1H, CH=CHCH2CH), 2.23 (ddd, 1H, J = 1.7, 10.3, 18.0 Hz, 
CH=CHCH2CH), 1.98 (dd, 1H, J = 1.9, 18.0 Hz, CH=CHCH2CH);  13C NMR (125 MHz, 
CDCl3) δ 169.0, 149.0, 138.2, 136.6, 133.8, 129.2, 128.5, 127.8, 127.7, 73.7, 71.4, 66.8, 
62.3, 53.8, 50.6, 40.2, 32.8;  IR (neat film) 3088 (br), 2560 (w), 2859 (m), 1688 (s), 1593 
(m), 1454 (m), 1277 (s), 1114 (s);  LRMS (ESI) m/z C19H19ClO3, (M-H)- 328.85, 
(M+Na)+ 352.86. 
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4-Benzyloxymethyl-8'-chloro-3a,4,7,7a-tetrahydro-3H-4,7-methano-indene-5-
carboxylic azide (196b), (MSB-V-003).  To a solution of acid 195b (0.526 g, 
1.59 mmol, 1.0 equiv) in dichloromethane (6.0 mL) at 23 °C was added oxalyl chloride 
(209 µL, 2.39 mmol, 1.5 equiv) and dimethylformamide (40 µL, catalytic), at which 
point the solution effervesced.  After 1 hr, the solvent of the brown solution was removed 
in vacuo.  Benzene (5 mL) was then added and removed in vacuo to remove residual 
hydrochloric acid.  The residue was then diluted with acetone (3 mL) and a solution of 
sodium azide (237 mg, 3.7 mmol, 2.3 equiv) in water (2.5 mL).  After 1.5 hr the reaction 
was diluted with dichloromethane (50 mL) then saturated sodium chloride (50 mL) and 
the layers were separated.  The aqueous layer was extracted with dichloromethane 
(2 x 50 mL), the organic layers were combined, dried with sodium sulfate, and reduced in 
vacuo.  The residue was purified via silica gel chromatography (1:1 hexanes: ethyl 
acetate) to yield acyl azide 196b (537 mg, 95%) as a clear oil.   
Rf  0.67 (1:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.37-7.28 (m, 5H, 
C6H6CH2O), 6.94 (d, 1H, J = 3.8 Hz, C=CHCHCH), 5.53 (dq, 1H, J = 2.0, 5.7 Hz, 
CH=CHCH2CH), 5.46 (m, 1H, CH=CHCH2CH), 4.62 (d, 1H, J = 12.1 Hz, PhCH2O), 
4.52 (d, 1H, J = 12.1 Hz, PhCH2O), 4.25 (d, 1H, J = 9.5 Hz, CCH2O), 4.09 (d, 1H, J = 
1.2 Hz, CHCl), 3.82-3.79 (m, 1H, C=CHCHCH), 3.65 (d, 1H, J = 9.5 Hz, CCH2O), 3.09 
(dt, 1H, J = 1.4, 4.1 Hz, C=CHCHCH), 2.81-2.77 (m, 1H, CH=CHCH2CH), 2.21 (ddd, 
1H, J = 2.2, 10.4, 18.1 Hz, CH=CHCH2CH), 1.95-1.90 (m, 1H, CH=CHCH2CH);  IR 
(neat film) 3053 (w), 2858 (m), 2259 (s), 2143 (s), 1692 (s), 1266 (s), 1187 (s) cm-1;  
LRMS (ESI) m/z C19H18ClN3O2, (M+Na)+ 377.86.  
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Ketone 193b, (MSB-V-004).  To a solution of acyl azide 196b (0.537 g, 1.51 mmol, 
1.0 equiv) in toluene (10.6 mL) was added ethanol (0.705 mL, 12.1 mmol, 8 equiv, dried 
under 4Å mol sieves) and heated up to 80 °C.  After 50 min the solvent was removed in 
vacuo and the residue was found to be a 4:1 mixture of enamine 205: imine 204 by 1H 
NMR analysis.  The residue was diluted with ethanol (10 mL) which was then reduced in 
vacuo to remove residual chlorinated solvents.  The residue was then diluted with ethanol 
(7.5 mL) and concentrated hydrochloric acid (12.0 N, 2.5 mL, 25% vol.) at which point a 
white precipitate formed.  An additional 15 mL of ethanol was then added to fully 
dissolve the material.  After 2.5 days the reaction was diluted with saturated sodium 
chloride (50 mL), extracted with dichloromethane (3x50 mL), dried with sodium sulfate, 
and reduced in vacuo.  The residue was purified via silica gel chromatography (8:1 
hexanes: ethyl acetate) to yield ketone 193b (263 mg, 58%) as a clear oil.   
Rf  0.69 (3:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.41-7.31 (m, 5H, 
C6H6CH2O), 5.63 (dq, 1H, J = 2.1, 6.1 Hz, CH=CHCH2CH), 5.52 (dq, 1H, J = 2.3, 
5.7 Hz, CH=CHCH2CH), 4.60 (d, 1H, J = 12.3 Hz, PhCH2O), 4.53-4.50 (m, 2H, 
PhCH2O, CHCl), 3.80-3.76 (m, 2H, CCH2O, CH2CHCH), 3.46 (d, 1H, J = 9.8 Hz, 
CCH2O), 2.94 (dt, 1H, J = 3.3, 10.1 Hz, CH=CHCH2CH), 2.82 (t, 1H, J = 4.5 Hz, 
CH2CHCH), 2.34 (d, 1H, J = 18.2 Hz, CH2CHCH),  2.23 (ddq, 1H, J = 2.1, 10.3, 18.0 
Hz, CH=CHCH2CH), 2.07 (dd, 1H, J = 4.4, 18.2 Hz, CH2CHCH), 1.95 (dq, 1H, J = 2.4, 
18.0 Hz, CH=CHCH2CH);  13C NMR (125 MHz, CDCl3) δ 210.1, 138.6, 133.3, 130.4, 
128.6, 127.9, 127.8, 73.9, 68.7, 67.4, 65.5, 51.2, 43.1, 42.2, 41.1, 31.7;  IR (neat film) 
3049 (w), 2973 (m), 2912 (w), 2859 (w), 1751 (s), 1102 (s) cm-1;  LRMS (ESI) m/z for 
C18H19ClO2, (M+Na)+ 324.97. 
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Ketone 193b, (MSB-IV-216).  To a solution of acid 195b (25.6 mg, 0.78 mmol, 
1.0 equiv) in toluene (2.0 mL) at 23 °C was added triethylamine (22 µL, 0.156 mmol, 
2 equiv) and diphenylphosphorylazide (17 µL, 0.082 mmol, 1.05 equiv).  After 15 min 
ethanol (35 µL, 0.624 mmol, 8 equiv, dried under 4A mol sieves) was added and the 
solution was heated up to 80 °C.  After 70 min the solvent was concentrated in vacuo and 
the residue was found to be a 2:1 mixture of enamine 204: imine 198b by 1H NMR 
analysis.  The residue was then diluted with ethanol (1.0 mL) at 23 °C and concentrated 
hydrochloric acid (0.5 mL) was added, at which point a white precipitate formed.  After 
30 min the reaction was diluted with saturated sodium chloride (25 mL), extracted with 
dichloromethane (3 x 25 mL), dried with sodium sulfate, and reduced in vacuo.  The 
residue was purified via silica gel chromatography (8:1 hexanes: ethyl acetate) to yield 
ketone 193b (22.2 mg, 94%) as a clear oil.  All spectra matched that of previously 
reported. 
 
 
 
Methyl Ether 207, (JM-I-186, 187).  To a solution of acid 195b (9 mg, 0.0273 mmol, 
1.0 equiv) in toluene (0.5 mL) at 23 °C was added triethylamine (7.1 µL, 0.0546 mmol, 
2 equiv) and diphenylphosphorylazide (6.2 µL, 0.0286 mmol, 1.05 equiv).  After 70 min, 
methanol (8.8 µL, 0.218 mmol, 8 equiv) was added and the solution was heated up to 
90 °C.  After 16 hr the solvent was concentrated in vacuo, dissolved in ethyl acetate 
(15 mL) and washed with saturated sodium carbonate (3 x 5 mL), brine (1 x 5 mL), dried 
(magnesium sulfate) and purified via silica gel chromatography (3% ethyl acetate in 
hexanes gradient to 5%, and then 10%) to yield imine (6.0 mg, 60%) and enamine 206 
(4.0 mg, 40%) as clear oils.  Imine 198b (2.4 mg) and enamine 206 (0.9 mg) were then 
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individually dissolved in methanol (0.1 mL) and hydrochloric acid was added (0.05 mL).  
After 5 hr the solutions were diluted with ethyl acetate (15 mL) and washed with 
saturated sodium bicarbonate (3 x 5 mL), and brine (1 x 5 mL).  The organic layers were 
then dried (sodium sulfate), filtered, and reduced in vacuo to equally afford a 3:1 mixture 
of chloride 193b and methyl ether 207 by 1H NMR.  The combined residues were 
purified via silica gel chromatography (5% ethyl acetate in hexanes gradient to 9%) to 
yield chloride 193b (2.8 mg, 80%) and methyl ether 207 (0.6 mg, 20%) as clear oils.   
Chloride 193b.  All spectra matched that of previously reported. 
Methyl ether 207.  Rf  0.27 (60% ethyl acetate in hexanes);  1H NMR (500 MHz, CDCl3) 
δ 7.37 – 7.24 (m, 5H, C6H6CH2O), 5.61 (dt, J = 6.0, 2.1 Hz, 1H, CH=CHCH2CH), 5.55 – 
5.50 (m, 1H, CH=CHCH2CH), 4.61 (d, J = 12.4 Hz, 1H, PhCH2O), 4.52 (d, J = 12.4 Hz, 
1H, PhCH2O), 3.98 (d, J = 0.8 Hz, 1H, CHOMe), 3.76 (d, J = 9.8 Hz, 1H, CCH2O), 3.55 
(dd, J = 6.1, 3.7 Hz, 1H, CH2CHCH), 3.48 (d, J = 9.8 Hz, 1H, CCH2O), 3.44 (s, 3H, 
OCH3), 2.90 (td, J = 10.0, 3.4 Hz, 1H, CH=CHCH2CH), 2.76 (t, J = 4.2 Hz, 1H, 
CH2CHCH), 2.27 – 2.14 (m, 2H, CH2CHCH, CH=CHCH2CH), 1.96 – 1.86 (m, 2H, 
CH2CHCH, CH=CHCH2CH);  13C NMR (126 MHz, CDCl3) δ 212.54, 138.72, 132.65, 
130.57, 128.35, 127.56, 127.50, 89.00, 73.55, 66.56, 65.81, 57.18, 50.41, 41.30, 40.48, 
38.12, 31.77;  IR (neat film) 3046 (w), 2924 (s), 2854 (m), 1747 (s), 1455 (m), 1103 (s) 
cm-1;  LRMS (ESI) m/z for C19H22O3, (M+H)+ 299.05, (M+Na)+ 321.07. 
 
 
 
Oxime 199b, (MSB-IV-245).  To a solution of ketone 193b (1.69 g, 5.6 mmol, 
1.0 equiv) in ethanol (37 mL) and water (19 mL) was added pyridine (4.5 mL, 56 mmol, 
10 equiv) and hydroxylamine hydrochloride (3.89 g, 56 mmol, 10 equiv) and heated up to 
95 °C.  After 27 hr the reaction was diluted with ethyl acetate (150 mL), then saturated 
sodium chloride (100 mL) and the layers were separated.  The aqueous layer was 
extracted with ethyl acetate (2 x 100 mL) and then the combined organic layers were 
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washed with water (5 x 100 mL), dried with sodium sulfate, and reduced in vacuo to 
afford to yield pure oxime 199b (1.72 g, 96%) as a white crystal.   
Rf  0.23 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.47-7.28 (m, 5H, 
C6H6CH2O), 6.91 (s, 1H, NOH), 5.66 (dq, 1H, J = 2.1, 5.2 Hz, CH=CHCH2CH), 5.47 
(dq, 1H, J = 2.3, 5.7 Hz, CH=CHCH2CH), 4.64 (d, 1H, J = 12.5 Hz, PhCH2O), 4.55 (d, 
1H, J = 12.5 Hz, PhCH2O), 4.34 (d, 1H, J = 1.1 Hz, CHCl), 3.73 (d, 1H, J = 10.0 Hz, 
CCH2O), 3.69-3.67 (m, 1H, CH2CHCH), 3.56 (d, 1H, J = 10.0 Hz, CCH2O), 2.90 (dt, 1H, 
J = 3.9, 9.7 Hz, CH=CHCH2CH), 2.61 (t, 1H, J = 4.2 Hz, CH2CHCH), 2.51 (d, 1H, J = 
17.9 Hz, CH2CHCH), 2.23-2.17 (m, 3H, CH=CHCH2CH, CH2CHCH);  13C NMR 
(125 MHz, CDCl3) δ 159.1, 138.8, 133.2, 130.3, 128.6, 128.0, 127.8, 73.9, 69.5, 66.8, 
60.6, 51.4, 43.0, 42.0, 32.1, 29.6;  IR (neat film) 3274 (br), 3048 (w), 2913 (w), 1452 (s), 
1100 (s) cm-1;  LRMS (ESI) m/z C18H20ClNO2, (M+H)+ 317.98, (M+Na)+ 339.90. 
 
 
 
Lactam 194b, lactam 208, and nitrile 209, (MSB-IV-260).  To a solution of oxime 
199b (1.65 g, 5.2 mmol, 1.0 equiv) in diethyl ether (260 mL) at 23 °C was added thionyl 
chloride (6.0 mL, 52 mmol, 10 equiv).  The solution turned yellow and a white 
precipitate formed. After 15 hr the reaction was diluted with diethyl ether (200 mL), and 
then poured into a solution of saturated sodium chloride (300 mL) and ice (100 mL).  
After partitioning of the layers, the aqueous layer was extracted with ethyl acetate 
(2 x 250 mL) and the combined organic layers were dried with sodium sulfate and 
concentrated in vacuo.  The residue was purified via silica gel chromatography (2:1 to 1:2 
hexanes: ethyl acetate) to yield lactam 194b (0.98 g, 59%) and lactam 208 (33 mg, 2%) 
as white solids and nitrile 209 as a clear oil. 
Lactam 194b.  Rf  0.11 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.38-
7.29 (m, 5H, C6H6CH2O), 6.06 (s, 1H, NH), 5.76 (dd, 1H, J = 2.1, 5.6 Hz, 
CH=CHCH2CH), 5.60 (dd, 1H, J = 2.3, 5.7 Hz, CH=CHCH2CH), 4.54 (s, 2H, PhCH2O), 
4.34 (s, 1H, CHCl), 3.82-3.78 (m, 1H, CH2CHCH), 3.69 (d, 1H, J = 9.5 Hz, CCH2O), 
 134 
3.61 (d, 1H, J = 9.5 Hz, CCH2O), 3.11 (dt, 1H, J = 7.2, 9.9 Hz, CH=CHCH2CH), 2.73-
2.71 (m, 1H, CH2CHCH), 2.46-2.44 (m, 4H, CH=CHCH2CH, CH2CHCH);  13C NMR 
(125 MHz, CDCl3) δ 170.0, 137.4, 133.4, 129.8, 128.5, 128.0, 127.6, 73.6, 72.1, 68.5, 
66.8, 52.7, 47.2, 43.3, 35.9, 32.0;  IR (neat film)  3198 (w), 3066 (w), 2942 (w), 1669 (s), 
1454 (w), 1106 (m), 696 (m) cm-1;  LRMS (ESI) m/z C18H20ClNO2, (M+H)+ 317.94. 
Lactam 208.  Rf  0.13 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.38-
7.31 (m, 5H, C6H6CH2O), 5.72 (dq, 1H, J = 2.2, 5.7 Hz, CH=CHCH2CH), 5.66 (dq, 1H, J 
= 2.4, 5.7 Hz, CH=CHCH2CH), 5.25 (br s, 1H, NH), 4.84 (s, 1H, CHCl), 4.66 (d, 1H, J = 
12.3 Hz, PhCH2O), 4.53 (d, 1H, J = 12.2 Hz, PhCH2O), 4.11 (d, 1H, J = 9.0 Hz, CCH2O), 
3.77 (dt, 1H, J = 2.3, 7.4 Hz, CH2CHCH), 3.52 (d, 1H, J = 9.0 Hz, CCH2O), 3.31 (dd, 
1H, J = 4.4, 11.1 Hz, CH2CHCH), 2.95 (ddd, 1H, J = 1.6, 2.5, 11.1 Hz, CH2CHCH), 2.86 
(dt, 1H, J = 6.6, 10.2 Hz, CH=CHCH2CH), 2.80 (br t, 1H, J = 6.4 Hz, CH2CHCH), 2.36 
(dq, 2H, J = 2.4, 6.6 Hz, CH=CHCH2CH);  IR (neat film) 3216 (w), 2935 (w), 2866 (w), 
1677 (s), 1494 (w), 1109 (m) cm-1;  LRMS (ESI) m/z C18H20ClNO2, (M+Na)+ 339.92. 
Nitrile 209.  Rf  0.11 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 9.78 (s, 
1H, OHC), 6.59 (s, 1H, C=CH), 5.87 – 5.76 (m, 1H, CHCH2CH=CH), 5.58 (dd, J = 5.5, 
2.0 Hz, 1H, CHCH2CH=CH), 3.73 (m, 2H, CHCHCH2CH=CH), 3.42 (q, J = 8.0 Hz, 1H, 
C=CHCH), 2.80 – 2.64 (m, 1H, CH2CH=CH), 2.53 (dd, J = 16.6, 7.9 Hz, 1H, NCCH2), 
2.48 – 2.37 (m, 2H, CH2CH=CH, NCCH2);  13C NMR (126 MHz, CDCl3) δ 189.95, 
150.26, 149.38, 133.62, 127.09, 118.66, 51.30, 45.55, 45.42, 37.75, 19.14;  IR (neat film) 
3054 (w), 2925 (m), 2859 (w), 2247 (w), 1682 (s), 1357 (m), 1165 (m) cm-1;  LRMS (EI) 
m/z for C11H11NO, (M+H)+ 174.0. 
 
 
 
Imide 216, (MSB-V-129).  To a solution of lactam 194b (0.85 g, 2.9 mmol, 1.0 equiv) in 
tetrahydrofuran (24 mL) was added di-tert-butyl carbonate (1.8 g, 8.0 mmol, 3 equiv), 
triethylamine (2.2 mL, 16.1 mmol, 6 equiv), and 4-dimethylamino pyridine  
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(82 mg, 0.67 mmol, 0.25 equiv) and heated up to 90 °C.  After 15 hr the reaction was 
diluted with ethyl acetate (250 mL), washed with hydrochloric acid (1.0 N, 3 x 100 mL), 
water (100 mL), and then saturated sodium chloride (100 mL).  The organic layer was 
dried with sodium sulfate, reduced in vacuo, and purified via silica gel chromatography 
(4:1 gradient to 2:1 hexanes: ethyl acetate) to yield imide 216 (0.98 g, 94%) as a yellow 
film.  
Rf  0.72 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.26-7.18 (m, 5H, 
C6H6CH2O), 5.69 (dd, 1H, J = 2.1, 5.7 Hz, CH=CHCH2CH), 5.48 (dd, 1H, J = 2.3, 5.7 
Hz, CH=CHCH2CH), 4.65 (s, 1H, CHCl) 4.54 (d, 1H, J = 12.4 Hz, PhCH2O), 4.30 (d, 
1H, J = 12.3 Hz, PhCH2O), 3.93 (d, 1H, J = 10.3 Hz, CCH2O), 3.77 (d, 1H, J = 10.3 Hz, 
CCH2O), 3.68-3.65 (m, 1H, CH2CHCH), 2.85-2.75 (m, 2H, CH=CHCH2CH), 2.67 (t, 1H, 
J = 4.7 Hz, CH2CHCH), 2.55 (dd, 1H, J = 4.8, 17.4 Hz, CH2CHCH), 2.37 (m, 2H, 
CH=CHCH2CH, CH2CHCH), 1.36 (s, 9H, C(CH3)3);  13C NMR (125 MHz, CDCl3) δ 
169.9, 153.6, 137.8, 134.1, 129.2, 128.8, 128.4, 127.7, 127.4, 83.6, 74.8, 72.9, 69.2, 68.5, 
52.9, 45.9, 43.6, 37.7, 32.1, 27.7;  IR (neat film)  2980 (m), 2934 (m), 1734 (s), 1699 (s), 
1454 (w), 1256 (s), 1157 (s), 1136 (m) cm-1;  LRMS (ESI) m/z C23H28ClNO4, (M+Na)+ 
439.92. 
 
 
 
Dialdehyde 212, (MSB-V-134).  To a solution of alkene 216 (33 mg, 0.08 mmol, 
1.0 equiv) in tetrahydrofuran (0.75 mL) and water (0.25 mL) at 23 °C was added osmium 
tetroxide (2 mg, 0.008 mmol, 0.1 equiv), sodium periodate (71 mg, 0.4 mmol, 5 equiv), 
and 2,6-lutidine (25 µL, 0.16 mmol, 2 equiv).  After 13 hr the reaction was diluted with 
saturated sodium thiosulfate (10 mL), and then extracted with ethyl acetate (3 x 10 mL).   
The organic layer was dried with sodium sulfate and concentrated in vacuo to afford a 
mixture aldehydes and hemiacetals. This residue was dissolved in ethyl acetate (14 mL) 
at 23 °C and triethylamine (1 mL) and silica gel (337 mg, 3:1 ratio Et3N mL:SiO2 g) were 
added.  After 2 hr the solution was filtered though a plug of silica gel and purified twice 
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via silica gel chromatography (8:1 hexanes: ethyl acetate with 5% triethylamine) to yield 
dialdehyde 212 (31 mg, 86%) as a white solid.   
Rf  0.41 (1:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 9.81 (s, 1H, CHO), 
9.80 (s, 1H, CHO), 7.36-7.28 (m, 5H, C6H6CH2O), 4.62 (s, 1H, CHCl), 4.59 (d, 1H, J = 
12.1 Hz, PhCH2O), 4.39 (d, 1H, J = 12.1 Hz, PhCH2O), 3.95 (d, 1H, J = 10.5 Hz, 
CCH2O), 3.88 (d, 1H, J = 10.5 Hz, CCH2O), 3.34 (dd, 1H, J = 5.3, 19.1 Hz, CH2CHCH), 
3.11 (dt, 1H, , J = 6.1, 8.6 Hz, CH2CHCH), 3.00 (br s, 1H, CHCH2CHO), 2.96 (dd, 1H, J 
= 4.8, 17.6 Hz, CHCH2CHO), 2.67 (dd, 1H, J = 8.7, 19.1 Hz, CH2CHCH), 2.56 (dd, 1H, 
J = 2.2, 17.6 Hz, CHCH2CHO), 2.23 (d, 1H, J = 6.3 Hz, CH2CHCH), 1.45 (s, 9H, 
C(CH3)3);  13C NMR δ (125 MHz, CDCl3) δ 201.2, 200.4, 168.7, 137.4, 128.5, 128.0, 
127.5, 84.5, 75.1, 73.2, 67.6, 66.0, 61.7, 46.1, 44.6, 42.0, 39.2, 27.9;  IR (neat film) 2925 
(m), 2853 (m), 2728 (w), 1732 (s), 1698 (s), 1368 (w), 1251 (m), 1143 (s);  LRMS (ESI) 
m/z C23H28ClNO6, (M-H)- 448.19. 
 
 
 
Diol 242, (MSB-IX-084).  To a solution of alkene 216 (1.1 g, 2.6 mol, 1.0 equiv) in 
acetone (150 mL) and water (30 mL) was added osmium tetroxide (67 mg, 0.26 mmol, 
0.1 equiv), 2,6-lutidine (0.3 mL, 2.6 mmol, 1 equiv), and N-methylmorpholine N-oxide 
50% wt solution in water (1.1 mL, 5.2 mmol, 2 equiv).  After 15 hr the solution was 
quenched with sodium bisulfite (200 mg) at which point the solution turned orange 
formed a dark brown precipitate.  The solution was then diluted with brine (300 mL), and 
extracted with ethyl acetate (3 x 200 mL). The organic layer was dried with sodium 
sulfate, and reduced in vacuo to afford diol 242 (1.3g) as an orange oil (1.3 g) and used 
without purification.   
Rf  0.09 (1: 1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.31 (m, 5H, 
C6H6CH2O), 4.74 (s, 1H, CHCl), 4.57 (d, J = 12.2 Hz, 1H, PhCH2O), 4.40 (d, J = 
12.2 Hz, 1H, PhCH2O), 4.20 (d, J = 3.4 Hz, 1H, CHCH2CHOH), 3.96 (br s, 1H, 
CHCHOH), 3.92 (d, J = 10.4 Hz, 1H, CCH2O), 3.81 (d, J = 10.4 Hz, 1H, CCH2O), 3.42 
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(br s, 1H, CHCH2CHOH), 3.28 (br s, 1H, CHCHOH), 3.06 (m, 1H, CHCHOH), 2.97 (m, 
1H, CHCH2CHOH), 2.83 (dd, J = 18.0, 4.6 Hz, 1H, CH2CH), 2.71 (d, J = 4.9 Hz, 1H, 
CH2CH), 2.60 (dd, J = 18.0, 1.8 Hz, 1H, CH2CH), 2.01 (m, 1H, CHCH2CHOH), 1.87 
(ddd, J = 14.2, 9.1, 3.2 Hz, 1H, CHCH2CHOH), 1.44 (s, 9H, C(CH3)3);  13C NMR (126 
MHz, CDCl3) δ 170.30, 152.58, 137.59, 128.35, 127.71, 127.30, 84.21, 77.72, 74.05, 
73.93, 72.94, 70.22, 68.19, 49.47, 46.65, 40.85, 37.62, 30.87, 27.62;  IR (neat film) 3425 
(br), 2980 (m), 2937 (m), 1739 (s), 1690 (s), 1679 (s), 1666 (s), 1368 (m), 1206 (m), 1123 
(s), 1096 (s), 910 (s), 698 (s) cm-1;  LRMS (ESI) m/z for C23H30ClNO6, (M-H)- 450.23, 
(M+Cl)- 486.21, (M+Na)+ 474.30. 
 
 
 
Dialdehyde 212, (MSB-IX-091). To a solution of crude diol 242 (1.17 g, 2.6 mol, 
1.0 equiv) in tetrahydrofuran (26 mL) and water (9 mL) at 23 °C was added 2,6-lutidine 
(0.15 mL, 1.3 mmol, 0.5 equiv) and sodium periodate (1.11 g, 5.2 mmol, 2 equiv), at 
which point the solution quickly turned cloudy and then colored tan with the formation of 
precipitate.  After fifteen hr the solution was quenched with saturated sodium thiosulfate 
(60 mL) and stirred for 5 min.  The aqueous solution was then extracted with ethyl 
acetate (3 x 60 mL) and the organic layer was dried with sodium sulfate and reduced in 
vacuo to afford a brown oil which was consistent with cyclic hemiacetals from the one 
step process as determined by 1H NMR.  (MSB-IX-092).  This residue was then 
dissolved in ethyl acetate (50 mL) and triethylamine (2 mL) and silica gel (500 mg, 4:1 
ratio (mL triethylamine: g silica gel) were added, at which point the solution turned deep 
red.  After four and 1/2 hr the solution was filtered though a plug of silica gel to yield 
dialdehyde 212 (1.13 g, 97% crude yield) as a purple oil.  The material was used without 
purification for the next step.  All spectra matched that of previously reported. 
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Diacetal 217, (MSB-V-145).  To a solution of dialdehyde 212 (9.5 mg, 0.021 mmol,  
1.0 equiv) in methanol (1.5 mL) was added trimethyl orthoformate (23 µL, 0.21 mmol, 
10 equiv) and toluenesulfonic acid monohydrate (1.2 mg, 0.006 mmol, 0.3 equiv).  After 
14 hr the reaction was diluted with ethyl acetate (20 mL), washed with saturated sodium 
bicarbonate (10 mL), and then saturated sodium chloride (2 x 10 mL).  The organic layer 
was dried with sodium sulfate and reduced in vacuo to yield diacetal 217 (11.3 mg, 99%) 
as a clear oil.   
Rf  0.44 (1:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.34-7.28 (m, 5H, 
C6H6CH2O), 4.73 (t, 1H, J = 6.5 Hz, CHCH2CH(OCH3)2), 4.66 (d, 1H, J = 12.1 Hz, 
PhCH2O), 4.61-4.58 (m, 2H, CH2CHCHCl, CHCH(OCH3)2), 4.37 (d, 1H, J = 12.1 Hz, 
PhCH2O), 4.03 (d, 1H, J = 10.4 Hz, CCH2O), 3.82 (d, 1H, J = 10.4 Hz, CCH2O), 3.36 (s, 
3H, OCH3), 3.33 (s, 3H, OCH3), 3.30 (s, 3H, OCH3), 3.27 (s, 3H, OCH3), 2.88 (dd, 1H, J 
= 4.7, 17.3 Hz, CH2CHCHCl), 2.69 (br s, 1H, CH2CHCHCl), 2.45 (dd, 1H, J = 2.2, 
17.3 Hz, CH2CHCHCl), 2.27 (dt, 1H, J = 7.3, 14.5 Hz, CHCH2CH(OCH3)2), 2.18 (q, 1H, 
J = 6.4 Hz, CHCH2CH(OCH3)2), 1.87 (t, 1H, J = 7.7 Hz, CHCH(OCH3)2), 1.73 (dt, 1H, J 
= 6.6, 14.2 Hz, CHCH2CH(OCH3)2), 1.43 (s, 9H, C(CH3)3);  13C NMR (125 MHz, 
CDCl3) δ 169.6, 152.9, 137.9, 128.4, 127.7, 127.4, 107.4, 102.5, 83.6, 76.3, 73.1, 68.3, 
67.2, 55.6, 54.8, 53.8, 52.3, 51.1, 43.5, 43.4, 42.3, 34.3, 27.7;  IR (neat film) 2980 (m), 
2894 (m), 2830 (w), 1737 (s), 1694 (s), 1368 (w), 1246 (m), 1123 (s), 1054 (m) cm-1;  
LRMS (ESI) m/z C27H40ClNO8, (M+Na)+ 564.30. 
 
 
                                                                                 
Carboxylic acid 219, (MSB-V-046).  To a solution of diacetal 217 (2.0 mg, 
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0.0037 mmol, 1.0 equiv) in methanol (0.25 mL) was added sodium hydroxide (25 µL, 
30 wt %, 10% by volume) and heated up to 35 °C.  After 48 hr the reaction was diluted 
ethyl acetate (10 mL) and then pH 6.0 buffer solution (10 mL).  The layers were 
separated and the aqueous layer was extracted with ethyl acetate (3 x 10 mL); the organic 
layers were then combined, dried with sodium sulfate, and reduced in vacuo to yield acid 
219 as a clear oil, which was used without purification.   
Rf  0.28 (3:1 ethyl acetate: hexanes);  LRMS (ESI) m/z C27H41ClNO9, (M+Na)+ 546.24.   
Methyl ester 220, (MSB-V-048).  To a solution of crude carboxylic acid 219 in benzene 
(0.7 mL) and methanol (0.2 mL) was added trimethylsilyldiazomethane  
(5.4 µL, 0.0107 mmol, 2.0 equiv) and the solution effervesced.  After 15 min the reaction 
was reduced in vacuo to yield aziridine methyl ester 220 (1.9 mg, 90%) as a clear oil.   
Rf  0.60 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.33-7.27 (m, 5H, 
C6H6CH2O), 4.55-4.51 (m, 2H, CHCH2CH(OCH3)2), PhCH2O), 4.39 (d, 1H, J = 12.0 Hz, 
PhCH2O), 4.20 (d, 1H, J = 4.8 Hz, CHCH(OCH3)2), 3.85 (d, 1H, J = 10.9 Hz, CCH2O), 
3.71 (d, 1H, J = 10.9 Hz, CCH2O), 3.68 (s, 3H, CO2CH3), 3.37 (s, 3H, OCH3), 3.33 (s, 
6H, OCH3, OCH3), 3.27 (m, 4H, CH2CHCHN, OCH3), 2.73 (dt, 1H, 6.0, 12.7 Hz, 
CH2CHCHN), 2.52-2.47 (m, 2H, CH2CHCHN), 2.01 (m, 1H, CHCH2CH(OCH3)2), 1.89-
1.83 (m, 2H, CHCH2CH(OCH3)2), 1.52 (m, 1H, CHCH(OCH3)2), 1.37 (s, 9H, C(CH3)3);   
13C DEPT 135 NMR (125 MHz, CDCl3) δ +128.3, +127.6, +108.0, +103.2, -72.7, -66.8, 
+56.1, +55.3, +53.6, +51.9, +51.3, +49.8, +49.2, +38.9, +36.5, -36.0, -34.1, +27.9;  IR 
(neat film) 2929 (m), 2830 (w), 1737 (s), 1714 (s), 1367 (w), 1288 (m), 1161 (s), 1046 
(m) cm-1;  LRMS (ESI) m/z C28H43NO9, (M+Na)+ 560.21. 
 
 
 
Lactone 225, (JM-III-276).  To a solution of the alkene 216 (90.8 mg, 0.218 mmol,  
1.0 equiv) in methanol (4.0 mL) and dichloromethane (4.0 mL) at -78 ºC was bubbled 
ozone for 10 min until the blue color persisted, then argon was bubbled through for 3 
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min. After the cooling bath was removed, sodium borohydride (41.2 mg, 1.090 mmol, 5 
equiv) was added.  The solution was warmed to 23 °C and stirring was continued for 50 
min until the consumption of starting material by TLC. The solution was then quenched 
with a saturated Rochelle’s salt solution (2 mL) and stirred at 23 °C for another 20 min. 
The mixture was then extracted with dichloromethane (3 x 2 mL) and the organic layers 
were combined, dried (sodium sulfate), and concentrated in vacuo.  The resulting residue 
was then dissolved in dichloromethane (3 mL) at 23 °C followed by addition of  
p-toluenesulfonic acid monohydrate (4.1 mg, 0.0218 mmol, 0.1 equiv). The resulting 
mixture was stirred for 3 hr until the consumption of starting material was indicated by 
TLC (1:1 ethyl acetate: hexane). To this mixture was then added triisopropylsilyl chloride 
(93.3 µL, 0.436 mmol, 2 equiv) and imidazole (56.7 mg, 0.872 mmol, 4 equiv). The 
resulting mixture was stirred at 23 °C for 21 hr, at which point it was diluted with ethyl 
acetate (50 mL), washed with water (20 mL), brine (20 mL), dried (sodium sulfate), 
filtered, and concentrated in vacuo. The residue was purified via silica gel 
chromatography (95:5 gradient to 80:20 hexane: ethyl acetate) to yield the lactone 225 
(121.1 mg, 91%) as clear oil.   
Rf  0.71 (50:50 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.35-7.28 (m, 5H, 
C6H6CH2O), 5.16 (d, 1H, J = 3.5 Hz, CHCl), 4.71 (s, 1H, NHBoc), 4.50 (ABq, 2H, J = 
12.0, PhCH2O), 4.54-4.47 (m, 1H, CO2CH2) 4.34 (dd, 1H, J = 5.4 11.6 Hz, CO2CH2), 
3.91 (d, 1H, J = 9.3 Hz, C6H5CH2OCH2), 3.78-3.73 (m, 2H, CH2OSi), 3.54 (d, 1H, J = 
9.2 Hz, C6H5CH2OCH2), 2.83-2.78 (m, 2H, CH2CO2, CHCH2CH2OSi), 2.76-2.70 (m, 2H, 
CHClCHCH), 2.56 (dd, 1H, J = 7.0, 15.8 Hz, CH2CO2), 2.01-1.95 (m, 1H, CH2CH2OSi), 
1.56-1.50 (m, 1H, CH2CH2OSi), 1.42 (s, 9H, C(CH3)3), 1.09-1.03 (m, 21H, 
Si(CH(CH3)2)3);  13C NMR (125 MHz, CDCl3) δ 172.2, 155.7, 138.1, 128.7, 128.0, 
127.8, 80.5, 73.8, 73.6, 68.0, 66.9, 66.8, 63.0, 44.9, 43.2, 38.0, 33.5, 28.5, 28.4, 18.3, 
12.1;  IR (neat film) 3030 (m), 2891 (m), 1749 (m), 1714(m), 1497 (m), 1249 (m), 1165 
(m), 1101 (m);  LRMS (ESI) m/z for C32H52ClNO6, (M+H)+ 610.2. 
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Alcohol 226, (JM-III-082).  To a solution of the benzyl ether 225 (17.1 mg,  
0.0281 mmol, 1.0 equiv) in tetrahydrofuran (1.0 mL) was added Pd(OH)2/C (11.8 mg, 
0.00842 mmol, 0.3equiv) and charged with a 1 atm hydrogen atmosphere via balloon. 
The resulting mixture was stirred at 23 °C for 14 h.  The mixture was then filtered 
through a pad of celite and the solvent was concentrated in vacuo. The residue was 
purified via silica gel chromatography (90:10 gradient to 60:40 hexane: ethyl acetate) to 
yield the alcohol 226 (13.1 mg, 90%) as clear oil.   
Rf  0.13 (80:20 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ  5.05 (s, 1H, 
NHBoc), 4.87 (d, 1H, J = 7.5 Hz, CHCl), 4.63 (dd, 1H, J = 9.0, 11.8 Hz, CO2CH2), 4.31 
(dd, 1H, J = 5.0, 11.6 Hz, CO2CH2),  3.91 (dd, 1H, J = 6.2, 11.9 Hz, CH2OH), 3.78-3.72 
(m, 2H, CH2OSi), 3.64 (dd, 1H, J = 7.2, 11.9 Hz, CH2OH), 3.19 (t, 1H, J = 6.7 Hz, OH), 
2.84 (dd, 1H, J = 7.9, 16.6 Hz, CH2CO2), 2.77-2.72 (m, 1H, CHCH2CH2OSi), 2.72-2.66 
(2H, m, CHClCHCH), 2.55 (dd, 1H, J = 5.4, 16.5 Hz, CH2CO2), 1.75-1.62 (m, 2H, 
CH2CH2OSi), 1.43 (s, 9H, C(CH3)3), 1.30-1.02 (m, 21H, Si(CH(CH3)2)3);  13C NMR (125 
MHz, CDCl3) δ 171.7, 156.2, 81.0, 68.2, 67.9, 67.8, 67.0, 42.2, 42.0, 38.1, 32.7, 29.0, 
28.6, 18.3, 12.2;  IR (neat film) 3421 (br), 2942 (m), 2866 (m), 1741 (m), 1709 (m), 1505 
(m), 1463 (m), 1251 (m), 1165(m);  LRMS (ESI) m/z for C25H46ClNO6Si, (M+H)+ 520.3. 
 
 
 
Lactone 227, (JM-III-112).  To a solution of the alcohol 226 (25.2 mg, 0.0486 mmol, 
1.0 equiv) in toluene (1.0 mL) was added benzaldehyde dimethyl acetal (36.5 µL, 
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0.243 mmol, 5 equiv) and p-toluenesulfonic acid monohydrate (1.8 mg, 0.00972 mmol, 
0.2 equiv). The resulting mixture was stirred at 23 °C for 3.5 hrs, and the solvent was 
concentrated in vacuo. The residue was purified via silica gel chromatography 
(95:5 gradient to 85:15 hexane: ethyl acetate) to yield the lactone 227 (17.5 mg, 59%) as 
clear oil.  
Rf  0.21 (80:20 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.51-7.49 (m, 2H, 
C6H5), 7.38-7.35 (m, 3H, C6H5), 5.74 (s, 1H, C6H5CH), 5.39 (d, 1H, J = 11.4 Hz, CHCl), 
4.82 (t, 1H, J = 11.5 Hz, PhCHOCH2), 4.54 (d, 1H, J = 9.2 Hz, CO2CH2), 4.32 (dd, 1H, J 
= 3.9, 11.7 Hz, PhCHOCH2), 3.80-3.74 (m, 2H, CH2OSi), 3.65 (d, 1H, J = 9.2 Hz, 
CO2CH2), 2.96 (dd, 1H, J = 8.6, 17.2 Hz, CH2CO2),  2.62 (dd, 1H, J = 5.8, 8.9 Hz, 
CH2CO2), 2.62-2.50 (m, 2H, CHCHCH2CH2OSi), 2.47-2.42 (m, 1H, CHClCH), 1.77-
1.72 (m, 2H, CH2CH2OSi), 1.43 (m, 30H, C(CH3)3), Si(CH(CH3)2)3);  13C NMR (125 
MHz, CDCl3) δ 172.0, 152.9, 139.5, 129.4, 128.6, 127.6, 92.3, 81.4, 75.2, 72.5, 67.9, 
67.8, 62.2, 44.8, 41.6, 38.2, 32.6, 29.4, 28.1, 18.4, 12.3;  IR (neat film) 2942 (m), 2866 
(m), 1749 (m), 1697 (s);  LRMS (ESI) m/z C32H50ClNO6Si, (M+H)+ 608.3. 
 
 
 
Alcohol 229, (JM-III-115).  To a solution of the lactone 227 (15.7 mg, 0.0258 mmol,  
1.0 equiv) in methanol (3.0 mL) was added a sodium hydroxide aqueous solution (30%, 
0.3 mL). The resulting mixture was stirred at 23 °C for 40 min, at which point the 
reaction was diluted with ethyl acetate (30 mL), washed with water (10 mL), and 
hydrochloric acid (1.6 mL, 2.0 N).  After the layers were separated, the aqueous layer 
was extracted with ethyl acetate (2 x 20 mL), and the combined organic layers were dried 
(sodium sulfate) and concentrated in vacuo. The resulting residue was then dissolved in 
benzene (1.5 mL) and methanol (0.5 mL), followed by addition of a 
trimethylsilyldiazomethane solution (2.0 M in diethyl ether, 26 µL, 0.0517 mmol, 
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2.0 equiv). The resulting solution was stirred at 23 °C for 30 min and reduced in vacuo to 
yield the alcohol 229 (17.1 mg, 0.0267 mmol, 99%) as clear oil. This material was used 
directly into the next step without further purification.   
Rf  0.62 (50:50 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.53-7.51 (m, 2H, 
C6H5), 7.36-7.34 (m, 3H, C6H5), 5.70 (s, 1H, C6H5CH), 5.14 (d, 1H, J = 12.0 Hz, CHCl), 
4.86 (dd, 1H, J = 2.1, 11.0 Hz, CH2OH), 4.60 (d, 1H, J= 9.3 Hz, PhCHOCH2), 3.93 (d, 
1H, J = 13.3 Hz, CH2OH), 3.80-3.76 (m, 1H, CH2OSi), 3.71 (s, 3H, CO2CH3), 3.69 (d, 
1H, J = 9.3 Hz, PhCHOCH2) 3.68-3.62 (m, 2H, CH2OH, CH2OSi), 2.98-2.96 (m, 2H, 
CH2CO2), 2.42-2.37 (m, 3H, CHClCHCHCH), 2.08-2.03 (m, 1H, CH2CH2OSi) 1.81-1.75 
(m, 1H, CH2CH2OSi), 1.10-1.06 (m, 21H, Si(CH(CH3)2)3), 1.02 (s, 9H, C(CH3)3);  13C 
NMR (125 MHz, CDCl3) δ 174.0, 154.0, 139.3, 129.4, 128.7, 127.9, 93.0, 82.1, 72.0, 
67.9, 62.2, 58.6, 52.0, 45.2, 45.1, 41.9, 32.4, 29.7, 28.0, 18.4, 12.3;  IR (neat film) 3425 
(br), 2943 (m), 2866 (m), 1738 (m), 1698 (m), 1680 (m);  LRMS (ESI) m/z for 
C33H54ClNO7Si, (M+H)+ 640.4. 
 
 
 
cis-Aldehyde 243, (JM-III-116).  To a solution of the crude alcohol 229 (17.1 mg, 
0.0258 mmol, 1.0 equiv) in dichloromethane (2.0 mL) was added Dess-Martin 
periodinane (21.9 mg, 0.0516 mmol, 2.0 equiv). The resulting mixture was stirred at 
23 °C for 1.5 h, at which point it was diluted with ethyl acetate (25 mL).  The organic 
layer was then washed with a saturated sodium bicarbonate solution (3 x 10 mL), water 
(10 mL), brine (10 mL), dried (sodium sulfate), and reduced in vacuo to afford crude  
cis-aldehyde 243.  
Rf  0.58 (95:5 ethyl acetate: benzene);  1H NMR (500 MHz, CDCl3) δ 10.14 (d, 1H, J = 
3.6 Hz, CHO), 7.62-7.58 (m, 2H, C6H5), 7.46-7.35 (m, 3H, C6H5), 5.79 (s, 1H, C6H5CH), 
5.42 (d, 1H, J = 12.7 Hz, CHCl), 4.74 (d, 1H, J = 9.4 Hz, PhCHOCH2), 3.96-3.90 (m, 
1H, CH2OSi), 3.89-3.85 (m, 1H, CH2OSi), 3.82 (m, 1H, PhCHOCH2), 3.81 (s, 3H, 
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CO2CH3), 3.04 (dd, 1H, J = 4.5, 16.5 Hz, CH2CO2), 3.06-3.01 (m, 1H, CHCH2CO2), 2.87 
(dd, 1H, J = 10.7, 16.8 Hz, CH2CO2), 2.65-2.55 (m, 2H, CHCHO, CHCH2CH2OSi), 2.06-
1.98 (m, 1H, CH2CH2OSi), 1.89-1.82 (m, 1H, CH2CH2OSi), 1.22-1.13 (m, 21H, 
Si(CH(CH3)2)3), 1.10 (s, 9H, C(CH3)3);  13C NMR (125 MHz, CDCl3) δ 204.1, 172.6, 
153.0, 139.3, 129.5, 128.5, 128.0, 92.6, 81.4, 75.4, 71.4, 66.7, 61.2, 52.2, 51.4, 45.7, 44.8, 
32.8, 29.1, 28.0, 18.4, 12.3;  IR (neat film) 2942, 2865, 1738, 1690;  LRMS (ESI) m/z for 
C33H52ClNO7Si, (M+H)+ 638.4.   
trans-Aldehyde 230, (JM-III-117).  Crude aldehyde 243 was dissolved in 
dichloromethane (1.8 mL) followed by addition of triethylamine (0.3 mL).  The resulting 
mixture was stirred at 23 °C for 41 hrs, at which point the solvent was removed in vacuo 
to yield a mixture of cis-aldehyde 243 to trans-aldehyde 230 (0.15:1.0) by 1H NMR 
analysis. The mixture was purified via silica gel chromatography (85:10:5 hexane: ethyl 
acetate: triethylamine) which induced epimerization of the remaining portion of  
cis-aldehyde 243 to yield trans-aldehyde 230 (14.7 mg, 89% over 4 steps).   
Rf  0.56 (95:5 ethyl acetate: benzene);  1H NMR (500 MHz, CDCl3) δ 9.53 (d, 1H, J = 
4.3 Hz, CHO), 7.48-7.44 (m, 2H, C6H5), 7.38-7.34 (m, 3H, C6H5), 5.71 (s, 1H, C6H5CH), 
5.10 (d, 1H, J = 10.9 Hz, CHCl), 4.64 (d, 1H, J = 9.4 Hz, PhCHOCH2), 3.76 (d, 1H, J = 
9.4 Hz, PhCHOCH2), 3.75-3.69 (m, 1H, CH2OSi), 3.67 (s, 3H, CO2CH3), 3.65-3.59 (m, 
1H, CH2OSi), 3.05 (dt, 1H, J = 4.2, 10.5 Hz, CHCHO), 2.85 (d, 1H, J = 11.8 Hz, 
CH2CO2), 2.58-2.47 (m, 3H, CHCH2CO2, CHCH2CH2OSi), 1.86-1.72 (m, 2H, 
CH2CH2OSi), 1.08-1.04 (m, 21H, Si(CH(CH3)2)3), 1.03 (s, 9H, C(CH3)3);  13C NMR (125 
MHz, CDCl3) δ 202.1, 172.5, 153.0, 139.5, 129.4, 128.6, 127.8, 92.4, 81.2, 74.3, 71.7, 
67.8, 61.0, 59.8, 52.2, 45.2, 44.1, 35.8, 32.5, 28.1, 18.4, 12.3;  IR (neat film) 2942 (m), 
2866 (m), 1738 (m), 1694 (s);  LRMS (ESI) m/z for C33H52ClNO7Si, (M+H)+ 638.4. 
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Lactone 203b, (JM-III-128).  To a solution of the alkene 216 (52.4 mg, 0.126 mmol, 
1.0 equiv) in methanol (1.5 mL) and dichloromethane (1.5 mL) at -78 ºC was bubbled 
ozone for 10 min until the blue color persisted, then argon was bubbled through for 3 
min. The cooling bath was then removed, and sodium borohydride (14.3 mg, 0.377 
mmol, 3 equiv) was added. After the solution was warmed up to room temperature, 
stirring was continued for 40 min until the consumption of all the starting material by 
TLC.  The solution was quenched with Rochelle’s salt solution (2 mL), and stirred at 
room temperature for 20 min.  The solution was then extracted with dichloromethane  
(5 x 10 mL). The organic layers were combined, dried (sodium sulfate), and concentrated 
in vacuo.  The residue was then dissolved in dichloromethane (3 mL) followed by 
addition of p-toluenesulfonic acid monohydrate (2.4 mg, 0.0126 mmol, 0.1 equiv). The 
resulting mixture was stirred at room temperature for 4 hr until the consumption of 
starting material was indicated by TLC (50: 50 ethyl acetate: hexane).  The mixture was 
then poured into dichloromethane (40 mL) and washed with a saturated sodium 
bicarbonate solution (3 x 20 mL), brine (1 x 20 mL), and then dried (sodium sulfate), 
filtered, and concentrated in vacuo.  The residue was purified via silica gel 
chromatography (80:20 hexane: ethyl acetate gradient to 50:50 hexane: ethyl acetate) to 
yield lactone 203b (42.8 mg, 0.945 mmol, 75%).  (note: The alcohol product is not very 
stable to column purification, and a higher yield would otherwise be expected)  
Rf  0.21 (35:65 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.38-7.30 (m, 5H, 
C6H5), 5.10 (d, 1H, J = 5.4 Hz, CHCl), 4.79 (s, 1H, NH), 4.52 (ABq, 2H, J = 11.8, 
31.7 Hz, PhCH2O), 4.55-4.50 (m, 1H, CO2CH2), 4.28 (dd, 1H, J= 4.9, 11.4 Hz, CO2CH2), 
3.85 (d, 1H, J = 9.4 Hz, C6H5CH2OCH2), 3.73-3.69 (m, 1H, CH2OH), 3.68-3.61 (m, 1H, 
CH2OH), 3.55 (d, 1H, J = 9.3 Hz, C6H5CH2OCH2), 2.80 (dd, 1H, J = 7.6, 16.0 Hz, 
CH2CO2), 2.85-2.78 (m, 1H, CHCH2CH2OH), 2.72-2.63 (m, 2H, CHClCHCH), 2.54 (dd, 
1H, J = 6.1, 16.3 Hz, CH2CO2), 1.90-1.82 (m, 1H, CH2CH2OH), 1.63-1.54 (m, 1H, 
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CH2CH2OH), 1.41 (s, 9H, C(CH3)3);  13C NMR (125 MHz, CDCl3) δ 172.1, 155.7, 137.6, 
128.9, 128.4, 128.0, 80.7, 74.1, 74.0, 67.9, 66.8, 66.4, 61.7, 43.2, 42.2, 38.2, 33.1, 28.8, 
28.6;  IR (neat film) 3429 (br), 2977 (w), 2930 (w), 2874 (w), 1743 (s), 1712 (s);  LRMS 
(ESI) m/z for C23H32ClNO6, (M+Na)+ 476.1. 
 
 
 
Alkene 233, (JM-IV-277).  Alcohol 203b (1.30 g, 2.88 mmol, 1 equiv) and  
2-nitrophenylselenocyanate (1.045 g, 4.61 mmol, 1.6 equiv) were azeotroped with 
toluene and then dissolved in tetrahydrofuran (41 mL). To this solution was added 
trimethylphosphine (8.6 mL, 8.64 mmol, 1.0 M in THF, 3.0 equiv) and the color instantly 
turned dark red (this color change is crucial to the success of the reaction).  The solution 
was stirred for 40 min until the consumption of all the starting material by TLC and 
hydrogen peroxide (30% in water, 16.3 mL, 144 mmol, 50 equiv) was added.  The 
resulting solution was stirred for 30 min and then diluted with ethyl acetate (100 mL), 
washed with water (2 x 50 mL), saturated sodium thiosulfate (1 x 50 mL), brine  
(1 x 50 mL), dried (magnesium sulfate), filtered and concentrated in vacuo. The residue 
was purified via ISCO combiflash (12 g column, 95:5 hexane: acetone gradient to  
80:20 hexane: acetone gradient elution over 30 column length) to yield the alkene 233  
(860.4 mg, 1.98 mmol, 69%).   
Rf  0.6 (50:50 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ  7.39-7.29 (m, 5H, 
C6H5), 5.74 (dt, J = 16.6, 10.6 Hz, 1H, CHCH=CH2), 5.18-5.13 (m, 2H, CHCH=CH2), 
4.82 (br s, 1H, NH), 4.58 (d, J = 11.8 Hz, 1H, PhCH2O), 4.48 (d, J = 11.8 Hz, 1H, 
PhCH2O), 4.48-4.44 (m, 1H, CHCl), 4.20 (dd, J = 11.9, 5.7 Hz, 1H, CH2O2C), 4.11 (dd, J 
= 11.9, 4.9 Hz, 1H, CH2O2C), 4.01 (d, J = 8.3 Hz, 1H, OCH2C), 3.67 (d, J = 9.3 Hz, 1H, 
OCH2C), 3.42 (t, J = 9.5 Hz, 1H, CHCH=CH2), 2.89-2.77 (m, 2H, CHCHCHCl), 2.72 
(dd, J = 15.0, 6.5 Hz, 1H, O2CCH2), 2.56 (dd, J = 15.5, 5.5 Hz, 1H, O2CCH2), 1.38 (s, 
9H, C(CH3)3);  13C NMR (125 MHz, CDCl3) δ 172.2, 154.5, 138.0, 133.5, 128.8, 128.2, 
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127.9, 120.3, 80.1, 74.1, 71.3, 67.8, 67.4, 66.5, 51.3, 41.3, 37.3, 32.8, 28.6;  IR (neat 
film) 3427(w), 3349 (w), 1748 (s), 1719 (s);  HRMS (ESI) m/z calcd for C23H30ClNO5Na 
(M+Na)+ 458.1710, observed 458.1693. 
 
 
 
Carbamate 234, (JM-V-013).  To a solution of alkene 233 (428.4 mg, 0.946 mmol) in 
acetonitrile (19 mL) was added N-bromosuccinimide (157.4 mg, 1.23 mmol, 1.3 equiv).   
The resulting solution was stirred for 40 min when another portion of  
N-bromosuccinimide (36.3 mg, 0.2 equiv) was added.  The resulting solution was stirred 
for 1 hr when a lot of precipitate appeared.  The solution was diluted with hexane (8 mL), 
and the solid was filtered off to yield carbamate 234 (270 mg, 63%). The filtrate was then 
diluted with ethyl acetate (50 mL) and washed with water (3 x 50 mL), brine (1 x 50 mL), 
dried (sodium sulfate), filtered, and concentrated in vacuo. The residue was partially 
purified via ISCO combiflash (4 g column, 95:5 hexane: acetone gradient to 60:40 
hexane: acetone gradient elution over 30 column lengths).  The resulting mixture which 
was washed with a 50:50 ethyl acetate: hexane solution and filtered to afford another 
portion of carbonate 234 (69 mg, 16%).   
1H NMR (500 MHz, CDCl3) δ 7.43 – 7.28 (m, 5H), 5.71 (s, 1H), 4.57 (dd, J = 30.6, 
11.9 Hz, 2H), 4.38 (dd, J = 12.7, 3.1 Hz, 1H), 4.33 – 4.21 (m, 2H), 3.89 – 3.80 (m, 2H), 
3.74 (dd, J = 12.4, 3.5 Hz, 1H), 3.61 (d, J = 9.8 Hz, 1H), 3.51 (d, J = 9.8 Hz, 1H), 3.13 (t, 
J = 9.5 Hz, 1H), 2.95 – 2.83 (m, 2H), 2.69 (ddd, J = 35.7, 20.3, 8.8 Hz, 2H);  13C NMR 
(126 MHz, CDCl3) δ 170.52, 153.23, 137.01, 128.85, 128.40, 128.04, 74.76, 73.96, 
72.16, 70.58, 66.18, 64.75, 41.96, 41.57, 35.95, 34.47, 31.84;  IR (neat film) 3240 (br), 
3130 (w), 2923 (w), 1720 (s), 1401 (m), 1099 (m), 1037 (m), 736 (m);  HRMS (ESI) m/z 
calcd for C19H21BrClNO5Na (M+Na)+ 480.0189, observed 480.0177. 
 
 148 
 
 
Aldehyde 236, (JM-V-017, 018).  To a solution of lactone 234 (339 mg, 0.739 mmol, 
1 equiv) in methanol (19 mL) was added sodium hydroxide (0.95 mL, 7.1 mmol, 
10 equiv, aq. 30%).  The resulting solution was stirred at room temperature for 40 min, at 
which point the reaction was diluted with a KHSO4 solution (10 mL) until the pH was 
adjusted to 2.  The solution was then diluted with dichloromethane (30 mL) and water 
(10 mL) and the phases were separated.  The aqueous layer was then diluted with 6.0 pH 
buffer (3 mL) and further extracted with a mixture of dichloromethane and methanol  
(5:1 ratio, 3 x 10 mL).  The organic layers were combined, washed with brine (20 mL), 
dried (sodium sulfate), filtered, and concentrated in vacuo.  The residue was then 
dissolved in benzene (12 mL) and methanol (6 mL), followed by addition of 
trimethylsilyldiazomethane (0.55 mL, 1.108 mmol, 1.5 equiv, 2.0 M in diethyl ether). 
The resulting solution was stirred at room temperature for 30 min at which point the 
solvent was removed in vacuo to give the impure crude hydroxy ester 235 (418mg). This 
residue was then dissolved in dichloromethane (18 mL) followed by the addition of Dess-
Martin periodinane (420 mg, 1.108 mmol, 1.5 equiv). The resulting solution was stirred 
at room temperature for 30 min at which point it was diluted with ethyl acetate (50 mL), 
washed with saturated sodium carbonate (3 x 50mL), brine (50 mL), dried (sodium 
sulfate), filtered, and concentrated in vacuo.  The residue was then dissolved in 
dichloromethane (18 mL) and triethylamine (1.8 mL, 10% by volume) was added.  After 
17 hr the solvent was concentrated in vacuo to afford crude aldehyde 236 (223 mg, 62%) 
which was used without purification for the next reaction.  (note: In the hydrolysis step, 
the work up procedure is very important in order to get good mass recovery. It is 
necessary to adjust the pH to 2 with KHSO4, and extract with CH2Cl2/MeOH, at the same 
time the buffer (pH 6.0) is added to avoid lactonization which has taken place when 2N 
HCl was used for the work up.)  
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Rf  0.24 (50:50 hexane: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 9.53 (d, J = 1.4 Hz, 
1H), 7.33 (ddd, J = 17.6, 14.4, 8.7 Hz, 5H), 5.79 (s, 1H), 4.53 – 4.46 (m, 2H), 4.40 – 4.30 
(m, 1H), 4.20 (d, J = 11.8 Hz, 1H), 3.77 (dd, J = 12.1, 2.8 Hz, 1H), 3.67 (s, 3H), 3.61 (d, 
J = 9.5 Hz, 1H), 3.57 (dd, J = 12.1, 4.3 Hz, 1H), 3.42 (d, J = 9.5 Hz, 1H), 2.99 (dd, J = 
10.7, 4.5 Hz, 1H), 2.95 – 2.86 (m, 1H), 2.75 (dd, J = 17.4, 3.9 Hz, 1H), 2.60 – 2.49 (m, 
2H), 1.26 (t, J = 7.1 Hz, 2H);  13C NMR (126 MHz, CDCl3) δ 199.06, 172.04, 154.22, 
136.80, 128.71, 128.29, 128.13, 76.37, 73.76, 72.59, 69.04, 63.97, 53.47, 52.08, 41.83, 
40.54, 33.93, 31.53, 28.90;  IR (neat film) 3245 (br), 3133 (w), 2954 (m), 2869 (w), 1721 
(s), 1664 (m), 1396 (m), 1176 (m), 1103 (m), 1044 (w), 913 (m), 737 (m);  LRMS (ESI) 
m/z for C20H23BrClNO6, (M+Na)+ 510.08, (M-H)- 486.13. 
 
 
 
Diol 237, (MSB-VII-246).  To a solution of dialdehyde 212 (194 mg, 0.432 mmol, 
1.0 equiv) in methanol (8.0 mL) was added sodium borohydride (33 mg, 0.864 mmol, 
2 equiv) at which point the reaction effervesced.  After 1 h the reaction was quenched 
with a saturated ammonium chloride solution (60 mL) and extracted with 
dichloromethane (3 x 25 mL).  The organic layer was dried with sodium sulfate and 
reduced in vacuo to yield diol 237 in (167 mg, 86%) in greater than 95% purity as a white 
film.   
Rf  0.2 (3:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.31 – 7.14 (m, 5H, 
C6H6CH2O), 4.57 – 4.47 (m, 2H, PhCH2O, CHCl), 4.28 (d, J = 12.2 Hz, 1H, PhCH2O), 
3.92 (d, J = 10.3 Hz, 1H, CCH2O), 3.84 – 3.72 (m, 2H, CCH2O, CHCH2OH), 3.72 – 3.56 
(m, 4H, CHCH2OH, CH2CH2OH), 2.78 (dd, 1H, J = 5.2, 17.9 Hz, CH2CH), 2.45 – 2.33 
(m, 2H, CH2CH), 2.19 – 2.04 (m, 2H, CHCH2CH2OH), 1.85 (dd, J = 13.9, 6.8 Hz, 1H, 
CHCH2OH), 1.54 – 1.43 (m, 1H, CHCH2CH2OH), 1.40 – 1.30 (m, 9H, C(CH3)3);  13C 
NMR (126 MHz, CDCl3) δ 170.16, 152.89, 137.62, 128.35, 127.73, 127.42, 83.74, 76.53, 
73.03, 67.86, 66.77, 66.60, 60.86, 53.18, 45.59, 43.57, 43.56, 33.85, 27.63;  IR (neat 
film) 3401 (br), 2978 (m), 2932 (w), 2892 (m), 1739 (s), 1691 (s), 1677 (m), 1391 (m), 
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1246 (m), 1144 (s), 1044 (m), 738 (m) cm-1;  LRMS (ESI) m/z C23H32ClNO6, (M+Na)+ 
475.96, (M+Cl)- 488.00. 
 
 
 
Monosubstituted alkene 238, (MSB-VIII-026 and 029).  To a solution of diol 237 
(151 mg, 0.333 mmol, 1.0 equiv) in tetrahydrofuran (8.9 mL) at 0 °C was added  
2-nitrophenylselenocyanate (76 mg, 0.333 mmol, 1 equiv) and tributylphosphine (98 µL, 
0.399 mmol, 1.2 equiv) and then warmed to room temperature.   No reaction was 
observed after 1.5 hr so more tributylphosphine from a different source was added  
(150 µl, 0.6 mmol, 1.5 equiv) at which point the solution turned dark red.  After 40 min 
the reaction was at 50% conversion to corresponding selenide as determined by TLC  
(Rf  0.37 (3:1 ethyl acetate: hexanes) and quenched with hydrogen peroxide (37% 
solution, 204 µl, 6.65 mmol, 20 equiv) at which point the solution turned yellow.  After 
1.5 hr the solution was diluted with saturated sodium thiosulfate solution (50 mL) and 
extracted with ethylacetate (3 x 40 mL).  The organic layer was dried (magnesium 
sulfate), filtered, and reduced in vacuo to afford a 3:1 mixture of 237:238 by 1H NMR as 
a yellow oil.  The residue was purified via ISCO (12 g column, 50:50 hexanes:ethyl 
acetate gradient to 100% ethyl acetate) to yield alkene 238 (52 mg, 35%) as a yellow film 
and diol 237 (112 mg, 74%) as a white film.  The recovered starting material 237 was  
re-subjected to the same procedure to afford an additional 238 (50 mg, 34%) for a total 
69% yield of 238.   
Rf  0.44 (3:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.38 – 7.23 (m, 5H, 
C6H6CH2O), 6.01 (dt, J = 17.0, 9.6 Hz, 1H, CHCH=CH2), 5.18 (d, J = 10.0 Hz, 1H, 
CHCH=CH2), 5.07 (d, J = 16.9 Hz, 1H, CHCH=CH2), 4.66 – 4.56 (m, 2H, PhCH2O, 
CHCl), 4.35 (d, J = 12.3 Hz, 1H, PhCH2O), 3.90 (d, J = 10.4 Hz, 1H, CCH2O), 3.80 (d, J 
= 10.2 Hz, 1H, CCH2O), 3.78– 3.63 (m, 2H, CHCH2OH), 2.90 (dd, J = 17.2, 4.1 Hz, 1H, 
CH2CH), 2.70 (br s, 1H, CH2CH), 2.59 – 2.46 (m, 2H, CH2CH, CHCH=CH2), 1.90 (dd, J 
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= 14.6, 7.8 Hz, 1H, CHCH2OH), 1.45 (s, 9H, C(CH3)3);  13C NMR (126 MHz, CDCl3) δ 
169.78, 152.37, 137.50, 136.14, 128.28, 127.66, 127.29, 117.85, 83.83, 74.68, 72.89, 
67.31, 66.28, 64.90, 52.69, 52.60, 43.88, 42.00, 27.54;  IR (neat film) 3452 (br), 2979 
(w), 2927 (w), 2857 (m), 1741 (s), 1692 (s), 1679 (m), 1367 (m), 1245 (s), 1144 (s), 1044 
(m), 736 (m) cm-1;  LRMS (ESI) m/z C23H30ClNO5, (M+Na)+ 458.16, (M-H)- 434.40. 
 
 
 
Azide 239, (MSB-VIII-032).  To a solution of alcohol 238 (102 mg, 0.234 mmol, 
1 equiv) in tetrahydrofuran (7.8 mL) at 0 °C was added diisopropyl azodicarboxylate  
(59.2 µL, 0.304 mmol, 1.3 equiv) followed by triphenylphosphine (80 mg, 0.304 mmol, 
1.3 equiv) and hydrazoic acid (1.5 M solution in benzene, 312 µL, 0.468 mmol, 2 equiv).  
After 5 hr the solution was reduced in vacuo and purified via ISCO (12 g column, 100:0 
hexanes: ethyl acetate gradient to 80:20) to yield acyl azide 239 (91.5 mg, 85%) as a clear 
oil.  
Rf  0.74 (1:1 ethyl acetate: hexanes); 1H NMR (500 MHz, CDCl3) δ 7.41 – 7.23 (m, 5H, 
C6H6CH2O), 5.99 (dt, J = 17.0, 9.6 Hz, 1H, CHCH=CH2), 5.23 (d, J = 10.1 Hz, 1H, 
CHCH=CH2), 5.10 (d, J = 16.8 Hz, 1H, CHCH=CH2), 4.65 – 4.57 (m, J = 10.0 Hz, 2H, 
PhCH2O, CHCl), 4.36 (d, J = 12.2 Hz, 1H, PhCH2O), 3.92 (d, J = 10.4 Hz, 1H, CCH2O), 
3.81 (d, J = 10.4 Hz, 1H, CCH2O), 3.54 – 3.40 (m, 2H, CHCH2N3), 2.90 (dd, J = 17.2, 
4.1 Hz, 1H, CH2CH), 2.66 (br s, 1H, CH2CH), 2.58 – 2.47 (m, 2H, CH2CH, 
CHCH=CH2), 1.91 (dd, J = 15.7, 7.7 Hz, 1H, CHCH2N3), 1.46 (s, 9H, C(CH3)3);  13C 
NMR (126 MHz, CDCl3) δ 168.99, 152.51, 137.65, 135.46, 128.45, 127.85, 127.48, 
118.44, 84.04, 74.78, 73.15, 67.49, 66.45, 54.79, 54.13, 50.18, 43.59, 43.12, 27.72;  IR 
(neat film) 2980 (w), 2928 (w), 2100 (s), 1741 (s), 1693 (s), 1680 (s), 1367 (m), 1272 
(m), 1245 (s), 1142 (s), 1107 (m), 740 (m) cm-1;  HRMS (ESI) m/z calcd for 
C23H29ClN4O4Na (M+Na)+ 483.1775, observed 483.1773. 
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Acyl hydrazide 240, (MSB-IX-062).  In a sealed tube a solution of imide 239 (248 mg, 
0.539 mmol, 1 equiv) in methanol (13 mL) was prepared.  Hydrazine (338 µL, 
10.7 mmol, 20 equiv) was then added and the vessel was capped and heated at 50 °C.  
After 38 hrs the solution was reduced in vacuo and purified via ISCO (12 g column, 
50:50 hexanes: ethyl acetate gradient 100% ethyl acetate) to afford acyl hydrazide 240 
(235 mg, 88%) as a white film.  
Rf  0.36 (ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.36 (m, 5H, C6H6CH2O), 6.81 (s, 
1H, NH), 5.77-5.70 (m, 1H, CHCH=CH2), 5.19 (d, 1H, J = 9.7 Hz, CHCH=CH2), 5.12 
(d, 1H, J = 17.5 Hz, CHCH=CH2), 5.02 (m, 2H, CHCl, NH), 4.56 (q, J = 12.0 Hz, 2H, 
PhCH2O), 3.91 (br s, 1H, NH), 3.68 (d, J = 9.2 Hz, 1H, CCH2O), 3.50 (dd, J = 12.6, 
3.6 Hz, 1H, CHCH2N3), 3.46 (d, J = 9.2 Hz, 1H, CCH2O), 3.35 (dd, J = 12.6, 4.8 Hz, 1H, 
CHCH2N3), 2.63 (t, J = 9.6 Hz, 1H, CHCH=CH2), 2.51 (tt, J = 7.4, 3.7 Hz, 1H, CH2CH), 
2.36 (m, 2H, CH2CH), 2.18 (m, 1H, CHCH2N3), 1.41 (s, 9H, C(CH3)3);  13C NMR (126 
MHz, CDCl3) δ 171.93, 155.62, 137.65, 135.49, 128.62, 128.03, 127.86, 119.67, 79.86, 
74.41, 73.64, 66.21, 64.12, 52.79, 51.62, 45.95, 45.36, 35.96, 28.43;  IR (neat film) 3425 
(w), 3308 (br), 2978 (w), 2927 (w), 2868 (w), 2100 (s), 1710 (s), 1665 (s), 1499 (s), 1366 
(m), 1272 (m), 1251 (s), 1166 (s), 1097 (m), 737 (m) cm-1;  LRMS (ESI) m/z 
C23H33ClN6O4, (M+H)+ 493.18, (M-H)- 491.23. 
 
 
 
Acyl azide 241, (MSB-IX-067).  To a solution of acyl hydrazide 240 (235 mg, 0.477 
mmol, 1 equiv) in dimethylformamide (9.5 mL) at -20 °C was added hydrochloric acid 
 153 
(1.0 M in diethyl ether, 1.2 mL, 1.192 mmol, 2.5 equiv) and t-butyl nitrite (61.4 µL, 
0.524 mmol, 1.1 equiv).  After 20 min the solution was diluted with diethyl ether (100 
mL), washed with water (4 x 50 mL), dried (magnesium sulfate), filtered, and reduced in 
vacuo to afford acyl azide 241 (229 mg, 95%) as clear oil.   
Rf  0.74 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.41 – 7.28 (m, 5H, 
C6H6CH2O), 5.82 – 5.67 (m, 1H, CHCH=CH2), 5.20 (d, J = 10.2 Hz, 1H, CHCH=CH2), 
5.13 (d, J = 17.2 Hz, 1H, CHCH=CH2), 5.03 (br s, 2H, CHCl, NH), 4.61 – 4.47 (m, 2H, 
PhCH2O), 3.69 (d, 1H, J = 9.4 Hz, CCH2O), 3.50 – 3.42 (m, 2H, CCH2O, CHCH2N3), 
3.33 (dd, J = 12.6, 5.2 Hz, 1H, CHCH2N3), 2.69 (dd, J = 16.1, 4.9 Hz, 1H, CH2CH), 2.64 
(t, 1H, J = 9.6 Hz, CHCH=CH2), 2.57 (dd, J = 16.1, 6.7 Hz, 1H, CH2CH), 2.46 – 2.34 (m, 
1H, CH2CH), 2.23 – 2.13 (m, 1H, CHCH2N3), 1.45 – 1.36 (m, 9H, C(CH3)3);  13C NMR 
(126 MHz, CDCl3) δ 179.14, 155.49, 137.57, 135.28, 128.55, 127.95, 127.78, 119.72, 
79.85, 74.27, 73.55, 65.96, 63.98, 52.71, 51.51, 45.81, 45.19, 38.39, 28.34;  IR (neat 
film) 2980 (w), 2919 (m), 2860 (w), 2140 (s), 2102 (s), 1714 (s), 1500 (m), 1369 (m), 
1271 (m), 1251 (m), 1166 (s), 1064 (m), cm-1;  LRMS (ESI) m/z C23H30ClN7O4, 
(M+Na)+ 526.14. 
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CHAPTER 4.  ACCESS TO THE TRANS-FUSED [3.3.0]-AZABICYCLIC RING 
SYSTEM OF THE REVISED STRUCTURE OF PALAU’AMINE: 
 SYNTHESIS OF THE NATURAL-PRODUCT ANALOG 
DIMETHYLCYCLOPENTAPHAKELLIN 
 
4.1 Introduction 
 The original (1a) and revised (1b) structures of palau’amine each possesses an 
intricate molecular architecture that features a highly substituted cyclopentane core (Ring 
E) (Figure 4.1).  The synthesis of these densely substituted and highly functionalized 
cyclopentane cores of both the original and revised structures of palau’amine has been 
established (Chapter 3), and now a method was desired to the append the phakellin ring 
substructure (Rings A, B, C, and D) onto the existing cyclopentane framework.  
Compared to the original structure (1a) of palau’amine, the revised structure (1b), 
diastereomeric at the C17 and C12 stereogenic centers, presents an additional synthetic 
challenge from the standpoint of forming the strained trans-fusion of the  
[3.3.0]-azabicyclic ring system (Rings E and D).  In light of these differences, it was 
unclear if methods capable of forming the less-strained cis-fused ring system within 1a 
would also be applicable to the analogous trans-fused ring system present within 1b.  
Therefore, it was chosen to develop a cyclization strategy to access the trans-fused ring 
system of 1b within the context of a simpler natural-product like substrate.   
 
 
Figure 4.1.  Structure of model target: dimethylcyclcopentaphakellin (245). 
 
 The structure of the natural product phakellin (22) (Figure 4.1), which possesses the 
A, B, C, and D rings of palau’amine, was considered as the basis for a scaffold of the 
envisioned palau’amine model target.  Fusing a simple cyclopentane (Ring E) onto the D 
ring of phakellin with a trans-stereochemical configuration at C11 and C12 (palau’amine 
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numbering) would lead to model target, dimethylcyclopentaphakellin (245), mimicking 
the pentacyclic ring system of the revised structure of palau’amine (1b).  Successful 
synthesis of 245 would, within context of a natural product-like molecule, require the 
development of novel methods with which to access the trans-fused [3.3.0]-bicyclic ring 
system as well as the rest of the phakellin heterocyclic ring structure.   
 
4.2 Retrosynthetic Analysis for Dimethylcyclopentaphakellin 
 With establishment of the model target, dimethylcyclopentaphakellin (245), in 
which to develop methods for the synthesis of the phakellin portion of palau’amine, a 
novel route was required to access this natural product-like molecule.  Retrosynthetic 
analysis of pentacyclic 245 reveals tetracyclic pyrazinone 246 (Scheme 4.1).  Multiple 
methods have recently been published that allow introduction of a guanidine ring (Ring 
C) onto related tricyclic pyrazinones (Schemes 1.10, 1.11, 1.12).1,2,3  Pyrazinone 246 
could be generated via a series of manipulations from tricyclic triazoline 247, the 
immediate product of an intramolecular [3+2]-dipolar cycloaddition of azide 248 with the 
tethered alkene.  A [3+2] cycloaddition was chosen as the key step to form the trans-
fused [3.3.0]-bicyclic ring system, as it would use a highly exothermic reaction that could 
potentially offset the high energy of cyclization to generate the trans-fused ring system. 
 
Scheme 4.1 
 
 
4.3 Formation of the Trans-Fused E,D-Bicyclic Ring System 
4.3.1 Background: [3+2] Cycloadditions of Azides with Olefins 
Dipolar cycloadditions of azides with olefinic bonds were first reported by Wolff in 
19124 and have since been shown to be useful synthetic transformations (Scheme 4.2).  
Alkyl azides are isolable 1,3-dipoles that undergo dipolar cycloaddition reactions with 
activated and unactivated alkenes to initially afford 1,2,3-triazoline products.5  The 
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intramolecular variant leads to multiple fused-nitrogen-containing heterocycles 
(Scheme 4.2). The interest in intramolecular cycloadditions stems, in part, from the 
potential to access α-diazo esters 251,6 vinylogous carbamates 252,7 and aziridines 2538 
via the controlled decomposition of triazoline cycloadducts9 250 derived from azide 249.   
 
Scheme 4.2 
 
 
The limited examples of intramolecular cycloadditions of alkyl azides with alkenes 
have largely been used to access pyrrolidine and piperidine motifs on carbohydrate-
derived substrates to access azasugars.6,7  After formation of the initial triazoline 
cycloadduct, the factors that determine which products are isolated depend on a number 
of variables including temperature, solvent, reagents, ring size, and in particular the 
stereochemistry of the alkene substrate.  Reaction of arabinose derived E-enoate triflate 
254 (Scheme 4.3A) with potassium azide directly provided cycloadduct triazoline 253 in 
68% yield, which upon exposure to base rapidly converted to α-diazoester 256.  In 
contrast, treatment of the diastereomeric Z-enoate triflate 257 (Scheme 4.3B) with 
potassium azide afforded α-diazoester 258 in 65% yield without any observed triazoline 
cycloadduct.  Subsequent heating of 258 at 110 °C in toluene lead to the formation of 
Z-vinylogous carbamate 259 in 85% yield after loss of N2.  In neither case was the initial 
alkyl azide product observed, suggestive of a facile cycloaddition at room temperature.  
A related system employed azido enoate 260 (Scheme 4.3C), which, contrary to the first 
two examples, was isolable in good yield via chromatography.  The heating of azido 
E-enoate 260 at 110 °C resulted in the isolation of vinylogous carbamate 261 directly in 
64% yield.  The Z-enoate isomer 262 (Scheme 4.3D) resulted in the formation of the 
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same geometric product 261, although it required a longer reaction time and was less 
efficient.  The four examples in Scheme 4.3 illustrate that it can be difficult to predict 
which product will be isolated from the [3+2]-dipolar cycloadditions of azides, but also 
suggests that under the certain circumstances there can be a progression of intermediates 
from the triazoline cycloadduct to the α-diazo ester and finally to the Z-vinylogous 
carbamate as a thermodynamic sink, driven by loss of nitrogen in the final step. 
 
Scheme 4.3 
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Unlike the intramolecular [3+2] cycloaddition of azides with activated alkenes, only 
a handful of examples exist for intramolecular azide cycloadditions with unactivated 
alkenes.  The cycloaddition with unactivated alkenes typically requires longer reactions 
time at high temperatures and generally provides only triazoline and aziridine products.  
For example, Z-vinyl sulfide 263 (Scheme 4.4A) was observed by Pearson and 
coworkers8d to cyclize and afford pyrrolizine 265 in 90% yield after heating for 15 hours 
at 100 °C.  This product is likely formed by initial generation of triazoline 264, followed 
by formation of pyrrolizine 265 via rearrangement to the corresponding vinyl aziridine.   
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In contrast, E-vinyl acetal 266 (Scheme 4.4B) affords isolable bicyclic triazoline 267 in 
62% yield under similar conditions.  However, triazoline 267 undergoes rapid 
decomposition upon exposure to silica gel to afford aziridine 268 in 14% yield.  The 
instability of triazoline intermediates to silica gel is precedented by other authors.8e  
Although the formation of aziridine products (i.e., 268) is also possible via nitrene 
addition to the alkene, temperatures higher than 160 °C are required to achieve non-
catalyzed nitrene formation from alkyl azides.8d 
 
Scheme 4.4 
 
 
Considering their ease of preparation, it is surprising that the intramolecular 
cycloaddition of alkyl azides with alkenes has seen only limited use in natural product 
synthesis.  One prominent example is found in the synthesis of Cuilofini and 
co-workers10 of antitumor antibiotic natural product (±)-FR66979 (272, Scheme 4.5), 
which used an intramolecular cycloaddition with an unactivated olefin to generate the 
benzazocine structural motif imbedded within the natural product.  Heating of aryl azide 
269 resulted in an intramolecular cycloaddition with the pendent unactivated alkene to 
afford tricyclic triazoline 270 in 80% yield.  Irradiation then afforded aziridinyl 
benzazepine 271 in 77% yield, which was progressed to antitumor agent FR66979 (272).  
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Scheme 4.5 
 
 
The examples listed in Schemes 4.3, 4.4 and 4.5 illustrate the diversity of products 
that can be obtained from the intramolecular [3+2]-dipolar cycloaddition of azido olefins.  
Both activated and unactivated olefins can lead to interesting products in which at least 
one cyclic C-N bond is formed.  Given this precedent, we believed that this type of 
cyclization could potentially be used to access the pyrrolidine ring within the trans-fused 
[3.3.0]-bicyclic ring system of 247.   
 
4.3.2 Synthesis of the Trans-Fused Ring System: [3+2]-Dipolar Cycloaddition 
 Having chosen a [3+2]-dipolar cycloaddition as the method to furnish the strained 
trans-fused [3.3.0]-bicyclic ring system 247 (Scheme 4.6), a strategy was required to 
access the trans-disubstituted cyclopentane cyclization precursors of general form 248. It 
was envisioned that cyclopentane 248 possessing the required trans-stereochemical 
configuration could be accessed via a transition-metal mediated cyclization of acyclic 
diene 273.  Functional group manipulations would then allow access to a variety of 
cyclization precursors.  
 
Scheme 4.6 
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 Access to the cyclization precursors of general form 248 (Scheme 4.6) used the 
zirconium-mediated cyclization of dienes developed concurrently by Taber11 and 
Negishi12 to access the 1,2-trans-disubstituted substitution pattern on simple 
cyclopentane intermediates.  This method allows access to either the cis or trans 
stereochemical arrangement simply by altering the substituents of the zirconium 
complex.  Symmetrical 4,4-dimethylhepta-1,6-diene (273) (Scheme 4.7) was used as the 
starting material for this sequence as it would lead to C2-symmetric products that would 
avoid the complicating formation of diastereomers in future steps.  The synthetic 
sequence began with the key cyclization of symmetrical diene 273* which after13 
sequential addition of dibutyl zirconocene (Cp2ZrBu2) and bromine afforded 
C2-symmetric dibromide 274 in 93% yield and >15:1 dr.†  Desymmetrization of 
dibromide 274 was achieved by nucleophilic displacement with sodium azide in 63% 
yield to provide bromo azide 275.  Subsequent Kornblum oxidation with trimethylamine 
N-oxide afforded azido aldehyde 276 in 87% yield.  Aldehyde 276 would serve as a 
useful branching point to access various cyclization precursors via olefination methods. 
 
Scheme 4.7 
 
 
 Cyclization precursors 278, 279 and 281 were accessed by olefination of aldehyde 
276 (Scheme 4.8).  Condensation of 276 with an unstabilized phosphonium ylide, 
generated from KHMDS and (methoxymethyl)triphenylphosphonium chloride (277),  
produced a mixture of Z and E enol ethers 278 and 279 in 3.5% and 5.5% yield, 
respectively. A higher olefination yield was obtained upon condensation of aldehyde 276 
with stabilized phosphonium ylide 280, methyl (triphenylphosphoranylidene)acetate, 
which supplied exclusively the E-isomer of α,β-unsaturated enoate 281 in 37% yield. 
                                                 
*
 4,4-dimethylhepta-1,6-diene (273) was synthesized in one step from 1-propylmagnesium bromide 
according to the procedure by Montigny and coworkers.13 
†
 The stereochemistry of dibromide 274 could not be confirmed at this stage, but was verified in 
intermediate 279 and extrapolated backwards. 
 162 
Scheme 4.8 
 
 
 Access to the three cyclization precursors 278, 279, and 281 allowed for evaluation 
of the proposed [3+2]-dipolar cycloaddition to access the trans-fused [3.3.0]-bicyclic ring 
system.  Unactivated enol ethers 278 and 279 (Scheme 4.9) were evaluated first in 
attempts to access aziridine 282.  No reaction was observed upon heating either isomer 
up to 150 °C; however, when the temperature was raised to 180 °C, enol ethers  278 and 
279 were consumed and the sole product observed was aziridine 283, possessing a cis-
fused [4.3.0.010,14]-tricyclic ring system.*,† 
 
Scheme 4.9 
 
 
 The formation of cis-fused tricycle 283 means that epimerization of the C11 center 
had occurred at some point during the reaction.  The unlikelihood for isomerization of the 
                                                 
*
 E-isomer 279 generated aziridine 283 more efficiently than Z-isomer 278, which produced minor 
unidentified byproducts. 
†
 Unfortunately aziridine 283 was unstable to purification, but could be analyzed spectroscopically in crude 
form due to the efficiency of the reaction. 
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desired trans-fused product 282 after formation in addition to the fact that the same 
stereoisomeric product 283 was independently observed from the individual enol ether 
isomers 278 and 279 suggests that isomerization occurs prior to aziridine formation.  
Corroborative evidence for isomerization comes from the control experiment in which 
enol ether 278 was subjected to otherwise identical conditions in the presence of ten 
equivalents of deuterium oxide (D2O) (Scheme 4.10).*  The same cis-fused aziridine 
product was observed, but with significant deuterium/protium exchange (80-85% for 
each center) at the C11, C10, and C6 centers.  Although the exact mechanism for the 
formation of aziridine 283 is unknown, based on literature precedent14 and the 
requirement for high reaction temperatures (i.e., 180 °C), it seems likely that alkyl nitrene 
formation is involved, followed by a [2+1] cyclization. 
 
Scheme 4.10 
 
 
 With no initial success in the desired intramolecular [3+2]-dipolar cycloaddition of 
the electron-rich alkenes, the cycloaddition of electron-deficient alkenes was explored in 
hopes that milder conditions would afford trans-fused cyclized products.  Indeed, upon 
heating, enoate 281 (Scheme 4.11) underwent cyclization to afford trans-fused 
Z-vinylogous carbamate 284 in 64% yield.†  The formation of the trans-fused product 
was verified by NOE interactions that allowed assignment of the bicyclic ring protons to 
either the top or bottom face of the framework.  The high coupling constant values 
(12.0-12.8 Hz) between the two methine protons and the adjacent axial protons highlight 
the antiperiplanar relationship that is only possible with the trans-fused [3.3.0-bicycle.   
 
 
                                                 
*
 The efficiency of the reaction with D2O, as determined by 1H NMR, was comparable to the corresponding 
anhydrous reaction. 
†
 The moderate yield is due, in part, to the instability of vinylogous carbamate 284 to silica gel, even upon 
treatment with triethylamine.   
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Scheme 4.11 
 
 
 During the course of these studies the need for an alternative O-protecting group for 
the vinylogous carbamate was required that could be removed under neutral conditions.  
The allyl group was chosen for its ease of removal under mild conditions that are 
orthogonal to many other protecting groups.15  Accordingly, aldehyde 276 (Scheme 
4.12A) prepared from bromide 275 was subjected to olefination with the stabilized ylide 
285, allyl (triphenylphosphoranylidene)acetate,16 to generate cyclization precursor enoate 
286 in 57% yield.  Alternatively, bromide 275 (Scheme 4.12B) could be transformed into 
enoate 286 in a one-pot sequence in comparable yield (45%), thereby obviating the need 
to manipulate volatile aldehyde 276.  Intramolecular [3+2]-dipolar cycloaddition of 
enoate 286 was then effected by heating in acetonitrile to afford trans-fused O-allyl 
vinylogous carbamate 287 in 71% yield.*  
 The mechanism for formation of the vinylogous carbamate product was studied 
with allyl ester 286.  Formation of vinylogous carbamate 287 occurred efficiently upon 
heating azide 280 in acetonitrile at 130 °C for 2 hours; however, when the cyclization 
was conducted at lower temperatures in aromatic solvents (e.g., benzene or xylenes), 
other reaction intermediates were observed (Scheme 4.13).  Partial conversion of azide 
286 to the initial cycloadduct, triazoline 288, was observed by 1H NMR over the course 
of 9 hours at 90 °C in deuteriobenzene.  After heating for an additional 15 hours, a new 
species was observed that was consistent with α-diazo ester 289.  The formation of 289 
was not only observed upon the heating of triazoline 288, but also upon the exposure of 
288 to silica gel.  Because of this instability, triazoline 288 was not isolable in pure form, 
although α-diazo ester 289 was isolated and characterized spectroscopically.  Regardless  
                                                 
*
 The olefination and cycloaddition reactions could also be accomplished in a one-pot sequence, but these 
conditions led to significant amounts of the cis-fused cycloadducts.  Chromatographically pure 286 was 
required to avoid partial epimerization during the cycloaddition reaction. 
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Scheme 4.12 
 
 
of how 289 was prepared, vinylogous carbamate 287 could be obtained upon continued 
heating in solution.  This transformation likely proceeds by nitrogen extrusion and C10 
deprotonation to form the putative vinyl anion 290, which upon C6 protonation affords 
287.  The olefin geometry of the vinylogous carbamate 287 is consistent with formation 
of a hydrogen bond between the carbonyl and pyrrolidine proton within diazo ester 289, 
when free rotation is possible around the indicated bond. 
 
Scheme 4.13 
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 In order to understand more about the proton transfers that occur during the 
formation of the vinylogous carbamate product, a cyclization control experiment with 
methyl ester 281 was conducted with ten equivalents of D2O present (Scheme 4.14).  
While 85% deuterium incorporation was observed at the C6-vinyl position, no 
incorporation of deuterium was observed at the C11-tertiary position, which is consistent 
with the lack of cis-to-trans isomerization.  Presuming no exchange occurs after 
vinylogous carbamate formation, significant deuterium incorporation at the C6-vinyl 
position is more consistent with the formation of vinyl anion 290 (Scheme 13), followed 
by an intermolecular proton trapping.  An alternative mechanism involving an 
intramolecular hydride transfer directly from the C10 to C6 position within diazo ester 
289 would generate C6-protio product 287 (Scheme 4.12), which is not supported 
experimentally.   
 
Scheme 4.14 
 
 
 In addition to the triazoline, α-diazoester, and vinylogous carbamate products 
observed during the cyclization reaction, in one experiment the corresponding aziridine 
product was also observed (Scheme 4.15).  Heating azide 281 at 105 °C in 
deuteriobenzene resulted in the formation of the expected vinylogous carbamate 284 in 
39% yield and aziridine containing trans-fused [4.3.0.010,14]-tricycle 291 in 25% yield.*   
 
Scheme 4.15 
 
                                                 
*
 The trans-fusion was assigned based on similar shifts and coupling patterns to vinylogous carbamate 284. 
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While the cause for the formation of aziridine 291 was not investigated it does provide 
evidence that trans-fused [4.3.0.010,14]-tricyclic products can be prepared and isolated.* 
 
4.4 Introduction of the A and B Rings: Tetracyclic Pyrazinone 
 With access to the trans-fused [3.3.0]-bicyclic core (Rings E and D) within 
vinylogous carbamate 287 and 284 (Scheme 4.16), the next synthetic goal was 
introduction of the A and B rings.  Pyrazinone 246 was selected as the next synthetic 
target as it possesses four of the five desired rings of the model target, as well as the 
correct oxidation state for introduction of the last guanidine ring onto the C10 and C6 
positions.  In addition, methods have been published that append a guanidine ring onto 
similar tricyclic pyrazinones.1,2,3  It was envisioned that pyrazinone 246 could be 
accessed from functional group interconversions of pyrrole amide 292, which in turn 
would be derived from trans-fused bicycle 287.  The requirement for an activated 
electron-deficient alkene during the [3+2] cycloaddition resulted in the incorporation of 
an addition carbon atom in the form of vinylogous carbamate carbonyl.  A method would 
also be required to remove this carbon prior to accessing pyrazinone 246. 
 
Scheme 4.16 
 
 
4.4.1 Introduction of the Pyrrole Amide 
 The first task in order to prepare pyrazinone 246 (Scheme 4.16) was acylation of the 
vinylogous carbamate nitrogen as a means to introduce the required pyrrole amide 
functionality.  Attempts to form the anion of 284 (Scheme 4.16) with hard bases 
(potassium carbonate, potassium hexamethyldisilizane, sodium hexamethyldisilizane, 
                                                 
*
 The formation of aziridine 291 is possibly the result of advantageous light selectively decomposing the 
triazoline cycloadduct as discussed in the background section (Scheme 4.5). 
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n-butyl lithium) followed by trapping with simple acylating agents (methyl 
chloroformate, ethyl chloroformate, di-tert-butyl dicarbonate) led only to the recovery of 
starting material.  Alternatively, subjection of vinylogous carbamate 284 (Scheme 4.17) 
to 2-(trichloroacetyl)pyrrole did not result in formation of the desired amide 294, but 
instead complete epimerization of the C11 stereogenic center occurred to yield cis-fused 
vinylogous carbamate 295.  The structure of 295 was verified by NOE experiments, with 
diagnostic correlations between the H11 and H12 methine protons and the proximal 
gem-dimethyl group. Coupling constant analysis also showed significantly smaller values 
(JH11,H12 = 7.2 Hz) than the corresponding trans-fused system (cf. 284, Scheme 4.11).  
Epimerization of 284 was likely effected by trace amounts of hydrochloric acid derived 
from trichloroketone 293 under the reaction conditions.  Indeed, trans-fused 
intermediates containing the vinylogous carbamate functionality were found to undergo 
epimerization at the C11 position under a variety of conditions including Brønsted acids, 
Lewis acids, and temperatures above 150 °C, adding to the difficulty of manipulating 
these intermediates. 
 
Scheme 4.17 
 
 
  A new N-acylation method was required that would not induce isomerization of the 
trans-fused system.  According to the protocol of Effenberger and co-workers,17  it was 
found that the use of benzoyl chloride with silver triflate and the hindered acid scavenger 
tri-tert-butylpyridine (TTBP) resulted in successful acylation to yield trans-fused 
vinylogous imide 296 in 52% yield. The geometry of the E-olefin, which had isomerized 
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during the reaction, was assigned based on the significant deshielding of the β-C16 
proton of 296 relative to starting material 284 possessing the Z-geometric configuration. 
 
Scheme 4.18 
 
 
 With the synthesis of amide 296, a method was identified that permits N-acylation 
of the trans-fused bicycle 284 without epimerization to the less-strained cis-fused 
product. Advancement of the synthesis to dimethylcyclopentaphakellin (245) would 
require modification of this method to introduce the desired pyrrole-2-carboxamide 292 
(Scheme 4.16).  The acylation conditions would not be compatible with the presence the 
nucleophilic nature of an unprotected pyrrole N-functionality; therefore, acylation would 
be attempted with a pyrrole derivative (i.e., 301, Scheme 4.19) protected with the Teoc 
(trimethylsilylethoxycarbamate) group, which can be removed under fluoride 
conditions.18  The synthesis of acyl chloride 301 began with Teoc protection of 
1H-pyrrole-2-carbaldehyde (297) with nitrophenyl 2-(trimethylsilyl)ethyl carbonate (298) 
to afford aldehyde 299 in 57% yield.  Pinnick oxidation produced carboxylic acid 300 in 
97% yield, which upon exposure to oxalyl chloride and catalytic dimethylformamide 
(DMF) generated acyl chloride 301 in 94% yield.  In order to avoid acid-catalyzed  
 
Scheme 4.19 
 
 170 
isomerization of the trans-fused ring system during the acylation reaction, it was vital to 
remove all traces of hydrochloric acid from the acylating reagent. This could be 
accomplished by either passage through a plug of silica gel pretreated with triethylamine 
or by a basic aqueous workup, with higher yields observed using the latter method. 
 
Scheme 4.20 
 
 
 Access to the two new coupling components, pyrrole 301 and allyl vinylogous 
carbamate 287 (Scheme 4.12), allowed for evaluation of the silver triflate acylation 
conditions with more complex substrates.  Exposure of vinylogous carbamate 287 
(Scheme 4.20) to acyl chloride 301 and silver triflate allowed for the isolation of 
trans-fused Z-olefin vinylogous imide 292 in 44% yield.  The mass balance for this 
reaction included formation of varying amounts of the following compounds: trans-fused 
E-olefin 302; cis-fused E-olefin 303,* cis-fused Z-olefin 304, as well as unreacted starting 
material 287.  Retention of the trans-fusion as well as the identity of the olefin geometry 
would prove vital for the future steps of the synthesis.  Accordingly, in order to obtain a 
high yield of Z-olefin 292, a short reaction time (i.e., 30 minutes) was required; whereas, 
stirring overnight resulted in the formation of trans-fused E-olefin product 302 in 39% 
yield.  The proportion of the cis-fused products, 303 and 304, increased over time within 
the crude mixture following aqueous work-up, suggesting that the Lewis acidic silver salt 
byproducts contribute to this isomerization. 
                                                 
*
 Analogous to benzamide 296 (Scheme 4.18), a deshielding of the distal protons of these E-olefin products 
was also observed (H16 and H11 on 303, and H16 on 302, Scheme 4.20) 
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4.4.2 Pyrazinone Formation by Hartwig-Buchwald Cross Coupling 
 With access to vinylogous imide 292 (Scheme 4.21), a method was needed to 
prepare pyrazinone 246.  It was envisioned that the B ring of tetracyclic pyrazinone 246 
could be constructed via an intramolecular Hartwig-Buchwald cross coupling of the vinyl 
bromide and pyrrole N-functionality within 305, which in turn could be accessed from 
O-allyl vinylogous imide 292 via an oxidative decarboxylative Hunsdiecker reaction.19 
 
Scheme 4.21 
 
 
 In order to test the feasibility of the Hartwig-Buchwald cross-coupling strategy a 
method to generate vinyl bromide 305 (Scheme 4.21) was required.  The preparation 
began with deprotection of the O-allyl group of vinylogous imide 292 (Scheme 4.22) to 
afford vinylogous carbamic acid 306 in 82% yield.*  Oxidative decarboxylation20 was 
then effected by exposure to potassium carbonate and NBS to generate a mixture of Z- 
and E-olefin isomers of vinyl bromide 307.  Subsequent addition of TBAF to the reaction  
 
Scheme 4.22 
 
                                                 
*
 Vinylogous carbamic acid 306 was unstable to prolonged storage and to acid, resulting in decarboxylation 
and isolation of enamide-derived products .  
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flask effected Teoc deprotection, which after isolation afforded Z-isomer 305 in 70% 
yield.*  Application of modified Hartwig-Buchwald cross-coupling conditions21 resulted 
in the formation of tetracyclic pyrazinone 246 in 79% yield.  Pyrazinone 246 bears four 
of the five desired rings of the dimethylcyclopentaphakellin target and, in addition, has 
the desired oxidation state at the C10,C6 alkene, which can serve as a synthetic handle 
for introduction of the last guanidine ring. 
 
4.4.3 Methods to Access Dibrominated Pyrazinones 
 Due to the susceptibility of the pyrrole ring within pyrazinone 246 (Scheme 4.22) to 
oxidation, a method for the protection of this ring was desired.  C4,C5-Dibromopyrrole 
derivatives have been shown to be stable and easily manipulated intermediates that are 
resistant to further oxidation because of the reduced electron density of the 
dibromopyrrole ring.3,22  Although the acylation/Hartwig-Buchwald route allowed access 
to pyrazinone 246 (Scheme 4.22), this method could not be used to access 
dibromopyrazinone 308 (Scheme 4.23).†  Instead, a new strategy was envisioned that 
would generate the C10,C6 alkene of dibromo pyrazinone 308 by activation and 
elimination of the hydroxyl functionality of cyclic hemiaminal 309, which in turn could 
be accessed via manipulation of α-diazo ester 289.  Acylation of the more nucleophilic 
N-functionality within 289 was anticipated to be more facile when compared to 
vinylogous carbamate 287 (cf. Scheme 4.20), and would likely be easily transferred to the 
synthesis of the revised structure of palau’amine (1b). 
 
Scheme 4.23 
 
 
                                                 
*
 The heterogeneous base potassium carbonate gave a significantly higher Z:E ratio than triethylamine. 
†
  The bromopyrrole substituents are incompatible with both the silver triflate acylation and Hartwig-
Buchwald cross-coupling conditions. 
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 α-Diazo ester 289 (Scheme 4.24), accessed in 33% yield from the cycloaddition of 
azide 286 in the presence of silica gel, was coupled with trimethylsilylethoxymethyl 
(SEM) protected dibromopyrrole acid 31123 to afford amide 312 in 30% yield.*,24  With 
the incorporation of the pyrrole amide moiety, efforts were focused on removal the extra 
carbonyl carbon, which was accomplished by conversion to cyclic hemiaminal 309 over 
four steps.  First, the diazo functionality was selectively oxidized with potassium 
peroxymonosulfate (Oxone) to generate α-keto ester 313 in 87% yield.  This moiety was 
selectively reduced to the diol with the use of sodium borohydride in isopropyl alcohol.†  
Fluoride-mediated removal of the SEM group at 65 °C then afforded diol 314 in 87% 
yield over two steps.  Finally, the C-C bond of diol 314 was cleaved upon subjection to 
sodium periodate.  The putative aldehyde formed from oxidative cleavage underwent 
cyclization with the pyrrole nitrogen to construct the B ring of cyclic hemiaminal 309 in 
50% yield as a single diastereomer.  Lastly, dibromopyrazinone 309‡ was accessed in 
46% yield by activation and elimination of the O-functionality of 309 upon exposure to  
phosphorus oxychloride in pyridine.2 
 
Scheme 4.24 
 
                                                 
*
 The SEM group was used as a protecting group due to the difficulty in accessing carbamate protected 
dibromopyrrole derivatives.  
†
 Reduction of α-keto-ester 313 with lithium borohydride effected cleavage of the amide bond.  Use of 
sodium borohydride in methanol and ethanol afforded different undesired reduction products.   
‡
 The trans-fusion of dibromopyrazinone 308 was independently varied by NOE correlations that were 
similar to 246. 
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During the manipulation of C6-ester pyrazinone 318 (Scheme 4.25), a shorter 
method to prepare dibromopyrazinone 308 was discovered that obviated the need for a 
pyrrole N-protecting group.  Acylation of diazo ester 289 with 4,5-dibromo-1H-pyrrole-
2-carboxylic acid (315) afforded amide 316 in 30% yield.  Subsequent oxidation with 
oxone afforded a 10:1 diastereomeric mixture of cyclic hemiaminal ethers 317 in 75% 
yield, which upon activation and elimination generated C6-ester pyrazinone 318 in 64% 
yield.  The allyl group was then removed without affecting the pyrrole bromides to access 
C6-carboxylic acid 319 in 99% yield based on 1H NMR.  Lastly, exposure to 
trifluoroacetic acid (10% v/v in dichloromethane) cleanly afforded dibromopyrazinone 
308. 
 
Scheme 4.25 
 
 
4.5 Synthesis of Dimethylcyclopentaphakellin: Installation of the C Ring Guanidine 
 The preparation of tetracyclic pyrazinone intermediates allowed for the evaluation 
of methods to introduce the final cis-fused guanidinyl moiety (Ring C) at C10 and C6 
(e.g., 308, Scheme 4.25).  Previously, work by the Austin and Lindel groups established 
means to append the fused urea C-Ring of dibromophakellstatin (26) (Scheme 4.26) onto 
tricyclic pyrazinone 79 by functionalization of the C10,C6 alkene through the use of 
either a hypervalent iodoazide source1 or an N-acyl nitrene source,2 respectively.  
Although these authors were unable to access the corresponding guanidine, 
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dibromophakellin (21), via 26,25 Feldman and coworkers3 were able accomplish this feat 
by conversion of 26 into ethyl isourea 89, followed by dissolution in ammonium 
propionate at 135 °C.  The work of these groups suggested that functionalization of 
tetracyclic pyrazinone 246 could be accomplished in an analogous fashion.  However, the 
presence of the additional trans-configured C11,C12 stereogenic-centers of 246 would 
have two complicating features: (1) it was unknown if the trans-configured bicycle would 
be susceptible to epimerization during these transformations; and (2) the additional 
stereocenters of 246 could result in formation of multiple diastereomeric products.  For 
any method to be amenable to the synthesis of dimethylcyclopentaphakellin (245) and, 
correspondingly, the revised structure of palau’amine (1b), it would have to possess a 
high degree of diastereoselectivity.    
 
Scheme 4.26 
 
 
4.5.1 Unsuccessful Functionalization of the Pyrazinone C10,C6 Alkene 
  Functionalization of the C10,C6 alkene of 246 (Scheme 4.27A) was first attempted 
according to the procedure by Lindel and co-workers.2  In the reported reaction, the 
reagent combination of ethyl-N-tosyloxycarbamate 84, calcium oxide, and water 
generated an electrophilic N-acyl nitrene source, and the incorporation of this nitrene and 
another equivalent of 84 effected the conversion of tricyclic pyrazinone 79 into 
tetracyclic urea 86 in 60% yield.  The use of non-brominated pyrazinone 79 was 
important as it was observed that the use of C4,C5-dibromo-substituted pyrazinone 320 
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lead to a dramatically reduced yield of the desired urea, 321.  Application of these 
conditions to trans-fused tetracyclic pyrazinone 246 (Scheme 4.27B) resulted only in 
decomposition of the starting material with no isolable products.  Variations in the 
stoichiometry and order of addition did not alter the outcome of the reaction. 
 
Scheme 4.27 
 
 
  With no success in use of an electrophilic N-acyl nitrene to functionalize the 
C10,C6 alkene, the procedure reported by Austin and co-workers1 using a hypervalent 
iodoazide source was evaluated.  The authors reported the hypervalent iodine-mediated 
diazidation of pyrazinone 79 (Scheme 4.28A) through the reagent combination of 
iodobenzene diacetate, azidotrimethylsilane, and tetraethylammonium iodide to generate 
an I(N3)- source that afforded cis-diazide 81 in 41% and trans-diazide 80 in 7% yield.   
 
Scheme 4.28 
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Application of this method for the diazidation of tetracyclic pyrazinone 246 (Scheme 
4.28B) resulted in the formation of at least three diastereomeric diazides 322, which 
underwent rapid elimination to form two diastereomeric allylic azides 323, resulting in 
loss of the trans-fusion of the [3.3.0]-bicyclic system.  Difficulty in the manipulation of 
multiple diazide isomers 322 that readily decomposed to allylic azides 323 made the 
pursuit of this route untenable.  However, this reaction was inspiring that 
bisfunctionalization of the C10,C6 alkene of tetracyclic 246 was possible and that the 
corresponding products could be isolated, if only transiently. 
 Unfortunately, application of the two known methods for functionalization of the 
C10,C6 alkene of pyrazinones were ultimately unsuccessful on pyrazinone 246.  The use 
of an electrophilic N-acyl nitrene led to decomposition, and while the hypervalent 
iodoazide reagent permitted functionalization of the C10, C6 alkene, the resulting diazide 
products were unstable.  In order to introduce the guanidine moiety, alternative 
electrophilic reagents would be investigated to functionalize the pyrazinone alkene.  
 
4.5.2 Successful Functionalization of the Pyrazinone C10,C6 Alkene 
 In order to introduce the desired cis-fused guanidine ring onto C10,C6 alkene of 
pyrazinone 246, a novel method for functionalization was envisioned.  Toward this end, it 
was proposed that activation of pyrazinone 246 (Scheme 4.29) could be accomplished by 
exposure to an electrophilic bromine source to generate bromonium 324.  Neighboring 
group assistance via electron donation from the adjacent C10 amide N-functionality could  
 
Scheme 4.29 
 
 178 
then generate N-acyl iminium 325.  Trapping of 325 with an external nucleophile (e.g., a 
protected guanidine) would result in trans-bromo guanidine 326, which could then 
undergo a facile 5-exo-tet cyclization to afford cyclic guanidine 327.    The steric 
encumbrance of the C6-bromo substituent was expected to direct the nucleophilic attack 
to the anti-face, giving rise to the trans-stereoconfiguration of 326 necessary for the 
5-exo-tet cyclization. 
 The modified procedure of Al-Mourabit26 for the activation of enamides was 
applied to pyrazinone 246 to test the feasibility of the electrophilic activation of the 
C10,C6 alkene (Scheme 4.30A).  Instead of alkene activation, the major product obtained 
upon reaction with Boc-guanidine and bromine was monobromopyrrole 328, wherein a 
bromine atom was substituted at the C5 position.  Evidently, the pyrrole is more prone to 
oxidation than the pyrazinone alkene.  Therefore, it was decided to continue studying the 
alkene bisfunctionalization with monobromopyrrole 328 in order to avoid competitive 
oxidation of the pyrrole.  Accordingly, the oxidation of pyrazinone 246 was optimized to 
generate pyrazinone 328 in 76% yield using pyridinium tribromide in 
dimethylformamide.  Unfortunately, further subjection of 328 (Scheme 4.30B) to a 
variety of oxidizing conditions, resulted in decomposition of the starting material or 
formation of a mixture of undesired products.  Conditions screened included electrophiles 
(bromine, iodine, N-iodosuccimide (NIS), NBS, benzyltrimethylammonium tribromide, 
benzyltrimethylammonium dichloroiodate, and 
bis(collidine)bromine(I)hexafluorophosphate), nucleophiles (Boc-guanidine,  
 
Scheme 4.30 
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N-acetyl-guanidine, thiourea, p-methoxybenzylamine, cyanamide, 
N,S-dimethylisothiourea, t-butylcarbamate), and solvents (dimethylformamide, 
acetonitrile, tetrahydrofuran, dichloromethane).   
  
Scheme 4.31 
 
 
 In one experiment, upon addition of 1.5 equivalents of NBS to monobromopyrrole 
328 (Scheme 4.31) in dichloromethane, tribromide 331 was obtained in 66% yield 
without any observed dibromide 329.  This suggests that after oxidation of the C10,C6 
alkene of 328 to generate the desired N-acyl iminium 325, elimination to generate 
dibromide 329 occurs significantly faster than iminium trapping.  Furthermore, C6-bromo 
pyrazinone 329 undergoes further oxidative bromination faster than the starting material  
328.  Conducting the reaction in the presence of a nucleophile (e.g., cyanamide) did not 
 
Scheme 4.32 
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significantly alter the outcome of the reaction.   
  Based on these observations, the problematic elimination of the N-acyl iminium 
substrates (e.g., 325, Scheme 4.32) was occurring faster than the desired nucleophilic 
trapping.  In order to outcompete the undesired elimination pathway, reagents with higher 
nucleophilicity, but less convenient synthetically, were considered. 
 Success at bisfunctionalization of the C10,C6 alkene could be accomplished by 
subjection of pyrazinone 328 (Scheme 4.33A) to NBS in the nucleophilic solvent 
methanol.  A single diastereomer of trans-bromo methyl ether 332 was isolated in 80% 
yield.  With the discovery of successful functionalization of the C10,C6 alkene in an 
alcoholic solvent, the highly nucleophilic and soluble N-source, tetrabutylammonium 
azide, was added to the reaction (Scheme 4.33B), resulting in formation of an inseparable 
2.5:1 mixture of trans-bromo azides 333 and 334 in a combined 76% yield.*  The 
stereochemistry of the new substituents in 332, 333, and 334 were verified by later 
synthetic intermediates; however, coupling constant analysis of these intermediates 
suggested that all three products retained the trans-fusion of the [3.3.0]-bicyclic system.  
The minor component, bromo azide 334, could be carried forward to prepare 
dimethylcyclopentaphakellin (245), wherein the C10,C6 guanidine stereoconfiguration 
 
Scheme 4.33 
 
                                                 
*
 A screen of non-nucleophilic solvents was undertaken (tetrahydrofuran, dimethylformamide, 
dichloromethane, isopropyl alcohol, and methanol/dichloromethane) with no improvement in yield as 
compared to methanol. 
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would match the revised structure of palau’amine (1b), while the major product, bromo 
azide 333, would give rise to its diastereomer, 10,6-epidimethylcyclopentaphakellin.   
 The difficulty in the characterization of structures 332, 333 and 334 owed in part to 
the instability of these compounds in solution, wherein an elimination occurs to generate 
predominately allylic bromide 335 (Scheme 4.34).  Samples of both methyl ether 332 and 
azide 333 decomposed upon standing in solution in deuteriobenzene or 
deuteriochloroform to afford the same product, allylic bromide 335.*  Despite the 
propensity of these compounds to undergo elimination, the formation of allylic bromide 
335 did help to confirm that the bromo substituent has been incorporated at C6 and 
methyl ether/azide substituents at C10. 
 
Scheme 4.34 
 
 
 Having established a method with which to bisfunctionalize the C10,C6 alkene of 
pyrazinone 328 in which one of the two required N-functionalities had been installed, 
efforts were focused on transformation of this synthetic handle into the guanidine moiety 
required for the target molecule.  Although the introduction of the azide at the C10 
position lead to formation of the desired stereoisomer 334 as the minor component in this 
model system, it was envisioned that application of the same method en route to the 
revised structure of palau’amine (1b) might occur with more favorable 
diastereoselectivity due to the presence of additional substituents blocking the α-face of 
the molecule. 
                                                 
*
 Methyl ether 332 was less susceptible to elimination than azide 333, consistent with the relative leaving 
group ability of the C10 substituents. 
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4.5.3 Introduction of the C Ring Guanidine 
 With the ability to prepare bisfunctionalized bromo azide 334 (Scheme 4.35), 
efforts were focused on accessing cyclic guanidine 327.  This task could likely be 
accomplished by stepwise conversion of the azide into amine 336, followed by 
functionalization to acyclic guanidine 326.  Finally, a 5-exo-tet cyclization would then 
lead to cyclic guanidine 327. 
 
Scheme 4.35 
 
 
 Unexpected complications were encountered upon attempted preparation of amine 
336 (Scheme 4.36).  Application of common azide reducing reagents27 
(tributylphosphine, triphenylphosphine/water, phenylselenol/triethylamine) did not lead 
to the isolation of the desired amine 336, but rather the clean conversion to 
monobromopyrazinone 328.  A likely mechanistic rationale for the formation of 328 is 
that through the use of potent nucleophiles (e.g., trialkylphosphines and phenylselenol), 
attack on the C6 bromide substituent occured with elimination of azide anion in 
preference to the desired azide reduction.   
 
Scheme 4.36 
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 In efforts to find milder conditions to effect the reduction of azides 333 and 334,* 
1,3-propanedithiol was explored as a reducing agent.23  However, the use of 
1,3-propanedithiol with triethylamine in methanol did not afford the expected bromo 
amine either.  Instead, amino methyl ether 337 was isolated in 45% yield in addition to 
other stereoisomers 338 and dithiol adducts 339.  Surprisingly, the N-functionality had 
transferred from C10 to the C6 position in these products, as evidenced by the COSY 
correlation between the H6 and amino protons. In addition, these products had 
incorporated one equivalent of either methanol or 1,3-propanedithiol at the C10 position. 
 
Scheme 4.37 
 
 
 The proposed mechanism for the formation of the unexpected rearrangement 
products of Scheme 4.37 is shown in Scheme 4.38.  The reduction of the azide 333 likely 
occurs as expected with 1,3-propanedithiol via intermediate 340 with extrusion of 
nitrogen gas and cyclic dithiane 341 to generate trans-bromo amine 342.  Then, a 
3-exo-tet cyclization likely occurs to afford aziridine 343, which after neighboring group 
assistance from the C10 amido group generates N-acyl imininium 344.   Finally, trapping 
with the one of the nucleophiles present in solution, either methanol or the 
1,3-propanedithiol reagent, generates the observed products with a formal transfer of the 
N-functionality from C10 to C6.  While the rearrangement was unexpected, the resulting 
products could be viable intermediates for the current synthesis if two tasks can be 
accomplished: (1) conversion of the amino group into an acyclic guanidine cyclization 
precursor; and (2) introduction of an alternative nucleophile at C10 that can be 
chemoselectively activated at a later time in order to regenerate an N-acyl iminium 
similar to 344 with the pendent C6 guanidine poised for cyclization.   
                                                 
*
 For clarity, only the major stereoisomer of the 2.5:1 mixture is drawn. 
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Scheme 4.38  
 
 
 Having prepared amine 337, methods for conversion of the amino group into a 
guanidine were investigated.  Many reagents exist for the conversion of amines into 
guanidines with various accompanying N-groups.28  Unfortunately, all attempts to 
directly transform amine 337 into guanidine 346 were not successful (Table 4.1).  The 
use of guanylpyrazole,29 cyanamide,30 cyanogen bromide with p-methoxybenzylamine31  
 
Table 4.1.  Survey of guanidylation methods. 
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all resulted in decomposition of the starting material.  By contrast, guanylbenzotriazole32 
and of N,N’-di-(tert-butoxycarbonyl)thiourea with mercury (II) chloride33 lead to 
formation of undesired byproducts.  Finally, aminoiminosulfonic acid34 and  
di-p-methoxybenzylcarbodiimide resulted in no reaction. 
 With no success in accessing guanidine 346 directly from amine 337, multistep 
methods were next explored with the use of isothiocyanates.  While the electron-rich  
4-methoxyphenyl isothiocyanate was found to be unreactive, the electron-deficient 
ethoxycarbonyl isothiocyanate (347) (Scheme 4.39) reacted efficiently with amine 337 to 
afford the thiourea product 348 in quantitative yield.  Conversion to guanidine 349 was 
accomplished in 80% yield over the two steps with EDCI as a coupling agent and 
hexamethyldisilizane as the nitrogen source.35 
 
Scheme 4.39 
 
 
 Having established methods to transform azide 333 into functionalized guanidine 
349, a substrate capable of facile guanidine cyclization with sought (Scheme 4.40) with 
two necessary changes: (1) an alternative protecting group for the guanidine that can 
easily be removed, and (2) a convenient synthetic handle at the C10 position that could be 
chemoselectively activated at a later stage to generate the required N-acyl iminium 352 
for guanidine cyclization.  While it had been convenient to incorporate a methyl aminal 
ether within guanidine 348 (Scheme 4.39) for the purposes of evaluating methods for 
guanidine installation, activation of this moiety to generate the required N-acyl iminium 
352 (Scheme 4.40) would likely be difficult.   Therefore, an alternative appendage was 
desired at C10 that would possess the potential for chemoselective activation as well as 
high nucleophilicity for its introduction.  Thiols possess both of these characteristics and 
have been used extensively in the field of carbohydrate synthesis for similar purposes.36  
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In addition, evidence of their applicability had already been observed with the formation 
of dithiol adduct 339 (Scheme 4.37).  
 
Scheme 4.40  
 
 
 Having identified the use of thiols to complete the synthesis of 
dimethylcyclopentaphakellin, the conditions for the azide reduction (Scheme 4.41) were 
altered to incorporate ethanethiol as the solvent.  Subjection of a 2.5:1 mixture of azides 
333 and 334 to 1,3-propanedithiol and triethylamine in ethanethiol solvent afforded four 
isolable products: monobromopyrazinone 328 in 11% yield, trans-aminothiol 353 in 36% 
yield (with the undesired C6 stereochemistry), and cis- and trans-aminothiols 354 and  
 
Scheme 4.41 
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355 (with the desired C6 stereochemistry) in 10% yield each.*  Fortunately, the three 
isomeric amines could be separated on silica gel and advanced separately toward  
10,6-epidimethylcyclopentaphakellin and dimethylcyclopentaphakellin. 
 10,7-Epidimethylcyclopentaphakellin 361 (Scheme 4.43) was prepared in four steps 
from amine 353, which possesses the undesired β-C6 stereogenic center.  First, 
condensation of amine 353 with benzyloxycarbonyl isothiocyanate (356) afforded 
thiourea 357 in 87% yield, at which point the relative stereochemistry could be verified 
by NOE correlations.  Benzyloxycarbonyl isothiocyanate was chosen as the coupling 
reagent because it would ultimately generate a benzyloxycarbonyl (Cbz) protected 
guanidine that could be removed simultaneously with the pyrrole bromide via 
hydrogenolysis.  Exposure of thiourea 357 to EDCI and hexamethyldisilizane then 
exchanged the sulfur atom for a nitrogen atom to generate cyclization-precursor 
guanidine 358 in 85% yield.  The ethyl thioether moiety was then activated with NIS37 to 
generate putative N-acyl iminium 359, which underwent cyclization from the pendent  
C6 guanidine in a 5-exo-trig fashion to generate β-cis-fused guanidine 360 in 69% yield  
 
Scheme 4.42 
 
                                                 
*
 The stereochemistry of 353, 354 and 355 were verified later via derivatization. 
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as a single diastereomer.  Crucial to isolation of guanidine 360 was the use of ethanethiol 
to quench the excess NIS after the reaction was complete.  Finally, global deprotection 
under conditions of hydrogenolysis afforded 10,7-epidimethylcyclopentaphakellin 361 in 
75% yield after HPLC purification.  The structure was rigorously verified by NOE 
correlations and the material was submitted to the MSKCC high-throughput screening 
facility to test against 16 common cancer cell lines in order to evaluate any potential 
anticancer bioactivity.38 
 Dimethylcyclopentaphakellin 245 (Scheme 4.44) was accessed by a similar route 
from amines 354 and 355, which possess the desired α-C6 stereochemistry, but are 
inconsequentially diastereomeric at the C10 stereocenter.  Diastereomeric amines 354 
and 355 were independently advanced to diastereomeric guanidines 362 and 363 in 81% 
and 97% yield over two steps, respectively.  The relative stereochemistry of each isomer 
was established by NOE correlations at this stage (Scheme 4.43).   
 
Scheme 4.43 
 
 
 Unlike β-C6-isomer 358 (cf. Scheme 4.42), neither α-C6-isomer was amenable to 
the use of NIS to achieve guanidine cyclization.*  Alternatively, 
bis(collidine)iodine(I)hexafluorophosphate39 (364) provided mild conditions to effect the 
5-exo-trig cyclization of N-acyl iminium 365 with minimal undesired byproducts to 
afford the same desired cis-fused guanidine 366 in 90% and 70% yield, respectively from 
362 and 363, as determined by 1H NMR.  Deprotection under hydrogenolysis conditions 
on small scale then afforded a single product that was consistent with 
dimethylcyclopentaphakellin (245), as determined by 1H NMR; however, the structure 
has not been unambiguously verified.     
                                                 
*
 The use of NIS resulted in elimination towards the C11 methine to generate the corresponding acyclic 
allylic guanidine, analogous to allylic bromide 335 (Scheme 4.34) 
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Scheme 4.44 
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4.6 Summary 
A synthesis of two diastereomers of dimethylcyclopentaphakellin has been achieved 
in 15 steps and 0.4% yield from 4,4-dimethylhepta-1,6-diene (273) (Scheme 4.45).  More 
importantly, a strategy to access the trans-fused [3.3.0]-azabicyclic ring system (Rings E 
and D) of the revised structure of palau’amine (1b) has been developed and proven in the 
context of the synthesis of these natural product analogs.  Key to the preparation of the 
trans-fused bicyclic vinylogous carbamate 287 was the use of an intramolecular  
[3+2]-dipolar cycloaddition on cyclopentane 286 possessing the desired trans-
stereochemical configuration.  After acylation of the N-functionality, three methods were 
successfully developed to access pyrazinone 246 and other brominated analogs.  Finally, 
a bisfunctionalization of the C10,C6 alkene of pyrazinone 328 was developed in order to 
introduce the final guanidine ring.  Precedented methods for guanidine incorporation 
were not amenable to this tetracyclic intermediate; however, a successful pathway was 
developed by the formal addition of bromoazide across the alkene in a regioselective 
manner.  Reduction of azide 333 with 1,3-propanedithiol in ethanethiol then generated 
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amino thioether 353.  Formation of the final guanidine ring was accomplished by 
conversion of amine 353 into guanidine 358 via the corresponding thiourea.  An 
electrophilic-iodine mediated cyclization then generated cis-fused guanidine 360 via the 
putative N-acyl iminium.  Finally, global deprotection afforded natural product analog 
10,6-epidimethylcyclopentaphakellin (361), which possesses the phakellin subunit and 
the trans-fused [3.3.0]-azabicyclic ring structure of the revised structure of palau’amine. 
 
Scheme 4.45 
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With the apparent success in the synthesis of dimethylcyclopentaphakellin (245) 
and the full demonstration in the synthesis of 10,6-epidimethylcyclopentaphakellin (361), 
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the strategy developed will now be applied to the advanced synthetic intermediates, 
prepared in Chapter 3, en route towards the revised structure of palau’amine (1b).  This 
method will hopefully allow for facile introduction of the phakellin subunit within 1b, 
permitting the completion of the total synthesis of this synthetically challenging natural 
product. 
 
4.7 Experimental 
General Procedures.  All reactions were performed in flame-dried round bottom or 
modified Schlenk (Kjeldahl shape) flasks fitted with rubber septa or glass stoppers under 
a positive pressure of argon, unless otherwise noted.  Air- and moisture-sensitive liquids 
and solutions were transferred via syringe or stainless steel cannula.  Organic solutions 
were concentrated by rotary evaporation below 30 °C at ca. 25 Torr.  Flash column 
chromatography was performed employing 230-400 mesh silica gel.  Thin-layer 
chromatography (analytical and preparative) was performed using glass plates precoated 
to a depth of 0.25 mm with 230-400 mesh silica gel impregnated with a fluorescent 
indicator (254 nm).  Reaction temperatures maintained through the use of the following 
baths unless stated otherwise:  above ambient temperature (oil bath), 0 °C (ice/water),  
-78 °C (dry ice/acetone). 
Materials.  Commercial reagents and solvents were used as received with the 
following exceptions.  Tetrahydrofuran, benzene, acetonitrile, dimethoxyethane, diethyl 
ether, toluene, and dichloromethane were dried by passage through activated alumina 
columns under a positive pressure of argon.  1,2-dichloroethane, dimethyl formamide, 
and dimethylsulfoxide was dried over activated 4 Å molecular sieves.  Triethylamine, 
pyridine, and methanol were distilled from calcium hydride at 760 Torr.   
Instrumentation.  Infrared (FTIR) spectra were obtained using a Perkin-Elmer 
Spectrum BX spectrophotometer or a Bruker Tensor 27 and referenced to a polystyrene 
standard.  Data are presented as the frequency of absorption (cm-1), and intensity of 
absorption (s = strong, m = medium, w = weak, br = broad).  Proton and carbon-13 
nuclear magnetic resonance (1H NMR or 13C NMR) spectra were recorded on a Varian 
Unity 400, Varian Unity 500, Varian Unity Inova 500NB NMR, or or Bruker Avance III 
500 spectrometer.  Chemical shifts are expressed in parts per million (δ scale) downfield 
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from tetramethylsilane and are referenced to residual protium in the NMR solvent 
(CHCl3: δ 7.26 for 1H, δ 77.16 for 13C; C6HD5: δ 7.16 for 1H, δ 128.06 for 13C; CHD2OD: 
δ 3.31 for 1H, δ 49.00 for 13C).  Data are presented as follows:  chemical shift, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quadruplet, ABq = non-first order 
quadruplet, p = pentet, br = broadened signal, m = multiplet and/or multiple resonances), 
integration, and coupling constants in Hertz (Hz).  1H NMR assignments were generally 
supported by COSY experiments.  
The following compounds were prepared according to literature methods:  allyl 
(triphenylphosphoranylidene)acetate (285),16  
4,5-dibromo-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrole-2-carboxylic acid (311).23 
 
 
 
4,4-dimethylhepta-1,6-diene (273), (MSB-V-202).  To dry solid zinc (56.2 g, 
0.865 mol, 2.66 equiv) was added dropwise a solution of allyl bromide 367 (105 g, 
0.865 mol, 2.66 equiv) in tetrahydrofuran (430 mL) dropwise over 1 hr.  To the resulting 
grey suspension was added dropwise a solution of 1-propynlmagnesium bromide 
(650 mL, 0.325 mol, 1 equiv, 0.5 M in THF) over one hr.  The resulting red solution was 
refluxed for 2 hr and then cooled to -10 °C and quenched with ice (500 g) and 
hydrochloric acid (12 M, 80 mL) dropwise.  The aqueous layer was then extracted with 
pentane (4 x 100 mL), and the pentane layers were washed with brine (2 x 80 mL), 
saturated potassium carbonate (3 x 50 mL), brine (2 x 50 mL), and dried with magnesium 
sulfate and concentrated in vacuo at 200 pascal to afford a ~300 mL solution of alkene 
273 in tetrahydrofuran.  This solution was distilled to afford a clear concentrated solution 
of alkene 273 in THF (32.13 g, 1: 0.88, alkene 273: THF, 54%).   
1H NMR (500 MHz, CDCl3) δ 5.82 (dq, 2H, J = 7.5, 10.2 Hz, CH2CH=CH2), 5.04-4.97 
(m, 4H, CH2CH=CH2), 1.96 (dd, 4H, J = 0.9, 1.9, CH2CH=CH2), 0.86 (s, 6H, CH3).  All 
spectra matched reported values.13 
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Dibromide 274, (MSB-V-177).  To a solution of alkene 273 (3.0 g, 0.024 mol, 1.0 equiv) 
in tetrahydrofuran (300 mL) at -78 °C was added dichlorozirconocene (7.06 g, 0.024 mol, 
1 equiv).   The solution was warmed to 23 °C until all salts dissolved, and then cooled 
back to -78 °C.  n-Butyl lithium was then added (31 mL, 0.048 mol, 2 equiv, 1.55 M in 
hexanes); the solution turned yellow, green and then black during the course of the 
addition.  The solution was warmed to 23 °C for 2 hr, then cooled back down to -78 °C, 
and fitted with an addition funnel containing bromine (9.1 g, 0.056 mol, 2.3 equiv) and 
carbon tetrachloride (30 mL).  The bromine solution was added dropwise over 1 hr to 
yield an orange solution which was then warmed to 23 °C.  After 1 hr the reaction cooled 
back to -78 °C , quenched with sulfuric acid (10% by volume, 300 mL), extracted with 
diethyl ether (3 x 200 mL), dried with sodium sulfate, and reduced in vacuo to afford a 
blue oil.  The residue was purified via silica gel chromatography (hexanes) to yield 
dibromide 274 (6.38 g, 93%) as a clear oil.   
Rf  0.31 (hexanes);  1H NMR (500 MHz, CDCl3) δ 3.04 (dd, 2H, J = 4.3, 10.1 Hz, 
CH2CHCH2Br), 2.86 (dd, 2H, J = 6.9, 10.1 Hz, CH2CHCH2Br), 1.79-1.75 (m, 2H, 
CH2CHCH2Br), 1.47 (dd, 2H, J = 7.5, 13.0 Hz, CH2CHCH2Br), 1.14 (dd, 2H, J = 8.8, 
13.0 Hz, CH2CHCH2Br), 0.80 (s, 6H, CH3);  13C NMR (125 MHz, CDCl3) δ 47.1, 45.8, 
37.4, 36.6, 30.3;  IR (neat film) 2953 (s), 2936 (m), 2864 (m), 1445 (w), 1366 (w), 1225 
(w), 653 (m). 
 
 
 
Bromoazide 275, (MSB-V-234).  To a solution of dibromide 274 (21.36 g, 0.075 mol, 
2.22 equiv) in dimethylformamide (50 mL) was added sodium azide (2.2 g, 0.034 mol, 
1.0 equiv) and tetraethylammonium bromide (7.8 g, 0.0387 mol, 1.11 equiv).  The 
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solution was covered in foil, and heated up to 80 °C.  After 15 hr the reaction was cooled, 
diluted with ethyl acetate (300 mL), washed with water (4 x 100 mL), a saturated sodium 
chloride solution (100 mL), dried (magnesium sulfate), and reduced in vacuo to afford a 
mixture of dibromide 274 and bromoazide 275 1.25:1 ratio respectively (by 1H NMR 
analysis).  The residue was purified via silica gel chromatography (10:1 gradient to 8:1 to 
5:1 hexanes: dichloromethane) to afford recovered dibromide 274 (10.79 g, 51%) and 
bromazide 275 (5.21 g, 63% based on sodium azide).   
Rf  0.42 (3:1 hexanes: dichloromethane);  1H NMR (500 MHz, CDCl3) δ 3.20 (dd, 1H,  
J = 4.6, 10.0 Hz, CH2CHCH2Br), 2.98 (dd, 1H, J = 7.4, 10.0 Hz, CH2CHCH2Br), 2.81 
(dd, 1H, J = 5.9, 12.2 Hz, CH2CHCH2N3), 2.70 (dd, 1H, J = 6.9, 12.1 Hz, 
CH2CHCH2N3), 1.81-1.76 (m, 1H, CHCH2Br), 1.70-1.65 (m, 1H, CHCH2N3), 1.56 (dd, 
1H, J = 8.1, 13.0 Hz, CH2CHCH2Br), 1.46 (dd, 1H, J = 8.3, 12.9 Hz, CH2CHCH2N3), 
1.20 (dd, 1H, J = 9.3, 12.9 Hz, CH2CHCH2Br), 1.05 (dd, 1H, J = 9.1, 12.9 Hz, 
CH2CHCH2N3), 0.91 (s, 3H, CH3), 0.89 (s, 3H, CH3);  13C NMR (125 MHz, CDCl3) δ 
55.2, 46.9, 45.8, 45.1, 43.7, 37.7, 37.1, 30.4, 30.3;  IR (neat film) 2955 (m), 2931 (m), 
2865 (w), 2099 (s), 1451 (w), 1366 (w), 1259 (m). 
 
 
 
Aldehyde 276, (MSB-VI-049).  Trimethylamine N-oxide dihydrate (5.44 g, 0.049 mol, 
4 equiv) was dissolved in anhydrous dimethylformamide (40 mL) and distilled until the 
solution began to turn orange.  At this point heating was removed, and the solution 
solidified upon cooling under high vacuum.  After 3 hr a solution of bromoazide 275 
(3.03 g, 0.0124 mol, 1.0 equiv) in dimethylsulfoxide (25 mL) was added.  After 12 hr the 
reaction was diluted with a saturated sodium chloride solution (150 mL) and ice (50 g), 
and extracted with diethyl ether (3 x 25 mL).  The combined organic layers were then 
washed with water (2 x 50 mL), a saturated sodium chloride solution (50 mL), dried with 
magnesium sulfate, and reduced in vacuo at 200 mBar to afford azide aldehyde 
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containing diethyl ether (2.21 g total, 1.83 g 276, 82%).  The material was used without 
purification in the next step.   
Rf  0.23 (1:1 hexanes: dichloromethane);  1H NMR (500 MHz, CDCl3) δ 9.68 (s, 1H, 
CHO), 3.39 (dd, J = 12.1, 5.1 Hz, 1H, CH2N3), 3.32 (dd, J = 12.0, 5.4 Hz, 1H, CH2N3), 
2.70 – 2.56 (m, 2H, CH2CHCHCH2), 1.80 – 1.67 (m, 3H, CH2, CH2), 1.36 – 1.27 (m, 1H, 
CH2), 1.08 (s, 3H, CH3), 0.97 (s, 3H, CH3);  13C NMR (126 MHz, CDCl3) δ 203.00, 
55.64, 55.62, 45.14, 41.33, 40.01, 39.28, 29.78, 28.96;  IR (neat film)  2955 (m), 2867 
(w), 2099 (s), 1722 (s), 1271 (w), cm-1;  LRMS (ES) m/z for C9H15O5N3, (M+Na)+ 
203.93. 
 
 
 
Enol ether 278 and enol ether 279, (MSB-V-191).  To a solution of (methoxymethyl) 
triphenylphosphonium chloride (189 mg, 0.552 mmol, 2.0 equiv) in tetrahydrofuran 
(5 mL) at -78 °C was added a solution of sodium hexamethyldisilizane (1.0 M in 
tetrahydrofuran, 0.50 mL, 0.497 mol, 1.8 equiv) to form an orange solution.  After 2 hr a 
solution of aldehyde 276 (50 mg, 0.276 mol, 1.0 equiv) in tetrahydrofuran (1.0 mL) was 
added.  After 1 hr the solution was warmed to room temperature.  After 2 hr of additional 
stirring the reaction was quenched with a saturated sodium bicarbonate solution (20 mL), 
diluted with water (20 mL), extracted with diethyl ether (3 x 20 mL), dried (magnesium 
sulfate), filtered, and concentrated in vacuo.  The residue was purified via silica gel 
chromatography (3:1 gradient to 1:1 pentane: dichloromethane) to afford enol ether 278 
(2.0 mg, 3.5%) and enol ether 279 (3.0 mg, 5.5%).   
E-Enol ether 279.  Rf  0.23 (3:1 hexanes: dichloromethane);  1H NMR (500 MHz, 
CDCl3) δ 6.29 (d, J = 12.6 Hz, 1H, CHCH=CHOMe), 4.57 (dd, J = 12.6, 9.2 Hz, 1H, 
CHCH=CHOMe), 3.51 (s, 3H, OCH3), 3.40 – 3.33 (dd, J = 4.3, 12.1 Hz, 1H, 
CH2CHCH2N3), 3.13 (dd, J = 12.1, 7.7 Hz, 1H, CH2CHCH2N3), 2.23 – 2.11 (m, 1H, 
CH2CHCH=CHOMe), 1.94 – 1.82 (m, 1H, CH2CHCH2N3), 1.73 (dd, J = 12.8, 8.1 Hz, 
1H, CH2CHCH2N3), 1.66 (dd, J = 12.8, 7.7 Hz, 1H, CH2CHCH=CHOMe), 1.33 – 1.23 
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(m, 2H, CH2CHCH=CHOMe, CH2CHCH2N3), 1.04 (s, 3H, CH3), 1.03 (s, 3H, CH3);  13C 
NMR (126 MHz, CDCl3) δ 147.46, 106.14, 56.22, 54.87, 49.81, 46.81, 45.52, 42.62, 
37.24, 31.28, 31.13;  IR (neat film) 2951 (m), 2934 (m), 2863 (w), 2096 (s), 1653 (m), 
1225 (m), 1207 (m), 1142 (m), 936 (m) cm-1.   
Z-Enol ether 278.  Rf  0.33 (3:1 hexanes: dichloromethane);  1H NMR (500 MHz, 
CDCl3) δ 5.91 (dd, J = 6.2, 0.9 Hz, 1H, CHCH=CHOMe), 4.21 (dd, J = 9.4, 6.2 Hz, 1H, 
CHCH=CHOMe), 3.57 (s, 3H, OCH3), 3.37 (dd, J = 12.2, 4.4 Hz, 1H, CH2CHCH2N3), 
3.12 (dd, J = 12.2, 8.1 Hz, 1H, CH2CHCH2N3), 2.76 (m, 1H, CH2CHCH=CHOMe), 1.92 
– 1.81 (m, 1H, CH2CHCH2N3), 1.76 – 1.66 (m, J = 12.5, 7.9 Hz, 2H, CH2CHCHCH2), 
1.32 – 1.16 (m, 2H, CH2CHCHCH2), 1.04 (s, 3H, CH3), 1.03 (s, 3H, CH3);  IR (neat film) 
2953 (m), 2934 (m), 2864 (w), 2097 (s), 1667 (m), 1286 (m), 1113 (m) cm-1. 
 
 
 
Aziridine 283, (MSB-V-194).  A solution of E-enol ether 279 (1.5 mg, 0.0072 mmol) in 
deuteriobenzene (0.5 mL) and heated up to 180 °C in a sealed tube.  After 10 hr the 
reaction was cooled and the solvent reduced in vacuo to afford aziridine 283 in >95% 
purity as determined by 1H NMR.   
Rf  0.13 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, C6D6) δ 4.17 – 4.05 (m, 2H, 
CH2CHCH(N)CHOMe), 3.97 (ddd, J = 16.3, 8.5, 1.6 Hz, 1H, CH2CHCH2N3), 3.63 (br d, 
J = 16.3 Hz, 1H, CH2CHCH2N3), 3.29 (m, 1H, CH2CHCH(N)CH), 3.13 (s, 3H, OCH3), 
2.54 – 2.42 (m, 1H, CH2CHCH2N3), 1.63 (ddd, J = 12.6, 9.3, 1.9 Hz, 1H, 
CH2CHCH2N3), 1.46 (ddd, J = 12.4, 8.4, 1.8 Hz, 1H, CH2CHCH(N)CH), 1.27 – 1.18 (m, 
2H, CH2CHCH2N3), 0.93 – 0.85 (m, 4H, CH2CHCH(N)CH, CH3), 0.80 (s, 3H, CH3);  IR 
(neat film) 2950 (s), 2928 (s), 2824 (m), 1651 (m), 1463 (m), 1365 (m), 1111 (m) cm-1;  
LRMS (ESI) m/z for C11H9NO, (M+H)+ 181.99. 
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Aziridine 283, (MSB-V-196).  A solution of Z-enol ether 278 (2.0 mg, 0.01 mmol) in 
deuteriobenzene (0.5 mL) and heated up to 180 °C in a sealed tube.  After 10 hr the 
reaction was cooled and the solvent reduced in vacuo to afford aziridine 283 in >75% 
purity as determined by 1H NMR.  All spectra matched that previously reported.  
 
 
 
11,10,6-Trideuterio-aziridine 283, (MSB-V-194).  A solution of E-enol ether 278 
(1.5 mg, 0.0072 mmol) in deuteriobenzene (0.5 mL) was added deuterium oxide 
(0.02 mL) and heated up to 180 °C in a sealed tube.  After 16 hr the reaction was cooled 
and the solvent reduced in vacuo to afford aziridine 11,10,6-trideuterio-283 in 80% 
purity as determined by 1H NMR.  All spectra matched that previously reported, except 
integrations of the following peaks.   
1H NMR (500 MHz, C6D6) δ 4.17 – 4.05 (m, 0.3H, CH2CHCH(N)CHOMe), 3.29 (m, 
0.2H, CH2CHCH(N)CH). 
 
 
 
Methyl ester 281, (MSB-V-204).  To a solution of aldehyde 276 (200 mg, 1.11 mmol, 
1.0 equiv) in toluene (5 mL) was added methyl (triphenylphosphoranylidene)acetate 
(876 mg, 2.62 mmol, 2.5 equiv) and heated up to 80 °C.  After 6 ½ hr the reaction was 
cooled and the solvent reduced in vacuo.  The residue was purified via silica gel 
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chromatography (2:1 dichloromethane: pentane gradient to dichloromethane) to afford 
methyl ester 281 (93.0 mg, 37%) in 90% purity as a clear oil.   
Rf  0.22 (1:1 hexanes: dichloromethane);  1H NMR (500 MHz, CDCl3) δ 6.85 (dd, J = 
15.6, 8.9 Hz, 1H, CHCH=CHCO2CH3), 5.82 (d, J = 15.6 Hz, 1H, CHCH=CHCO2CH3), 
3.73 (s, 3H, OCH3), 3.34 (dd, J = 12.2, 4.8 Hz, 1H, CH2CHCH2N3), 3.20 (dd, J = 12.2, 
7.1 Hz, 1H, CH2CHCH2N3), 2.57 – 2.45 (m, 1H, CHCH=CHCO2CH3), 2.17 – 2.06 (m, 
1H, CH2CHCH2N3), 1.77 (dd, J = 12.9, 8.2 Hz, 1H, CH2CHCH2N3), 1.72 (dd, J = 13.0, 
8.0 Hz, 1H, CH2CH), 1.43 (dd, J = 12.9, 10.0 Hz, 1H, CH2CH), 1.34 (dd, J = 12.9, 
9.9 Hz, 1H, CH2CHCH2N3), 1.07 (s, 3H, CH3), 1.06 (s, 3H, CH3);  13C NMR (126 MHz, 
CDCl3) δ 167.04, 151.65, 120.83, 54.67, 51.66, 47.69, 46.23, 45.71, 45.42, 38.20, 30.82, 
30.75;  IR (neat film)  2953 (m), 2934 (m), 2865 (m), 2098 (s), 1719 (s), 1651 (m), 1451 
(w), 1367 (w), 1269 (m), 1156 (m), 986 (w), 930 (w) cm-1. 
 
 
 
Methyl vinylogous carbamate 284, (MSB-V-225).  A solution of methyl ester 281 
(17.5 mg, 0.074 mmol, 1.0 equiv) in acetonitrile (1.0 mL) was heated up to 115 °C in a 
sealed tube.  After 17 hr the reaction was cooled and found to be mixture of 281 and 284 
by TLC.  The vessel was then sealed and heated up to 130 °C.  After 4 hr the solution 
was cooled and the solvent reduced in vacuo.  The residue was purified via silica gel 
chromatography (3:1 hexanes: dichloromethane w/ 1% triethylamine) to afford methyl 
vinylogous carbamate 284 (9.8 mg, 64%) as a white solid.   
Rf  0.32 (dichloromethane);  1H NMR (500 MHz, C6D6) δ 7.74 (br s, 1H, NH), 4.87 (s, 
1H, C(N)=CHCO2), 3.65 (s, 3H, OCH3), 2.62 (ddd, J = 8.6, 6.2, 2.0 Hz, 1H, 
CH2CHCH2N), 2.40 (t, J = 9.8 Hz, 1H, CH2CHCH2N), 2.15 (dt, J = 12.9, 6.2 Hz, 1H, 
CH2CH), 1.74 – 1.59 (m, 1H, CH2CHCH2N), 1.22 (dd, J = 11.7, 6.4 Hz, 1H, CH2CH), 
1.06 (dd, J = 11.6, 6.0 Hz, 1H, CH2CHCH2N), 0.97 (t, J = 11.8 Hz, 1H, CH2CH), 0.82 (s, 
3H, CH3), 0.81 (s, 3H, CH3), 0.74 (t, J = 12.0 Hz, 1H, CH2CHCH2N);  13C NMR 
(126 Hz, C6D6) δ 171.01, 164.64, 77.58, 55.69, 50.10, 50.01, 47.17, 45.02, 40.63, 38.77, 
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31.65, 31.53;  IR (neat film) 2948 (w), 2867 (w), 1597 (s), 1223 (m), 1146 (s), 1051 (w), 
779 (w) cm-1;  LRMS (ESI) m/z for C12H19NO2, (M+H)+ 209.96, (M+Na)+ 231.97. 
 
 
 
6,14-Dideuterio-methyl vinylogous carbamate 284, (MSB-V-225).  To a solution of 
methyl ester 281 (1.5 mg, 0.0063 mmol) in deuteriobenzene (0.5 mL) was added 
deuterium oxide (0.02 mL), capped and heated up to 130 °C in a sealed tube.  After 12 hr 
the reaction was cooled and the solvent reduced in vacuo.  The residue was purified via 
silica gel chromatography (3:1 hexanes: dichloromethane w/ 1% triethylamine) to afford 
methyl vinylogous carbamate 6,14-dideuterio-284 (9.8 mg, 64%) as a white solid.  All 
spectra matched that previously reported, except integrations of the following peaks.   
1H NMR (500 MHz, C6D6) δ 7.74 (br s, not present, NH), 4.87 (s, 0.15H, C(N)=CHCO2). 
 
 
 
Aziridine 291, (MSB-V-207).  A solution of methyl ester 281 (18.0 mg, 0.074 mmol) in 
deuteriobenzene (0.75 mL) was heated up to 105 °C in a sealed tube.  After 12 hr the 
reaction was cooled, the solvent reduced in vacuo, and found to be mixture of 281 and 
284: and 291 by 1H NMR.  The residue was diluted again with deuteriobenzene and 
heated again at 105 °C.  After 12 hr the solution was cooled and the solvent reduced in 
vacuo.  The residue was purified via silica gel chromatography twice (3:1 hexanes: 
dichloromethane w/ 1% triethylamine and then 6:1 hexanes: dichloromethane w/ 1% 
triethylamine) to afford methyl vinylogous carbamate 284 (5.5 mg, 39%) as a white solid 
and aziridine 291 (4.0 mg, 25%) as a clear oil.   
Methyl vinylogous carbamate 284.  All spectra matched that previously reported. 
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Aziridine 291.  Rf  0.12 (dichloromethane);  1H NMR (500 MHz, C6D6) δ 3.36 (s, 3H, 
OCH3), 3.19 (dd, J = 10.1, 5.9 Hz, 1H, CH2CHCH2N), 2.48 (dd, J = 5.0, 2.2 Hz, 1H, 
CH2CHCH(N)CH), 2.35 (dddd, J = 12.4, 9.3, 9.3, 6.0 Hz, 1H, CH2CHCH2N), 2.22 (d, J 
= 2.2 Hz, 1H, CH2CHCH(N)CH), 1.53 (t, J = 10.8 Hz, 1H, CH2CHCH2N), 1.40 (ddd, J = 
12.3, 6.3, 5.7, 5.3 Hz, 1H, CH2CHCH(N)CH), 1.23 (dd, J = 11.5, 6.3 Hz, 1H, 
CH2CHCH(N)CH), 1.04 (dd, J = 11.8, 6.0 Hz, 1H, CH2CHCH2N), 0.95 (t, J = 12.0 Hz, 
1H, CH2CHCH(N)CH), 0.88 (s, 3H, CH3), 0.85 (s, 3H, CH3), 0.68 (t, J = 12.2 Hz, 1H, 
CH2CHCH2N);  IR (neat film) 2950 (s), 2864 (m), 2092 (w), 1744 (s), 1438 (m), 1365 
(m), 1285 (m), 1205 (m), 1178 (m) cm-1;  LRMS (ESI) m/z for C12H19NO2, (M+H)+ 
210.00. 
 
 
 
Allyl ester 286 and α-diazo ester 289, (MSB-VI-100).  To neat aldehyde 276 (2.9 g, 
0.016 mol, 1.0 equiv) was added ally (triphenylphosphoranylidene)acetate (11.5 g, 
0.032 mol, 2.0 equiv) in a solution of toluene (50 ml) and heated up to 70 °C.  After 13 hr 
the reaction was cooled and the solvent reduced in vacuo.  The residue was purified via 
silica gel chromatography (4:1 gradient to 2:1 hexane: ethyl acetate w/ 1% triethylamine 
gradient to 100% ethylacetate) to afford allyl ester 286 (2.40 g, 57%) as a clear oil and  
α-diazo ester 289 (8.7 g, 30:1 ratio triphenylphosphine: 289) as an orange oil.  (Note:  
α-diazo ester 289 was not a major component of the crude mixture as determined by 1H 
NMR, and was isolated due to decomposition of triazoline 288 during chromatographic 
purification.)  
Allyl ester 286.  Rf  0.46 (dichloromethane);  1H NMR (500 MHz, CDCl3) δ 6.87 (dd, J = 
15.6, 8.8 Hz, 1H, CH=CHCO2), 6.01 – 5.89 (m, 1H, CH2CH=CH2), 5.84 (dd, J = 15.6, 
0.8 Hz, 1H, CH=CHCO2), 5.40 – 5.30 (dq, J = 17.2, 1.5 Hz, 1H, CH2CH=CH2), 5.25 (dd, 
J = 10.4, 1.3 Hz, 1H, CH2CH=CH2), 4.65 (t, J = 1.3 Hz, 1H, CH2CH=CH2), 4.64 (t, J = 
1.3 Hz, 1H, CH2CH=CH2), 3.34 (dd, J = 12.2, 4.8 Hz, 1H, CH2CHCH2N3), 3.21 (dd, J = 
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12.2, 7.1 Hz, 1H, CH2CHCH2N3), 2.56 – 2.46 (m, 1H, CH2CH), 2.16 – 2.07 (m, 1H, 
CH2CHCH2N3), 1.80 – 1.69 (m, 2H, CH2CHCHCH2), 1.43 (dd, J = 12.9, 10.0 Hz, 1H, 
CH2CH), 1.34 (dd, J = 12.9, 9.9 Hz, 1H, CH2CHCH2N3), 1.07 (s, 3H, CH3), 1.06 (s, 3H, 
CH3);  13C NMR (126 MHz, CDCl3) δ 166.15, 151.75, 132.36, 120.83, 118.25, 65.09, 
54.56, 47.60, 46.15, 45.60, 45.33, 38.12, 30.74, 30.67;  IR (neat film)  2953 (m), 2934 
(m), 2865 (m), 2098 (s), 1720 (s), 1651 (m), 1451 (w), 1367 (w), 1269 (m), 1156 (m), 
986 (w), 930 (w) cm-1;  LRMS (ESI) m/z for C14H21N3O2, (M-H)- 262.09, (M+H)+ 
264.09, (M+Na)+ 286.04. 
α-Diazo ester 289.  Rf  0.19 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, C6D6) (the 
spectra of this compound was very broad) δ 5.78 – 5.67 (m, 1H, CH2CH=CH2), 5.11 (d, J 
= 17.2 Hz, 1H, CH2CH=CH2), 4.95 (d, J = 10.3 Hz, 1H, CH2CH=CH2), 4.59 – 4.48 (m, 
2H, CH2CH=CH2), 3.67 (br d, J = 6.3 Hz, 1H, CH2CHCHN), 2.53 (dd, J = 9.2, 6.7 Hz, 
1H, CH2CHCH2N), 2.36 (t, J = 9.6 Hz, 1H, CH2CHCH2N), 1.79 (br s, 2H, 
CH2CHCHCH2), 1.45 (dd, J = 11.6, 5.7 Hz, 1H, CH2), 1.20 (dd, J = 11.7, 5.5 Hz, 1H, 
CH2), 0.96 (s, 3H, CH3), 0.93 (s, 3H, CH3), 0.89 – 0.81 (m, 2H, CH2CHCHCH2);  LRMS 
(ESI) m/z for C15H18ON2, (M+H)+ 243.31, (M+Na)+ 265.19. 
  
 
 
Allyl vinylogous carbamate 286, (MSB-VIII-241).  Trimethylamine N-oxide dihydrate 
(1.83 g, 0.024 mol, 4 equiv) was dissolved in anhydrous dimethylformamide (12 mL) and 
distilled until the solution began to turn orange.  At this point heating was removed, and 
the solution solidified upon cooling under high vacuum.  After 7 hr under vaccum a 
solution of bromoazide 275 (1.5 g, 0.006 mol, 1.0 equiv) in dimethylsulfoxide (10 mL) 
was added.  After stirring for 14 hr conversion of bromoazide 275 was complete as 
determined by TLC analysis, at which point a solution in toluene (1 mL) of allyl 
(triphenylphosphoranylidene)acetate (2.86 g, 0.008 mol, 1.3 equiv) was added and heated 
up to 70 °C for 20 min.  The solution was then cooled and diluted with a saturated 
ammonium chloride solution (150 mL), extracted with diethyl ether (3 x 100 mL), dried 
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(magnesium sulfate), filtered, and concentrated in vacuo.   The residue was purified via 
ISCO silica gel flash chromatography (95:5 gradient to 50:50 hexane: ethyl acetate) to 
afford allyl ester 286 (715 mg, 45%) as a clear oil. All spectra matched that previously 
reported. 
 
 
 
Allyl vinylogous carbamate 287, (MSB-VI-135).  A solution of azide 286 (377 mg, 
1.43 mmol, 1.0 equiv) in acetonitrile (5 mL) and heated up to 130 °C in a sealed tube.  
After 4 hr the reaction was cooled and the solvent reduced in vacuo.  The residue was 
purified via silica gel chromatography (3:1 hexanes: ethyl acetate w/ 5% triethylamine) to 
afford vinylogous carbamate 287 (239 mg, 71%) as a yellow solid.   
Rf  0.63 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.50 (s, 1H, NH), 
5.96 – 5.84 (m, 1H, CH2CH=CH2), 5.25 (ddd, J = 17.2, 3.2, 1.6 Hz, 1H, CH2CH=CH2), 
5.13 (ddd, J = 10.4, 2.8, 1.3 Hz, 1H, CH2CH=CH2), 4.52 (dq, J = 5.7, 0.8 Hz, 1H, 
CH2CH=CH2), 4.46 (d, J = 0.8 Hz, 1H, NC=CHCO2), 3.40 – 3.32 (ddd, 1H, J = 9.5, 6.0, 
2.0 Hz, CH2CHCH2N), 3.03 (t, J = 9.8 Hz, 1H, CH2CHCH2N), 2.57 (td, J = 12.7, 6.4 Hz, 
1H, CH2CH), 2.21 – 2.05 (m, 1H, CH2CHCH2N), 1.57 (dd, J = 11.7, 6.4 Hz, 1H, 
CH2CH), 1.51 (dd, J = 11.7, 6.1 Hz, 1H, CH2CHCH2N), 1.28 – 1.18 (m, 2H, 
CH2CHCHCH2), 1.09 (s, 3H, CH3), 1.07 (s, 3H, CH3);  13C NMR (126 MHz, CDCl3) δ 
169.97, 165.38, 133.67, 116.94, 76.55, 63.37, 55.83, 50.11, 47.61, 45.40, 40.73, 38.72, 
31.80, 31.74;  IR (neat film)  3375 (m), 2946 (m), 2864 (m), 1655 (s), 1610 (m), 1459 
(m), 1365 (w), 1304 (w), 1229 (m), 1150 (m), 1047 (m), 994 (w), 927 (w), 780 (m) cm-1;  
LRMS (ESI) m/z for C14H21NO2, (M-H)- 234.24, (M+H)+ 236.07, (M+Na)+ 258.07. 
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Allyl vinylogous carbamate 287, (MSB-V-126).  A solution of a 30:1 mixture of 
triphenylphosphine oxide and α-daizo ester 289 (8.7 g, 1.43 mmol) in acetonitrile 
(50 mL) and heated up to 130 °C in a sealed tube.  After 2 ½ hr the reaction was cooled 
and the solvent reduced in vacuo.  The residue was purified via silica gel chromatography 
(3:1 hexanes: ethyl acetate w/ 1% Et3N) to afford vinylogous carbamate 287 (387 mg) as 
a yellow solid.  All spectra matched that previously reported. 
 
 
 
cis-fused Methyl vinylogous carbamate 295, (MSB-V-231).  To a solution of methyl 
vinylogous carbamate 284 (5.0 mg, 0.024 mmol, 1.0 equiv) in dichloromethane (2 mL) 
was added 2-(trichloroacetyl) pyrrole (28.5 mg, 0.134 mmol, 5.6 equiv) and heated up to 
70 °C in a sealed tube.  After 12 hr the reaction was cooled and the solvent reduced in 
vacuo.  The residue was purified via silica gel chromatography (1:1 hexanes: 
dichloromethane w/ 1% triethylamine) to afford cis-fused methyl vinylogous carbamate 
295 (3.0 mg, 60%) as a white solid. 
Rf  0.41 (dichloromethane);  1H NMR (500 MHz, C6D6) δ 8.02 (s, 1H, NH), 4.80 (s, 1H, 
C(N)=CHCO2), 3.67 (d, J = 0.4 Hz, 3H, OCH3), 2.91 (dd, J = 10.2, 8.2 Hz, 1H, 
CH2CHCH2N), 2.82 (m, 1H, CH2CH), 2.54 (dd, J = 10.2, 2.7 Hz, 1H, CH2CHCH2N), 
2.12 (qd, J = 10.6, 2.8 Hz, 1H, CH2CHCH2N), 1.48 (ddd, J = 12.8, 9.2, 1.8 Hz, 1H, 
CH2CH), 1.32 – 1.22 (m, 2H, CH2CHCH2N, CH2CH), 0.86 – 0.80 (m, 4H, CH2CHCH2N, 
CH3), 0.66 (s, 3H, CH3);  13C NMR (126 MHz, C6D6) δ 171.71, 171.13, 76.72, 52.51, 
49.93, 49.37, 47.89, 46.56, 41.73, 39.08, 28.51, 27.51;  IR (neat film) 3351 (w), 2951 
(m), 2866 (w), 1684 (m), 1661 (s), 1654 (s), 1599 (s), 1243 (m), 1214 (m), 1151 (s), 1045 
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(m), 781 (w) cm-1;  LRMS (ESI) m/z for C12H19NO2, (M-H)- 207.97, (M+H)+ 209.95, 
(M+Na)+ 231.99. 
 
 
 
trans-fused E-vinylogous benzimide 296.  To a vinylogous carbamate 284 (14 mg, 0.67  
mmol, 1.0 equiv) in dichloromethane (2.0 mL) at 0 °C  was added tri-tert-butylpyridine 
(33 mg, 1.34 mmol, 2.0 equiv), benzoyl chloride (9.4 µL, 0.08 mmol, 1.2 equiv) and 
silver trifluoromethylsulfonate (20.4 mg, 0.08 mmol, 1.2 equiv), at which point a white 
precipitate began to form.  After stirring for 35 min the solution was diluted with 
saturated sodium bicarbonate (10 mL) and extracted with dichloromethane (3 x 10 mL).  
The resulting residue was purified by silica gel flash chromatography (99:1 
dichloromethane: ethyl acetate) to afford vinylogous imide 296 (11.0 mg, 52%) as a 
white solid.   
Rf  0.32 (99:1 dichloromethane: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.65 (d, J = 
2.0 Hz, 1H, C6H5), 7.28 – 7.22 (m, 2H, C6H5), 7.10 – 6.95 (m, 2H, C6H5), 3.47 (s, 3H, 
OCH3), 3.01 (dd, J = 9.2, 6.3 Hz, 1H, CH2CHCH2N), 2.68 – 2.51 (m, 3H, CH2CHCH2N, 
CH2CH), 1.44 (td, J = 12.1, 6.4 Hz, 1H, CH2CHCH2N), 1.33 (t, J = 11.5 Hz, 1H, 
CH2CH), 1.07 – 0.97 (m, 4H, CH2CHCH2N, CH3), 0.89 (s, 1H, CH3), 0.71 (t, J = 11.9 
Hz, 1H, CH2CHCH2N);  13C NMR (126 MHz, C6D6) δ 170.21, 167.90, 155.73, 138.00, 
130.18, 128.59, 128.50, 127.28, 101.24, 55.68, 54.20, 50.60, 47.77, 43.12, 42.73, 40.54, 
31.97, 31.80;  IR (neat film) 2949 (m), 2865 (w), 1714 (s), 1670 (s), 1619 (m), 1374 (s), 
1351 (s), 1328 (m), 1301 (w), 1279 (w), 1218 (m), 1147 (s), 1117 (s), 1067 (m), 840 (s), 
701 (m) cm-1;  LRMS (ESI) m/z for C19H23O3N, (M+H)+ 314, (M+Na)+ 336. 
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2-(trimethylsilyl)ethyl 2-formyl-1H-pyrrole-1-carboxylate (299), (MSB-VI-012).  To 
a solution of a 1H-pyrrole-2-carbaldehyde (297) (0.52 g, 5.5 mmol, 1.2 equiv) in 
tetrahydrofuran (15 mL) at 0 °C was added sodium hydride (60% in mineral oil, 229 mg, 
6.0 mmol, 1.3 equiv).  After stirring for 30 min nitrophenyl 2-(trimethylsilyl)ethyl 
carbonate (1.32 g, 4.6 mmol, 1 equiv) was added, at which point the solution turned red 
and then orange.  After stirring for 15 hr the solution was then diluted with ethyl acetate 
(100 mL), filtered through celite to remove precipitate, washed with brine (50 mL), dried 
(magnesium sulfate), and concentrated in vacuo.  The resulting brown residue was 
purified by silica gel flash chromatography (50:50 hexanes: dichloromethane gradient 
dichloromethane) to afford pyrrole 299 (621 mg, 57%) as a white solid. 
Rf  0.36 (1:1 hexanes: dichloromethane);  1H NMR (500 MHz, CDCl3) δ 10.37 (s, 1H, 
CHO), 7.48 (dd, J = 3.1, 1.7 Hz, 1H, O=CC=CHCH=CH), 7.21 (dd, J = 3.7, 1.7 Hz, 1H, 
O=CC=CHCH=CH), 6.31 (t, J = 3.4 Hz, 1H, O=CC=CHCH=CH), 4.56 – 4.49 (m, 2H, 
OCH2CH2(SiCH3)3 ), 1.24 – 1.16 (m, 2H, OCH2CH2(SiCH3)3), 0.10 (s, 9H, 
OCH2CH2(SiCH3)3);  13C NMR (126 MHz, CDCl3) δ 182.44, 150.20, 135.07, 127.17, 
121.48, 112.33, 67.45, 17.81, -1.40;  IR (neat film) 2956 (m), 2901 (w), 1753 (s), 1670 
(s), 1546 (m), 1444 (s), 1386 (m), 1338 (m), 1294 (s), 1248 (s), 1129 (s),1063 (s), 860 (s), 
839 (s), 751 (s) cm-1;  LRMS (ESI) m/z for C11H17O3NSi, (M+Na)+ 261.98. 
 
 
 
1-((2-(trimethylsilyl)ethoxy)carbonyl)-1H-pyrrole-2-carboxylic acid (300), (MSB-VI-
258).  To a solution of 2-(trimethylsilyl)ethyl 2-formyl-pyrrole-1-carboxylate (299) 
(2.185 g, 9.1 mmol, 1.0 equiv) in tert-butanol (36 mL) and water (9 mL) was added 
potassium phosphate (6.22 g, 45.7 mmol, 5 equiv), trans-2-methyl-butene (5.0 mL), and 
sodium chlorite (4.1 g, 45.7 mmol, 5 equiv).  After stirring for 3 hr the solution was 
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diluted with water (400 mL) and pH 6.0 buffer (100 mL), extracted with ethyl acetate 
(4 x 100 mL), dried (magnesium sulfate), and concentrated in vacuo to afford a yellow oil 
that solidified to afford pyrrole 300 (2.25 g, 97%) as an light tan solid.   
Rf  0.13 (3:1 hexanes: ethyl acetate w/ 0.5% acetic acid); 1H NMR (500 MHz, CDCl3) δ 
12.87 (br s, 1H, CO2H), 7.50 – 7.42 (m, 2H, O=CC=CHCH=CH), 6.33 (t, J = 3.5 Hz, 1H, 
O=CC=CHCH=CH), 4.63 – 4.54 (m, 2H, OCH2CH2(SiCH3)3), 1.26 – 1.18 (m, 2H, 
OCH2CH2(SiCH3)3), 0.11 (s, 9H, OCH2CH2(SiCH3)3);  13C NMR (126 MHz, CDCl3) δ 
159.69, 153.27, 127.99, 127.48, 126.67, 112.30, 69.19, 17.67, -1.44;  IR (neat film) 
3134 (w), 3055 (br), 2955 (m), 2901 (w), 1770 (s), 1697 (s), 1548 (m), 1456 (s), 1420 (s), 
1387 (m), 1339 (m), 1306 (s), 1285 (s), 1251 (m), 1178 (s), 1103 (s), 1063 (s), 860 (s), 
839 (s), 750 (s) cm-1;  LRMS (ESI) m/z for C11H17O4NSi, (M+Na)+ 278.03, (M-H)- 
254.03. 
 
 
 
2-(trimethylsilyl)ethyl 2-(chlorocarbonyl)-1H-pyrrole-1-carboxylate (301), (MSB-
VI-258).  To a solution of 1-((2-(trimethylsilyl)ethoxy)carbonyl)-1H-pyrrole-2-
carboxylic acid (300) (271 mg, 1.06 mmol, 1.0 equiv) in dichloromethane (11 mL) was 
added oxalyl chloride (140 µL, 1.59 mmol, 1.5 equiv) and dimethylformamide (2 drops), 
at which point the solution began to effervesce.  After stirring for 1hr the solution was 
diluted with saturated sodium bicarbonate (25 mL), extracted with dichloromethane  
(3 x 25 mL), dried (magnesium sulfate), and concentrated in vacuo to afford acyl chloride 
301 (271 mg, 94%) as brown oil in > 95% purity.   
Rf  0.81 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.18 (dd, J = 3.0, 1.7 
Hz, 1H, O=CC=CHCH=CH), 6.99 (dd, J = 3.8, 1.7 Hz, 1H, O=CC=CHCH=CH), 5.62 (t, 
J = 3.4 Hz, 1H, O=CC=CHCH=CH), 4.20 – 4.12 (m, 2H, OCH2CH2(SiCH3)3), 0.91 – 
0.83 (m, 2H, OCH2CH2(SiCH3)3), -0.19 (s, 9H, OCH2CH2(SiCH3)3);  13C NMR 
(126 MHz, C6D6) δ 155.68, 149.59, 131.47, 129.76, 127.35, 111.24, 67.75, 17.12, -1.84;  
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IR (neat film) 2956 (w), 1781 (s), 1760 (s), 1437 (m), 1412 (m), 1300 (s), 1278 (s), 
1250 (m), 1144 (s), 860 (s), 840 (s), 793 (s), 762 (s) cm-1. 
 
 
 
trans-Fused Z-vinylogous imide 292, trans-fused E-vinylogous imide 302, cis-fused 
E-vinylogous imide 303, and cis-fused E-vinylogous carbamate 304, (MSB-VII-109).  
To a vinylogous carbamate 287 (640 mg, 2.72  mmol, 1.0 equiv) in dichloromethane (30 
mL) at 0 °C  was added tri-tert-butylpyridine (1.16 g, 1.34 mmol, 2.0 equiv), acyl 
chloride 301 (1.21 g, 4.4 mmol, 1.6 equiv) and silver trifluoromethylsulfonate (967 mg, 
3.8 mmol, 1.4 equiv), at which point a white precipitate began to form.  After stirring for 
75 min the solution was filtered through celite to afford a cloudy solution which was 
diluted with saturated sodium bicarbonate (60 mL) and extracted with dichloromethane 
(2 x 50 mL).  The organic layer was then washed with 0.1 N hydrochloric acid (80 mL), 
dried (sodium sulfate), diluted with triethylamine (2 mL) and concentrated in vacuo.  The 
resulting residue was purified by silica gel flash chromatography (8:1 gradient to 4:1 
hexanes: ethyl acetate all w/ 2% triethylamine) to afford vinylogous imide 292 (558 mg, 
44%) as a yellow solid in addition to recovered vinylogous amide 287 (113 mg, 18%) as 
a yellow solid and a mixture of 287, 302, 303, and 304 (171 mg, ~27%) as a yellow oil. 
trans-fused Z-vinylogous imide 292.  Rf  0.45 (2:1 hexanes: ethyl acetate);  1H NMR 
(500 MHz, CDCl3) δ 7.21 (dd, J = 1.5, 3.3 Hz, 1H, O=CC=CHCH=CH), 6.49 (dd, J = 
3.2, 1.5 Hz, 1H, O=CC=CHCH=CH), 6.16 (t, J = 3.3 Hz, 1H, O=CC=CHCH=CH), 5.89 
(ddd, J = 16.3, 11.0, 5.8 Hz, 1H, CH2CH=CH2), 5.33 – 5.23 (m, J = 9.4 Hz, 2H, 
CH2CH=CH2), 5.17 (d, J = 10.4 Hz, 1H, NC=CHCO2, CH2CH=CH2), 4.55 – 4.48 (m, J = 
10.5, 6.3 Hz, 2H, CH2CH=CH2), 4.48 – 4.31 (m, 2H, OCH2CH2(SiCH3)3), 3.86 (dd, J = 
9.3, 6.8 Hz, 1H, CH2CHCH2N), 3.33 (dd, J = 10.6, 9.8 Hz, 1H, CH2CHCH2N), 2.67 (tdd, 
J = 11.5, 6.3, 1.6 Hz, 1H, CH2CH), 2.27 – 2.13 (m, 1H, CH2CHCH2N), 1.65 – 1.56 (m, 
2H, CH2CHCHCH2), 1.26 (m, 2H, CH2CHCHCH2), 1.15 – 1.06 (m, 8H, CH3, CH3, 
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OCH2CH2(SiCH3)3), 0.06 (s, 9H, OCH2CH2(SiCH3)3);  13C NMR (126 MHz, CDCl3) δ 
165.54, 162.45, 150.82, 149.80, 132.97, 128.81, 122.75, 117.92, 116.28, 111.13, 99.99, 
66.79, 64.80, 54.98, 53.64, 46.29, 45.30, 41.72, 39.21, 32.07, 31.94, 17.69, -1.42;  IR 
(neat film) 2952 (m), 2895 (w), 2866 (w), 2096 (w), 1748 (s), 1720 (s), 1644 (m), 1467 
(m), 1412 (m), 1354 (m), 1307 (s), 1251 (m), 1137 (m), 1052 (m), 860 (m), 839 (m), 743 
(m) cm-1;  LRMS (ESI) m/z for C25H36O5N2Si, (M-H)- 471.08, (M+H)+ 473.06, (M+Na)+ 
495.15. 
trans-fused E-vinylogous imide 302.  Rf  0.63 (2:1 hexanes: ethyl acetate);  1H NMR 
(500 MHz, CDCl3) δ 7.21 (dd, J = 3.0, 1.4 Hz, 1H, O=CC=CHCH=CH), 6.74 – 6.40 (br 
s, 1H, C(N)=CHCO2), 6.36 (d, J = 1.8 Hz, 1H, O=CC=CHCH=CH), 6.19 (t, J = 3.3 Hz, 
1H, O=CC=CHCH=CH), 5.89 (ddd, J = 22.5, 10.7, 5.5 Hz, 1H, CH2CH=CH2), 5.26 (dd, 
1H, J = 17.2, 1.2 Hz, CH2CH=CH2), 5.16 (dd, J = 10.5, 1.1 Hz, 1H, CH2CH=CH2), 4.53 
(br d, J = 4.5 Hz, 2H, CH2CH=CH2), 4.42 – 4.32 (m, 2H, OCH2CH2(SiCH3)3), 3.60 (br s, 
1H, CH2CHCH2N), 3.15 (dd, J = 10.1, 10.8 Hz, 1H, CH2CHCH2N), 2.85 – 2.73 (m, 1H, 
CH2CHCH2N), 2.23 (dd, J = 12.6, 6.0 Hz, 1H, CH2CH), 2.15 – 2.04 (m, 1H, CH2CH), 
1.50 (dd, J = 11.7, 6.0 Hz, 1H, CH2CHCHCH2), 1.31 (t, J = 12.0 Hz, 1H, CH2CH), 1.16 
(t, J = 12.0 Hz, 1H, CH2CHCHCH2), 1.10 (s, 3H, CH3), 1.09 – 1.05 (m, 2H, 
OCH2CH2(SiCH3)3), 1.05 (s, 3H, CH3), 0.03 (s, 9H, OCH2CH2(SiCH3)3);  13C NMR (126 
MHz, CDCl3) δ 166.95, 163.35, 155.45, 149.63, 132.79, 128.71, 121.57, 117.37, 114.20, 
111.51, 100.40, 67.00, 64.35, 55.51, 52.60, 47.25, 43.41, 42.18, 40.69, 31.96, 31.85, 
17.59, -1.52;  IR (neat film) 2950 (m), 2895 (w), 2866 (w), 1752 (s), 1718 (s), 1685 (s), 
1624 (s), 1459 (m), 1408 (s), 1356 (s), 1321 (s), 1278 (s), 1112 (s), 1057 (m), 858 (s), 
840 (s), 733 (m) cm-1;  LRMS (ESI) m/z for C25H36O5N2Si, (M-H)- 471.44, (M+H)+ 
473.27, (M+Na)+ 495.33. 
cis-fused E-vinylogous imide 303.  Rf  0.53 (2:1 hexanes: ethyl acetate);  1H NMR (500 
MHz, CDCl3) δ 7.28 – 7.23 (m, 1H, O=CC=CHCH=CH), 6.45 – 6.35 (m, 1H, 
O=CC=CHCH=CH), 6.25 – 6.19 (dd, J = 1.3, 3.5 Hz, 1H, O=CC=CHCH=CH), 6.14 (br 
s, 1H, C(N)=CHCO2), 5.90 (tt, J = 6.6, 5.4 Hz, 1H, CH2CH=CH2), 5.27 (dt, J = 17.1, 1.3 
Hz, 1H, CH2CH=CH2), 5.18 (dt, J = 10.4, 1.3 Hz, 1H, CH2CH=CH2), 4.61 – 4.51 (m, 2H, 
CH2CH=CH2), 4.42 – 4.35 (m, 2H, OCH2CH2(SiCH3)3), 4.15 (q, J = 9.1 Hz, 1H, 
CH2CH), 3.74 (dd, J = 9.4, 10.5 Hz, 1H, CH2CHCH2N), 3.45 (dd, J = 10.8, 4.3 Hz, 1H, 
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CH2CHCH2N), 2.74 (td, J = 8.5, 4.9 Hz, 1H, CH2CHCH2N), 2.34 (dd, J = 7.8, 12.8 Hz, 
1H, CH2), 1.77 (dd, J = 12.7, 8.0 Hz, 1H, CH2), 1.39 (dd, J = 12.6, 9.5 Hz, 1H, CH2), 
1.31 (dd, J = 12.8, 7.8 Hz, 1H, CH2), 1.13 – 1.04 (m, 5H, OCH2CH2(SiCH3)3, CH2), 0.99 
(s, 3H, CH3), 0.04 (s, 9H, OCH2CH2(SiCH3)3);  LRMS (ESI) m/z for C25H36O5N2Si, (M-
H)- 471.49, (M+H)+ 473.19, (M+Na)+ 495.29. 
cis-fused E-vinylogous carbamate 304.  Rf  0.65 (2:1 hexanes: ethyl acetate);  1H NMR 
(500 MHz, CDCl3) δ 7.82 (br s, 1H, NH), 5.96 (ddt, J = 17.2, 10.6, 5.6 Hz, 1H, 
CH2CH=CH2), 5.30 (dq, J = 17.2, 1.6 Hz, 1H, CH2CH=CH2), 5.18 (dq, J = 10.4, 1.4 Hz, 
1H, CH2CH=CH2), 4.56 (br d, J = 5.5 Hz, 2H, CH2CH=CH2), 4.46 (s, 1H, 
C(N)=CHCO2), 3.70 (dd, J = 10.2, 8.2 Hz, 1H, CH2CHCH2N), 3.32 – 3.25 (m, 2H, 
CH2CHCH2N, CH2CH), 2.91 – 2.80 (m, 1H, CH2CHCH2N), 1.88 (ddd, J = 12.9, 9.4, 1.8 
Hz, 1H, CH2CH), 1.76 (ddd, J = 12.5, 8.0, 1.8 Hz, 1H, CH2CHCH2N), 1.50 (dd, J = 12.7, 
7.0 Hz, 1H, CH2CHCH2N), 1.25 (dd, J = 12.6, 9.7 Hz, 1H, CH2CH), 1.04 (s, 3H, CH3), 
0.97 (s, 3H, CH3);  LRMS (ESI) m/z for C14H21NO2, (M-H)- 234.24, (M+H)+ 236.07, 
(M+Na)+ 258.07. 
 
  
 
Z-vinylogous carbamic acid 306, (MSB-VI-242).  To a solution of vinylogous imide 
292 (236 mg, 0.5  mmol, 1.0 equiv) in tetrahydrofuran (5 mL) was added a prepared 1:1 
mixture of formic acid and triethylamine in a solution of tetrahydrofuran (1.0 M, 
1.5 mmol, 3.0 equiv), and tetrakis(triphenylphosphine)palladium (58 mg, 0.05 mmol, 
0.1 equiv).  After stirring for 15 hr the solution was concentrated in vacuo.  The resulting 
residue was purified by silica gel flash chromatography (20:1 dichloromethane: 
methanol) to afford vinylogous carbamic acid 306 (176 mg, 82%) as a yellow solid.  
Rf  0.16 (20:1 dichloromethane: methanol);  1H NMR (500 MHz, CDCl3) δ 7.23 (dd, J = 
3.2, 1.6 Hz, 1H, O=CC=CHCH=CH), 6.49 (dd, J = 3.4, 1.5 Hz, 1H, O=CC=CHCH=CH), 
6.17 (t, J = 3.3 Hz, 1H, O=CC=CHCH=CH), 5.24 (d, J = 1.7 Hz, 1H, NC=CHCO2), 4.49 
– 4.31 (m, 2H, OCH2CH2Si(CH3)3), 3.88 (dd, J = 9.5, 6.7 Hz, 1H, CH2CHCH2N), 3.35 
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(dd, J = 9.8, 10.8 Hz, 1H, CH2CHCH2N), 2.73 – 2.64 (m, 1H, CH2CH), 2.23 – 2.11 (m, 
1H, CH2CHCH2N), 1.65 – 1.58 (m, 2H, CH2CHCHCH2), 1.30 (t, J = 11.8 Hz, 1H, 
CH2CH), 1.25 (t, J = 11.7 Hz, 1H, CH2CHCH2N), 1.16 - 1.08 (m, 8H, 
OCH2CH2Si(CH3)3), CH3, CH3), 0.07 (s, 9H, OCH2CH2Si(CH3)3);  LRMS (ESI) m/z for 
C22H32N2O5Si, (M-H)- 430.87. 
 
 
 
Vinyl bromide 307 vinyl bromide 305, (MSB-VII-054).  To a solution of vinylogous 
carbamic acid 306 (154 mg, 0.35  mmol, 1.0 equiv) in dimethylformamide (4 mL) was 
added potassium carbonate (147 mg, 1.07 mmol, 3.0 equiv) and N-bromosuccinimde 
(68.5 mg, 0.385 mmol, 1.1 equiv).  After stirring for 15 min the complete conversion of 
306 to the two geometric isomers of vinyl bromide 307 was determined by TLC analysis.   
(MSB-VII-055).  To this solution of vinyl bromides 307 was added 4Å molecular sieves 
(50 mg) and a solution of tetrabutylammonium fluoride (1.0 M in tetrahydrofuran, 
384 µL, 0.385 mmol, 1.1 equiv).  After stirring for 10 min the solution was diluted with 
ethyl acetate (25 mL), washed with water (3 x 25 mL), brine (1 x 25 mL), dried (sodium 
sulfate), and concentrated in vacuo.  The resulting residue was purified by silica gel flash 
chromatography (2:1 hexanes: ethyl acetate) to afford vinyl bromide 305 (79.7 mg, 71%) 
its E-geometric isomer (18 mg, 16%) as white solids.  (note: regardless of the duration 
used to remove solvent post purification, ethyl acetate would remain in the sample of 305 
(~ 33 mol %))  
Pyrrole 305.  Rf  0.37 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 9.42 
(s, 1H, NH), 6.96 (br s, 1H, O=CC=CHCH=CH), 6.73 (br s, 1H, O=CC=CHCH=CH), 
6.27 (q, J = 2.9 Hz, 1H, O=CC=CHCH=CH), 5.64 (br s, 1H, NC=CHBr), 4.20 (dd, J = 
7.7, 8.2 Hz, 1H, CH2CHCH2N), 3.49 (dd, J = 10.3, 9.7 Hz, 1H, CH2CHCH2N), 2.54 – 
2.43 (m, 1H, CH2CH), 2.26 – 2.11 (m, 1H, CH2CHCH2N), 1.65 (m, 2H, CH2CHCHCH2), 
1.31 (t, J = 11.6 Hz, 1H, CH2CH), 1.24 (t, J = 12.0 Hz, 1H, CH2CHCH2N), 1.16 (s, 3H, 
CH3), 1.14 (s, 3H, CH3);  13C NMR (126 MHz, CDCl3) δ 160.59, 144.73, 125.49, 122.77, 
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113.64, 109.83, 88.08, 54.59, 53.49, 47.85, 45.48, 41.67, 39.18, 32.03, 31.89;  IR (neat 
film)  3272 (br), 2951 (m), 2928 (w), 2865 (m), 1659 (w), 1611 (s), 1545 (w), 1407 (s), 
1357 (s), 1214 (w), 1134 (w), 1104 (w), 1053 (w), 769 (m), 738 (s) cm-1; LRMS (ESI) 
m/z for C15H19N2BrO, (M-H)- 321.00, (M+Na)+ 345.13. 
Vinyl bromide 307, (MSB-VII-054).  In a separate reaction using the same procedure as 
above on 306 (14.5 mg), the solution was concentrated in vacuo and resulting residue was 
purified by silica gel flash chromatography (6:1 hexanes: ethyl acetate) to afford vinyl 
bromide 307 (7.8 mg, 50%) and its E-geometric isomer (1.0 mg, 6%) as white solids.   
Rf  0.6 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.28 (dd, J = 3.1, 1.5 
Hz, 1H, O=CC=CHCH=CH), 6.48 (d, J = 1.8 Hz, 1H, O=CC=CHCH=CH), 6.16 (t, J = 
3.3 Hz, 1H, O=CC=CHCH=CH), 5.49 (s, 1H, NC=CHBr), 4.46 (td, J = 10.3, 8.2 Hz, 1H, 
OCH2CH2Si(CH3)3), 4.38 (dt, J = 18.6, 9.4 Hz, 1H, OCH2CH2Si(CH3)3), 3.88 (dd, J = 
7.4, 9.4 Hz, 1H, CH2CHCH2N ), 3.35 (t, J = 10.5 Hz, 1H, CH2CHCH2N), 2.56 (td, J = 
11.5, 6.2 Hz, 1H, CH2CH), 2.20 – 1.98 (m, 1H, CH2CHCH2N), 1.61 (m, 2H, 
CH2CHCHCH2), 1.33 – 1.19 (m, 2H, CH2CHCHCH2), 1.17 – 1.11 (m, 8H, CH3, CH3 
OCH2CH2Si(CH3)3), 0.06 (s, J = 3.1 Hz, 8H, OCH2CH2Si(CH3)3);  13C NMR (126 MHz, 
CDCl3) δ 161.28, 149.92, 144.23, 129.09, 123.67, 116.66, 110.96, 87.16, 66.74, 55.39, 
52.68, 47.16, 45.49, 41.74, 39.45, 32.16, 32.02, 17.71, -1.38;  IR (neat film)  2952 (m), 
2894 (w), 2865 (w), 1747 (s), 1649 (m), 1453 (m), 1413 (m), 1362 (m), 1308 (s), 1250 
(m), 1103 (w), 1056 (w), 933 (w), 860 (m), 839 (m), 768 (m), 738 (m) cm-1; LRMS (ESI) 
m/z for C21H31N2BrO3Si, (M+H)+ 467.22, (M+Na)+ 489.17. 
 
 
 
Pyrazinone 246, (MSB-VII-056).  To a solution of vinyl bromide 305 (79 mg, 
0.245 mmol, 1.0 equiv) in tetrahydrofuran (2.5 mL) was added a solution of lithium tert-
butoxide (1.0 M in tetrahydrofuran, 0.27 mL, 0.27 mmol, 1.1 equiv), at which point the 
solution turned cloudy and peach colored.  After 20 min additional tetrahydrofuran 
(3 mL) was added, but the solution did not clear up.  After 25 min 
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bis(dibenzylideneacetone)palladium (13.2 mg, 0.0229 mmol, 0.1 equiv) and a solution of 
tri-tert-butylphosphine (1.0 M in toluene, 46 µL, 0.046 mmol, 0.2 equiv) at which point 
the solution turned cloudy brown.  The vessel was then capped and heated up to 80 °C.  
Over the course of 10 min the solution became red and transparent.  After stirring for 
11 hr additional lithium tert-butoxide (1.0 M in tetrahydrofuran, 0.135 mL, 0.13 mmol, 
0.5 equiv), bis(dibenzylideneacetone)palladium (16 mg, 0.025 mmol, 0.13 equiv) and tri-
tert-butylphosphine (1.0 M in toluene, 56 µL, 0.056 mmol, 0.25 equiv) was added and the 
reaction was stirred at 80 °C,  After 7 hr the solution was cooled and filtered through 
celite with ethyl acetate and concentrated in vacuo to afford a red oil.  The residue was 
purified via silica gel chromatography (1:1 hexanes: ethyl acetate) to afford pyrazinone 
246 (46.8 mg, 79%) as an orange solid.  
Rf  0.33 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.05 (d, J = 3.7 Hz, 
1H, O=CC=CHCH=CH), 7.03 (br s, 1H, O=CC=CHCH=CH), 6.81 (br s, 1H, CC(N)H), 
6.51 (apt t, J = 3.3 Hz, 1H, O=CC=CHCH=CH), 4.33 (dd, J = 10.9, 6.3 Hz, 1H, 
CH2CHCH2N), 3.31 (t, J = 11.0 Hz, 1H, CH2CHCH2N), 3.02 – 2.90 (m, 1H, CH2CH), 
2.31 – 2.15 (m, 1H, CH2CHCH2N), 1.79 (dd, J = 11.6, 6.3 Hz, 1H, CH2CH), 1.69 (dd, J = 
11.8, 6.1 Hz, 1H, CH2CHCH2N), 1.45 – 1.32 (m, 2H, CH2CHCHCH2), 1.20 (s, 3H, CH3), 
1.17 (s, 3H, CH3);  13C NMR (126 MHz, CDCl3) δ 155.54, 130.50, 124.15, 118.17, 
111.98, 109.31, 102.11, 52.12, 50.05, 47.49, 45.47, 40.75, 39.71, 31.94, 31.93;  IR (neat 
film) 3109 (m), 2932 (m), 2863 (w), 1696 (w), 1628 (s), 1466 (w), 1383 (w), 1262 (w), 
751 (s), 738 (s) cm-1;  LRMS (ESI) m/z for C15H18ON2, (M+H)+ 243.31, (M+Na)+ 
265.19. 
 
 
 
α-Daizo ester 289, (MSB-VIII-245).  To a solution of azide 286 (715 mg, 2.72 mmol, 
1.0 equiv) in toluene (10 mL) was added silica gel (200 mg, 25% weight percent), and 
then heated up to 80 °C.  After stirring for 23 hr the solution was cooled, filtered through 
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celite and concentrated in vacuo to afford a 1:1 mixture of azide 286 and α-diazo ester 
289 by 1H NMR.  The residue was purified via silica gel chromatography (4:1 hexanes: 
ethyl acetate w/ 2% triethylamine gradient to 100% ethyl acetate) to afford α-diazo ester 
289 (235 mg, 33%, with a regular unknown 15% impurity) as a yellow oil and recovered 
azide 286 (286 mg, 40%).  All spectra matched that previously reported. 
 
 
 
Pyrrole amide 312, (MSB-VIII-263).  To a solution of α-diazo ester 289 (5.8 mg, 
0.022 mmol, 1.0 equiv) in dichloromethane was added 2,6-lutidine (6.64 µL, 
0.044 mmol, 2.0 equiv), pyrrole acid 311 (9.0 mg, 0.035 mmol, 1.6 equiv), and (2-(7-aza-
1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) 
(12.5 mg, 0.033 mmol, 1.5 equiv) was added.  After 2 hr the solution was diluted with 
saturated sodium bicarbonate (10 mL), extracted with dichloromethane (2 x 10 mL), 
dried (sodium sulfate), concentrated in vacuo. The residue was purified twice by silica 
gel flash chromatography (4:1 gradient to 2:1 hexanes: ethyl acetate) pyrrole amide 312 
(3.3 mg, 30%) as a clear oil.   
Rf  0.63 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 6.51 (s, 1H, CHCBr), 
6.22 (d, J = 10.2 Hz, 1H, NCH2O), 5.61 (m, 1H, CH2CH=CH2), 5.21 (d, J = 10.3 Hz, 1H, 
NCH2O), 5.05 (d, J = 17.2 Hz, 1H, CH2CH=CH2), 4.89 (d, J = 10.4 Hz, 1H, 
CH2CH=CH2), 4.49 – 4.38 (m, 2H, CH2CH=CH2), 4.33 (d, J = 10.6 Hz, 1H, 
CH2CHCHN), 3.58 – 3.45 (m, 2H, OCH2CH2Si(CH3)3), 3.31 (br s, 1H, CH2CHCH2N), 
2.86 (t, J = 9.9 Hz, 1H, CH2CHCH2N), 2.61 (br s, 1H, CH2CHCHN), 1.49 (m, 1H, 
CH2CHCH2N), 1.42 (dd, J = 11.7, 6.4 Hz, 1H, CH2CHCHN), 1.17 (dd, J = 11.7, 6.2 Hz, 
1H, CH2CHCH2N), 0.95 (s, 3H, CH3), 0.90 (s, 3H, CH3), 0.89 – 0.77 (m, 4H, 
CH2CHCHN, CH2CHCH2N, OCH2CH2Si(CH3)3), -0.09 (s, 9H, OCH2CH2Si(CH3)3);   
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  IR (neat film) 2951 (s), 2866 (m), 2105 (s), 1696 (s), 1625 (m), 1435 (s), 1374 (m), 
1308 (m), 1275 (m), 1248 (m), 1130 (m), 1097 (s), 859 (m), 837 (m), 744 (w) cm-1;  
LRMS (ESI) m/z for C25H36O4N4Br2Si, (M+Na)+ 665.1, (M+Cl)- 677.2. 
 
 
 
Keto ester 313, (MSB-IX-034).  To a solution of sodium carbonate (20.9 mg, 
0.248 mmol, 10 equiv) in acetone (0.5 mL) and water (0.25 ml) at 0 °C was added oxone 
(76 mg, 0.124 mmol, 5 equiv).  After 4 min α-diazo ester 312 (16.0 mg, 0.025 mmol, 
1.0 equiv) was added in a solution of dichloromethane (1.0 mL) and stirred vigorously.  
After 3 min the solution was warmed to room temperature.  After 45 min the solution was 
diluted with water (10 mL), extracted with dichloromethane (3 x 10 mL), dried (sodium 
sulfate), concentrated in vacuo to afford keto ester 313 (13.6 mg, 87%) as a clear oil in 
>95% purity.   
Rf  0.52 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 6.48 (s, 1H, CHCBr), 
6.11 (d, J = 10.4 Hz, 1H, NCH2O), 5.62 (ddd, J = 22.7, 10.9, 5.6 Hz, 1H, CH2CH=CH2), 
5.21 (d, J = 10.4 Hz, 1H, NCH2O), 5.15 (dd, J = 17.2, 1.2 Hz, 1H, CH2CH=CH2), 4.92 
(d, J = 10.5 Hz, 1H, CH2CH=CH2), 4.89 (d, J = 10.7 Hz, 1H, CH2CHCHN), 4.51 – 4.38 
(m, 2H, CH2CH=CH2), 3.55 – 3.43 (m, 2H, OCH2CH2Si(CH3)3), 3.23 (dd, J = 9.1, 
6.6 Hz, 1H, CH2CHCH2N), 2.78 (dd, J = 10.6, 9.7 Hz, 1H, CH2CHCH2N), 2.10 (qd, J = 
12.1, 6.6 Hz, 1H, CH2CHCHN), 1.61 – 1.49 (m, 1H, CH2CHCH2N), 1.40 (dd, J = 12.0, 
6.4 Hz, 1H, CH2CHCHN), 1.15 (dd, J = 11.8, 6.3 Hz, 1H, CH2CHCH2N), 1.08 (t, J = 
12.1 Hz, 1H, CH2CHCHN), 0.87 (s, 3H, CH3), 0.86 (s, 3H, CH3), 0.84 – 0.77 (m, 3H, 
CH2CHCH2N, OCH2CH2Si(CH3)3), -0.09 (s, 9H, OCH2CH2Si(CH3)3);  13C NMR (126 
MHz, C6D6) δ 190.05, 161.42, 160.05, 131.41, 127.16, 118.74, 117.23, 111.32, 99.92, 
75.66, 66.34, 66.25, 64.30, 53.16, 52.30, 50.65, 44.70, 40.74, 40.48, 31.82, 31.67, 18.01, 
-1.32;  IR (neat film) 2953 (m), 2920 (m), 2850 (w), 1732 (s), 1617 (m), 1437 (s), 1263 
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(s), 1093 (s), 1052 (m), 860 (m), 837 (m), 799 (m), 741 (s) cm-1;  LRMS (ESI) m/z for 
C25H36O5N2Br2Si, (M-H)- 629.3, (M+Cl)- 665.1, (M+Na)+ 653.2. 
 
 
 
Diol 368, (MSB-IX-039).  To a solution of keto ester 313 (5.0 mg, 0.0008 mmol, 
1.0 equiv) in isopropyl alcohol (1.0 mL) was added sodium borohydride (1 mg, 
0.026 mmol, 3 equiv).  After stirring for 16 hr the solution was diluted with hydrochloric 
acid (0.1 M, 10 mL), extracted with dichloromethane (3 x 10 mL), dried (sodium sulfate), 
and concentrated in vacuo.  The resulting residue was purified by silica gel flash 
chromatography (1:1 hexanes: ethyl acetate) to afford diol 368 (6.4 mg, 140%) as a clear 
oil. 
Rf  0.54 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, C6D6) δ 6.31 (s, 1H, CHCBr), 
6.28 (br s, 1H, CH(OH)CH2OH), 6.00 (d, J = 10.5 Hz, 1H, NCH2O), 5.12 (d, J = 10.4 
Hz, 1H, NCH2O), 3.90 (dd, J = 6.7, 9.0 Hz, 1H, CH2CHCHN), 3.72 – 3.63 (m, 2H, 
CH(OH)CH2OH), 3.51 – 3.40 (m, 3H, CH(OH)CH2OH, OCH2CH2Si(CH3)3 ), 3.30 (dd, J 
= 9.7, 5.2 Hz, 1H, CH2CHCH2N), 2.67 (t, J = 6.4 Hz, 1H, CH(OH)CH2OH), 2.37 (t, J = 
10.2 Hz, 1H, CH2CHCH2N), 1.45 – 1.32 (m, 3H, CH2CH(CH)CH2N), 1.11 (dd, J = 11.8, 
5.2 Hz, 1H, CH2CHCHN), 0.96 (t, J = 13.8 Hz, 1H, CH2CHCH2N), 0.90 (s, 3H, CH3), 
0.87 (s, 3H, CH3), 0.83 – 0.77 (m, 2H, OCH2CH2Si(CH3)3), 0.69 (t, J = 11.4 Hz, 1H, 
CH2CHCHN), -0.10 (s, 9H, OCH2CH2Si(CH3)3);  IR (neat film) 3369 (br), 2950 (s), 2923 
(s), 2864 (m), 1606 (s), 1438 (s), 1249 (m), 1094 (s), 859 (m), 837 (m) cm-1;  LRMS 
(ESI) m/z for C22H36O4N2Br2Si, (M-H)- 577.2, (M+Cl)- 613.1, (M+H)+ 579.0, (M+Na)+ 
601.3. 
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Pyrrole 314, (MSB-IX-046).  To a solution of diol 368 (6.5 mg, 0.011 mmol, 1.0 equiv) 
in tetrahydrofuran (0.5 mL) was added a solution of tetrabutylammonium fluoride (1.0 M 
in tetrahydrofuran, 20 µL, 0.067 mmol, 6 equiv), capped and heated up to 65 °C.  After 
stirring for 12 hr the solution was cooled, diluted with ethyl acetate (10 mL), washed with 
water (3 x 10 mL), dried (sodium sulfate), filtered, and concentrated in vacuo.  The 
resulting residue was purified by silica gel flash chromatography (1:1 gradient to 2:1 
ethyl acetate: hexanes) to afford pyrrole 314 (4.3 mg, 85% over two steps) as a clear film.  
Rf  0.54 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, C6D6) δ 9.79 (br s, 1H, NH), 
6.85 (br s, 1H, OH), 6.19 (s, 1H, CHCBr), 3.82 – 3.69 (m, 2H, CHCH(OH)CH2OH), 3.64 
(br s, 1H, CH(OH)CH2OH), 3.51 (dd, J = 10.7, 4.5 Hz, 1H, CH(OH)CH2OH), 3.11 (dd, J 
= 8.1, 6.5 Hz, 1H, CH2CHCH2N), 2.85 (br s, 1H, OH), 2.28 (t, J = 9.9 Hz, 1H, 
CH2CHCH2N), 1.40 (dd, J = 12.0, 6.2 Hz, 1H, CH2CHCHN) 1.34 – 1.25 (m, 1H, 
CH2CHCHN), 1.20 – 1.07 (m, 2H, CH2CHCH2N), 0.95 (t, J = 11.9 Hz, 1H, 
CH2CHCHN), 0.91 (s, 3H, CH3), 0.88 (s, 3H, CH3), 0.68 (t, J = 11.3 Hz, 1H, 
CH2CHCH2N);  IR (neat film) 3390 (br), 3053 (w), 2955 (m), 2925 (m), 2851 (w), 1591 
(w), 1440 (m), 1264 (s), 1090 (w), 747 (s) cm-1;  LRMS (ESI) m/z for C16H22O3N2Br2, 
(M-H)- 447.0, (M+Na)+ 471.0. 
 
 
 
Hemiaminal 309, (MSB-IX-048).  To a solution of diol 314 (4.3 mg, 0.001 mmol, 
1.0 equiv) in tetrahydrofuran (0.4 mL) and water (0.13 mL) was added sodium periodate 
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(8.2 mg, 0.038 mmol, 4.0 equiv).  After stirring for 12 hr the solution was diluted with 
saturated sodium thiosulfate (10 mL), extracted with ethyl acetate (3 x 10 mL), dried 
(sodium sulfate), and concentrated in vacuo to afford hemiaminal 309 (2.0 mg, 50%) as a 
white solid in greater than 95% purity.   
Rf  0.27 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, C6D6) δ 7.44 – 7.34 (m, 1H, 
COH), 6.89 (s, 1H, HC=CBr), 5.40 (dd, 1H, CHCH(N)OH), 3.66 (dd, J = 10.1, 7.0 Hz, 
1H, CH2CHCH2N), 3.03 (t, J = 10.2 Hz, 1H, CH2CHCH2N), 2.56 (dd, J = 10.6, 2.7 Hz, 
1H, CHCH(N)OH), 2.38 (dd, J = 10.9, 6.4 Hz, 1H, CH2CH), 1.43 – 1.34 (m, 1H, 
CH2CHCH2N), 1.30 (dd, J = 11.7, 6.4 Hz, 1H, CH2CH), 1.24 (dd, J = 11.5, 6.2 Hz, 1H, 
CH2CHCH2N), 1.03 (t, J = 11.9 Hz, 1H, CH2CHCH2N), 0.90 (d, J = 2.3 Hz, 6H, CH3, 
CH3), 0.65 (t, J = 11.8 Hz, 1H, CH2CH);  IR (neat film)  3132 (br), 2948 (w), 2864 (w), 
1635 (s), 1577 (m), 1541 (m), 1448 (m), 1420 (m), 1335 (w), 1138 (m), 1079 (w), 974 
(m), 741 (s) cm-1;  LRMS (ESI) m/z for C15H18Br2O2N2, (M-H)- 414.79, (M+Cl)- 450.89, 
(M+Na)+ 420.80.  
 
 
 
Dibromopyrazinone 308, (MSB-IX-093).  To a solution of hemiaminal 309 (2.3 mg, 
0.0055 mmol, 1.0 equiv) in pyridine (0.275 mL) at 0 °C was added phosphorus 
oxychloride (1.0 µL, 0.011 mmol, 2.0 equiv).  After stirring for 1 hr the solution was 
warmed to room temperature and additional phosphorus oxychloride (5.0 µL, 
0.055 mmol, 10.0 equiv) was added.  After stirring for 15 hr the solution diluted with 
ethyl acetate (10 mL), washd with 1.0 M hydrochloric acid (3 x 10 mL), dried (sodium 
sulfate), and concentrated in vacuo.  The residue diluted with deuteriobenzene and 1 µL 
of 1,8-diazabicyclo[5.4.0]undec-7-ene, concentrated and purified by silica gel flash 
chromatography (4:1 hexanes: ethyl acetate) to afford dibromopyrazinone 308 (1.0 mg, 
46%) as a white solid.  
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Rf  0.45 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.38 (s, 1H, 
HC=CBr), 6.36 (d, J = 1.8 Hz, 1H, NCH=CN), 3.99 (dd, J = 10.8, 6.3 Hz, 1H, 
CH2CHCH2N), 2.70 (t, J = 11.0 Hz, 1H, CH2CHCH2N), 2.10 (td, J = 11.5, 6.2 Hz, 1H, 
CH2CH), 1.41 – 1.28 (m, 1H, CH2CHCH2N), 1.10 (dd, J = 11.6, 6.3 Hz, 1H, CH2CH), 
1.03 (dd, J = 11.6, 6.0 Hz, 1H, CH2CHCH2N), 0.84 (s, 3H, CH3), 0.83 (s, 3H, CH3), 0.76 
(t, J = 11.7 Hz, 1H, CH2CH), 0.66 (t, J = 12.0 Hz, 1H, CH2CHCH2N);  13C NMR 
(126 MHz, C6D6) δ 153.07, 140.62, 126.13, 111.82, 103.49, 99.56, 88.61, 52.00, 49.17, 
47.31, 44.79, 40.16, 39.04, 31.55, 31.52;  IR (neat film)  2955 (w), 2919 (s), 2851 (m), 
2280 (m), 1656 (w), 1461 (w), 1400 (w), 1329 (w), 1264 (s), 1096 (w), 1017 (m), 812 
(m), 740 (s) cm-1;  LRMS (ESI) m/z for C15H16Br2ON2, (M+Na)+ 420.80, (M+H)+ 
398.80. 
 
 
 
α-Diazo ester 316, (MSB-VIII-142).  To a solution of α-diazo ester 289 (15.7 mg, 
0.06 mmol, 1.0 equiv) in dichloromethane (2.0 mL) at 0 °C was added pyridine (96 µL, 
1.19 mmol, 20 equiv), pyrrole acid 315 (32 mg, 0.119 mmol, 2 equiv), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (34.3 mg, 0.18 mmol, 3 equiv), and 4-
dimethylaminopyridine (0.7 mg, 0.0056 mmol, 0.1 equiv) was added and then warmed to 
room temperature.  After 2 ½ hours the solution was diluted with dichloromethane (10 
mL), washed with saturated sodium bicarbonate (2 x 10 mL), dried (sodium sulfate), 
concentrated in vacuo. The residue was purified by silica gel flash chromatography (4:1 
hexanes: ethyl acetate) to afford pyrrole amide 316 (9.2 mg, 30%) as a clear oil.   
Rf  0.40 (4:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 12.08 (br s, 1H, NH), 
6.29 (s, 1H, CBr=CH), 5.63 (ddd, J = 16.2, 10.9, 5.7 Hz, 1H, CH2CH=CH2), 5.04 (dd, J = 
17.2, 1.4 Hz, 1H, CH2CH=CH2), 4.89 (d, J = 10.4 Hz, 1H, CH2CH=CH2), 4.46 (dd, J = 
13.3, 5.7 Hz, 1H, CH2CH=CH2), 4.41 (dd, J = 13.5, 5.6 Hz, 1H, CH2CH=CH2), 4.21 (d, J 
= 10.6 Hz, 1H, C(N)H), 3.20 (dd, J = 6.7, 5.6 Hz, 1H, CH2CHCH2N), 2.81 (t, J = 9.6 Hz, 
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1H, CH2CHCH2N), 2.64 (br s, 1H, CH2CH), 1.41 (dd, J = 11.7, 6.4 Hz, 1H, CH2CH), 
1.33 – 1.20 (m, 2H, CH2CHCH2N, CH2CH), 1.17 (dd, J = 11.5, 6.2 Hz, 1H, 
CH2CHCH2N), 0.96 (s, 3H, CH3), 0.93 – 0.87 (m, 4H, CH2CH, CH3), 0.83 (t, J = 11.9 
Hz, 1H, CH2CHCH2N);  13C NMR (126 MHz, C6D6) δ 164.95, 160.98, 132.56, 127.00, 
118.28, 118.03, 116.37, 106.67, 99.99, 65.16, 58.13, 52.40, 51.36, 49.31, 44.78, 40.85, 
40.65, 31.92, 31.80;  IR (neat film) 3129 (w), 2951 (m), 2865 (w), 2103 (s), 1693 (s), 
1584 (m), 1442 (s), 1393 (m), 135611 (m), 1272 (m), 1130 (m), 1102 (m), 977 (m), 931 
(w), 750 (m) cm-1;  LRMS (ESI) m/z for C19H22O3N4Br2, (M-H)- 510.68, (M+Na)+ 
534.83. 
 
 
 
Hemiaminal 317 (MSB-IX-070).  To a solution of sodium carbonate (0.82 mg, 
0.097 mmol, 10 equiv) in acetone (0.15 mL) and water (0.075 ml) at 0 °C was added 
oxone (29 mg, 0.0037 mmol, 5 equiv).  After 2 min diazo ester 316 (5.0 mg, 0.00073 
mmol, 1.0 equiv) was added in a solution of dichloromethane (0.15 mL) and stirred 
vigorously and warmed to room temperature.  After 50 min additional sodium carbonate 
(0.82 mg, 0.097 mmol, 10 equiv) and oxone (29 mg, 0.0037 mmol, 5 equiv) were added.  
After 40 min the solution was diluted with acetone (0.1 mL) and dicholoromethane (0.1 
mL) and additional sodium carbonate (0.82 mg, 0.097 mmol, 10 equiv) and oxone (29 
mg, 0.0037 mmol, 5 equiv) were added.  After 40 min the solution was diluted with water 
(10 mL), extracted with dichloromethane (3 x 10 mL), dried (sodium sulfate), 
concentrated in vacuo.  The residue can be purified via silica gel chromatography (1:1 
gradient to 2:1 ethyl acetate: hexanes) to afford hemiaminal 317 as a white solid. 
Rf  0.27 (2:1 hexanes: ethyl acetate);  1H NMR (NMR was very broad) (500 MHz, C6D6) 
δ 7.01 (s, 1H, CHCBr), 5.68 (br s, 1H, CH2CH=CH2), 5.08 (br d, J = 15.6 Hz, 1H, 
CH2CH=CH2), 4.94 (d, J = 10.3 Hz, 1H, CH2CH=CH2), 4.55 (dd, J = 12.9, 6.1 Hz, 1H, 
CH2CH=CH2), 4.39 (br s, 1H, CH2CH=CH2), 3.67 (dd, J = 10.1, 7.1 Hz, 1H, 
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CH2CHCH2N), 3.54 (d, J = 9.4 Hz, 1H, CH2CHCHN), 2.88 (t, J = 10.7 Hz, 1H, 
CH2CHCH2N), 2.43 – 2.28 (m, J = 10.6, 6.6 Hz, 1H, CH2CHCHN), 1.47 (dd, J = 11.5, 
6.4 Hz, 1H, CH2CHCHN), 1.39 – 1.27 (m, 1H, CH2CHCH2N), 1.18 (dd, J = 11.6, 6.1 Hz, 
1H, CH2CHCH2N), 0.94 (t, J = 11.9 Hz, 1H, CH2CHCH2N), 0.89 (m, 6H, CH3, CH3), 
0.80 (t, J = 12.0 Hz, 1H, CH2CHCHN);  IR (neat film) 3132 (m), 2951 (s), 2922 (m), 
2864 (w), 2849 (w), 1742 (m), 1632 (s), 1552 (m), 1445 (m), 1415 (m), 1318 (m), 1253 
(m), 1200 (m), 1179 (m), 982 (w) cm-1;  LRMS (ESI) m/z for C19H22O4N2Br2, (M+H)+ 
500.81, (M+Na)+ 523.0, (M+Cl)+ 535.1. 
 
 
 
C6-Ester pyrazinone 318, (MSB-IX-083).  To a solution of hemiaminal 317 (3.0 mg, 
0.006 mmol, 1.0 equiv) in pyridine (0.6 mL) at 0 °C was added phosphorus oxychloride 
(5.0 µL, 0.055 mmol, 9.0 equiv) and warmed to room temperature.  After stirring for 
15 hr, additional phosphorus oxychloride (10.0 µL, 0.11 mmol, 18 equiv) was added.  
After stirring for 48 hr the solution was diluted with ethyl acetate (10 mL), washd with 
1.0 M hydrochloric acid (3 x 10 mL), dried (sodium sulfate), and concentrated in vacuo.  
The resulting residue was purified by silica gel flash chromatography (4:1 hexanes: ethyl 
acetate) to afford C6-ester dibromopyrazinone 318 (1.9 mg, 66%) as a clear oil.  
Rf  0.60 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.39 (s, 1H, 
HC=CBr), 5.77 (ddt, J = 16.5, 10.4, 6.0 Hz, 1H, CH2CH=CH2), 5.10 (dd, J = 17.2, 
1.4 Hz, 1H, CH2CH=CH2), 4.97 (dd, J = 10.4, 1.1 Hz, 1H, CH2CH=CH2), 4.62 – 4.48 (m, 
2H, CH2CH=CH2), 3.86 (dd, J = 10.8, 6.6 Hz, 1H, CH2CHCH2N), 2.57 (t, J = 11.0 Hz, 
1H, CH2CHCH2N), 2.18 (ddd, J = 13.4, 11.8, 6.2 Hz, 1H, CH2CH), 1.74 (dd, J = 12.0, 
6.6 Hz, 1H, CH2CH), 1.40 – 1.28 (m, 1H, CH2CHCH2N), 1.25 (t, J = 11.9 Hz, 1H, 
CH2CH), 1.01 (dd, J = 11.7, 6.1 Hz, 1H, CH2CHCH2N), 0.86 (s, 3H, CH3), 0.85 (s, 3H, 
CH3), 0.63 (t, J = 12.1 Hz, 1H, CH2CHCH2N);  13C NMR (126 MHz, C6D6) δ 160.86, 
152.54, 136.55, 131.83, 127.08, 119.20, 113.40, 108.22, 106.20, 103.33, 66.44, 53.11, 
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48.23, 47.05, 43.98, 41.22, 39.92, 31.62, 31.57;  IR (neat film)  2946 (w), 2923 (m), 2851 
(m), 1655 (s), 1610 (m), 1462 (w), 1405 (w), 1339 (w), 1265 (s), 1100 (w), 1015 (m), 814 
(m), 740 (s) cm-1;  LRMS (ESI) m/z for C19H20Br2O3N2, (M+H)+ 483.10, (M+Na)+ 
505.84. 
 
 
 
Vinylogous carbamic acid 319, (MSB-IX-112).  To a solution of ally ester 318 (0.8 mg, 
0.0016 mmol, 1.0 equiv) in dichloromethane (0.3 mL) and water (0.05 mL) was added 
bis(triphenylphosphine)palladium(II) dichloride (0.1 mg, 0.00016 mmol, 0.1 equiv).  The 
solution was then deoxygenated through the action of three freeze/pump/thaw cycles.  To 
this solution was added tributyltin hydride (0.6 µL, 0.0024 mmol, 1.5 eq), at which point 
the solution turned pale red.  The solution was stirred for 20 min and the solvent was 
reduce.  To this residue was added and removed portions of acetonitrile (2 x 300 µL) in 
order to remove water.  The resulting residue was purified by silica gel flash 
chromatography (20:1 gradient to 10:1 to 1:1 hexanes: ethyl acetate to 1:1 hexanes: ethyl 
acetate with 1% acetic acid) to afford a mixture of vinylogous carbamic acid 319 and 
tributyltin hydroxide (1.3 mg, 90% yield 319) as a clear oil.  (Note: long exposure of 319 
to silica gel during purification led to a loss of material, likely via the decarboxylation 
observed in Scheme 4.24)   
Rf  0.38 (2:1 hexanes: ethyl acetate with 2% acetic acid);  1H NMR (500 MHz, C6D6) δ 
7.44 (s, 1H, HC=CBr), 3.90 (dd, J = 5.6, 10.6 Hz, 1H, CH2CHCH2N), 2.60 (t, J = 
11.0 Hz, 1H, CH2CHCH2N), 2.42 – 2.30 (m, 1H, CH2CH), 1.96 (dd, J = 1H, CH2CH), 
1.62 – 1.54 (m, 1H, CH2CHCH2N), 1.06 (dd, J = 11.6, 5.9 Hz, 1H, CH2CHCH2N), 0.97 
(s, 3H, CH3), 0.77 (t, J = 7.4 Hz, 1H, CH2CH), 0.69 (t, J = 12.1 Hz, 1H, CH2CHCH2N);  
LRMS (ESI) m/z for C16H16Br2O3N2, (M-CO2H)- 397.02. 
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Dibromopyrazinone 308, (MSB-IX-102).  To a solution of crude vinylogous carbamic 
acid 319 (0.1 mg, 0.0023 mmol, impure with tributyltin hydride) in dichloromethane 
(0.2 mL) was added trifluoroacetic acid (0.1 µL in 10 µL dichloromethane, 0.0013 mmol, 
5 equiv).  After stirring for 16 hr the solution was diluted with saturated sodium 
bicarbonate (1 mL), extracted with ethyl acetate (2 x 1 mL), washed with 0.1 M 
hydrochloric acid (1 x 1 mL), dried (sodium sulfate), and concentrated in vacuo to afford 
dibromopyrazinone 308 in 80% purity as determined by 1H NMR.  All spectra matched 
that previously reported. 
 
 
 
Diazide 322 and allylic azide 323, (MSB-VII-022).  A solution of iodobenzene diacetate 
(13 mg, 0.040 mmol, 4.9 equiv) in dichloromethane (0.2 mL) at -30 °C was added 
trimethylsilyl azide (11.0 µL, 0.083 mmol, 10 equiv).  After 35 min tetraethylammonium 
iodide (10.7 mg, 0.042 mmol, 5 equiv) was added, at which point the solution turned 
yellow and was warmed to room temperature.  After 30 min the solution was cooled 
down to -78 °C, at which point solid pyrazinone 246 (2.0 mg, 0.0083 mmol, 1.0 equiv) 
was added.  The solution was stirred at -78 °C for 18 hr and then slowly warmed to room 
temperature over 2 hr.  After stirring for 1 hr the solution was concentrated in vacuo and 
found to be a 5.0:1.6:1.0 mixture of allylic azide 323, diazide 322 and pyrazinone 246.  
The residue can be purified via silica gel chromatography (2:1 hexanes: ethyl acetate) to 
afford diazide 322 and allylic azide 323 as a clear oils. 
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Diazide 322.  Rf  0.36 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.07 
(d, J = 3.7 Hz, 1H, O=CC=CHCH=CH), 6.99 (t, J = 1.3 Hz, 1H, O=CC=CHCH=CH), 
6.40 (t, J = 0.8, 3.5 Hz, 1H, O=CC=CHCH=CH), 5.44 (s, 1H, CH(N)(N3)), 4.03 (dd, J = 
10.5, 6.7 Hz, 1H, CH2CHCH2N), 3.14 (t, J = 10.7 Hz, 1H, CH2CHCH2N), 2.58 – 2.38 
(m, 2H, CH2CHCHCH2), 1.73 (dd, J = 11.9, 6.1 Hz, 1H, CH2), 1.45 (dd, J = 11.9, 6.6 Hz, 
1H, CH2), 1.38 (t, J = 11.2 Hz, 1H, CH2), 1.22 – 1.12 (m, 7H, CH2, CH3, CH3);  IR (neat 
film) 2953 (m), 2927 (m), 2867 (w), 2109 (s), 1652 (s), 1557 (m), 1459 (m), 1416 (m), 
1371 (m), 1249 (m), 1073 (m), 745 (m) cm-1;  LRMS (ESI) m/z for C15H18ON8, (M+H)+ 
327.2, (M+Na)+ 349.2. 
Allylic azide 323.  Rf  0.71 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 
7.16 (dd, J = 1.4, 2.8 Hz, 1H, O=CC=CHCH=CH), 7.13 – 7.11 (m, 2H, 
O=CC=CHCH=CH, CH(N)(N3)), 6.60 (dd, J = 3.9, 2.6 Hz, 1H, O=CC=CHCH=CH), 
4.06 (dd, J = 12.4, 6.9 Hz, 1H, CH2CHCH2N), 3.98 (dd, J = 12.4, 1.8 Hz, 1H, 
CH2CHCH2N), 3.04 – 2.89 (m, 1H, CH2CHCH2N), 2.15 (s, 2H, CH2), 1.96 (dd, J = 13.2, 
7.9 Hz, 1H, CH2CHCH2N), 1.37 (dd, J = 13.0, 11.0 Hz, 1H, CH2CHCH2N), 1.18 (s, 3H, 
CH3), 1.05 (s, 3H, CH3);  LRMS (ESI) m/z for C15H17ON5, (M+Na)+ 306.4.   
 
 
 
Bromopyrazinone 328, (MSB-VII-077).  To a solution of pyrazinone 246 (40.0 mg, 
0.165 mmol, 1.0 equiv) in dimethylformamide (3.3 mL) was added pyridinium 
tribromide (27.2 mg, 0.085 mmol, 0.52 equiv).  After stirring for 20 min the remaining 
pyridinium tribromide (25.2 mg, 0.079 mmol, 0.48 equiv) was added.  After stirring for 
20 min a small amount of starting material was still present as determined by TLC, at 
which point pyridinium tribromide (1.3 mg, 0.004 mmol, 0.025 equiv) was added.  After 
30 min the solution was diluted with saturated sodium thiosulfate (50 mL), extracted with 
ethyl acetate (2 x 20 mL), dried (sodium sulfate), and concentrated in vacuo to afford a 
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red film.  The resulting residue was purified by silica gel flash chromatography (2:1 
hexanes: ethyl acetate) to afford dibromopyrazinone 328 (40.0 mg, 76%) as a white solid.  
Rf  0.36 (1:1hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.31 (d, J = 4.2 Hz, 
1H, HC=CH-CBr), 6.54 (d, J = 1.9 Hz, 1H, NCH=CN), 6.35 (d, J = 4.2 Hz, 1H, HC=CH-
CBr), 4.07 (dd, J = 10.8, 6.3 Hz, 1H, CH2CHCH2N), 2.77 (t, J = 10.9 Hz, 1H, 
CH2CHCH2N), 2.15 (td, J = 11.6, 5.4 Hz, 1H, CH2CH), 1.38 (ddd, J = 17.4, 12.7, 6.3 Hz, 
1H, CH2CHCH2N), 1.12 (dd, J = 11.5, 6.3 Hz, 1H, CH2CH), 1.04 (dd, J = 11.6, 6.0 Hz, 
1H, CH2CHCH2N), 0.84 (s, 3H, CH3), 0.83 (s, 3H, CH3), 0.79 (t, J = 11.7 Hz, 1H, 
CH2CH), 0.68 (t, J = 12.0 Hz, 1H, CH2CHCH2N);  IR (neat film)  2951 (m), 2931 (w), 
2865 (w), 1691 (w), 1644 (s), 1435 (w), 1414 (m), 1366 (m), 1350 (m), 733 (s) cm-1;  
LRMS (ESI) m/z for C15H17Br1ON2, (M+H)+ 321.09, (M+Na)+ 343.09. 
 
 
 
Tribromide 331, (MSB-VII-002).  A solution of monobromopyrrole 328 (2.0 mg, 
0.0063 mmol, 1.0 equiv) in dichloromethane (0.3 mL) was added N-bromosuccinimide 
(1.2 mg, 0.0069 mmol, 1.1 equiv).  After 25 min additional N-bromosuccinimide (0.5 mg, 
0.0030 mmol, 0.4 equiv) was added.  After 40 min the solution was diluted with water 
(10 mL), extracted with dichloromethane (3 x 5 mL), dried (sodium sulfate) and 
concentrated in vacuo to afford a 2:1 of tribromide 331 and monobromopyrrole 328.  The 
residue can be purified via silica gel chromatography (2:1 hexanes: ethyl acetate) to 
afford tribromide 331 as a clear oil. 
Rf  0.51 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.27(m, 1H, 
O=CC=CHCH=CH), 7.14 (d, J = 4.2 Hz, 1H, O=CC=CHCH=CH), 6.62 (d, J = 4.2 Hz, 
1H, O=CC=CHCH=CH), 4.15 (dd, J = 12.4, 6.1 Hz, 1H, CH2CHCH2N), 4.07 (d, J = 12.2 
Hz, 1H, CH2CHCH2N), 3.43 – 3.34 (m, 1H, CH2CHCH2N), 2.62 (s, 2H, CH2), 1.84 (dd, 
J = 13.1, 7.8 Hz, 1H, CH2CHCH2N), 1.29 – 1.22 (m, 4H, CH2CHCH2N, CH3), 1.03 (s, 
3H, CH3);  IR (neat film) 3114 (w), 2954 (m), 2929 (w), 2866 (w), 1678 (s), 1644 (s), 
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1436 (m), 1418 (m), 1365 (m), 1353 (m), 1289 (w), 735 (m) cm-1;  LRMS (ESI) m/z for 
C15H15ON2Br3, (M+H)+ 478.31. 
 
 
 
Bromo methyl ether 330, (MSB-VII-021).  To a solution of monobromopyrrole 328 
(1.0 mg, 0.0031 mmol, 1.0 equiv) in methanol (0.2 mL) was added a solution of bromine 
(13.0 mg/0.2 mL methanol, 7.7 µL, 0.0031 mmol, 1.0 equiv) (note: the activity of 
bromine solution decreases over the course of an hour and should be used immediately 
after prepared).  After stirring for 19 hr the solution was quenched with saturated sodium 
thiosulfate, extracted with dichloromethane (3 x 5 mL), dried (sodium sulfate), and 
concentrated in vacuo.  The residue was purified via silica gel chromatography (2:1 
hexanes: ethyl acetate) to afford a mixture of bromo methyl ether 330 (0.8 mg, 80%) as a 
clear oil. 
Rf  0.46 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.03 (d, J = 3.8 Hz, 
1H, HC=CHCBr), 6.44 (s, 1H, CHNBr), 5.97 (d, J = 3.8 Hz, 1H, HC=CHCBr), 3.81 (dd, 
J = 10.4, 7.1 Hz, 1H, CH2CHCH2N), 3.09 (t, J = 10.7 Hz, 1H, CH2CHCH2N), 2.85 – 2.79 
(m, 1H, CH2CHCH2N), 2.13 – 2.08 (m, 1H, CH2CH), 1.31 (m, 1H, CH2), 1.21 (dd, J = 
6.4, 11.7 Hz, 1H, CH2), 0.94 (s, 3H, CH3), 0.92 (s, 3H, CH3), 0.91 – 0.86 (m, 1H, CH2), 
0.80 (t, J = 11.9 Hz, 1H, CH2);  IR (neat film)  2951 (m), 2928 (m), 2865 (w), 1658 (s), 
1562 (w), 1452 (m), 1429 (s), 1379 (m), 1299 (m), 1149 (w), 1072 (m), 1052 (m), 740 
(m) cm-1;  LRMS (ESI) m/z for C16H20Br2O2N2, (M+H)+ 431.10, (M+Na)+ 453.12. 
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Bromoazide 333 and 334, (MSB-VII-079).  To a solution of monobromopyrrole 328 
(10.0 mg, 0.031 mmol, 1.0 equiv) in methanol (0.5 mL) was added tetrabutylammonium 
azide (176 mg, 0.62 mmol, 20 equiv) and then a solution of bromine (0.15 mM in 
methanol, 60 µL, 4.9 mg, 0.031 mmol, 1.0 equiv) (note: the activity of the bromine 
solution decreases rapidly over the course of an hr and should be used immediately after 
preparation).  After stirring for 10 min additional bromine was added (0.15 mM in 
methanol, 3 µL, 0.0015 mmol, 0.05 equiv) and then quenched with saturated sodium 
thiosulfate, extracted with dichloromethane (3 x 10 mL), dried (sodium sulfate), and 
concentrated in vacuo.  The residue was purified via silica gel chromatography (4:1 
hexanes: ethyl acetate) to afford a 2.5:1 mixture of bromoazides 333 and 334 (10.2 mg, 
76%) as a clear oil and bromomethyl ether 332 (2.5 mg, 15%).  (note: although the 
bromoazides were unstable upon standing neat or in solution, the integrity of a sample 
could be maintained by storing in benzene with 5% triethylamine at -20 °C)  
Bromoazide 333.  Rf  0.57 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 
7.02 (d, J = 3.9 Hz, 1H, HC=CHCBr), 6.13 (s, 1H, CHNBr), 5.94 (d, J = 3.9 Hz, 1H, 
HC=CHCBr), 4.18 (dd, J = 10.4, 6.1 Hz, 1H, CH2CHCH2N), 2.74 (t, J = 10.6 Hz, 1H, 
CH2CHCH2N), 2.64 – 2.53 (m, 1H, CH2CHCH2N), 2.29 (td, J = 13.1, 7.3 Hz, 1H, 
CH2CH), 1.59 (t, J = 12.1 Hz, 1H, CH2), 1.15 – 1.08 (m, 1H, CH2), 0.98 (dd, J = 11.7, 
6.0 Hz, 1H, CH2), 0.86 (s, 3H, CH3), 0.82 (s, 3H, CH3), 0.56 (t, J = 11.7 Hz, 1H, CH2);  
IR (neat film)  2955 (m), 2926 (m), 2867 (w), 2110 (s), 1667 (s), 1565 (w), 1429 (m), 
1403 (m), 1368 (m), 1300 (m), 1248 (m), 740 (m) cm-1;  LRMS (ESI) m/z for 
C15H17Br2ON5, (M+H)+ 442.1, (M+Na)+ 464.1. 
Bromoazide 334.  Rf  0.60 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 
7.02 (d, J = 3.8 Hz, 1H, HC=CHCBr), 6.39 (s, 1H, CHNBr), 5.94 (d, J = 4.0 Hz, 1H, 
HC=CHCBr), 3.87 (dd, J = 10.3, 7.0 Hz, 1H, CH2CHCH2N), 2.95 (t, J = 10.8 Hz, 1H, 
CH2CHCH2N), 2.74 – 2.64 (m, 1H, CH2CH), 2.11 – 1.96 (m, 1H, CH2CHCH2N), 1.43 – 
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1.27 (m, 1H, CH2), 1.15 – 1.08 (m, 2H, CH2, CH2), 0.87 (s, 3H, CH3, CH3), 0.72 (t, J = 
11.8 Hz, 1H, CH2);  IR (neat film)  2955 (m), 2926 (m), 2867 (w), 2110 (s), 1667 (s), 
1565 (w), 1429 (m), 1403 (m), 1368 (m), 1300 (m), 1248 (m), 740 (m) cm-1;  LRMS 
(ESI) m/z for C15H17Br2ON5, (M+H)+ 442.1, (M+Na)+ 464.1. 
 
 
 
Allylic bromide 335, (MSB-VII-039).  A freshly purified sample of bromo methyl ether 
332 was diluted with deuterochloroform and a 1H NMR acquisition 5 min later showed in 
to be pure.  After standing for 72 hr at room temperature the sample was found exist 
entirely as allylic bromide 335 by TLC and 1H NMR. 
Rf  0.29 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.27 (s, 1H, 
CH(N)Br), 7.14 (d, J = 4.2 Hz, 1H, HC=CHCBr), 6.62 (d, J = 4.2 Hz, 1H, HC=CHCBr), 
4.15 (dd, J = 12.4, 6.1 Hz, 1H, CH2CHCH2N), 4.07 (d, J = 12.2 Hz, 1H, CH2CHCH2N), 
3.38 (ddd, J = 13.0, 11.4, 6.8 Hz, 1H, CH2CHCH2N), 2.62 (s, 2H, CH2), 1.84 (dd, J = 
13.2, 7.8 Hz, 1H, CH2CHCH2N), 1.28 – 1.18 (m, 4H, CH2CHCH2N, CH3), 1.04 (s, 3H, 
CH3);  IR (neat film)  2954(m), 2865 (w), 1677 (s), 1642 (s), 1436 (m), 1419 (m), 1366 
(m), 1353 (m), 735 (m) cm-1;  LRMS (ESI) m/z for C15H16Br2ON2, (M+H)+ 399.02, 
(M+Na)+ 421.07. 
 
 
 
Allylic bromide 335, (MSB-VII-040).  A freshly purified sample of a 2:5:1 mixture of 
bromoazides 333 and 334 (3 mg, 0.0075 mmol) was diluted with deuteriochloroform and 
10 min later a 1H NMR spectrum was acquired to afford 0.71:0.26:0.09 mixture of bromo 
 228 
azide 333: bromo azide 334: and allylic bromide 335.  An addititional acquisition 10 min 
later showed a decrease in the proportion of bromoazides 333 and 335.  After an 11 hr 
incubation, allylic bromide 335 was found to be the exclusive product by 1H NMR.  In a 
separate experiment, a different freshly purified sample of bromoazide 333 and 334 
(3 mg, 0.0075 mmol) was diluted with deuteriobenzene and after 10 min was found to be 
a clean 2.5:1 mixture of 333 and 334 by 1H NMR.  After 11 hr, the sample was found to 
exist as 4:1 ratio of allylic bromide 335 and bromoazide 333 as determined by 1H NMR.  
All spectra matched that previously reported. 
 
 
 
Amino methyl ether 337, amino methyl ether 338, amino thio ether 339, (MSB-VII-
094).  To a 2.5:1 mixture of trans-azido bromides 333 and 334 (27.0 mg, 0.061 mmol, 
1.0 equiv) in methanol (1.2 mL) was added triethylamine (83 µL, 0.61 mmol, 10 equiv) 
and 1,3-propanedithiol (30.6 µL, 0.30 mmol, 5 equiv).  After stirring for 30 min the 
solution was concentrated in vacuo and purified via silica gel chromatography (2:1 
gradient to 1:1 hexanes: ethyl acetate w/ 1% triethylamine) to afford a mixture of amino 
methyl ether 337 (10.0 mg, 45%), and a mixture of amino methyl ethers 338 and amino 
thioethers 339 (3.5 mg, 20%) as a clear oils. 
Amino methyl ether 337.  Rf  0.26 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, 
C6D6) δ 7.06 (d, J = 3.9 Hz, 1H, HC=CHCBr), 6.09 (d, J = 3.9 Hz, 1H, HC=CHCBr), 
5.04 (s, 1H, CH(N)(NH2)), 3.88 (dd, J = 10.6, 7.3 Hz, 1H, CH2CHCH2N), 2.99 (t, J = 
10.7 Hz, 1H, CH2CHCH2N), 2.77 (s, 3H, OCH3), 2.49 (dt, J = 13.1, 9.2 Hz, 1H, CH2CH), 
2.22 (td, J = 11.9, 6.1 Hz, 1H, CH2CHCH2N), 1.39 (d, J = 9.2 Hz, 2H, CH2CH), 1.30 (dd, 
J = 11.6, 6.4 Hz, 1H, CH2CHCH2N), 0.98 (s, 3H, CH3), 0.97 (s, 3H, CH3), 0.88 (t, J = 
11.9 Hz, 1H, CH2CHCH2N);  13C NMR (126 MHz, C6D6) δ 157.19, 125.64, 113.73, 
113.31, 103.46, 91.90, 67.56, 57.36, 52.46, 46.96, 44.36, 43.17, 41.35, 36.86, 32.01, 
31.93;  IR (neat film)  3376 (w), 3292 (w), 2950 (m), 2865 (w), 1646 (s), 1549 (m), 1422 
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(s), 1385 (m), 1082 (m), 738 (m) cm-1;  LRMS (ESI) m/z for C16H22BrO2N3, (M+H)+ 
368.09, (M-H)- 366.07. 
Amino methyl ethers 338 and amino thioethers 339.  Rf  0.24 (1:1 hexanes: ethyl 
acetate);  LRMS (ESI) m/z for C18H26BrOS2N3, (M+H)+ 444.09, (M+Na)+ 468.10, (M-
H)- 442.03 and LRMS (ESI) m/z for C16H22BrO2N3, (M+H)+ 368.09, (M+Na)+ 390.08, 
(M-H)- 366.09. 
 
 
 
Amine 353, amine 354, amine 355, and pyrazinone 328, (MSB-VII-160).  To a 
solution of a 2.5:1 mixture of trans-bromoazides 333 and 334 (28 mg, 0.063 mmol, 
1.0 equiv) in ethanethiol (1.0 mL) was added triethylamine (86 µL, 0.63 mmol, 10 
equiv).  After stirring for 1 hr partial conversion of starting material was observed by 
TLC, at which point 1,3-propanedithiol (25 µL, 0.25 mmol, 4.0 equiv) was added.  After 
stirring for 2 hr the solution was concentrated in vacuo, diluted with methanol (1 mL) and 
then 1,3-propanedithiol (20 µL, 0.2 mmol, 3.3 equiv) was added.  After stirring for 2 hr 
the solvent was concentrated in vacuo and the resulting residue was purified via silica gel 
chromatography (3:1 hexanes: ethyl acetate w/ 1% triethylamine) to afford amine 353 
(8.9 mg, 36% over two steps), amine 354 (2.6 mg, 10% over two steps), amine 355 
(2.6 mg, 10% over two steps) as clear films and pyrazinone 328 (3 mg, 10%) as a white 
solid.  
Pyrazinone 328.  All spectra matched that previously reported.  
Amine 353.  Rf  0.23 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.06 (d, 
J = 3.9 Hz, 1H, HC=CHCBr), 6.12 (d, J = 3.9 Hz, 1H, HC=CHCBr), 5.13 (s, 1H, 
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CHNN), 3.91 (dd, J = 10.8, 7.5 Hz, 1H, CH2CHCH2N), 2.99 (t, J = 10.7 Hz, 1H, 
CH2CHCH2N), 2.75 (dt, J = 12.1, 6.6 Hz, 1H, CH2CH), 2.60 (m, 1H, CH2CHCH2N), 
2.19 (dq, J = 11.5, 7.4 Hz, 1H, SCH2CH3), 2.04 (dq, J = 11.4, 7.4 Hz, 1H, SCH2CH3), 
1.43 (t, J = 11.6 Hz, 1H, CH2), 1.34 – 1.28 (m, 2H, CH2), 1.27 – 1.15 (br s, 2H, NH2), 
1.00 (s, 3H, CH3), 0.98 (s, 3H, CH3), 0.92 (t, J = 11.8 Hz, 1H, CH2), 0.77 (t, 3H, 
SCH2CH3);  IR (neat film)  3383 (w), 2951 (m), 2928 (m), 2865 (w), 2111 (w), 1637 (s), 
1547 (m), 1420 (s), 1384 (m), 1265 (m), 740 (m) cm-1;  LRMS (ESI) m/z for 
C17H24BrOSN3, (M+H)+ 398.09, (M-H)- 395.94. 
Amine 355.  Rf  0.40 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.09 (dd, 
J = 4.0, 1.2 Hz, 1H, HC=CHCBr), 6.08 (dd, J = 4.0, 1.5 Hz, 1H, HC=CHCBr), 4.91 (br s, 
1H, CHNN), 4.17 (ddd, J = 10.4, 6.0, 1.2 Hz, 1H, CH2CHCH2N), 2.84 (dt, J = 10.8, 
1.3 Hz, 1H, CH2CHCH2N), 2.65 (td, J = 12.8, 7.0 Hz, 1H, CH2CH), 2.37 – 2.26 (m, 2H, 
SCH2CH3), 2.23 – 2.09 (m, 1H, CH2CHCH2N), 1.94 (t, J = 11.6 Hz, 1H, CH2), 1.38 – 
1.25 (m, 1H, CH2), 1.20 – 1.08 (m, 3H, NH2, CH2), 1.00 (s, 3H, CH3), 0.96 (s, 3H, CH3), 
0.88 (dt, J = 7.4, 1.4 Hz, 3H, SCH2CH3), 0.85 – 0.71 (m, 1H, CH2);   LRMS (ESI) m/z 
for C17H24BrOSN3, (M+H)+ 398.10, (M+Na)+ 420.04, (M-H)- 396.13. 
Amine 354.  Rf  0.46 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.08 (dd, 
J = 3.8, 1.6 Hz, 1H, HC=CHCBr), 6.11 (d, J = 3.8, 1.5 Hz, 1H, HC=CHCBr), 3.97 (t, J = 
9.2 Hz, 1H), 3.85 (dd, J = 9.3, 7.9 Hz, 1H, CH2CHCH2N), 3.09 (t, J = 10.9 Hz, 1H, 
CH2CHCH2N), 2.68 – 2.53 (m, 1H), 2.33 (m, 2H), 2.27 – 2.13 (m, 2H), 2.08 – 1.97 (m, 
1H), 1.80 – 1.68 (m, 1H), 1.50 – 1.41 (m, 2H), 1.30 (dd, J = 10.6, 6.4 Hz, 1H, CH2), 1.00 
(s, 3H, CH3), 0.98 (s, 3H, CH3), 0.96 – 0.89 (m, 1H), 0.76 (td, J = 7.4, 1.4 Hz, 3H, 
SCH2CH3);  IR (neat film)  3383 (w), 2950 (m), 2931 (m), 2865 (w), 1643 (s), 1549 (m), 
1420 (s), 1400 (m), 1320 (m), 1259 (m), 1100 (w), 738 (m) cm-1;  LRMS (ESI) m/z for 
C17H24BrOSN3, (M+H)+ 398.09, (M+Na)+ 420.16, (M-H)- 396.02. 
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Thiourea 357, (MSB-VII-161).  To a solution of amine 353 (8.9 mg, 0.0224 mmol, 
1.0 equiv) in benzene (1.0 mL) was added benzyloxycarbonyl isothiocyanate (8.6 mg, 
0.045 mmol, 2.0 equiv) and heated up to 40 °C.  After 30 min the solution was cooled 
and concentrated in vacuo.  The residue was purified via silica gel chromatography (2:1 
hexanes: ethyl acetate) to afford thiourea 357 (11.3 mg, 87%) as a clear oil.   
Rf  0.22 (2:1 hexanes: ethyl acetate);  1H MR (500 MHz, C6D6) δ 10.41 (d, J = 8.6 Hz, 
1H, CHNH), 7.92 (br s, 1H, NH), 7.53 (d, J = 8.7 Hz, 1H, CHNH), 7.09 (dd, J = 8.8, 
5.4 Hz, 1H, HC=CH), 7.04 – 6.95 (m, 3H, C6H6), 6.89 – 6.76 (m, 2H, C6H6), 6.05 (d, J = 
6.9 Hz, 1H, HC=CH), 4.44 (q, J = 12.0 Hz, 2H, PhCH2O), 4.01 (dd, J = 10.6, 7.6 Hz, 1H, 
CH2CHCH2N), 3.03 (t, J = 10.8 Hz, 1H, CH2CHCH2N), 2.64 (dt, J = 17.6, 5.8 Hz, 1H, 
CH2CHCH2N), 2.58 – 2.47 (m, 1H, CH3CH2S), 2.47 – 2.29 (m, 2H, CH3CH2S, CH2CH), 
2.06 (dd, J = 11.4, 5.8 Hz, 1H, CH2CH), 1.60 (t, J = 11.7 Hz, 1H, CH2CH), 1.23 (dd, J = 
11.8, 6.7 Hz, 1H, CH2CHCH2N), 1.01 (s, 3H, CH3), 0.97 (s, 3H, CH3), 0.87 (t, J = 
7.5 Hz, 3H, SCH2CH3), 0.82 (t, J = 11.9 Hz, 1H, CH2CHCH2N);  13C NMR (126 MHz, 
C6D6) δ 179.61, 156.34, 152.67, 134.32, 128.91, 128.82, 128.71, 126.52, 115.42, 114.33, 
105.53, 75.28, 68.91, 68.51, 57.65, 47.30, 44.34, 44.22, 41.03, 40.64, 32.14, 31.76, 25.18, 
14.27;  IR (neat film)  3194 (w), 2951 (m), 2866 (w), 1717 (s), 1636 (s), 1522 (s), 1423 
(m), 1405 (m), 1374 (m), 1231 (m), 1195 (m), 740 (m) cm-1;  LRMS (ESI) m/z for 
C26H31O3N4BrS2, (M-H)- 589.03, (M+Na)+ 613.10. 
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Guanidine 358, (MSB-VII-163).  To a solution of thiourea 357 (11.3 mg, 0.019 mmol, 
1.0 equiv) in acetonitrile (0.6 mL) and benzene (0.2 mL) was added hexamethyldisilizane 
(40 µL, 0.191 mmol, 10 equiv) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (18 mg, 0.095 mol, 5.0 equiv).  After 13 hr the reaction was diluted with 
water (10 mL), extracted with ethyl acetate (3 x 5 mL), dried with magnesium sulfate, 
and concentrated in vacuo.  The residue was purified via silica gel chromatography (2:1 
(90:10:0.6:0.6 dichloromethane: methanol: water: ammonium hydroxide): 
dichloromethane) to afford guanidine 358 (9.3 mg, 85% over two steps) as a white solid.  
Rf  0.14 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, MeOD) δ 7.41 – 7.23 (m, 5H, 
C6H6), 6.87 (d, J = 4.0 Hz, 1H, HC=CH), 6.72 (br s, 1H, CHNH), 6.38 (d, J = 4.0 Hz, 1H, 
HC=CH), 5.25 (d, J = 12.8 Hz, 1H, PhCH2O), 5.13 (d, J = 12.8 Hz, 1H, PhCH2O), 3.81 
(dd, J = 10.6, 7.6 Hz, 1H, CH2CHCH2N), 2.97 (t, J = 10.9 Hz, 1H, CH2CHCH2N), 2.77 – 
2.63 (m, 1H, CH2CHCH2N), 2.45 (dt, J = 14.9, 7.4 Hz, 1H, CH3CH2S), 2.39 – 2.26 (ddd, 
J = 17.9, 12.2, 6.6 Hz, 2H, CH3CH2S, CH2CH), 1.66 (dd, J = 11.8, 6.8, 1H, 
CH2CHCH2N), 1.61 (dd, J = 11.5, 5.7, 1H, CH2CH), 1.39 (t, J = 11.6 Hz, 1H, CH2CH), 
1.19 (t, J = 11.9 Hz, 1H, CH2CHCH2N), 1.11 (s, 3H, CH3), 1.08 (t, J = 7.5 Hz, 3H, 
SCH2CH3), 0.97 (s, 3H, CH3);  13C NMR (126 MHz, MeOD) δ 159.04, 139.14, 131.37, 
129.48, 128.43, 126.41, 115.43, 114.61, 107.41, 76.28, 67.83, 65.68, 58.19, 48.18, 45.09, 
44.98, 41.69, 40.83, 32.40, 32.06, 25.72, 14.78 (two carbonyls absent);  IR (neat film)  
3434 (w), 3305 (w), 2949 (m), 2866 (w), 1655 (s), 1619 (s), 1535 (s), 1426 (s), 1409 (s), 
1382 (m), 1280 (s), 1101 (s), 740 (m) cm-1;  LRMS (ESI) m/z for C26H32O3N5BrS, 
(M-H)- 572.14, (M+H)+ 574.16, (M+Na)+ 596.10. 
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Guanidine 360, (MSB-VII-265).  To a solution of ethyl hemiaminal thioether 358 
(7.8 mg, 0.014 mmol, 1.0 equiv) in dichloromethane (1.0 mL) was added  
N-iodosuccinimide (9.0 mg, 0.041 mmol, 3.0 equiv).  After 25 min the reaction was 
quenched with ethanethiol (20 µL) and the solution was purified directly via silica gel 
chromatography (4:1 gradient to 3:1 dichloromethane: (90:10:0.6:0.6 dichloromethane: 
methanol: water: ammonium hydroxide)) to afford cyclic guanidine 360 (4.8 mg, 69%) as 
a white solid.   
Rf  0.36 (1:1 dichloromethane: (90:10:0.6:0.6 dichloromethane: methanol: water: 
ammonium hydroxide));  1H NMR (500 MHz, MeOD) δ 7.52 – 7.33 (m, 5H, C6H5), 6.85 
(d, J = 4.1 Hz, 1H, HC=CH), 6.31 (d, J = 4.1 Hz, 1H, HC=CH), 5.55 – 5.47 (m, 2H, 
CHN, PhCH2O), 5.16 (d, J = 11.6 Hz, 1H, PhCH2O), 3.74 (dd, J = 9.9, 6.0 Hz, 1H, 
CH2CHCH2N), 2.99 (t, J = 10.5 Hz, 1H, CH2CHCH2N), 2.61 (td, J = 12.9, 6.5 Hz, 1H, 
CH2CH), 2.22 – 2.09 (m, 1H, CH2CHCH2N), 1.50 – 1.34 (m, 3H, CH2CHCHCH2), 1.10 
(s, 3H, CH3), 1.03 (s, 3H, CH3), 0.94 (t, J = 11.8 Hz, 1H, CH2CHCH2N);  13C NMR 
(126 MHz, MeOD) δ 159.30, 158.80, 153.03, 136.29, 130.51, 130.17, 129.97, 125.87, 
115.96, 115.56, 107.30, 86.45, 72.79, 69.96, 59.09, 50.55, 48.14, 45.52, 40.27, 38.75, 
32.09, 31.95;  IR (neat film)  3430 (w), 2952 (m), 2918 (m), 2849 (w), 1718 (s), 1652 (s), 
1507 (m), 1419 (s), 1212 (m), 1168 (m), 739 (m) cm-1;  LRMS (ESI) m/z for 
C24H26O3N5Br, (M-H)- 510.24, (M+H)+ 512.10, (M+Na)+ 534.12. 
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10,6-Epidimethylcyclopentaphakellin (361), (MSB-VIII-124).  To a solution of 
guanidine 360 (4.8 mg, 0.009 mmol, 1.0 equiv) in methanol (0.4 mL) was added 10% 
palladium on carbon (0.1 mg, 0.0001 mmol, 0.1 equiv) and the atmosphere was 
exchanged with hydrogen gas at balloon pressure.  After 6 hr the vessel was recharged 
with hydrogen.  After 14 hr the solution was diluted with methanol (0.3 mL), palladium 
on carbon (0.1 mg, 0.0001 mmol, 0.1 equiv) was added, the vessel was recharged with 
hydrogen, and stirred for an additional 36 hr.  The solution was then filtered through 
celite, concentrated in vacuo and resubjected to the reaction conditions as before.  After 
36 hr the solution was transferred to larger flask (10 mL schlenk), diluted to a total of 
1.0 mL methanol and resubjected to the reaction conditions.  After 18 hr the solution was 
filtered through celite and concentrated in vacuo to afford clean product.  The residue 
was dissolved (1.5 mL, 80:20 acetonitrile: water, w/ 0.1% trifluoroacetic acid) and 
purified by reverse phase prep-HPLC (C18 sunfire column, 10 x 150 mm, 80:20 to 50:50 
(acetenitrile w/ 0.1% trifluoroacetic acid): (water w/ 0.1% trifluoroacetic acid) over 
20 min).  The retention time of 10,6-epidimethylcyclopentaphakellin·TFA was 6.2 min.  
The fractions collected between 6.0-6.4 min was lyophilized (36 h) to yield  
10,6-epidimethylcyclopentaphakellin 361 (2.1 mg, 75%) as the free base.40   
Rf  0.07 (1:1 dichloromethane: (90:10:0.6:0.6 dichloromethane: methanol: water: 
ammonium hydroxide));  1H NMR (500 MHz, MeOD) δ 7.10 (dd, J = 1.6, 2.6 Hz, 1H, 
O=CC=CHCH=CH), 6.92 (dd, J = 3.9, 1.5 Hz, 1H, O=CC=CHCH=CH), 6.41 (dd, J = 
2.9, 3.7 Hz, 1H, O=CC=CHCH=CH), 5.96 (s, 1H, CHN), 4.06 (dd, J = 10.2, 5.8 Hz, 1H, 
CH2CHCH2N), 3.19 (t, J = 10.6 Hz, 1H, CH2CHCH2N), 2.56 (td, J = 12.8, 6.5 Hz, 1H, 
CH2CH), 2.34 – 2.19 (m, 1H, CH2CHCH2N), 1.64 (dd, J = 11.7, 6.6 Hz, 1H, CH2CH), 
1.60 (dd, J = 12.1, 6.5 Hz, 1H, CH2CHCH2N), 1.50 (t, J = 12.1 Hz, 1H, CH2CH), 1.26 (t, 
J = 11.9 Hz, 1H, CH2CHCH2N), 1.185 (s, 3H, CH3), 1.175 (s, 3H, CH3);  13C NMR 
(126 MHz, MeOD) δ 159.66, 159.14, 124.72, 124.20, 115.29, 113.17, 82.71, 66.23, 
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61.74, 50.77, 48.16, 45.83, 40.47, 38.65, 32.08, 31.97;  IR (neat film)  3349 (br), 2950 
(m), 2866 (w), 1624 (s), 1556 (m), 1419 (m), 1365 (w), 1117 (w), 744 (m) cm-1;  LRMS 
(ESI) m/z for C16H21ON5, (M-H)- 298.0, (M+H)+ 300.1, (M+Na)+ 322.1. 
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Thiourea 369, (MSB-VII-162).  To a solution of amine 355 (2.6 mg, 0.0065 mmol, 
1.0 equiv) in benzene (1.0 mL) was added benzyloxycarbonyl isothiocyanate (2.5 mg, 
0.013 mmol, 2.0 equiv) and heated up to 40 °C.  After 90 min the solution was cooled 
and concentrated in vacuo.  The residue was purified via silica gel chromatography (3:1 
hexanes: ethyl acetate) to afford thiourea 369 (4.5 mg, 99%) as a clear oil.   
Rf  0.49 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 10.77 (br d, J = 9.5 
Hz, 1H, CH(N)NH), 7.67 (br s, 1H, NH), 7.40 (d, J = 9.8 Hz, 1H, CH(N)NH), 7.11 (d, J 
= 3.9 Hz, 1H, HC=CH), 7.04 – 6.98 (m, 3H, C6H5), 6.90 – 6.83 (m, 2H, C6H5), 6.05 (d, J 
= 3.9 Hz, 1H, HC=CH), 4.58 (d, J = 12.0 Hz, 1H, PhCH2O), 4.47 – 4.35 (m, 2H, 
PhCH2O, CH2CHCH2N), 2.97 – 2.81 (m, 2H, CH2CHCH2N, CH2CH), 2.55 (dt, J = 14.8, 
7.4 Hz, 1H, CH3CH2S), 2.46 – 2.33 (m, 2H, CH2CHCH2N, CH3CH2S), 1.94 (t, J = 12.6 
Hz, 1H, CH2), 1.58 (dd, J = 12.2, 7.4 Hz, 1H, CH2), 1.05 (dd, J = 11.8, 5.8 Hz, 1H, CH2), 
0.99 (t, J = 7.4 Hz, 3H, CH3CH2S), 0.86 (s, 3H, CH2), 0.85 (s, 3H, CH3), 0.68 (t, J = 11.7 
Hz, 1H, CH2);  IR (neat film)  3197 (br), 2953 (m), 2928 (m), 2867 (w), 1734 (m), 1655 
(m), 1638 (m), 1524 (s), 1422 (m), 1402 (m), 1232 (m), 1197 (m), 1031 (m), 741 (m)  
cm-1;  LRMS (ESI) m/z for C26H31O3N4BrS2, (M-H)- 589.05, (M+H)+ 591.13, (M+Na)+ 
613.12. 
 
 
 
Guanidine 363, (MSB-VII-164).  To a solution of thiourea 369 (4.5 mg, 0.0076 mmol, 
1.0 equiv) in acetonitrile (0.4 mL) was added hexamethyldisilizane (16 µL, 0.076 mmol, 
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10 equiv) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (7.3 mg, 
0.038 mol, 5.0 equiv).  After 13 hr the reaction was diluted with water (10 mL), extracted 
with ethyl acetate (3 x 10 mL), dried with magnesium sulfate, and concentrated in vacuo.  
The residue was purified via silica gel chromatography (1:1 hexanes: ethylacetate w/ 5% 
triethylamine gradient to 95:5 ethyl actate: triethylamine) to afford guanidine 363 
(3.6 mg, 97% over two steps) as a white solid.   
Rf  0.51 (3:1 ethyl acetate: hexanes);  1H NMR (500 MHz, MeOD) δ 7.44 – 7.22 (m, 5H, 
C6H5), 6.85 (d, J = 4.0 Hz, 1H, HC=CH), 6.67 (br s, 1H, CHN), 6.30 (d, J = 3.9 Hz, 1H, 
HC=CH), 5.33 (d, J = 12.5 Hz, 1H, PhCH2O), 5.20 (d, J = 12.8 Hz, 1H, PhCH2O), 4.03 
(dd, J = 10.3, 6.0 Hz, 1H, CH2CHCH2N), 3.03 (t, J = 10.6 Hz, 1H, CH2CHCH2N), 2.91 
(td, J = 13.1, 7.5 Hz, 1H, CH2CH), 2.71 (dg, J = 14.9, 7.5 Hz, 1H, CH3CH2S), 2.62 (dg, 
1H, J = 13.1, 7.5 Hz, CH3CH2S), 2.47 – 2.35 (m, 1H, CH2CHCH2N), 1.59 – 1.47 (m, 2H, 
CH2CHCHCH2), 1.44 – 1.35 (m, 1H, CH2CH), 1.18 (t, J = 7.5 Hz, 3H, SCH2CH3), 1.14 – 
1.07 (m, 4H, CH2CHCH2N, CH3), 1.00 (s, 3H, CH3);  13C NMR (126 MHz, MeOD) δ 
158.57, 129.51, 128.66, 128.31, 128.01, 125.29, 116.28, 114.14, 108.81, 74.68, 68.14, 
63.91. 63.73, 61.11, 45.24, 41.05, 38.51, 32.30, 32.07, 25.02, 24.41, 14.78, (2 carbonyl 
peaks not present);  IR (neat film)  3393 (w), 3316 (w), 2952 (m), 2932 (m), 2866 (w), 
1651 (s), 1619 (s), 1536 (s), 1453 (m), 1453 (m), 1422 (m), 1312 (m), 1277 (m), 1105 
(m), 739 (m) cm-1;  LRMS (ESI) m/z for C26H32O3N5BrS, (M-H)- 572.08, (M+H)+ 
574.11, (M+Na)+ 596.10. 
 
 
 
Thiourea 370, (MSB-VII-166).  To a solution of amine 354 (2.14 mg, 0.0054 mmol, 
1.0 equiv) in benzene (1.0 mL) was added benzyloxycarbonyl isothiocyanate (10.0 mg, 
0.052 mmol, 8.0 equiv) and heated up to 40 °C.  After 90 min the solution was cooled 
and concentrated in vacuo.  The residue was purified via silica gel chromatography (5:1 
benzene: ethyl acetate) to afford thiourea 370 (3.2 mg, 99%) as a clear oil.   
 241 
Rf  0.36 (4:1 benzene: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 11.17 (d, J = 10.0 Hz, 
1H, NH), 8.08 (br s, 1H, NH), 7.12 – 7.09 (m, 2H, C6H5, HC=CH), 7.05 – 6.98 (m, 4H, 
C6H5, CHNN), 6.96 – 6.90 (m, 2H, C6H5), 6.12 (d, J = 3.9 Hz, 1H, HC=CH), 4.77 (d, J = 
12.0 Hz, 1H, PhCH2O), 4.62 (d, J = 12.0 Hz, 1H, PhCH2O), 3.77 (dd, J = 10.7, 7.7 Hz, 
1H, CH2CHCH2N), 2.91 (t, J = 10.8 Hz, 1H, CH2CHCH2N), 2.56 (m, 1H, CH2CHCH2N), 
2.29 – 2.14 (m, 3H, CH2CH, CH3CH2S), 1.51 (dd, J = 11.4, 6.4 Hz, 1H, CH2), 1.45 (dd, J 
= 14.7, 8.6 Hz, 1H, CH2), 1.21 (dd, J = 11.6, 6.6 Hz, 1H, CH2), 1.02 – 0.97 (s, 3H, CH3), 
0.91 (s, 3H, CH3), 0.76 (t, J = 7.4 Hz, 3H, SCH2CH3);  IR (neat film)  3183 (br), 2951 
(m), 2929 (m), 2866 (w), 1724 (m), 1647 (m), 1636 (m), 1520 (s), 1405 (m), 1326 (m), 
1226 (m), 1204 (m), 1171 (m), 1026 (m), 739 (m) cm-1;  LRMS (ESI) m/z for 
C26H31O3N4BrS2, (M-H)- 589.00, (M+H)+ 591.18, (M+Na)+ 613.13. 
 
 
 
Guanidine 362, (MSB-VII-170).  To a solution of thiourea 370 (3.2 mg, 0.0054 mmol, 
1.0 equiv) in acetonitrile (0.3 mL) was added hexamethyldisilizane (11.3 µL, 
0.054 mmol, 10 equiv) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (5.2 mg, 0.027 mol, 5.0 equiv).  After 13 hr the reaction was diluted with 
water (5 mL), extracted with ethyl acetate (3 x 5 mL), dried with magnesium sulfate, and 
reduced in vacuo.  The residue was purified via silica gel chromatography (2:1 hexanes: 
ethylacetate) to afford guanidine 362 (2.5 mg, 81% over two steps) as a white solid.   
Rf  0.43 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, MeOD) δ 7.34 – 7.20 (m, 5H, 
C6H5), 6.86 (d, J = 3.9 Hz, 1H, HC=CH), 6.52 (s, 1H, CHN), 6.32 (d, J = 3.9 Hz, 1H, 
HC=CH), 5.15 – 4.97 (m, 2H, PhCH2O), 3.80 (dd, J = 10.7, 7.6 Hz, 1H, CH2CHCH2N), 
3.25 (t, J = 10.9 Hz, 1H, CH2CHCH2N), 2.85 – 2.71 (m, 1H, CH2CHCH2N), 2.34 – 2.22 
(m, 2H, CH2CH, CH3CH2S), 2.06 (ddd, J = 20.8, 15.5, 8.1 Hz, 1H, CH3CH2S), 1.64 (dd, 
J = 11.7, 6.5 Hz, 1H, CH2CHCH2N), 1.34 (t, J = 11.9 Hz, 1H, CH2CH), 1.21 (m, 2H, 
CH2CHCHCH2), 1.11 (s, 3H, CH3), 1.06 (s, 3H, CH3), 1.01 (t, J = 7.4 Hz, 3H, 
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SCH2CH3);   13C NMR (126 MHz, MeOD) δ 164.79,  162.49, 159.28, 139.30, 129.47, 
128.66, 128.31, 128.17, 116.55, 116.28, 104.78, 76.15, 72.22, 68.30, 61.97, 61.10, 45.80, 
45.44, 41.70, 38.85, 32.21, 32.07, 24.41, 14.84;  IR (neat film)  3413 (br), 3295 (w), 2950 
(m), 2932 (m), 2867 (w), 1653 (s), 1618 (s), 1538 (s), 1424 (m), 1302 (m), 1267 (m), 
1115 (m), 740 (m) cm-1;  LRMS (ESI) m/z for C26H32O3N5BrS, (M-H)- 572.02, (M+H)+ 
574.15, (M+Na)+ 596.15. 
 
 
 
Gaunidine 366, (MSB-VII-174).  To a solution of ethyl hemiaminal thioether 362 
(0.5 mg, 0.0009 mmol, 1.0 equiv) in dichloromethane (0.2 mL) was added 
bis(collidine)iodine(I)hexafluorophosphate (5.0 mg, 0.0097 mmol, 10.0 equiv).  After 
3 hr the solution purified directly via silica gel chromatography (3:1 dichloromethane: 
(90:10:0.6:0.6 dichloromethane: methanol: water: ammonium hydroxide)) to afford 
cyclic guanidine 366 (0.45 mg, 100%, 10% impure with the corresponding eliminated 
allylic guanidine) as a white solid.   
Rf  0.31 (1:2 dichloromethane: (90:10:0.6:0.6 dichloromethane: methanol: water: 
ammonium hydroxide));  1H NMR (500 MHz, MeOD) δ 7.46 – 7.24 (m, 5H, C6H5), 6.90 
(d, J = 4.1 Hz, 1H, HC=CH), 6.42 (d, J = 4.1 Hz, 1H, HC=CH), 6.04 (s, 1H, CHN), 5.10 
(d, J = 4.8 Hz, 2H, PhCH2O), 3.99 – 3.86 (m, 1H, CH2CHCH2N), 3.07 (t, J = 10.4 Hz, 
1H, CH2CHCH2N), 2.57 – 2.50 (m, 2H, CH2CHCHCH2), 1.75 – 1.64 (m, 1H, CH2), 1.62 
– 1.49 (m, 2H, CH2), 1.29 (s, 3H, CH3), 1.16 (m, 3H, CH3), 0.90 (t, J = 6.4 Hz, 1H, CH2);  
LRMS (ESI) m/z for C24H26O3N5Br, (M-H)- 510.4, (M+Cl)- 546.4, (M+H)+ 512.1, 
(M+Na)+ 534.1. 
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Guanidine 366, (MSB-VII-177).  To a solution of ethyl hemiaminal thioether 363 
(1.0 mg, 0.0019 mmol, 1.0 equiv) in dichloromethane (0.3 mL) was added 
bis(collidine)iodine(I)hexafluorophosphate (5.0 mg, 0.0097 mmol, 5.0 equiv).  After 3 hr 
the solution purified directly via silica gel chromatography (3:1 (90:10:0.6:0.6 
dichloromethane: methanol: water: ammonium hydroxide): dichloromethane) to afford 
cyclic guanidine 366 (0.9 mg, 93%, 25% impure with the corresponding eliminated 
allylic guanidine) as a white solid. All spectra matched that previously reported. 
 
 
 
Dimethylcyclopentaphakellin (245), (MSB-VII-180).  To a solution of guanidine 366 
(0.5 mg, 0.001 mmol, 1.0 equiv) in methanol (0.4 mL) was added sodium acetate (1 mg, 
0.012 mmol, 12 equiv) and 10% palladium on carbon (0.1 mg, 0.0001 mmol, 0.1 equiv) 
and the atmosphere was exchanged with hydrogen gas at balloon pressure.  After 14 hr 
the solution was filtered through celite and concentrated in vacuo to afford crude 
dimethylcyclopentaphakellin (245) (0.3 mg, 60% crude) as a white solid. 
Rf  0.12 (90:10:0.6:0.6 dichloromethane: methanol: water: ammonium hydroxide);  1H 
NMR (500 MHz, MeOD) δ 7.00 – 6.98 (m, 1H, O=CC=CHCH=CH), 6.80 – 6.77 (m, 1H, 
O=CC=CHCH=CH), 6.27 (m, 1H, O=CC=CHCH=CH), 5.66 (s, 1H, CHN), 3.86 – 3.80 
(m, 1H, CH2CHCH2N), 3.13 – 3.07 (m, 1H, CH2CHCH2N), 2.77 – 2.68 (m, 1H, CH2CH), 
2.37 – 2.30 (m, 1H, CH2CHCH2N), 2.18 – 2.11 (m, 1H, CH2), 1.73 – 1.64 (m, 1H, CH2), 
1.64 – 1.57 (m, 1H, CH2), 1.21 – 1.16 (m, 1H, CH2), 1.15 (s, 6H, CH3, CH3), 1.12 – 1.04 
(m, 1H, CH2);  LRMS (ESI) m/z for C16H21ON5, (M-H)- 298.19, (M+H)+ 300.14. 
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CHAPTER 5.  ADVANCED SYNTHETIC EFFORTS TOWARDS  
THE REVISED STRUCTURE OF PALAU’AMINE 
 
5.1 Synthetic Strategy 
The synthesis of the fully functionalized cyclopentane core of the revised structure 
of palau’amine (1b) (see Chapter 3) has allowed access to intermediates possessing the 
desired array of functionality with proper stereochemistry that will allow for further 
advancement to the target 1b.  Furthermore, the model study directed toward the 
synthesis of a simplified analog of 1b (dimethylcyclopentaphakellin, see Chapter 4), 
demonstrated that the trans-fused [3.3.0]-bicyclic ring system within the hexacyclic 
skeleton could be constructed via an intramolecular [3+2]-dipolar cycloaddition of an 
alkyl azide with a pendent electron-deficient alkene.  In addition, installation of the 
phakellin ring system through the use of N-acyl iminium chemistry allowed for 
preparation of intermediates that possessed five of the six rings of 1b. The current 
challenge is to apply this strategy, which was validated in the model study, to the total 
synthesis of the revised structure of palau’amine (1b) using the densely functionalized 
cyclopentane 241 (Scheme 5.1).  However, the additional functionality and steric 
encumbrance could possibly hamper the application of this strategy on such a highly 
substituted substrate.  In addition, aziridine formation by displacement of C17-chloro 
substituent by backside attack of the C16 N-functionality could further complicate 
forward progress of the project (see Scheme 3.21).  Nonetheless, application of the 
developed approach would involve advancement of acyl azide 241, prepared in  
 
Scheme 5.1 
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Chapter 3, to the cyclization precursor 100, possessing an electron-deficient alkene.  An 
intramolecular [3+2]-dipolar cycloaddition would then generate triazoline 99, securing 
the trans-fusion of the [3.3.0]-bicyclic ring system.  Cyclization methods developed in 
Chapter 4 would provide tetracyclic pyrazinone 98 and, finally, installation of the two 
guanidines rings would allow access to 1b, completing the total synthesis of the revised 
structure of palau’amine. 
 
5.2 Synthesis of [3+2] Cycloaddition Precursors 
Application of the envisioned [3+2]-dipolar cycloaddition strategy required 
transformation of the acyl azide moiety within 241 (Scheme 5.2) into a stable functional 
group, as well as the mono-substituted alkene into an electron-deficient α,β-unsaturated 
ester, without concomitant aziridine formation.  The previous studies had found that 
aziridine formation on monocyclic cyclopentanes (i.e., 241) possessing the 
stereochemical configuration of the revised structure of palau’amine (1b) was quite facile 
under basic and thermal conditions (Scheme 3.21).  In order to address this issue, any 
further transformations would have to be limited to non-basic conditions and at the 
minimal temperature required for reaction.   
The acyl azide moiety within 241 would serve as a versatile intermediate from 
which to generate multiple cyclization precursors.  Introduction of the C19  
N-functionality of the natural product was possible via a Curtius rearrangement; however, 
for ease of characterization in future intermediates, acyl azide 241 was first converted 
into the methyl ester 372 via methanolysis in 66% yield.  Allyl enoate 373 was 
subsequently accessed via a three-step process involving dihydroxylation, oxidative 
cleavage, and Wittig olefination in 71% over three steps.  Alternatively, the C19 
N-functionality could be installed via a Curtius rearrangement to afford carbamate 374 in 
63% yield; however, subsequent intermediates were difficult to analyze by 1H NMR due 
to the hindered rotation of the additional carbamate moiety.  Advancement of carbamate 
374 allowed access to differentially protected allyl and methyl α,β-unsaturated esters 375 
and 376 via similar three step homologation methods in 32% and 60% respective yields 
over three steps.   
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Scheme 5.2 
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5.3 Synthesis of the Trans-Fused [3.3.0]-Azabicyclic Ring System 
With preparation of the electron-deficient olefins 373, 375, and 376 complete, the 
proposed intramolecular [3+2] dipolar cycloaddition was evaluated.  Subjection of 373 
(Scheme 5.3) to the optimal conditions from the model study (acetonitrile, 130 °C, 
2 hours) resulted in the formation of three new products 378, 379, and 380; none of 
which were found to be the desired trans-fused vinylogous carbamate 377.  Instead, 
cis-fused vinylogous carbamate 378 was isolated in 54% along with tricyclic carbamates 
379 and 380 in low yields (18% and 5%, respectively), each derived from different 
cyclizations involving the carbonyl oxygen of the Boc group.  The configuration of the 
bicyclic-ring fusion of each compound was verified by NOE, wherein 378 and 379 were 
found to possess a cis-fused [3.3.0]-bicyclic ring system and 380 was found to possess a 
trans-fused [4.3.0]-bicyclic ring system.   
A possible mechanism for the formation of the products 378, 379, and 380 is 
presented in Scheme 5.4.  Under the high temperatures of the reaction conditions two 
initial mechanistic pathways likely occur.  In the first alternative (path A, Scheme 5.4), 
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Scheme 5.3 
 
 
the cycloaddition of 373 proceeds as desired to afford the trans-fused cycloadduct, 
triazoline 381.  Decomposition of triazoline 381 can proceed to generate trans-fused 
vinylogous carbamate 377 (path A1) or trans-fused C10-aziridine 382 (path A2).  
However, neither of these products appear to be stable under the reaction conditions and 
undergo isomerization to the thermodynamically favored cis-fused [3.3.0]-bicyclic 
vinylogous carbamate 378 and trans-fused [4.3.0]-tricyclic carbamate 380, respectively.  
Alternatively, it is possible that prior to cyclization, cyclopentane 373 undergoes 
aziridine formation to generate 383 (path B, Scheme 5.4) via backside attack of the 
C16 N-functionality to displace the C17-chloro substituent.  One assumption that 
determines the order of the steps of this pathway requires that C17-aziridine formation 
does not occur after cycloaddition due to the altered conformation of the subsequent 
trans-fused bicyclic intermediates that would lead to a highly strained transition state for 
aziridine ring closure.  After formation of aziridine 383, cycloaddition would afford 
tetracyclic triazoline 384.  A series of transformations driven by the highly strained 
nature of intermediate 384 would then provide tricyclic carbamate 379.  These steps 
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would involve aziridine opening followed by trapping with the Boc carbamate carbonyl 
O-functionality and loss of butene, decomposition of the triazoline to generate the 
vinylogous carbamate moiety with loss of nitrogen gas, and epimerization at C11 to the 
thermodynamically favored cis-fused structure.  The combined results of Scheme 5.4 
suggest that the desired cycloaddition is kinetically viable, but that the desired products 
were not stable under the elevated temperatures of the reaction conditions.   In addition, 
the behavior of these intermediates as well as related systems observed in Chapter 4 
suggests that epimerization of the C11 stereocenter occurs most readily when the 
vinylogous carbamate moiety is present, likely via enamine/imine tautomerization. 
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In order to probe whether the desired cyclization products could be isolated prior to 
C11 epimerization, the cycloaddition was conducted at lower reaction temperatures.  
Indeed, heating of azide 373 (Scheme 5.5) at 80 °C in toluene for 20 hours resulted in 
isolation of the desired tricyclic triazoline 381 in quantitative yield.  The stereochemistry 
of the trans-fusion of 381 was verified by NOE correlations.*  Contrary to expectations, 
the fully functionalized substrate 373 yielded the initial cycloadduct, triazoline 381, that 
was stable to further reaction and even isolation, which is fortuitous as it lacks the 
vinylogous carbamate moiety that likely leads to C11 epimerization pathways.  Having 
validated the method to generate the trans-fused bicyclic core of the revised structure of 
palau’amine (1b), efforts were then focused of elaboration to the rest of phakellin ring 
structure.   
 
Scheme 5.5 
 
 
5.4 Progress Toward the Phakellin Ring Structure 
With a method to generate trans-fused triazoline 381, a selective manner was 
required with which to transform triazoline 381 into tetracyclic pyrazinone 386 (Scheme 
5.6).  Three methods were developed in the dimethylcyclopentaphakellin model study 
that allowed for such a transformation on simpler systems.  Application of these methods 
to the fully functionalized triazoline 381 would result in three parallel routes to access 
pyrazinone 386:  (1) decomposition of triazoline 381 into trans-fused bicyclic vinylogous 
carbamate 377, followed by formation of vinyl bromide 385 and, finally, use of a 
Hartwig-Buchwald cross-coupling cyclization to access pyrazinone 386; (2) formation of 
α-diazo ester 387 followed by truncation of the ester carbonyl via oxidative cleavage to 
                                                 
*
 381 was found to possess similar coupling constants to the model intermediates (e.g., vinylogous 
carbamate 287, Scheme 4.11). 
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access hemiaminal 388, and finally elimination of the C-6 O-functionality to generate the 
C10,C6 alkene of pyrazinone 386; and lastly (3) use of α-diazo ester 387 to access 
C6-ester pyrazinone 389 via the corresponding hemiaminal and, finally, reductive 
decarboxylation to generate C6-protio pyrazinone 386.  As method (1) would involve 
formation of the potentially labile vinylogous carbamate moiety, methods (2) and (3), 
which both involve diazo ester formation, were explored to access pyrazinone 386. 
 
Scheme 5.6 
 
5.4.1 Introduction of the Pyrrole Amide 
With establishment of a synthetic plan, efforts were then focused on transformation 
of triazoline 381 into the corresponding α-diazo ester.  During the model study of 
dimethylcyclopentaphakellin 245, model triazoline 288 (Scheme 5.7A) could not be 
isolated in high purity from 286, as it was unstable to extended heating in solution and 
exposure to silica gel, resulting in both cases in the formation of α-diazo ester 289.  In 
contrast, the fully functionalized triazoline 381 (Scheme 5.7B) was generated in 
quantitative conversion from azide 373, but attempts to convert 381 to the corresponding 
α-diazo ester upon continued heating resulted in undefined decomposition.  In addition, 
silica gel also had no affect on triazoline 381. 
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Scheme 5.7 
 
 
With no initial success in the formation of α-diazo ester 390 (Scheme 5.8A) under 
thermal conditions or exposure to silica gel, basic conditions were screened for its 
formation.  Upon exposure of triazoline 381 to 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU),* rapid and efficient conversion to α-diazo ester 390 (IR, 2105 cm-1) was 
observed.  However, this intermediate was difficult to analyze spectroscopically and was 
only identified after EDCI coupling of the pyrrolidine moiety with pyrrole acid 311 to  
 
Scheme 5.8 
 
                                                 
*
 The other bases evaluated for the formation of α-diazo ester 390 included pyridine, 2,6-lutidine, 
diisopropylethylamine, triethylamine, sodium ethoxide, and the P-4 phosphazene base (1-tert-butyl-4,4,4-
tris(dimethylamino)-2,2-bis[tris(dimethylamino)-phosphoranylidenamino]-2Λ5,4Λ5-
catenadi(phosphazenium) tetrafluoroborate salt; however, DBU was the only effective base. 
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generate pyrrole amide 391 in 50% yield over two steps.  This two-step sequence not 
only generated the α-diazo ester functionality, but also served to introduce the necessary 
A ring pyrrole.  After evaluating alternative conditions, it was found that the three steps 
involving cycloaddition, diazo ester formation, and amide coupling could be performed 
together in sequence to afford a more efficient process (Scheme 5.8B).  In this one-pot 
procedure, the cycloaddition reaction was carried out in the presence of DBU, which 
allowed for the rapid conversion of the triazoline cycloadduct to the corresponding 
α-diazo ester, thus minimizing unproductive thermal triazoline decomposition over the 
course of the cycloaddition reaction.  After consumption of the starting material 373, the 
reaction solution was then cooled, diluted with dichloromethane, and treated with the 
coupling reagents to afford amide 391 in 61% yield.   
The transformation of the monocyclic cyclization precursors into trans-fused 
[3.3.0]-bicyclic amides was successfully applied to multiple derivatives (Table 5.1).  
Entry 1 possessing the C19-ester substituent represents the data described in Scheme 
5.8B.  Substrates possessing a C19 N-functionality were also amenable to the cyclization 
process, as seen with products 392, 394, and 395 (Entries 2-5).  An improvement in the 
yield of 392 was observed upon using HATU ((2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate) as the coupling reagent rather than EDCI with 
4-dimethylaminopyridine (DMAP) (Entry 3 vs Entry 2).  HATU has been proven to be 
very efficient in the coupling of sterically hindered amines.1  N-Carbamate-derived 
pyrrole-2-carboxyamides (i.e., 394) could also be accessed (Entry 4); however, the yield 
was lower (30%) because of apparent byproduct formation resulting from additional 
carboxylic acid decomposition.  Finally, even pyrrole acids lacking an N-protecting group 
(315) were amenable to coupling (Entry 5), albeit in lower yield to afford amide 395.   
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Table 5.1.  Tandem cycloaddition/acylation to form trans-fused bicyclic amides. 
R1
BnO
Cl
H
N
N
Boc
O
OR2
N2
R3N
O
Br
H
H
R4
H
N
H
H
Cl
OR2
O
N
N
N
BnO
R1
Boc
R3N
O
Br
R4
HO conditions
Entry
general
procedure
pyrrole acid
coupling
reagents
product yield
SEMN
O
Br
Br
HO
373
R1 = Allyl
R2 = CO2Me
B
EDCI, DMAP
pyridine
PhCh3/CH2Cl2
0 to 23 °C
391
R1 = CO2Me
R2 = Allyl
R3 = SEM
R4 = Br
61%
starting
material
1
SEMN
O
Br
Br
HO
376
R1 = Me
R2 = NHCbz
B
EDCI, DMAP
pyridine
PhCh3/CH2Cl2
0 to 23 °C
392
R1 = NHCbz
R2 = Me
R3 = SEM
R4 = Br
60%2
SEMN
O
Br
Br
HO
376
R1 = Me
R2 = NHCbz
B
HATU
2,6-lutidine
PhCh3/CH2Cl2
23 °C
392
R1 = NHCbz
R2 = Me
R3 = SEM
R4 = Br
75%3
TeocN
O
BrHO
376
R1 = Me
R2 = NHCbz
B
EDCI, DMAP
pyridine
PhCh3/CH2Cl2
0 to 23 °C
394
R1 = NHCbz
R2 = Me
R3 = Teoc
R4 = H
30%4
HN
O
Br
Br
HO
375
R1 = Allyl
R2 = NHCbz
A
EDCI, DMAP
2,6-lutidine
CH2Cl2
0 to 23 °C
395
R1 = NHCbz
R2 = Allyl
R3 = H
R4 = Br
26%5
Procedure A: two-step. 1) PhCH3, 75 °C, 20 hr, concentrate; 2) DBU, CH2Cl2, 23 °C, then addition of coupling reagents
Procedure B: one-pot. i) PhCH3, DBU, 75 °C, 20 hr; ii) dilute with CH2Cl2, then addition of coupling reagents
311
311
311
393
315
 
 
5.4.2 Progress Toward Tetracyclic Pyrazinone 
 With the successful synthesis of amide derivatives 398 (Scheme 5.9) via triazolines 
397, efforts were focused on accessing the tetracyclic structure of the revised structure of 
palau’amine (1b) present within pyrazinone 400.  According to the methods developed in 
Chapter 4, it was envisioned that the B ring of could be constructed by manipulation of 
α-diazo ester 398 into hemiacetal 399, followed by activation and elimination of the 
C6 O-functionality to generate the C10,C6 alkene of pyrazinone 400. 
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Scheme 5.9 
 
 
 Progress toward C19 carbamate-derived pyrazinone 403 allowed access to the most 
advanced synthetic intermediate prepared, diol 402 (Scheme 5.10).  Oxidation of α-diazo 
ester 392 to the α-keto ester 401 was efficiently effected by oxone.  Subsequent reduction 
of keto ester 401 with lithium borohydride led to undesired cleavage of the pyrrole amide 
C-N bond.*  Alternatively, selective reduction of keto ester 401 was accomplished with  
 
Scheme 5.10 
 
                                                 
*
 In the model and fully functionalized substrates, significant cleavage of the pyrrole amide bond upon 
exposure to lithium borohydride was only experienced with SEM derived pyrroles. 
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sodium borohydride in isopropyl alcohol2 to afford diol 402 as a single diastereomer in 
60% yield over two steps.  Future efforts will focus on accessing tetracyclic 403 by 
removal of the pyrrole N-SEM group, followed by oxidative cleavage of the diol, 
cyclization with the pyrrole, and elimination to establish the B ring of pyrazinone 403.   
 
5.5 Summary 
A diastereoselective synthesis of the trans-fused azabicyclo[3.3.0]octane core of 
the revised structure of palau’amine (1b) has been developed (Scheme 5.11).  The 
racemic synthesis of diol 402, possessing the fully elaborated A, D, and E rings of 1b in 
addition to the C19 N-functionality, was accomplished in 27 steps from commercially 
available benzoquinone (104) in an overall yield of 0.9%.  This accomplishment was 
predicated on the successful development of novel manner to generate the 
chlorocyclopentane core (Ring E, 131b) via a [4+2] Diels-Alder/[3,3]-sigmatropic-
rearrangement strategy and the trans-fused bicyclic ring system (i.e., 392) via an 
intramolecular [3+2]-dipolar cycloaddition of an alkyl azide.  The only other synthesis of 
a related synthetic intermediate possessing the trans-fused bicyclic ring system, reported 
by Romo and co-workers3 in 2008 (Scheme 1.8), was accomplished in 23 steps and an 
overall yield of 0.7%.  
In order to develop access to the densely substituted cyclopentane core of the revised 
structure of palau’amine (1b) the [3,3]-sigmatropic rearrangement of the 
tricyclodecadienes (i.e., 129) was studied.  Insight into the substituent effects that affect 
both the thermodynamic and kinetic parameters were identified.  This lead to an efficient 
synthesis of the chlorocyclopentane core of 1b, 131b, which was progressed to the fully 
functionalized cyclopentane 374 via strategically designed ring opening events.  Access 
to the advanced trans-fused azabicyclo[3.3.0]octane 392 was made possible by 
application of the approach developed to construct the phakellin substructure, validated in 
the synthesis of palau’amine analog dimethylcyclopentaphakellin (245).  This approach 
used the intramolecular [3+2]-azide-cycloaddition/acylation strategy to generate α-diazo 
ester 392 from monocyclic azide 376.  This reaction represents the most complicated 
example reported to date using an intramolecular [3+2]-azide-cycloaddition.  Not only is 
the cycloaddition facile and diastereoselective, but has been shown to provide a variety of  
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different cycloaddition products in a controlled manner under different sets of conditions.  
This method could have broad applicability to the synthesis of complex pyrrolidines and 
piperidines present within a wide range of different natural products.   
Having accessed the trans-fused bicyclic core of the revised structure of 
palau’amine (1b), future efforts will involve accessing tetracyclic pyrazinone 403 
following the steps outlined for Scheme 5.10.  Finally, introduction of the two guanidines 
(Rings C and F) will follow the method developed in Chapter 4 or alternative strategies 
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delineated in Chapter 6.  Application of these new methods will hopefully culminate in 
the total synthesis of this structurally complex immunosuppressive natural product, 
thereby bringing closure to the tumultuous tale for the structural characterization of 
palau’amine.   
 
5.6 Experimental 
General Procedures.  All reactions were performed in flame-dried round bottom 
or modified Schlenk (Kjeldahl shape) flasks fitted with rubber septa or glass stoppers 
under a positive pressure of argon, unless otherwise noted.  Air- and moisture-sensitive 
liquids and solutions were transferred via syringe or stainless steel cannula.  Organic 
solutions were concentrated by rotary evaporation below 30 °C at ca. 25 Torr.  Flash 
column chromatography was performed employing 230-400 mesh silica gel.  Thin-layer 
chromatography (analytical and preparative) was performed using glass plates precoated 
to a depth of 0.25 mm with 230-400 mesh silica gel impregnated with a fluorescent 
indicator (254 nm).  Reaction temperatures were maintained through the use of the 
following baths unless stated otherwise:  above ambient temperature (oil bath), 0 °C 
(ice/water), -78 °C (dry ice/acetone). 
Materials.  Commercial reagents and solvents were used as received with the 
following exceptions:  tetrahydrofuran, benzene, acetonitrile, dimethoxyethane, diethyl 
ether, toluene, and dichloromethane were dried by passage through activated alumina 
columns under a positive pressure of argon.  Ethanol, 1,2-dichloroethane, dimethyl 
formamide, and dimethylsulfoxide was dried over activated 4 Å molecular sieves.  
Triethylamine, pyridine, and methanol were distilled from calcium hydride at 760 Torr.   
Instrumentation.  Infrared (FTIR) spectra were obtained using a Perkin-Elmer 
Spectrum BX or a Bruker Tensor 27 spectrophotometer and referenced to a polystyrene 
standard.  Data are presented as the frequency of absorption (cm-1), and intensity of 
absorption (s = strong, m = medium, w = weak, br = broad).  Proton and carbon-13 
nuclear magnetic resonance (1H NMR and 13C NMR) spectra were recorded on a Varian 
Unity 400, Varian Unity 500, Varian Unity Inova 500NB NMR or Bruker Avance III 500 
spectrometer.  Chemical shifts are expressed in parts per million (δ scale) downfield from 
tetramethylsilane and are referenced to residual protium in the NMR solvent (CHCl3: δ 
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7.26 for 1H, δ 77.16 for 13C; C6HD5: δ 7.16 for 1H, δ 128.06 for 13C; CHD2OD: δ 3.31 for 
1H, δ 49.00 for 13C).  Data are presented as follows:  chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quadruplet, ABq = non-first order quadruplet, p = 
pentet, br = broadened signal, m = multiplet and/or multiple resonances), integration, and 
coupling constants in Hertz (Hz).  1H NMR assignments were generally supported by 
COSY experiments. 
The following compounds were prepared according to literature methods:  allyl 
(triphenylphosphoranylidene)acetate (285),4  
4,5-dibromo-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrole-2-carboxylic acid (311).5   
 
 
 
 
Methyl Ester 372, (MSB-VIII-053).  To a solution of acyl azide 241 (31 mg, 
0.062 mmol, 1.0 equiv) in methanol (3 mL) at 23 °C was added potassium carbonate 
(4.25 mg, 0.031 mmol, 0.5 equiv).  After stirring for 1 ½ hr the solution was diluted with 
saturated ammonium chloride (40 mL) and extracted with dichloromethane (3 x 30 mL).  
The combined organic layers were then dried (sodium sulfate), filtered, and concentrated 
in vacuo.  The residue was purified by silica gel flash chromatography (3:1 gradient to 
1:1 hexanes: ethyl acetate) to afford methyl ester 372 (20 mg, 66%) as a clear oil.  In 
addition, 9% (2.6 mg) was isolated of the corresponding methyl carbamate, the result of 
methanol trapping of the isocyanate of the spontaneous Curtius rearrangement.   
Rf  0.52 (3:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.42 – 7.28 (m, 5H, 
C6H6CH2O), 5.82 – 5.65 (m, 1H, CHCH=CH2), 5.19 (d, J = 10.3 Hz, 1H, CHCH=CH2), 
5.12 (d, J = 17.2 Hz, 1H, CHCH=CH2), 5.02 (s, 2H, CHCl, NH), 4.56 (q, J = 12.0 Hz, 
2H, PhCH2O), 3.73 – 3.65 (m, 4H, CH3, CCH2O), 3.51 – 3.39 (m, 2H, CCH2O, 
CHCH2N3), 3.34 (dd, J = 12.6, 4.8 Hz, 1H, CHCH2N3), 2.72 – 2.58 (m, 2H, CH2CH, 
CHCH=CH2), 2.53 (dd, J = 15.5, 6.9 Hz, 1H, CH2CH), 2.43 – 2.30 (m, 1H, CH2CH), 
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2.24 – 2.11 (m, 1H, CHCH2N3), 1.39 (s, 9H, C(CH3)3);  13C NMR (126 MHz, CDCl3) δ 
172.62, 155.51, 137.72, 135.53, 128.61, 128.00, 127.84, 119.62, 79.79, 74.44, 73.64, 
66.18, 64.08, 52.78, 51.97, 51.48, 45.98, 45.18, 35.91, 28.43;  IR (neat film) 3418 (w), 
3334 (w), 2926 (m), 2867 (w), 2100 (s), 1736 (s), 1714 (s), 1498 (m), 1454 (m), 1366 
(m), 1272 (m), 1250 (m), 1167 (s), 1070 (m) cm-1;  LRMS (ESI) m/z for C23H30ClN7O4, 
(M+Na)+ 526.14. 
 
 
 
Carbamate 374, (MSB-VIII-247).  To a solution of acyl azide 241 (39 mg, 0.077 mmol, 
1.0 equiv) in toluene (1 mL) at 23 °C was added benzyl alcohol (64.4 µL, 0.619 mmol, 
8.0 equiv) at which point the vessel was capped and heated up to 75 °C.  After stirring for 
13 hr the solution was cooled and solvent concentrated in vacuo.  The residue was 
purified by ISCO silica gel chromatography (4 g column, 10:1 gradient to 3:1 hexanes: 
ethyl acetate) to afford carbamate 374 (28.3 mg, 63%) as a clear oil.  
Rf  0.37 (3:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.43 – 7.28 (m, 10H, 
C6H5, C6H5), 5.82 – 5.67 (m, 1H, CHCH=CH2), 5.29 (br s, 1H, CbzNH), 5.21 (dd, J = 
1.5, 10.3 Hz, 1H, CHCH=CH2), 5.16 – 5.08 (m, 3H, CHCH=CH2, C6H6CH2O2C), 5.08 - 
4.98 (m, 2H, CHCl, BocNH), 4.56 (q, J = 12.0 Hz, 2H, PhCH2O), 3.70 (d, J = 9.2 Hz, 
1H, CCH2O), 3.57 (dd, J = 12.6, 3.1 Hz, 1H, CHCH2N3), 3.48 (t, J = 8.3 Hz, 3H, 
CCH2O, NHCH2CH), 3.36 (dd, J = 12.6, 3.9 Hz, 1H, CHCH2N3), 2.66 (t, J = 9.4 Hz, 1H, 
CHCH=CH2), 2.23 (br s, 1H, CHCH2N3), 2.08 (ddd, J = 15.8, 9.8, 4.9 Hz, 1H, 
NHCH2CH), 1.45 – 1.38 (s, 9H, C(CH3)3);  13C NMR (126 MHz, CDCl3) δ 156.90, 
155.62, 137.69, 136.75, 135.42, 128.59, 128.14, 128.08, 127.99, 127.83, 119.56, 79.93, 
74.31, 73.60, 66.84, 64.48, 64.41, 52.62, 51.19, 48.86, 43.07, 40.26, 28.40;  IR (neat 
film)  3420 (w), 3339 (w), 2976 (w), 2924 (m), 2852 (w), 2099 (s), 1713 (s), 1498 (s), 
1454 (m), 1366 (m), 1248 (s), 1165 (m), 1096 (m), 735 (m) cm-1;  LRMS (ESI) m/z for 
C24H33O5N4Cl, (M-H)- 491.19, (M+Cl)- 527.02, (M+H)+ 493.17, (M+Na)+ 515.16. 
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Diol 404, (MSB-VIII-055).  To a solution of alkene 372 (20.0 mg, 0.041 mmol, 
1.0 equiv) in acetone (3.0 mL) and water (1.0 mL) was added 2,6-lutidine (2.3 µL, 
0.02 mmol, 0.5 equiv), N-methylmorpholine N-oxide 50% wt solution in water (17 µL, 
0.08 mmol, 2 equiv), and osmium tetroxide (1.0 mg, 0.004 mmol, 0.1 equiv), at which 
point the solution turned yellow.  After 16 hr the solution was quenched with sodium 
bisulfite (50 mg) at which point the solution turned dark brown.  The solution was then 
diluted with water (15 mL), and extracted with ethyl acetate (3 x 10 mL). The organic 
layer was dried with magnesium sulfate, and reduced in vacuo to afford a 1:1 mixture of 
epimeric diols 404 a clear oil which was used without purification.  
Rf  0.26 (1: 1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.44 – 7.26 (m, 
10H), 5.51 (s, 1H), 5.35 (s, 1H), 5.15 (d, J = 11.1 Hz, 1H), 5.07 (br d, J = 8.1 Hz, 1H), 
4.67 (dd, J = 16.3, 11.9 Hz, 2H), 4.54 (d, J = 11.7 Hz, 1H), 4.44 (d, J = 12.0 Hz, 1H), 
3.93 (br t, 1H), 3.89 – 3.79 (m, J = 17.6, 7.0 Hz, 2H), 3.77 – 3.65 (m, 8H), 3.65 – 3.58 
(m, 2H), 3.57 – 3.38 (m, 5H), 3.36 (dd, J = 12.3, 4.6 Hz, 1H), 3.12 (dd, J = 12.3, 6.5 Hz, 
1H), 2.75 – 2.60 (m, 2H), 2.57 (s, 2H), 2.54 – 2.41 (m, 2H), 2.41 – 2.34 (m, 2H), 2.28 – 
2.21 (m, J = 15.7, 9.4 Hz, 1H), 2.21 – 2.09 (m, 3H), 1.48 – 1.39 (m, 17H);  LRMS (ESI) 
m/z for C24H35ClN4O7, (M-H)- 525.13, (M+H)+ 527.21, (M+Na)+ 549.07. 
 
 
 
Aldehyde 405, (MSB-VIII-056).  To a solution of diols 404 (22.0 mg, 0.041 mmol, 
1.0 equiv) in tetrahydrofuran (1.5 mL) and water (0.5 mL) at 23 oC was added sodium 
periodate (0.35 mg, 0.16 mmol, 4 equiv).  After 25 hr the solution was diluted with 
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saturated sodium thiosulfate (10 mL) and stirred for 10 min.  The aqueous solution was 
then extracted with ethyl acetate (3 x 10 mL) and the organic layer was dried with 
magnesium sulfate and reduced in vacuo to afford aldehyde 405 (20 mg, 99% crude 
yield) as a clear oil which was greater than 95% pure by 1H NMR.   
Rf  0.75 (1: 1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 9.64 (s, 1H, CHO), 
7.41 – 7.29 (m, 5H, C6H5), 5.22 (s, 1H, NH), 4.71 (br d, J = 9.3 Hz, 1H, CHCl), 4.63 (d, J 
= 11.9 Hz, 1H, PhCH2O), 4.56 (d, J = 11.9 Hz, 1H, PhCH2O), 3.80 (d, J = 9.3 Hz, 1H, 
CCH2O), 3.70 (s, 3H, CH3), 3.57 (m, 2H, CCH2O, CHCH2N3), 3.38 (dd, J = 12.5, 5.5 Hz, 
1H, CHCH2N3), 2.99 (d, J = 9.3 Hz, 1H, CHCHO), 2.66 (dd, J = 15.7, 4.7 Hz, 1H, 
O2CCH2CH), 2.61 – 2.44 (m, 2H, O2CCH2CH, CHCH2N3), 2.39 (dd, J = 13.3, 8.3 Hz, 
1H, O2CCH2CH), 1.39 (s, 9H, C(CH3)3);  LRMS (ESI) m/z for C23H31ClN4O6, (M-H)- 
493.12, (M+H)+ 495.13, (M+Na)+ 517.06. 
 
 
 
Allyl ester 373, (MSB-VIII-061).  To a solution of aldehyde 405 (20.0 mg, 0.041 mmol, 
1.0 equiv) in toluene (1.5 mL) was added allyl (triphenylphosphoranylidene)acetate 
(30.0 mg, 0.082 mmol, 2.0 equiv) and then heated up to 70 °C.  After stirring for 30 min 
the solvent was removed in vacuo.  The residue was purified by silica gel flash 
chromatography (3:1 gradient to 2:1 hexanes: ethyl acetate) to afford allyl ester 373 
(17.1 mg, 71% over three steps) as a clear oil.   
Rf  0.51 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.44 – 7.27 (m, 5H, 
C6H5), 6.88 (dd, J = 15.7, 8.8 Hz, 1H, CHCH=CHCO2), 6.00 – 5.85 (m, 2H, 
CH2CH=CH2, CHCH=CHCO2), 5.32 (dd, J = 17.2, 1.3 Hz, 1H, CH2CH=CH2), 5.24 (dd, 
J = 10.4, 1.0 Hz, 1H, CH2CH=CH2), 5.06 (d, J = 10.4 Hz, 1H, CHCl), 5.00 (s, 1H, NH), 
4.69 – 4.57 (m, 3H, CH2CH=CH2, PhCH2O), 4.54 (d, J = 12.0 Hz, 1H, PhCH2O), 3.71 (s, 
3H, CH3), 3.66 (d, J = 9.2 Hz, 1H, CCH2O), 3.50 – 3.37 (m, 2H, CCH2O, CHCH2N3), 
3.33 (dd, J = 12.7, 4.2 Hz, 1H, CHCH2N3), 2.85 (t, J = 9.5 Hz, 1H, CHCH=CH2CO2), 
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2.68 (dd, J = 15.6, 4.4 Hz, 1H, O2CCH2CH), 2.52 (dd, J = 15.6, 6.7 Hz, 1H, 
O2CCH2CH), 2.35 (ddd, J = 15.5, 9.9, 5.4 Hz, 1H, O2CCH2CH), 2.31 – 2.22 (m, 1H, 
CHCH2N3), 1.39 (s, 9H, C(CH3)3);  13C NMR (126 MHz, CDCl3) δ 179.42, 172.38, 
165.68, 146.04, 137.4, 132.34, 128.75, 128.22, 127.97, 125.02, 118.49, 81.67, 74.66, 
73.75, 65.50, 65.27, 64.50, 52.06, 51.09, 50.78, 46.13, 44.53, 35.46, 28.4;  IR (neat film) 
3348 (w), 2978 (m), 2930 (m), 2872 (w), 2102 (s), 1717 (s), 1651 (w), 1498 (m), 1454 
(w), 1367 (m), 1276 (m), 1251 (m), 1164 (m), 991 (w), 738 (w) cm-1;  HRMS (ESI) m/z 
calc’d for C28H37O7N4ClNa, (M+Na)+ 599.2248, observed 599.2249. 
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Diol 405, (MSB-VIII-249).  To a solution of alkene 374 (28 mg, 0.048 mmol, 1.0 equiv) 
in acetone (2.0 mL) and water (0.67 mL) was added 2,6-lutidine (5.6 µL, 0.048 mmol, 
1.0 equiv), N-methylmorpholine N-oxide 50% wt solution in water (20 µL, 0.096 mmol, 
2 equiv), and osmium tetroxide (1.0 mg, 0.004 mmol, 0.1 equiv), at which point the 
solution turned yellow.  After 2.5 days the solution was quenched with sodium bisulfite 
(200 mg) and water (10 mL) and stirred for 10 min.  The solution was then extracted with 
ethyl acetate (3 x 10 mL), dried with sodium sulfate, and reduced in vacuo to afford a 1:1 
mixture of epimeric diols 405 (21.6 mg) as a clear oil which was used without 
purification.  Rf  0.1 (2: 1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.49 – 
7.27 (m), 5.69 (br s), 5.42 – 4.95 (m), 4.73 – 4.37 (m), 4.04 – 3.90 (m), 3.90 – 3.80 (m), 
3.79 – 3.49 (m), 3.50 – 3.29 (m), 3.26 – 3.13 (m), 2.35 (dd, J = 5.6, 7.4 Hz), 2.31 – 2.20 
(m), 2.15 – 2.07 (m), 2.04 – 1.95 (m), 1.94 – 1.85 (m), 1.46 – 1.40 (m);  LRMS (ESI) m/z 
for C24H35ClN4O7, (M-H)- 525.13, (M+H)+ 527.21, (M+Na)+ 549.07. 
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Aldehyde 406, (MSB-VIII-253).  To a solution of diols 405 (21.6 mg, 0.035 mmol, 
1.0 equiv) in tetrahydrofuran (2.6 mL) and water (0.8 mL) at 23 °C was added sodium 
periodate (29.9 mg, 0.14 mmol, 4.0 equiv).  After stirring for 14 hr the solution was 
diluted with saturated sodium thiosulfate (10 mL) and extracted with ethyl acetate (3 x 
10 mL).  The combined organic layers were then dried (sodium sulfate), filtered, and 
concentrated in vacuo to afford crude aldehyde 406 (18.2 mg, 89% crude). The residue 
was used in the next reaction without purification.  Small Scale Procedure with 
Purification of aldehyde 406:  a procedure similar to above was used with the following 
amounts: diol 7 (3.8 mg, 0.0061 mmol, 1.0 equiv), sodium periodate (5.2 mg, 
0.024 mmol, 4 equiv) for 6 hrs. Purification by silica gel flash chromatography (4:1 
hexanes: ethyl acetate) afforded aldehyde 406 (0.6 mg, 16% over two steps) as a clear 
film.   
Rf  0.51 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 9.65 (s, 1H, 
CHCHO), 7.41 – 7.29 (m, 10H, C6H5, C6H5), 5.20 (s, 1H, NH), 5.15 – 5.04 (m, 3H, NH, 
C6H6CH2O2C), 4.70 (br d, J = 9.4, 1H, CHCl), 4.64 (d, J = 11.9 Hz, 1H, PhCH2O), 4.55 
(d, J = 11.8 Hz, 1H, PhCH2O), 3.77 (d, J = 9.1 Hz, 1H, CCH2O), 3.59 – 3.53 (m, 2H, 
CCH2O, CH2), 3.52 – 3.40 (m, 3H, NHCH2CH, CHCH2N3), 2.96 (d, J = 9.3 Hz, 1H, 
CHCHO), 2.61 (br s, 1H, CHCH2N3), 2.07 (br s, 1H, NHCH2CH), 1.40 (s, 9H, C(CH3)3);  
LRMS (ESI) m/z for C29H36O6N5Cl, (M-H)- 583.97, (M+Cl)- 620.04, (M+Na)+ 608.16, 
(M+K)+ 624.10. 
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Allyl ester 375, (MSB-IX-060).  To a solution of aldehyde 406 (18.2 mg, 0.031 mmol, 
1.0 equiv) in toluene (0.75 mL) at 23 °C was added allyl 
(triphenylphosphoranylidene)acetate (22.4 mg, 0.062 mmol, 2.0 equiv) and then heated 
up to 75 °C.  After stirring for 1 hr the solvent was removed in vacuo.  The residue was 
purified by silica gel flash chromatography (4:1 gradient to 2:1 hexanes: ethyl acetate) to 
afford allyl ester 375 (10.5 mg, 32% over three steps) as a clear oil.   
Rf  0.41 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.45 – 7.28 (m, 10H, 
C6H5, C6H5), 6.87 (dd, J = 15.7, 8.8 Hz, 1H, CHCH=CHCO2), 6.01 – 5.83 (m, 2H, 
CH2CH=CH2, CHCH=CHCO2), 5.33 (d, J = 17.2 Hz, 1H, CH2CH=CH2), 5.25 (d, J = 
10.4 Hz, 1H, CH2CH=CH2), 5.20 (br s, 1H, CbzNH), 5.15 – 4.98 (m, 4H, CHCl, BocNH, 
C6H6CH2O2C), 4.65 – 4.57 (m, 3H, CH2CH=CH2, PhCH2O), 4.53 (d, J = 12.0 Hz, 1H, 
PhCH2O), 3.68 – 3.56 (m, 2H, CCH2O, CHCH2N3), 3.55 – 3.37 (m, 3H, NHCH2CH, 
CCH2O), 3.32 (dd, J = 12.8, 3.2 Hz, 1H, CHCH2N3), 2.84 (t, J = 9.6 Hz, 1H, 
CHCH=CH2CO2), 2.32 (br s, 1H, CHCH2N3), 2.05 (br t, J = 11.1 Hz, 1H, NHCH2CH), 
1.39 (s, 9H, C(CH3)3);  13C NMR (126 MHz, CDCl3) δ 165.64, 156.99, 155.46, 146.08, 
137.30, 136.70, 132.32, 128.73, 128.65, 128.21, 128.07, 127.96, 124.91, 118.56, 74.57, 
73.71, 66.97, 65.31, 64.77, 63.59, 50.70, 50.69, 48.07, 42.98, 39.46, 28.40;  IR (neat 
film)  3420 (w), 3342 (w), 2977 (w), 2930 (m), 2872 (w), 2100 (s), 1715 (s), 1520 (m), 
1498 (m), 1454 (m), 1367 (m), 1251 (s), 1165 (m), 737 (m) cm-1;  LRMS (ESI) m/z for 
C34H42O7N5Cl, (M-H)- 666.32, (M+Cl)- 702.42, (M+Na)+ 690.51. 
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Methyl ester 376, (MSB-VIII-198).  To a solution of crude aldehyde 406 (5.5 mg, 
0.0095 mmol, 1.0 equiv) in toluene (0.5 mL) was added methyl 
(triphenylphosphoranylidene)acetate (6.3 mg, 0.019 mmol, 2.0 equiv) and then heated up 
to 75 °C.  After stirring for 20 min the solution was cooled and the solvent was removed 
in vacuo.  The residue was purified by silica gel flash chromatography (4:1 gradient to 
1:1 hexanes: ethyl acetate) to afford methyl ester 376 (3.6 mg, 60% over three steps) as a 
clear oil.   
Rf  0.43 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, CDCl3) δ 7.41 – 7.28 (m, 10H, 
C6H5, C6H5), 6.85 (dd, J = 15.7, 8.8 Hz, 1H, CHCH=CHCO2), 5.87 (d, J = 15.7 Hz, 1H, 
CHCH=CHCO2), 5.20 – 5.13 (m, 1H, CHCH2NH ), 5.11 (d, J = 1.6 Hz, 2H, 
C6H6CH2O2C), 5.07 (br d, J = 13.5 Hz, 1H, BocNH), 5.01 (br s, 1H, CHCl), 4.61 (d, J = 
12.1 Hz, 1H, PhCH2O), 4.52 (d, J = 12.0 Hz, 1H, PhCH2O), 3.72 (s, 3H, CH3), 3.63 (d, J 
= 9.2 Hz, 1H, CCH2O), 3.58 (dd, J = 12.9, 3.3 Hz, 1H, CHCH2N3), 3.55 – 3.47 (m, J = 
12.1, 6.4 Hz, 1H, NHCH2CH), 3.47 – 3.39 (m, 2H, NHCH2CH, CCH2O), 3.32 (dd, J = 
12.8, 3.3 Hz, 1H, CHCH2N3), 2.84 (t, J = 9.7 Hz, 1H, CHCH=CHCO2), 2.30 (br t, J = 
10.4 Hz, 1H, CHCH2N3), 2.10 – 1.98 (m, 1H, NHCH2CH), 1.40 (s, 9H, C(CH3)3);  13C 
NMR (126 MHz, CDCl3) δ 166.45, 157.03, 155.47, 145.99, 137.30, 136.70, 128.73, 
128.66, 128.22, 128.08, 127.99, 124.81, 80.30, 74.52, 73.71, 66.98, 64.78, 63.53, 51.61, 
50.74, 50.55, 48.03, 43.06, 39.49, 28.35;  IR (neat film)  3422 (w), 3346 (br), 2978 (w), 
2930 (m), 2872 (w), 2102 (s), 1712 (s), 1522 (m), 1500 (m), 1473 (m), 1454 (m), 1368 
(m), 1282 (s), 1253 (s), 1166 (m), 739 (m) cm-1;  LRMS (ESI) m/z for C32H40O7N5Cl, 
(M-H)- 640.11, (M+Cl)- 676.05, (M+H)+ 642.11, (M+Na)+ 664.11. 
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cis-Fused vinylogous carbamate 378, piperdine 380, and tricyclic vinylogous 
carbamate 379, (MSB-VIII-031).  In a sealed tube a solution of azide 373 (4.5 mg, 
0.008 mmol) in acetonitrile (1.0 mL) was heated up to 130 °C.  After stirring for 2 ¼ hr 
the solution was cooled concentrated in vacuo and found to be a mixture of five products 
as determined by 1H NMR.  The residue was diluted with acetonitrile again (1 mL) and 
heated at 130 °C for an additional 2 hr, at which point it was concentrated in vacuo and 
found to be a mixture of three products.  The residue was purified by silica gel flash 
chromatography (79:19:2 hexanes: ethyl acetate: triethylamine gradient to 49:49:2 
hexanes: ethyl acetate: triethylamine gradient to 98:2 ethyl acetate: triethylamine) to 
afford cis-fused vinylogous carbamate 378 (2.3 mg, 54%) as a clear oil and a mixture of 
379 and 380.  This residue was further purified via silica gel preparatory plate 
chromatography (2:1 ethyl acetate: hexanes) to afford tricyclic vinylogous carbamate 379 
(0.8 mg, 18%) and piperdine 380 (0.2 mg, 5%) as clear oils.   
cis-Fused vinylogous carbamate 378.  Rf  0.29 (2:1 hexanes: ethyl acetate);  1H NMR 
(500 MHz, C6D6) δ 8.04 (s, 1H, NHC=CHCO2), 7.25 – 7.05 (m, 5H, C6H5), 5.98 (ddd, J 
= 16.0, 10.9, 5.6 Hz, 1H, CH2CH=CH2), 5.27 (dg, J = 17.2, 1.6 Hz, 1H, CH2CH=CH2), 
5.17 (d, J = 11.3 Hz, 1H, CHCl), 5.04 (dd, J = 10.4, 1.4 Hz, 1H, CH2CH=CH2), 4.88 (s, 
1H, NHC=CHCO2), 4.79 (dt, J = 5.5, 1.4 Hz, 1H, CH2CH=CH2), 4.46 (s, 1H, NH), 4.25 
(d, J = 11.9, 1H, CHCHCH2N), 4.09 (q, J = 11.8 Hz, 2H, PhCH2O), 3.26 (s, 2H, 
CCH2O), 3.21 – 3.12 (m, 4H, CHCHCH2N, CH3), 2.97 (dd, J = 10.4, 6.3 Hz, 1H, 
CHCHCH2N), 2.65 – 2.52 (m, 2H, CHCH2CO2), 2.08 – 1.96 (m, 1H, CHCHCH2N), 1.81 
(dd, J = 15.8, 10.6 Hz, 1H, CHCH2CO2), 1.35 (s, 9H, C(CH3)3);  13C NMR (126 MHz, 
C6D6) δ 171.89, 170.31, 164.94, 154.21, 137.79, 134.61, 128.67, 116.75, 79.94, 77.72, 
73.86, 69.29, 66.27, 65.93, 63.68, 54.60, 50.96, 50.18, 46.96, 41.56, 38.03, 28.29 (benzyl 
group partially obscured by C6HD5 peak);  IR (neat film) 3423 (w), 3346 (m), 3056 (w), 
2977 (m), 2928 (m), 2857 (w), 1738 (s), 1709 (s), 1655 (s), 1595 (s), 1367 (m), 1274 (s), 
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1215 (m), 1146 (s), 1024 (m), 780 (m), 747 (m) cm-1;  LRMS (ESI) m/z for 
C28H37O7N2Cl, (M+H)+ 549.21. 
Piperdine 380.  Rf  0.21 (2:1 ethyl acetate: hexanes);  1H NMR (500 MHz, CDCl3) δ 7.40 
– 7.28 (m, 5H, C6H5), 5.92 (ddd, J = 16.9, 10.5, 5.6 Hz, 1H, CH2CH=CH2), 5.37 (dd, J = 
17.2, 1.3 Hz, 1H, CH2CH=CH2), 5.29 (d, J = 10.6 Hz, 1H, CH2CH=CH2), 4.98 (d, J = 5.2 
Hz, 1H, CHCl), 4.90 (s, 1H, NH), 4.68 (t, J = 5.6 Hz, 2H, CH2CH=CH2), 4.58 (s, 2H, 
PhCH2O), 3.88 (dd, J = 10.5, 9.9 Hz, 1H, CHCH(O)CH(N)CO2), 3.73 (d, J = 9.4 Hz, 1H, 
CCH2O), 3.71 – 3.61 (m, 5H, CH3, CCH2O, NH), 3.42 (d, J = 9.7 Hz, 1H, 
CHCH(O)CH(N)CO2), 3.17 (dd, J = 12.8, 3.8 Hz, 1H, CHCH2NH), 2.64 (dd, J = 17.1, 
8.8 Hz, 1H, CHCH2CO2), 2.51 (t, J = 12.2 Hz, 1H, CHCH2NH), 2.43 (dd, J = 17.2, 
5.5 Hz, 1H, CHCH2CO2), 2.21 – 2.11 (m, 1H, CHCH2CO2), 1.92 (t, J = 11.4 Hz, 1H, 
CHCH(O)CH(N)CO2), 1.71 – 1.61 (m, 1H, CHCH2NH);  IR (neat film) 3031 (w), 2953 
(m), 2918 (m), 2850 (w), 1752 (s), 1454 (w), 1380 (w), 1265 (s), 1187 (m), 1102 (m), 
1049 (m), 740 (s) cm-1;  HRMS (ESI) m/z calc’d for C24H30O7N2Cl, (M+H)+ 493.1742, 
observed 493.1739. 
Tricyclic vinylogous carbamate 379.  Rf  0.31 (2:1 ethyl acetate: hexanes);  1H NMR 
(500 MHz, CDCl3) δ 8.03 (s, 1H, NHC=CHCO2), 7.43 – 7.30 (m, 5H C6H5), 5.98 (ddd, J 
= 18.8, 10.4, 5.6 Hz, 1H, CH2CH=CH2), 5.42 (s, 1H, NH), 5.32 (d, J = 18.8 Hz, 1H, 
CH2CH=CH2), 5.22 (d, J = 10.4 Hz, 1H, CH2CH=CH2), 5.02 (s, 1H, NHC=CHCO2), 
4.75 (d, J = 5.8 Hz, 1H, CH(O)CHCH2), 4.69 – 4.56 (m, 3H, PhCH2O, CH2CH=CH2), 
4.53 (d, J = 11.1 Hz, 1H, PhCH2O), 3.93 (d, J = 9.3 Hz, 1H, CCH2O), 3.68 (s, 3H, CH3), 
3.63 (d, J = 9.2 Hz, 1H, CCH2O), 3.52 (dd, J = 10.6, 5.7 Hz, 1H, CHCHCH2N), 3.35 (d, 
7.4 Hz, 1H, CHCHCH2N), 3.31 (d, 10.6 Hz, 1H, CHCHCH2N), 2.81 – 2.70 (m, 2H, 
CHCHCH2N, CH(O)CHCH2), 2.47 (dd, J = 17.3, 4.3 Hz, 1H, CH(O)CHCH2), 2.38 – 
2.25 (m, 1H, CH(O)CHCH2);  IR (neat film) 3348 (w), 3055 (w), 2953 (w), 2918 (m), 
2850 (w), 1761 (s), 1737 (s), 1658 (m), 1595 (s), 1265 (s), 1228 (m), 1151 (m), 1098 (w), 
739 (s) cm-1;  HRMS (ESI) m/z calc’d for C24H28O7N2Na, (M+Na)+ 479.1794, observed 
479.1800. 
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Triazoline 381, (MSB-VIII-113).  A solution of azide 373 (6.2 mg, 0.011 mmol) in 
toluene (0.50 mL) was heated up to 80 °C.  After stirring for 22 hr the solution was 
cooled and the solvent removed in vacuo to afford triazoline 381 (6.3 mg, 100%) as a 
white solid.   
Rf  0.29 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.14 – 6.98 (m, 5H, 
C6H5), 5.60 (ddd, J = 22.7, 10.7, 5.5 Hz, 1H, CH2CH=CH2), 5.38 (d, J = 4.4 Hz, 1H, 
CHCHCH(N)CO2), 5.10 (dd, J = 17.2, 1.5 Hz, 1H, CH2CH=CH2), 4.91 (dd, J = 10.5, 
1.3 Hz, 1H, CH2CH=CH2), 4.65 (s, 1H, NH), 4.43 (d, J = 8.6 Hz, 1H, CHCl), 4.39 – 4.33 
(m, 1H, CH2CH=CH2), 4.33 – 4.27 (m, 1H, CH2CH=CH2), 4.17 (s, 2H, PhCH2O), 3.99 
(dd, J = 10.9, 4.5 Hz, 1H, CHCHCH(N)C)2), 3.75 (d, J = 9.3 Hz, 1H, CCH2O), 3.59 (dd, 
J = 9.5, 7.0 Hz, 1H, CHCH2N), 3.27 – 3.16 (m, 5H, CCH2O, CHCH2N, CH3), 2.44 (dd, J 
= 15.5, 3.1 Hz, 1H, CHCH2CO2), 2.06 – 1.97 (m, 1H, CHCH2N), 1.96 – 1.88 (m, 1H, 
CHCH2CO2), 1.83 (dd, J = 15.5, 10.2 Hz, 1H, CHCH2CO2), 1.40 (s, 9H, (CH3)3 ), 1.15 
(dd, J = 13.0, 11.0 Hz, 1H, CHCHCH(N)CO2);  IR (neat film)  3410 (w), 3030 (w), 2924 
(m), 2852 (w), 1737 (s), 1720 (s), 1368 (m), 1264 (s), 1165 (m), 750 (m) cm-1;  LRMS 
(ESI) m/z for C28H37O7N4Cl, (M-H)- 575.13, (M+H)+ 577.49, (M+Na)+ 599.19. 
 
 
 
Triazoline 407, (MSB-VIII-200).  A solution of azide 376 (0.5 mg, 0.00078 mmol) in 
toluene (0.50 mL) was heated up to 75 °C.  After stirring for 22 hr the solution was 
cooled and solvent removed in vacuo to afford triazoline 407 as a white solid in > 95% 
purity as determined by 1H NMR.  
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Rf  0.18 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.30 – 7.02 (m, 10H, 
C6H5, C6H5), 5.30 (d, J = 4.3 Hz, 1H, CHCHCH(N)CO2), 5.09 – 5.02 (m, 3H, 
C6H6CH2O2C, NH), 4.56 (s, 1H, NH), 4.42 (d, J = 8.7 Hz, 1H, CHCl), 4.16 (s, 2H, 
PhCH2O), 3.88 – 3.78 (m, 2H, CCH2O, CHCHCH(N)CO2), 3.63 – 3.55 (m, J = 7.2 Hz, 
1H, CHCH2NH), 3.24 (d, J = 9.3 Hz, 1H, CCH2O), 3.19 (s, 3H, CH3), 3.07 – 2.97 (m, 
1H, CHCH2N), 2.88 (t, J = 10.2 Hz, 1H, CHCH2NH), 2.82 – 2.74 (m, 1H, CHCH2N), 
2.09 – 1.96 (m, 1H, CHCH2N), 1.56 – 1.45 (m, 1H, CHCH2NH), 1.39 (s, 9H, (CH3)3), 
1.10 (dd, 1H, 13.3, 10.6 Hz, 1H, CHCHCH(N)CO2);  IR (neat film)  3344 (br), 2975 (w), 
2927 (m), 2854 (w), 1716 (s), 1709 (s), 1519 (m), 1366 (m), 1247 (s), 1164 (m), 1095 
(m), 738 (m) cm-1;  LRMS (ESI) m/z for C32H40O7N5Cl, (M-H)- 640.20, (M+Cl)- 676.31, 
(M+H)+ 642.38, (M+Na)+ 664.43. 
 
 
 
Triazoline 408 and pyrrole amide 395, (MSB-IX-088).  A solution of azide 375 
(1.0 mg, 0.0015 mmol) in toluene (0.2 mL) was heated up to 75 °C.  After stirring for 
23 hr the solution was cooled and solvent removed in vacuo to afford triazoline 408 as a 
white solid in a 4:1 mixture with azide 375 as determined by 1H NMR.  This mixture was 
used as is for the next synthetic step.  Alternatively heating azide 375 in acetonitrile at 
60 °C for 41 hr cleanly affords triazoline 408.   
Triazoline 408.  Rf  0.29 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.30 
– 7.24 (m, 5H, C6D5), 5.59 (ddt, J = 17.1, 10.5, 4.9 Hz, 1H, CH2CH=CH2), 5.36 (d, J = 
4.3 Hz, 1H, CHCHCH(N)CO2), 5.13 – 4.98 (m, 4H, CH2CH=CH2, C6H6CH2O2C, NH), 
4.91 (d, J = 10.3 Hz, 1H, CH2CH=CH2), 4.57 (s, 1H, NH), 4.41 (d, J = 8.4 Hz, 1H, 
CHCl), 4.38 – 4.26 (m, 2H, CH2CH=CH2), 4.18 (s, 2H, PhCH2O), 3.86 – 3.80 (m, J = 9.5 
Hz, 2H, CCH2O, CHCHCH(N)CO2), 3.60 – 3.56 (m, 1H, CHCH2NH), 3.24 (d, J = 9.3 
Hz, 1H, CCH2O), 3.04 – 2.97 (m, 1H, CHCH2N), 2.88 (t, J = 9.8 Hz, 1H, CHCH2NH), 
2.80 – 2.76 (m, 1H, CHCH2N), 2.04 – 2.00 (m, 1H, CHCH2N), 1.44 – 1.31 (m, 9H, 
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(CH3)3), 1.10 (dd, 13.2, 10.7 Hz, 1H, CHCHCH(N)CO2;  IR (neat film)  3354 (br), 2975 
(w), 2925 (m), 2850 (w), 1733 (s), 1716 (s), 1558 (m), 1533 (m), 1507 (m), 1489 (m), 
1366 (m), 1249 (m), 1163 (m), 1095 (m), 737 (m) cm-1;  LRMS (ESI) m/z for 
C34H42O7N5Cl, (M-H)- 915.3, (M+Na)+ 939.3.   
Pyrrole amide 395, (MSB-IX-100).  To the previous solution of 408 was added 
dichloromethane (0.3 ml) at 23 °C followed by 1,8-diazabicyclo[5.4.0]undec-7-ene 
(0.5 µL 0.0033 mmol, 2 equiv).  After 15 min, the vessel was capped and heated up to 
50 °C.  After stirring for 1 hr the solution was cooled to 0 °C, at which point 2,6-lutidine 
(3.4 µL, 0.03 mmol, 20 equiv), pyrrole acid 315 (1.6 mg, 0.006 mmol, 4 equiv), 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.4 mg, 0.0075 mmol, 5 equiv), 
and a solution of 4-dimethylaminopyridine (2 mg DMAP/0.5 mL CH2Cl2, 0.5 µL, 
0.0001 mmol, 0.1 equiv) was added.  After 20 min the solution was warmed to room 
temperature, and then stirred for an additional 3 ½ hr.  The solution was then diluted with 
saturated sodium bicarbonate (10 mL), extracted with dichloromethane (3 x 10 mL), 
dried (sodium sulfate), concentrated in vacuo. The residue was purified by silica gel flash 
chromatography (4:1 hexanes: ethyl acetate) to afford pyrrole amide 395 (0.35 mg, 26%), 
as a clear oil in addition to azide 375 (0.4 mg, 40%) and triazoline 408 (0.1 mg, 10%).   
Rf  0.34 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.30 – 7.24 (m, 5H, 
C6D5), 6.74 (s, 1H, BrC=CH), 6.41 – 6.33 (br s, 1H, C=CBrNH), 5.65 – 5.50 (m, 1H), 
5.17 – 4.92 (m, 6H), 4.92 – 4.81 (m, 2H), 4.65 – 4.56 (m, 1H), 4.55 – 4.50 (m, 1H), 4.50 
– 4.38 (m, 3H), 4.37 – 4.25 (m, 5H), 4.20 – 4.15 (m, 1H), 4.15 – 4.09 (m, 1H), 4.06 – 
3.97 (m, 1H), 3.87 – 3.75 (m, 1H), 3.65 – 3.55 (m, 1H), 3.07 – 2.97 (m, 2H), 2.97 – 2.87 
(m, 2H), 1.91 – 1.75 (m, 1H), 1.44 (s, 9H, C(CH3)3);  LRMS (ESI) m/z for 
C39H43O8N6ClBr2, (M-H)- 915.11, (M+Cl)- 951.25, (M+Na)+ 939.39. 
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Pyrrole amide 391, (MSB-VIII-134).  To a solution of triazoline 381 (3.0 mg, 
0.005 mmol, 1.0 equiv) in dichloromethane (1.0 mL) was added a solution of 
1,8-diazabicyclo[5.4.0]undec-7-ene (1 µL DBU/ 0.5 mL CH2Cl2, 49 µL, 0.0026 mmol, 
0.5 equiv).  After stirring for 2 hr an additional portion of the DBU solution was added 
(10 µL, 0.0005 mmol, 0.1 equiv).  After stirring for 20 min, the solution was cooled to 
0 °C, at which point pyridine (21 µL, 0.260 mmol, 50 equiv), pyrrole acid 311 (8.3 mg, 
0.021 mmol, 4 equiv), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(5.0 mg, 0.026 mol, 5.0 equiv), and a solution of 4-dimethylaminopyridine (1.3 mg 
DMAP/ 0.5 mL CH2Cl2, 25 µL, 0.0005 mmol, 0.1 equiv) was added.  After 30 min the 
solution was warmed to room temperature, and then stirred for an additional 90 min.  The 
solution was then diluted with saturated sodium bicarbonate (10 mL), extracted with 
dichloromethane (2 x 10 mL), dried (sodium sulfate), concentrated in vacuo. The residue 
was purified by silica gel flash chromatography twice (4:1 gradient to 2:1 hexanes: ethyl 
acetate) to afford pyrrole amide 391 (2.6 mg, 50%) as a yellow oil.   
Rf  0.62 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.30 – 7.22 (m, 3H, 
C6H5), 7.10 – 7.03 (m, 2H, C6H5), 6.61 (s, 1H, BrC=CH), 6.17 (d, J = 10.6 Hz, 1H, 
NCH2O), 5.66 – 5.56 (m, 1H, CH2CH=CH2), 5.19 (d, J = 10.4 Hz, 1H, NCH2O), 5.12 – 
5.00 (m, 2H, CH2CH=CH2), 4.94 – 4.85 (br d, J = 10.3 Hz, 1H, CH2CH=CH2), 4.77 (d, J 
= 10.9 Hz, 1H, CHCH(N)(CN2)), 4.56 – 4.40 (m, 2H, CHCl), 4.39 – 4.24 (m, 3H), 3.77 
(m, 2H), 3.75 – 3.67 (m, 1H), 3.57 – 3.47 (m, 2H, OCH2CH2Si(CH3)3), 3.37 (s, 1H), 3.18 
(s, 3H, CH3), 2.46 (dd, J = 12.5, 4.1  Hz, 1H, O2CCH2CH), 2.21 – 2.08 (m, 1H, 
O2CCH2CH), 2.02 – 1.97 (m, 1H), 1.92 (dd, J = 15.9, 9.6 Hz, 1H, O2CCH2CH), 1.42 (s, 
9H, C(CH3)3), 0.82 (t, J = 7.6 Hz, 2H, OCH2CH2Si(CH3)3), -0.05 (s, 9H, 
OCH2CH2Si(CH3)3);  IR (neat film) 3359 (w), 2952 (m), 2917 (m), 2849 (w), 2107 (s), 
1716 (s), 1686 (s), 1624 (m), 1436 (s), 1391 (m), 1248 (s), 1163 (s), 1094 (s), 836 (m) 
cm-1;  LRMS (ESI) m/z for C39H52O9N5ClBr2Si, (M+Na)+ 978.09, (M+Cl)- 989.81.  
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Pyrrole amide 391, (MSB-VIII-149).  In a sealed tube, to a solution of azide 373 
(0.5 mg, 0.001 mmol, 1.0 equiv) in toluene (0.2 mL) was added 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.15 µL 0.001 mmol, 1.0 equiv).  The vessel was then 
capped and heated up to 75 °C.  After stirring for 44 hr the solution diluted with 
dichloromethane (0.2 mL) and cooled to 0 °C, at which point pyridine (1.5 µL, 
0.019 mmol, 20 equiv), pyrrole acid 311 (1.6 mg, 0.004 mmol, 4 equiv), 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (0.4 mg, 0.002 mmol, 2 equiv), and a 
solution of 4-dimethylaminopyridine (2 mg 4-dimethylaminopyridine/0.5 mL 
dichloromethane, 0.5 µL, 0.0001 mmol, 0.1 equiv) was added.  After 20 min the solution 
was warmed to room temperature, and then stirred for an additional 3 hr.  The solution 
was then diluted with saturated sodium bicarbonate (10 mL), extracted with 
dichloromethane (3 x 10 mL), dried (sodium sulfate), concentrated in vacuo. The residue 
was purified by silica gel flash chromatography (4:1 gradient to 2:1 hexanes: ethyl 
acetate) to afford pyrrole amide 391 (0.56 mg, 61%) as a clear oil.  All spectra matched 
that previously reported. 
 
 
 
Pyrrole amide 392, (MSB-VIII-212).  In a sealed tube, to a solution of azide 376 
(0.65 mg, 0.001 mmol, 1.0 equiv) in toluene (0.2 mL) and dichloromethane (0.2 ml) was 
added 1,8-diazabicyclo[5.4.0]undec-7-ene (0.15 µL 0.001 mmol, 1.0 equiv).  The vessel 
was then capped and heated up to 75 °C.  After stirring for 44 hr the solution was cooled 
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to 0 °C, at which point pyridine (3.27 µL, 0.04 mmol, 50 equiv), pyrrole acid 311 
(1.6 mg, 0.004 mmol, 4 equiv), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (0.4 mg, 0.002 mmol, 2 equiv), and a solution of 4-dimethylaminopyridine 
(2 mg 4-dimethylaminopyridine/0.5 mL dichloromethane, 0.5 µL, 0.0001 mmol, 
0.1 equiv) was added.  After 20 min the solution was warmed to room temperature, and 
then stirred for an additional 2 hr.  The solution was then diluted with saturated sodium 
bicarbonate (10 mL), extracted with dichloromethane (3 x 10 mL), dried (sodium 
sulfate), concentrated in vacuo. The residue was purified by silica gel flash 
chromatography (4:1 gradient to 2:1 hexanes: ethyl acetate) to afford pyrrole amide 392 
(0.6 mg, 60%) as a clear oil.   
Rf  0.44 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.29 – 7.21 (m, 6H, 
C6D5), 7.11 – 7.03 (m, 4H, C6D5), 6.60 (s, 1H, BrC=CH), 6.13 (d, J = 9.8 Hz, 1H, 
NCH2O), 5.23 (d, J = 10.3 Hz, 1H, NCH2O), 5.05 (d, J = 12.2 Hz, 1H, C6H6CH2O2C), 
4.99 (d, J = 11.4 Hz, 1H, C6H6CH2O2C), 4.92 – 4.86 (br s, 1H, NH), 4.66 (d, J = 10.9 Hz, 
1H, CHCH(N)(CN2)), 4.47 – 4.36 (m, 1H, CHCl), 4.27 (s, 3H, CH3), 4.09 (t, J = 5.8 Hz, 
1H, CHCH2N), 3.98 – 3.87 (m, 1H, PhCH2O), 3.85 – 3.72 (m, 1H, PhCH2O), 3.72 – 3.62 
(m, 1H, CHCH2N), 3.60 – 3.50 (m, 2H, OCH2CH2Si(CH3)3), 3.27 (br s, 2H, CCH2O), 
2.93 (m, 3H, NCH2CHCHCH2NH), 1.99 – 1.86 (m, 1H, CHClCH), 1.85 – 1.74 (m, 1H), 
1.73 – 1.63 (m, 1H), 1.62 – 1.53 (m, 1H), 1.52 – 1.43 (m, 1H), 1.41 (s, 9H, C(CH3)3), 
1.26 – 1.19 (m, 1H), 1.15 – 1.07 (m, 1H), 1.07 – 0.98 (m, 1H), 0.89 – 0.80 (m, 2H, 
OCH2CH2Si(CH3)3), -0.07 (s, 9H, OCH2CH2Si(CH3)3);  IR (neat film) 3341 (br), 2953 
(w), 2920 (m), 2850 (w), 2110 (s), 1712 (s), 1695 (s), 1626 (w), 1527 (w), 1436 (m), 
1366 (m), 1248 (s), 1162 (m), 1095 (s), 837 (m) cm-1;  LRMS (ESI) m/z for 
C43H55O9N6ClBr2Si, (M-H)- 1019.12, (M+Cl)- 1055.16, (M+Na)+ 1043.15. 
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Pyrrole amide 392, (MSB-VIII-267).  In a sealed tube, to a solution of azide 376 
(3.1 mg, 0.0048 mmol, 1.0 equiv) in toluene (0.2 mL) and dichloromethane (0.2 ml) was 
added 1,8-diazabicyclo[5.4.0]undec-7-ene (0.7 µL 0.0048 mmol, 1.0 equiv).  The vessel 
was then capped and heated up to 75 °C.  After stirring for 23 hr the solution was cooled 
and reduced to 1/3 volume and then diluted with dichloromethane (0.3 mL), at which 
point 2,6-lutidine (11.25 µL, 0.10 mmol, 20 equiv), pyrrole acid 311 (3.85 mg, 
0.01 mmol, 2 equiv), and (2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate (HATU) (3.7 mg, 0.01 mmol, 2 equiv) was added.  After 5 ½ hr the 
solution was diluted with saturated sodium bicarbonate (10 mL), extracted with 
dichloromethane (3 x 10 mL), dried (sodium sulfate), concentrated in vacuo. The residue 
was purified twice by silica gel flash chromatography (4:1 gradient to 1:1 hexanes: ethyl 
acetate) and then (8:1 gradient to 4:1 benzene: ethyl acetate) to afford pyrrole amide 392 
(4.0 mg, 25% impure by mass with HATU byproduct, 75%) as a clear oil.  All spectra 
matched that previously reported.   
 
 
 
Pyrrole amide 394, (MSB-VIII-201).  In a sealed tube, to a solution of azide 407 
(1.3 mg, 0.002 mmol, 1.0 equiv) in toluene (0.2 mL) and dichloromethane (0.2 mL) was 
added 1,8-diazabicyclo[5.4.0]undec-7-ene (0.31 µL 0.002 mmol, 1.0 equiv).  The vessel 
was then capped and heated up to 75 °C.  After stirring for 42 hr, the solvent was reduced 
to ½ volume, at which point it was diluted with dichloromethane (0.2 mL), cooled to 0 °C 
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and pyridine (3.25 µL, 0.04 mmol, 20 equiv), pyrrole acid 393 (2.7 mg, 0.008 mmol, 
4 equiv), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.2 mg, 
0.006 mmol, 3 equiv), and a solution of 4-dimethylaminopyridine (2 mg 4-
dimethylaminopyridine/0.5 mL dichloromethane, 0.5 µL, 0.0001 mmol, 0.05 equiv) was 
added.  After 20 min the solution was warmed to room temperature, and then stirred for 
an additional 3 hr.  The solution was then diluted with saturated sodium bicarbonate 
(10 mL), extracted with dichloromethane (3 x 10 mL), dried (sodium sulfate), 
concentrated in vacuo. The residue was purified by silica gel flash chromatography (4:1 
hexanes: ethyl acetate) to afford pyrrole amide 394 (0.4 mg, 21%) as a clear oil.   
Rf  0.30 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) (the spectra was 
exceptionally broad and difficult to interpret) δ 7.28 – 7.19 (m, 10H, C6D6, C6D6), 6.34 (s, 
1H, BrC=CH), 6.11 (d, 1H, J = 16.5 Hz), 5.18 – 5.11 (m, 1H), 5.11 – 4.95 (m, 4H), 4.93 
– 4.87 (m, 1H), 4.70 (d, J = 11.3 Hz, 1H), 4.47 – 4.42 (m, 1H), 4.33 – 4.23 (m, 3H), 4.21 
– 4.13 (m, 3H), 4.10 (d, J = 12.3 Hz, 1H), 4.01 – 3.91 (m, 2H), 3.80 – 3.73 (m, 1H), 3.64 
– 3.49 (m, 3H), 3.40 (s, 1H), 3.33 – 3.26 (m, 2H), 3.23 – 3.15 (m, 2H), 3.03 – 2.97 (m, 
1H), 2.97 – 2.89 (m, 2H), 2.89 – 2.85 (m, 1H), 2.64 – 2.58 (m, 1H), 2.30 – 2.14 (m, 3H), 
1.81 – 1.73 (m, 1H), 1.73 – 1.65 (m, 2H), 1.42 (s, 9H, C(CH3)3), -0.14 (s, 9H, 
OCH2CH2Si(CH3)3);  IR (neat film) 3342 (br), 2951 (w), 2917 (m), 2856 (w), 2108 (s), 
1734 (s), 1697 (s), 1623 (w), 1528 (w), 1439 (m), 1364 (m), 1252 (s), 1161 (m), 1097 (s) 
cm-1;  LRMS (ESI) m/z for C43H544O10N6ClBrSi, (M-H)- 955.04, (M+Cl)- 994.09, 
(M+Na)+ 979.23. 
 
 
 
Keto ester 401, (MSB-IX-040).  To a solution of sodium carbonate (0.62 mg, 
0.0073 mmol, 10 equiv) in acetone (0.2 mL) and water (0.2 ml) at 0 °C was added oxone 
(2.2 mg, 0.0037 mmol, 5 equiv).  After 2 min diazo ester 392 (0.75 mg, 0.00073 mmol, 
1.0 equiv) was added in a solution of dichloromethane (0.2 mL) and stirred vigorously.  
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After 15 min the solution was warmed to room temperature.  After 3 hr the solution was 
diluted with water (10 mL), extracted with dichloromethane (3 x 10 mL), dried (sodium 
sulfate), concentrated in vacuo and found to be a mixture of 392 and 401.  The residue 
was subjected to the same procedure as before to achieve 90% conversion and used 
without purification in the next step.   
Rf  0.61 (2:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.30 – 7.19 (m, 8H, 
C6D5), 7.05 (t, J = 7.3 Hz, 2H, C6D5), 6.61 (s, 1H, BrC=CH), 6.03 (d, J = 9.9 Hz, 1H, 
NCH2O), 5.53 (s, 1H, NH), 5.27 (d, J=10.4, 1H, NCH2O) 5.23 (d, J = 11.0 Hz, 1H), 5.05 
(d, J = 12.4 Hz, 1H, C6H6CH2O2C), 4.99 (d, J = 12.0 Hz, 1H, C6H6CH2O2C), 4.73 (d, J = 
8.7 Hz, 1H, CHCl), 4.22 – 4.14 (m, 1H), 4.03 – 3.95 (m, 2H), 3.74 – 3.68 (m, 1H), 3.53 
(m, 2H), 3.32 (d, J = 9.2 Hz, 1H, CCH2O), 3.24 (s, 3H, CH3), 3.00 – 2.89 (m, 1H), 2.83 – 
2.75 (m, 2H), 2.14 (m, 2H), 1.93 – 1.81 (m, 1H), 1.64 – 1.56 (m, 1H), 1.46 (s, 9H, 
C(CH3)3), 0.85 (t, J = 6.9 Hz, 2H, OCH2CH2Si(CH3)3), -0.05 (s, 9H, OCH2CH2Si(CH3)3);  
IR (neat film) 2955 (w), 2918 (m), 2850 (w), 1718 (s), 1507 (w), 1436 (m), 1264 (s), 
1163 (m), 1093 (m), 740 (s) cm-1;  LRMS (ESI) m/z for C43H55O10N4ClBr2Si, (M-H)- 
1007.39, (M+Cl)- 1042.92, (M+Na)+ 1031.44. 
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Diol 402, (MSB-IX-041).  To a solution of keto ester 401 (0.74 mg, 0.001 mmol, 
1.0 equiv) in isopropyl alcohol (0.5 mL) was added sodium borohydride (1 mg, 
0.026 mmol, 20 equiv).  After stirring for 19 hr the solution was diluted with 
hydrochloric acid (0.1 M, 10 mL), extracted with dichloromethane (3 x 10 mL), dried 
(sodium sulfate), and concentrated in vacuo. The residue was purified by silica gel flash 
chromatography (1:1 hexanes: ethyl acetate) to afford diol 402 (0.45 mg, 60%) as a clear 
oil.   
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Rf  0.45 (1:1 hexanes: ethyl acetate);  1H NMR (500 MHz, C6D6) δ 7.29 – 7.18 (m, 10H, 
C6D5, C6D5), 6.45 (s, 1H, CHCBr), 5.92 (d, J = 10.5 Hz, 1H, NCH2O), 5.31 (br s, 1H), 
5.20 – 5.11 (m, 1H, NCH2O), 5.05 (d, J = 12.2 Hz, 1H, C6H6CH2O2C), 4.92 (m, 2H, 
C6H6CH2O2C), 4.74 (d, J = 7.7 Hz, 1H, CHCl), 4.48 (d, J = 12.0 Hz, 1H), 4.41 – 4.34 (m, 
2H), 4.34 – 4.16 (m, 4H), 4.12 – 3.99 (m, 2H), 3.80 – 3.63 (m, 2H), 3.61 – 3.48 (m, 2H), 
3.42 – 3.37 (m, 2H), 3.37 – 3.29 (m, 1H), 3.01 – 2.83 (m, 1H), 2.72 – 2.56 (m, 2H), 2.46 
– 2.39 (m, 1H), 2.08 – 1.99 (m, 1H), 1.47 (s, 9H, C(CH3)3), 0.82 (m, 2H, 
OCH2CH2Si(CH3)3), -0.01 (s, 9H, OCH2CH2Si(CH3)3);  LRMS (ESI) m/z for 
C42H57O9N4ClBr2Si, (M-H)- 981.23, (M+Cl)- 1017.20, (M+Na)+ 1005.49. 
 
 
 
2-(Trimethylsilyl)ethyl 4-bromo-2-formyl-pyrrole-1-carboxylate (410), (MSB-VIII-
138).  To a solution of a 20:1 mixture of 4,5-dibromo-1H-pyrrole-2-carbaldehyde and 
4-bromo-1H-pyrrole-2-carbaldehyde (409) (4.46 g, 17.6 mmol, 1.0 equiv) in 
tetrahydrofuran (35 mL) at 0 °C was added sodium hydride (60% in mineral oil, 1.41 g, 
36 mmol, 2 equiv).  After stirring for 1 hr nitrophenyl 2-(trimethylsilyl)ethyl carbonate 
(5.0 g, 17.6 mmol, 1 equiv) was added, at which point the solution turned dark green.  
After stirring for 12 hr tetrahydrofuran (20 mL) was added to the resulting orange 
suspension.  The solution was then diluted with ethyl acetate (100 mL), filtered to remove 
precipitate, and washed with brine (100 mL), water (2 x 100 mL), saturated ammonium 
chloride (2 x 100 mL), dried (magnesium sulfate), and concentrated in vacuo.  The 
resulting purple residue was purified by ISCO silica gel flash chromatography (80 g 
column, 50:50 gradient to 30:70 hexanes: dichloromethane) to afford pyrrole 410 
(116 mg, 2.5%) as a brown oil.  (note: poorly nucleophilic dibrominated-2-acyl-pyrroles 
are difficult to protect with N-carbamate protecting groups)6 
Rf  0.19 (1:1 hexanes: dichloromethane);  1H NMR (500 MHz, CDCl3) δ 10.31 (s, 1H, 
CHO), 7.46 (d, J = 1.6 Hz, 1H, CH=CBr), 7.14 (d, J = 1.6 Hz, 1H, CH=CBr), 4.56 – 4.47 
(m, 2H, OCH2CH2(SiCH3)3), 1.23 – 1.14 (m, 2H, OCH2CH2(SiCH3)3), 0.10 (s, 9H, 
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OCH2CH2(SiCH3)3);  13C NMR (126 MHz, CDCl3) δ 181.41, 149.11, 134.87, 125.80, 
122.54, 101.80, 68.03, 17.77, -1.48;  IR (neat film) 3152 (m), 2955 (m), 2856 (m), 1762 
(s), 1675 (s), 1449 (s), 1330 (s), 1297 (s), 1246 (s), 1111 (s),1071 (s), 917 (s), 837 (s), 
764 (s) cm-1;  LRMS (ESI) m/z for C11H16O3N1BrSi, (M+Na)+ 339.87. 
 
 
 
4-Bromo-1-((2-(trimethylsilyl)ethoxy)carbonyl)-pyrrole-2-carboxylic acid (393), 
(MSB-VIII-138).  To a solution of 2-(trimethylsilyl)ethyl 4-bromo-2-formyl-pyrrole-1-
carboxylate (410) (116 mg, 0.365 mmol, 1.0 equiv) in tert-butanol (1.5 mL) and water 
(0.5 mL) was added potassium phosphate (496 mg, 3.65 mmol, 10 equiv), 
trans-2-methyl-butene (0.2 mL, 1.6 mmol, 5 equiv), and sodium chlorite (330 mg, 
3.65 mmol, 10 equiv).  After stirring for 12 hr the solution was diluted with saturated 
sodium chloride (50 mL), extracted with ethyl acetate (3 x 30 mL), dried (magnesium 
sulfate), and concentrated in vacuo.  The residue was purified by silica gel flash 
chromatography (2:1 hexanes: ethyl acetate w/ 0.5% acetic acid) to afford pyrrole 393 
(91 mg, 75%) as an orange solid.   
Rf  0.32 chromatography (2:1 hexanes: ethyl acetate w/ 0.5% acetic acid);  1H NMR (500 
MHz, CDCl3) δ 11.89 (br s, 1H, CO2H), 7.43 (d, J = 1.8 Hz, 1H, CH=CBr), 7.21 (d, J = 
1.8 Hz, 1H, CH=CBr), 4.58 – 4.47 (m, 2H, OCH2CH2(SiCH3)3), 1.25 – 1.13 (m, 2H, 
OCH2CH2(SiCH3)3), 0.08 (s, 9H, OCH2CH2(SiCH3)3);  13C NMR (126 MHz, CDCl3) δ 
160.73, 150.95, 127.60, 126.61, 126.31, 100.80, 69.13, 17.55, -1.51;  IR (neat film) 3138 
(m), 3048 (br), 2956 (m), 2901 (m), 1763 (s), 1701 (s), 1459 (m), 1420 (m), 1297 (s), 
1246 (s), 1066 (s), 921 (m), 837 (s), 770 (m) cm-1;  LRMS (ESI) m/z for C11H16O4NBrSi, 
(M-H)- 331.85, (M+Na)+ 355.85. 
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CHAPTER 6.  FUTURE DIRECTIONS 
 
6.1 Strategies for the Completion of the Total Synthesis of the Revised Structure of 
Palau’amine 
With the successful synthesis of the trans-fused azabicyclo[3.3.0]octane core (402, 
Scheme 6.1) of the revised structure of palau’amine (1b) complete, in addition to the 
development of a novel strategy to introduce the phakellin ring system proven in the 
model study towards dimethylcyclopentaphakellin (245, Scheme 4.44), the foundation for 
the total synthesis of the 1b has been laid.  The next step is to access the fully 
functionalized tetracyclic pyrazinone 403, which should be possible via one of three 
methods delineated in Chapter 5 (Scheme 5.6) developed to access similar pyrazinones in 
Chapter 4.   
 
Scheme 6.1 
 
 
Once pyrazinone 403 has been accessed, two important challenges remain to access 
the revised structure of palau’amine (1b, Scheme 6.1): namely, formation of the spiro 
guanidine (Ring F) and the diastereoselective introduction of the cis-fused guanidine 
(Ring C) on the α-face of the structure.  Three methods are proposed for the 
bisfunctionalization of the C10,C6 alkene of pyrazinone 403 (Scheme 6.2A) en route to 
the Ring C cis-fused guanidine. Application of the method that successfully accessed the 
C ring guanidine of dimethylcyclopentaphakellin (245, Scheme 4.44) would involve the 
electrophilic activation of the C10,C6 alkene of pyrazinone 403 followed by trapping 
with an azide nucleophile to give rise to trans-βC6-bromo-αC10-azide 414.  The 
diastereoselectivity for this process is governed by the facial approach of the bromine 
electrophile to the pyrazinone C10,C6 alkene.  During the model system, the facial 
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selectivity of this reaction gave predominately the undesired α-bromo-β-azido 
stereoconfiguration, as a consequence of unfavorable steric interactions with the axial 
βC11 proton.  In the case of fully functionalized pyrazinone 403, possessing two 
additional bulky substituents on the α-face at the C16 and C18, approach of the bromine 
electrophile to the β-face will likely be favored leading to N-acyl iminium 413.  Trapping 
with the external nucleophile, tetrabutyl ammonium azide, anti to the βC6-bromo 
substituent would then lead to desired αC10-azide 414.  However, based on molecular 
models, upon formation of the N-acyl iminium 413 of a highly functionalized substrate 
like 403, possessing the four additional cyclopentane substituents relative to the model 
system, intramolecular addition of the C16-carbamate O-functionality would likely occur 
to generate 415 in preference to trapping with an external nucleophile.  Nevertheless, 
strategies could be envisioned that would take advantage of the newly formed αC10 C-O 
bond of cyclic carbamate 415 to the revised structure of palau’amine (1b). In addition to 
the two possible methods outlined in Scheme 6.2A for bisfunctionalization of the C10,C6 
alkene, an alternative cyclization is proposed that would more directly lead to the natural  
 
Scheme 6.2 
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product.  It is envisioned that preparation of hydrazino guanidine 416 (Scheme 6.2B) 
followed by subjection to an electrophilic bromine source would lead directly to the 
desired αC10 C-N bond of 417, in which the α-facial selectivity would be enforced by 
the placement of the hydrazine on the a-face of the scaffold.  Displacement of the 
βC6-bromo substituent of 417 via a 5-exo-tet cyclization of the pendent guanidinyl 
nitrogen would then furnish the desired α-cis-fused guanidine (Ring C) of 418 in a 
concise fashion. 
  Access to hydrazinoguanidine 416 (Scheme 6.2B) would require a method to 
generate the N-N hydrazine bond from the corresponding C16-amino derivative 423 
(Scheme 6.4).  Vederas and co-workers1 demonstrated in 1993 that N-carbamate 
oxaziridines (Scheme 6.3) can be used to introduce a hydrazino N-N bond onto amines 
under mild reaction conditions.  In contrast to the better known N-arylsulfonyl 
oxaziridines, in which the oxygen atom is donated to a nucleophile,2 N-alkylcarbamoyl 
oxaziridine 419 transfers the nitrogen atom to amine 420 along with its N-carbamate 
group to afford hydrazine 421. 
 
Scheme 6.3 
 
 
Application of this hydrazine approach would also allow for a concise method to 
introduce both guanidine functionalities of palau’amine.  Two different strategies are 
proposed that differ in the timing for the introduction of the F-ring guanidine.  The first 
strategy (Scheme 6.4) would involve the use of allyloxycarbonyl (alloc) protected 
oxaziridine 422 and introduce the guanidine functionalities of both the C and F rings 
simultaneously prior to cyclization.  Transfer of the N-functionality of oxaziridine 422 to 
primary amine 423 (where R represents the tetracyclic pyrazinone structure of amine 
423) would generate the desired N-N bond of hydrazine 424.  Removal of the alloc group 
would provide hydrazine 425, which upon reaction with two equivalents of 
benzyloxycarbonyl isothiocyanate (356) would afford bisthiourea 426.  Exchange of both 
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S-atoms for N-atoms would then allow for the preparation of bisguanidinyl hydrazine 427 
possessing the guanidinyl moieties for both the C and F ring.   
 
Scheme 6.4 
 
Alternatively, the second strategy to introduce the guanidinyl hydrazine (Scheme 
6.5) would initially incorporate only the C ring guanidinyl functionality prior to 
cyclization.  This strategy would require the preparation of thiourea-derived oxaziridine 
429 from 428 and 356.  Transfer of N-functionality to amine 423 would generate 
hydrazinothiourea 430.  Lastly, exchange of the sulfur atom for a nitrogen atom would 
allow access to monoguanidinyl hydrazine 431. 
 
Scheme 6.5 
 
 
Application of either hydrazine strategy would use pyrazinone 403 (Scheme 6.6) 
and follow similar pathways.  For simplicity, only the first strategy is illustrated in which 
both guanidine functionalities are introduced simultaneously.  Deprotection of  
C16-N-Boc pyrazinone 403, followed by hydrazine formation and alloc removal would 
generate hydrazine 425.  Reaction of 425 with two equivalents of isothiocyanate 356 
followed by exchange of the sulfur atoms for nitrogen atoms would provide bisguanidinyl 
hydrazine 427.  The key bisfunctionalization of the C10,C6 pyrazinone alkene of 427 
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followed by cyclization would generate α-cis-fused guanidine 432 through the formation 
of two new αC-N bonds.  Global deprotection under conditions of hydrogenolysis would 
then remove three Cbz groups, one benzyl ether, two bromopyrrole substituents and 
cleave the hydrazine N-N bond to generate primary alcohol 433.  The remaining task 
would involve chemoselective oxidation of the C20 alcohol to the aldehyde, after which 
cyclization from the C16-guanidinyl nitrogen atom would generate the final F ring, 
completing the total synthesis of the revised structure of palau’amine (1b). 
 
Scheme 6.6 
 
 
  An alternative strategy for incorporation of the C ring guanidine would involve use 
of C6-ester pyrazinone 434 (Scheme 6.7).  434 could be accessed from α-diazo ester 395 
(Table 5.1) via a method developed during the model study (Scheme 4.25).  Removal of 
C6 ester O-allyl group followed by Curtius rearrangement of the corresponding 
carboxylic acid would allow access to urea 435.  According to the procedure of Kishi and 
co-workers3 on a similar system, diastereoselective protonation at C6 on the β-face of 
vinyl urea 435 would generate the corresponding C10 N-acyl iminium which would 
undergo cyclization from the pendent urea nitrogen atom to install the cis-fused α-
configured C ring.  Transformation of urea 436 into the guanidine 437 would then follow 
the method developed by Feldman and co-workers4 for the formation of 
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dibromophakellin (4) (Scheme 1.12).  Access to the revised structure of palau’amine (1b) 
would then involve similar manipulations illustrated in Scheme 6.6 to construct the final 
F ring guanidine and effect global deprotection.   
 
Scheme 6.7 
 
 
6.2 Methods to Develop an Enantioenriched Synthesis of Palau’amine 
 At this time, the absolute configuration of (-)-palau’amine is unknown.  However, 
verification could be accomplished via preparation of either enantiomer of palau’amine.  
It is envisioned that adaptation of the current racemic route to allow access to 
enantioenriched material would be straightforward.  Although palau’amine possesses 
eight stereogenic carbon atoms, access to enantioenriched material early in the synthesis 
would permit installation of the remaining stereocenters via substrate-controlled 
diastereoselectively.  Early in the synthetic sequence, enone 109 (Scheme 6.8) serves as 
the intermediate from which the fully functionalized cyclopentane core of either the 
original (1a) or revised (1b) structures of palau’amine has been accessed (Schemes 2.39, 
3.26, and 3.27).  Zwanenburg and coworkers5 previously reported the enzymatic kinetic 
resolution of this compound via selective hydrolysis with pig liver esterase to generate  
(-)-acid 438 and (+)-ester 109 on multigram scale.  Separation of these two components 
and esterification of (-)-acid 438 would then allow access to enantioenriched material of 
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either enantiomeric form of ester 109, from which either enantiomer of either the original 
or revised structure of palau’amine could be synthesized. 
 
Scheme 6.8 
 
 
6.3 Strategies for the Syntheses of the Other Members of the Pyrrole-Imidazole 
Alkaloids 
The establishment of an efficient route to the trans-fused azabicyclo[3.3.0]octane 
core of the revised structure of palau’amine (1b) should pave the way for the synthesis of 
other related congeners.  These related compounds include the anti-fungal and  
anti-insecticidal styloguanidines (12, 13, 14, and 19), which differ from palau’amine in 
the connectivity of the A ring pyrrole.  Two methods that could potentially be used to 
access the styloguanidine ring system are illustrated in Scheme 6.9 and 6.10.  In the first 
method, acylation of trans-fused vinylogous carbamate 440 with stannane-substituted-
pyrrolo acyl chloride 441 would generate vinylogous imide 442.  An oxidative 
decarboxylation would then introduce the C6-vinyl bromide, based on precedent from 
similar systems from the model study (Scheme 4.22).  An intramolecular Stille coupling 
of pyrrolo stannane 443 would then construct the crucial C3,C6 C-C bond of 444.  
Further manipulations similar to those shown in Scheme 6.6 would introduce the 
remaining guanidine rings to furnish styloguanidine (12). 
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Scheme 6.9 
 
 
  Alternatively, styloguanidine (12) could be accessed from α-diazo ester 445 
(Scheme 6.10) using a rhodium catalyzed C-H insertion and an oxidative N-acyl iminium 
cyclization as the key bond-forming steps.  Acylation of α-diazo ester 445 with an 
appropriately substituted pyrrole acid would generate cyclization precursor 446.  
Formation of the B ring would then be accomplished via selective decomposition of  
α-diazo ester 446 into the corresponding rhodium carbenoid, which after C-H insertion at 
the C3 position would generate the new C3,C6 C-C bond within 447.  Conversion of the 
C6-allyl ester into trichloroethoxysulfonyl-(Tces)-derived guanidine 448 would then be 
possible via a Curtius rearrangement.  Finally, the C ring guanidine would be installed 
according to the procedure of Romo and coworkers6 using iodobenzene diacetate and  
 
Scheme 6.10 
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magnesium oxide to generate the corresponding N-acyl iminium at the C10 position of 
448, followed by cyclization of the pendent guanidine.  Further manipulations as shown 
in Scheme 6.6 would introduce the F ring guanidine within styloguanidine (12). 
  Congeners possessing the same ring system as the revised structure of palau’amine 
(1b) could be accessed in a straightforward manner by derivatization of palau’amine 
itself or an earlier synthetic intermediate (i.e., 449, Scheme 6.11).  Selective bromination 
at the C4 position of 449 would generate monobromopalau’amine (10), and further 
bromination at C5 would allow access to dibromopalau’amine (11).  In addition, selective 
bromination and acylation at C19 would allow access to konbu’acidin A (15) and B (20). 
 
Scheme 6.11 
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APPENDIX A.  ADVANCED SYNTHETIC EFFORTS TOWARDS THE 
REVISED STRUCTURE OF PALAU’AMINE VIA THE BIOMIMETIC 
OXIDATIVE CYCLIZATION STRATEGY 
 
A.1 Biomimetic Oxidative Cyclization Strategy 
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A.2 Synthesis of Cyclization Precursors 
 
Scheme A.2 
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 Scheme A.3 
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Scheme A.5 
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Scheme A.6 
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A.3 Oxidative Cyclization to Access the Pentacyclic Core 
 
Scheme A.7 
 
 
A.3.1 Oxidative Cyclizations Using an Imidazole Sulfide 
 
Scheme A.8 
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Scheme A.9 
 
 
A.4 Future Directions: Oxidative Cyclizations Using an Imidazole Sulfoxide 
  
Scheme A.10 
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A.5 Experimental 
 
 
 
 (JM-V-4, 6, 7  and JM-V-17, 18, 19).  To the lactone (339 mg, 0.739 mmol) in MeOH 
(19 mL) was added NaOH (0.95 mL, aq. 30%) and the solution resulted was stirred at rt 
for 40 min. After addition of CH2Cl2, H2O to this solution KHSO4 solution was added to 
adjust the pH to 2, and this was followed by addition of buffer (3.0 mL, pH 6.0). The aq. 
layer was extracted with 20% MeOH/CH2Cl2 (3X) and the organic layer was combined, 
washed with brine and dried (Na2SO4).  The residue was dissolved in PhH (12mL) and 
MeOH (6 mL) and this was followed by addition of TMSCHN2 (0.55 mL, 1.108 mmol, 
2.0 M in ether). The resulted solution was stirred at rt for 30 min and solvent was 
removed to give the crude hydroxyester.  To the crude hydroxyester in CH2Cl2 was added 
Dess-Martin periodinane  (420 mg, 1.108 mmol, 1.5 eq). After the resulted solution was 
stirred at rt for 30 min it was diluted with EtOAc and washed with Na2CO3 (3X), brine, 
dried (Na2SO4) and concentrated in vacuo. The residue was dissolved in CH2Cl2 and Et3N 
and stirred at rt for 17 h. The solvents was removed in vacuo and then dissolved in 
CH2Cl2 (7.4 mL) and MeOH (7.4 mL). To the above solution was added NaBH4 and 
stirred at rt for 30 min, H2O and Rochelle’s salt was added. After stirring for 20 min the 
solution was extracted with CH2Cl2 (3X), the organic layer was combined, dried and 
concentrated in vacuo and the residue was purified via ISCO combiflash (8 g column, 
90:10 hexane:ethyl acetate gradient to 40:60 hexane: ethyl acetate gradient elution over 
55 column length) to yield the azide as a foam (236 mg, 62%).  Note: In the dydrolysis 
step, work up procedure is very important in order to get good mass recovery. It is 
necessary to adjust the pH to 2 with KHSO4, and extract with CH2Cl2/MeOH, at the same 
time the buffer (pH 6.0) is added to avoid lactonization which has taken place when 2N 
HCl was used for the work up.  
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(JM-IV-111).  Rf = 0.20 (50:50 hexane:ethyl acetate);  1H NMR (500 MHz, CDCl3)   
7.38-7.31 (m, 5H, C6H5), 6.05 (s, 1H, NH), 4.61 (d, 1H, J = 12.0 Hz, PhCH2O), 4.51 (d, 
1H, J = 12.0Hz, PhCH2O), 4.25-4.17 (m, 1H, CH2BrCH), 4.18 (d, 1H, J = 12.0 Hz, 
CHCl), 3.77 (dd, 1H, J = 3.4, 11.8 Hz, CH2Br), 3.68 (s, 3H, OCH3), 3.58 (d, 1H, J = 9.8 
Hz, PhCH2OCH2), 3.52 (dd, 1H, J = 4.2, 12.3 Hz, CH2Br), 3.51 (d, 1H, J = 9.8 Hz, 
PhCH2OCH2), 3.42 (dd, 1H, J = 5.9, 12.4 Hz, CH2N3), 3.34 (dd, 1H, J = 6.2, 12.3 Hz, 
CH2N3), 2.66-2.52 (m, 3H,  CH2CO2, CH2BrCHCH), 2.32-2.25 (m, 1H, CHClCH), 1.92-
1.85 (m, 1H, CHClCHCH); 13C NMR (125 MHz, CDCl3)  172.2, 154.6, 137.4, 128.9, 
128.4, 128.4, 76.9, 73.9, 72.3, 69.4, 64.3, 53.8, 52.2, 44.6, 42.2, 42.0, 33.6, 32.1;  IR 
(neat film) 3242 (w), 3132 (w), 2950 (w), 2103 (s), 1719 (s);  HRMS (ESI) m/z calcd for 
C20H24BrClN4O5Na (M+Na)+ 537.0516, observed 537.0516. 
 
 
 
(JM-V-23).  To a solution of the bromide (236 mg, 0.459 mmol, 1.0 equiv) in THF (9.2 
mL) was added (Boc)2O (297.5 mg, 1.377 mmol, 3.0 eq), DMAP (5.6 mg, 0.0459 mmol, 
0.1 eq), the solution which resulted was heated up to reflux for 4 h, at this point, DBU 
(0.35 mL, 2.295mmol, 5 eq) was added, and the resulted solution was refluxed for 
another 16 h. The  mixture was then diluted with EtOAc and washed with water (3X), 
brine, and then dried (MgSO4), filtered, and concentrated in vacuo. The residue was 
purified via ISCO combiflash (8 g column, 90:10 hexane:ethyl acetate gradient to 40:60 
hexane: ethyl acetate gradient elution over 55 column length) to yield the azide as white 
solid (158 mg, 64%). Rf = 0.50 (40:60 hexane:ethyl acetate);  1H NMR (500 MHz, 
CDCl3)   7.35-7.30 (m, 2H, C6H5), 7.30-7.26 (m, 3H, C6H5), 4.81 (d, 1H, J = 2.0 Hz, 
OCCH2), 4.54 (s, 2H, PhCH2O), 4.40 (d, 1H, J = 5.2 Hz, CHCl), 4.37 (d, 1H, J = 2.0 Hz, 
OCCH2), 4.09 (d, 1H, J = 9.8 Hz, PhCH2OCH2), 3.70 (s, 3H, OCH3), 3.67 (d, 1H, J = 9.9 
Hz, PhCH2OCH2), 3.60 (dd, 1H, J = 3.4, 12.8 Hz, CH2N3), 3.53 (dd, 1H, J = 4.6, 12.7 Hz, 
CH2N3), 3.08 (d, 1H, J = 11.4 Hz, CHCCH2), 2.63-2.58 (m, 1H, CHClCH), 2.61 (s, 2H, 
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CH2CO2),  2.04-2.01 (m, 1H, CHClCHCH), 1.51 (s, 9H, C(CH3)3);  13C NMR (125 MHz, 
CDCl3)  171.8, 152.1, 150.2, 147.9, 138.0, 128.7, 128.0, 127.6, 96.5, 85.7, 73.8, 72.5, 
70.1, 67.1, 52.3, 50.4, 47.9, 47.0, 45.2, 36.9, 28.0;  IR (neat film) 2981 (w), 2920 (w), 
2851 (w), 2102 (s), 1786 (s), 1669 (m);   LRMS (ESI) m/z for C25H31ClN4O7Na (M+Na)+ 
557.3; HRMS (ESI) m/z calcd for C25H31ClN4O7Na (M+Na)+ 557.1779, observed 
557.1800. 
 
 
(JM-V-8).  To the azide (40 mg, 0.0748 mmol) in MeOH (1.0 mL) and CH2Cl2 (2.0 mL) 
was added PMe3 (0.22 mL, 0.224 mmol, 3 eq), the solution resulted was stirred at rt for 
1h and solvent was removed in vacuo. The residue was dissolved in acetone (3 mL) and 
followed by addition NaHCO3 (1mL, aq), H2O (1.0 mL) and freshly prepared acid 
chloride (0.224 mmol, 3 eq) in acetone (1 mL). The biphase mixture was stirred at rt for 
30 min and then diluted with EtOAc, washed with NaHCO3, H2O, brine and dried 
(Na2SO4). The solution was concentrated in vacuo, and purified by silica gel 
chromatography (95:5 hexane:ethyl acetate gradient to 80:20 hexane:ethyl acetate) to 
yield the pyrrole amide X ( 44.5 mg, 67%).  Preparation of the pyrrole acid chloride: To 
the pyrrole acid (89.5 mg, 0.224 mmol, 3 eq) in CH2Cl2 (4 mL) was added (COCl)2 (29.3 
uL, 0.337 mmol, 4.5 eq) and DMF (1.7 uL, 0.0224, 0.3 eq). The solution resulted was 
stirred at rt for 45 min, and solvent was removed in vacuo. The residue was dissolved in 
EtOAc and washed with NaHCO3 (3X), H2O and brine. The organic layer was dried, 
filtered and concentrated in vacuo and used freshly.  (Note: Without washing with 
NaHCO3 the acid chloride might still contain trace amount acid and that could 
decompose the vinyl carbamate ether in the starting material) 
H-NMR (500 MHz; CDCl3): δ  7.30-7.14 (m, 8H), 6.80 (s, 1H), 5.80 (t, J = 13.9 Hz, 
1H), 5.59 (d, J = 10.7 Hz, 1H), 4.88 (d, J = 2.0 Hz, 1H), 4.78 (d, J = 1.9 Hz, 1H), 4.54-
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4.47 (m, 3H), 4.40 (d, J = 6.8 Hz, 1H), 3.93 (d, J = 9.6 Hz, 1H), 3.86 (ddd, J = 14.4, 7.6, 
4.0 Hz, 1H), 3.73-3.68 (m, 5H), 3.59-3.56 (m, 3H), 3.23 (dt, J = 14.5, 4.5 Hz, 1H), 3.12 
(d, J = 11.4 Hz, 1H), 2.86 (dd, J = 16.6, 3.8 Hz, 1H), 2.58-2.49 (m, 3H), 2.01-1.96 (m, 
1H), 1.54-1.48 (m, 12H), 0.97-0.85 (m, 3H), -0.01- -0.05 (m, 11H);  13-C NMR (126 
MHz; CDCl3): δ 173.5, 160.8, 152.3, 149.8, 148.5, 137.7, 128.75, 128.63, 128.0, 127.6, 
116.3, 111.5, 100.4, 98.6, 85.6, 77.6, 75.4, 73.7, 71.9, 69.7, 69.0, 66.6, 52.6, 47.5, 47.1, 
46.3, 38.1, 36.8, 28.0, 18.2, -1.1. 
 
 
 
(JM-V-10).  To the vinyl carbamate ether (44.5 mg, 0.0502 mmol) in CH3CN (1.6 mL) 
and H2O (0.8 mL) was added I2 (14 mg, 0.0552 mmol, 1.1 eq) and CF3CO2Ag (12.2 mg, 
0.0552 mmol, 1.1 eq). The solution resulted was stirred at rt for 10 min and diluted with 
CH2Cl2 and the organic layer was filtered through a pad of celite and Na2SO4. The 
solvent was removed in vacuo to afford the crude iodoketone.  To the crude iodoketone in 
acetone (1.6 mL) was added NaN3 (65.3 mg, 1.004 mmol, 20 eq) in H2O (0.8 mL). The 
biphase mixture was vigorously stirred at rt for 4 h and a aliquot was worked up and the 
complete consumption of iodoketone was confirmed by HNMR. The mixture was poured 
into EtOAc and H2O and aq layer was extracted with EtOAc (2X) after partition. The 
organic layer was washed with H2O, brine, dried (Na2SO4) and concentrated in vacuo to 
give the crude azide. This crude azide was purified via silica gel chromatography (hexane 
gradient to 80:20 hexane:ethyl acetate) to yield the azide (33.7 mg, 74%). Note: The 
crude azide could be used directly to the next step without purification (see JM-V-38, 
39).  1H-NMR (500 MHz; CDCl3): δ  7.39-7.21 (m, 9H), 6.98-6.96 (m, 1H), 6.82 (dt, J = 
20.6, 1.4 Hz, 1H), 5.84-5.70 (m, 3H), 5.60-5.55 (m, 1H), 4.74-4.74 (m, 1H), 4.56-4.43 
(m, 4H), 4.31-4.18 (m, 2H), 4.15-4.03 (m, 2H), 3.79-3.58 (m, 11H), 3.33-3.13 (m, 4H), 
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2.85-2.70 (m, 2H), 2.66-2.45 (m, 5H), 1.46-1.40 (m, 13H), 1.49-1.34 (m, 13H), 0.98-0.88 
(m, 3H), 0.03—0.03 (9H);  13-C NMR (126 MHz; CDCl3): δ 206.2, 173.4, 160.9, 154.9, 
137.3, 128.92, 128.86, 128.84, 128.66, 128.50, 128.36, 128.22, 128.09, 127.6, 116.4, 
111.7, 100.4, 80.8, 75.5, 74.2, 71.85, 71.80, 70.2. 
 
 
 
(JM-V-12).  To the azide (33.7 mg, 0.0372 mmol) in MeOH (0.8 mL) and CH2Cl2 (1.6 
mL) was added PMe3 (0.11 mL, 0.112 mmol, 3.0 eq). The solution resulted was stirred at 
rt for 1 h, and solvent was removed in vacuo. The residue was dissolved in CH2Cl2 
followed by addition of Alloc-NCS (Preparation see JM-IV-227). The solution resulted 
was stirred at rt for 35 min and solvent was removed in vacuo and residue was purified 
via silica gel chromatography (hexane gradient to 85:15 hexane:ethyl acetate) to yield the 
thiourea ( 26.7 mg, 69%). 
 
 
 
(JM-V-41).  To the thiourea (23 mg, 0.0219 mmol) in CH2Cl2 (1.6 mL) was added 
Me3OBF4 and the solution resulted was stirred at rt for 30 min. The solvent was removed 
in vacuo  and the residue was dissolved in EtOAc. The mixture was filtered through a pad 
 302
of celite to afford the crude isothiourea. To the crude isothiourea in CH2Cl2 (1.6 mL) was
added H2O (3 uL) and PdCl2(PPh3)2 and the solution resulted was cooled down to -78 C
and degassed. Bu3SnH (7.0 uL, 0.0263 mmol, 1.2 eq) was added and the solution was 
warmed up to rt. The solution was stirred for 15 min and silica gel (80 mg) was added. 
The solvent was removed in vacuo and the residue was left on bench for 4 d. The res
was extracted with CH2Cl2/EtOAc (1:1) and filtered through celite. The filtrate was 
concentrated in vacuo and purified via silica gel chromatography to yield the imidazole 
(13.2 mg, 75%).  Note: The imidazole was obtained as a 1:1.5 mixture, an
 
 
idue 
d it is 
temporary assigned to be caused by the tautomers of the imidazole ring.  
 
 
 
(JM-V-40).  To the pyrrole (6.1 mg, 0.00655 mmol) in CH2Cl2 (0.5 mL) at 0 ºC was 
added TFA (30 uL, 0.404 mmol, 61 eq) in CH2Cl2 (1.0 mL) and the solution resulte
warmed up to rt after 30 min. The solution was stirred at rt for another 6 h and the 
mixture was diluted with CH2Cl2 and washed with Na2CO3, brine and dried (Na2SO4). 
The solvent was removed in vacuo and the residue was purified via preparative TLC (4% 
MeOH in CH2Cl2) to afford the deprotected pyrrole (1.8 mg, 34%) and recovered st
material (1.6 mg, 26%). No
d was 
arting 
te: The deprotected pyrrole existed in a mixture of free 
idazole and its TFA salt 
.  
im
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ashed with Na2CO3, brine and dried 
a2SO4). The solvent was removed in vacuo and the residue was purified via silica gel 
chromatography to afford the sulfoxide (1.8 mg).  
 
(JM-V-47).  To the sulfide (2.0 mg, 0.0025 mmol) in CH2Cl2 (0.1 mL) at -78 ºC was 
added precooled mCPBA (0.56 mg, 0.0025, 1 eq) in CH2Cl2 (0.1 mL). The solution 
resulted was stirred for 40 min and Me2S (4.6 uL, 0.0625 mmol, 25 eq) was added. After
40 min, the mixture was diluted with CH2Cl2 and w
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(JM-V-56).  To the sulfoxide (0.5 mg, 0.000612 mmol) in CH2Cl2 at -78 ºC was added 
Et3N (0.2 uL, 0.00184 mmol, 3.0 eq) and SOCl2 (0.05 uL, 0.000734 mmol, 1.2 eq). The 
solution resulted was stirred for 5 min and solvent was removed in vacuo. The residue 
as purified by via preparative TLC (5% MeOH in CH2Cl2) to afford JM-V-56-C2 (MS 
99, and 835 (HCl salt)).  
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